SUZANO S.A., 20-F filed on 4/28/2025
Annual and Transition Report (foreign private issuer)
v3.25.1
Document and Entity Information
12 Months Ended
Dec. 31, 2024
shares
Document and Entity Information  
Document Type 20-F
Document Annual Report true
Entity Registrant Name Suzano S.A.
Document Registration Statement false
Current Fiscal Year End Date --12-31
Document Period End Date Dec. 31, 2024
Document Transition Report false
Document Shell Company Report false
Entity File Number 001-38755
Entity Incorporation, State or Country Code D5
Entity Address, Address Line One Av. Professor Magalhães Neto, 1,752 10th Floor, Rooms 1009, 1010 and 1011
Entity Address, City or Town Salvador
Entity Address, Country BR
Entity Address, Postal Zip Code 41810-012
Entity Common Stock, Shares Outstanding 1,264,117,615
Entity Well-known Seasoned Issuer Yes
Entity Voluntary Filers No
Entity Current Reporting Status Yes
Entity Interactive Data Current Yes
Entity Filer Category Large Accelerated Filer
Entity Emerging Growth Company false
Document Financial Statement Error Correction [Flag] false
ICFR Auditor Attestation Flag true
Document Accounting Standard International Financial Reporting Standards
Entity Shell Company false
Entity Central Index Key 0000909327
Document Fiscal Year Focus 2024
Document Fiscal Period Focus FY
Amendment Flag false
Auditor Firm ID 1351
Auditor Name PricewaterhouseCoopers Auditores Independentes Ltda.
Auditor Location São Paulo, Brazil
Business Contact [Member]  
Document and Entity Information  
Entity Address, Address Line One Av. Brigadeiro Faria Lima, 1,355 - 7th Floor
Entity Address, City or Town São Paulo
Entity Address, Country BR
Entity Address, Postal Zip Code 01452-919
Contact Personnel Name Marcos Moreno Chagas Assumpção
Country Region +55
City Area Code 11
Local Phone Number 3503-9330
Contact Personnel Email Address ri@suzano.com.br
Ordinary shares  
Document and Entity Information  
Title of 12(b) Security Our common shares without par value*
No Trading Symbol Flag true
Security Exchange Name NYSE
ADR [Member]  
Document and Entity Information  
Title of 12(b) Security American Depositary Shares, or ADSs,** each representing one of our common shares
Trading Symbol SUZB3/SUZ
Security Exchange Name NYSE
Notes 4.000% due 2025, issued by Fibria Overseas Finance Ltd.  
Document and Entity Information  
Title of 12(b) Security 4.000% Notes due 2025, issued by Suzano International Finance B.V. (successor to Fibria Overseas Finance Ltd.)
Trading Symbol FBR/25
Security Exchange Name NYSE
Notes 5.500% due 2027, issued by Fibria Overseas Finance Ltd.  
Document and Entity Information  
Title of 12(b) Security 5.500% Notes due 2027, issued by Suzano International Finance B.V. (successor to Fibria Overseas Finance Ltd.)
Trading Symbol FBR/27
Security Exchange Name NYSE
Notes 6.000% due 2029, issued by Suzano Austria GmbH  
Document and Entity Information  
Title of 12(b) Security 6.000% Notes due 2029, issued by Suzano Austria GmbH
Trading Symbol SUZ/29
Security Exchange Name NYSE
Notes 5.000% due 2030, issued by Suzano Austria GmbH  
Document and Entity Information  
Title of 12(b) Security 5.000% Notes due 2030, issued by Suzano Austria GmbH
Trading Symbol SUZ/30
Security Exchange Name NYSE
Notes 3.750% due 2031, issued by Suzano Austria GmbH  
Document and Entity Information  
Title of 12(b) Security 3.750% Notes due 2031, issued by Suzano Austria GmbH
Trading Symbol SUZ/31
Security Exchange Name NYSE
Notes 2.500% due 2028, issued by Suzano Austria GmbH  
Document and Entity Information  
Title of 12(b) Security 2.500% Notes due 2028, issued by Suzano Austria GmbH
Trading Symbol SUZ/28
Security Exchange Name NYSE
Notes 3.125% due 2032, issued by Suzano Austria GmbH  
Document and Entity Information  
Title of 12(b) Security 3.125% Notes due 2032, issued by Suzano Austria GmbH
Trading Symbol SUZ/32
Security Exchange Name NYSE
v3.25.1
CONSOLIDATED BALANCE SHEET - BRL (R$)
Dec. 31, 2024
Dec. 31, 2023
CURRENT    
Cash and cash equivalents R$ 9,018,818,000 R$ 8,345,871,000
Marketable Securities Current 12,971,547,000 12,823,886,000
Trade and other current receivables 9,132,860,000 6,848,454,000
Inventories 7,962,324,000 5,946,948,000
Recoverable taxes 1,109,619,000 888,539,000
Derivative financial instruments 1,006,427,000 2,676,526,000
Current 92,133,000 113,743,000
Other assets 889,232,000 925,105,000
Total current assets 42,182,960,000 38,569,072,000
NON-CURRENT    
Marketable securities 391,964,000 443,400,000
Recoverable taxes 1,179,125,000 1,373,647,000
Deferred taxes 7,984,015,000 545,213,000
Derivative financial instruments 2,880,673,000 1,753,928,000
Non-Current Advances To Suppliers 2,503,537,000 2,242,229,000
Judicial deposits 487,993,000 361,693,000
Other assets 156,880,000 182,463,000
Biological assets 22,283,001,000 18,278,582,000
Investments 1,816,923,000 608,013,000
Property, plant and equipment 64,986,040,000 59,289,069,000
Right of use 5,180,691,000 5,196,631,000
Intangible 13,902,303,000 14,749,085,000
Total non-current 123,753,145,000 105,023,953,000
TOTAL ASSET 165,936,105,000 143,593,025,000
CURRENT    
Trade accounts payable 6,033,285,000 5,572,219,000
Loans, financing and debentures 10,501,387,000 4,758,247,000
Lease liabilities 872,228,000 753,399,000
Derivative financial instruments 2,760,273,000 578,763,000
Taxes payable 363,715,000 443,454,000
Payroll and charges 1,232,971,000 766,905,000
Liabilities for assets acquisitions and associates 21,166,000 93,405,000
Dividends payable 2,200,917,000 1,316,528,000
Advances from customers 145,200,000 172,437,000
Other liabilities 346,796,000 339,683,000
Total current liabilities 24,477,938,000 14,795,040,000
NON-CURRENT    
Loans, financing and debentures 90,934,144,000 72,414,445,000
Lease liabilities 6,100,687,000 5,490,383,000
Derivative financial instruments 7,694,547,000 1,857,309,000
Liabilities for assets acquisitions and associates 99,324,000 93,782,000
Provision for judicial liabilities 2,926,750,000 2,860,409,000
Employee benefit plans 721,560,000 833,683,000
Deferred taxes 12,596,000 11,377,000
Share-based compensation plans 361,974,000 268,489,000
Advances from customers 74,715,000 74,715,000
Other liabilities 116,295,000 83,093,000
Total non-current liabilities 109,042,592,000 83,987,685,000
TOTAL LIABILITIES 133,520,530,000 98,782,725,000
EQUITY    
Share capital 19,235,546,000 9,235,546,000
Capital reserves 60,226,000 26,744,000
Treasury shares (1,339,197,000) (1,484,014,000)
Retained earnings 12,978,898,000 35,376,198,000
Other reserves 1,348,796,000 1,538,296,000
Controlling shareholders' 32,284,269,000 44,692,770,000
Non-controlling interest 131,306,000 117,530,000
Total equity 32,415,575,000 44,810,300,000
TOTAL LIABILITIES AND EQUITY R$ 165,936,105,000 R$ 143,593,025,000
v3.25.1
CONSOLIDATED STATEMENTS OF INCOME (LOSS) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Profit or loss [abstract]      
NET SALES R$ 47,403,282 R$ 39,755,575 R$ 49,830,946
Cost of sales (27,401,527) (25,076,675) (24,821,288)
Gross profit 20,001,755 14,678,900 25,009,658
OPERATING INCOME (EXPENSES)      
Selling (2,938,547) (2,596,377) (2,483,194)
General and administrative (2,619,844) (1,923,228) (1,709,767)
Income from associates and joint ventures (13,845) (19,379) 284,368
Other operating income, net 1,261,573 2,076,372 1,121,716
OPERATING PROFIT BEFORE NET FINANCIAL INCOME (EXPENSES) 15,691,092 12,216,288 22,222,781
NET FINANCIAL INCOME (EXPENSES)      
Financial expenses (5,541,903) (4,659,162) (4,590,370)
Financial income 1,737,434 1,825,649 967,010
Derivative financial instruments (9,112,683) 5,526,714 6,761,567
Monetary and exchange variations, net (15,884,993) 3,087,727 3,294,593
NET INCOME (LOSS) BEFORE TAXES (13,111,053) 17,997,216 28,655,581
Income and social contribution taxes      
Current (1,365,599) (395,392) (510,896)
Deferred 7,431,946 (3,495,443) (4,749,798)
Net income (loss) for the year (7,044,706) 14,106,381 23,394,887
Attributable to      
Resulted of the year attributable to controlling shareholders' (7,074,198) 14,084,848 23,381,617
Non-controlling interest R$ 29,492 R$ 21,533 R$ 13,270
Earnings (loss) per share      
Basic R$ (5.59313) R$ 10.85794 R$ 17.57724
Diluted R$ (5.59313) R$ 10.85387 R$ 17.57305
v3.25.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Statement of comprehensive income [abstract]      
Net income (loss) for the year R$ (7,044,706) R$ 14,106,381 R$ 23,394,887
Other comprehensive income (loss)      
Fair value investments in equity measured at fair value through other comprehensive income [1] (362,797) (1,311) (3,441)
Tax effect on the fair value of investments (1,434) 446 1,170
Actuarial gain (loss) on post-employment plans of subsidiaries 5,430 (480) (9,499)
Tax effect of the actuarial (gain) loss (1,846) 163 3,260
Actuarial gain (loss) on post-employment plans of subsidiaries 132,344 (128,047) (3,182)
Tax effect of the actuarial loss (44,997) 43,536 1,082
Items with no subsequent effect on income (273,300) (85,693) (10,610)
Exchange rate variation on conversion of financial information of the subsidiaries abroad 163,185 4,707 (16,035)
Realization of the above items   471 (235,737)
Items with no subsequent effect on income 163,185 5,178 (251,772)
Total comprehensive income (loss) (7,154,821) 14,025,866 23,132,505
Attributable to      
Controlling shareholders' (7,184,313) 14,004,333 23,119,235
Non-controlling interest R$ 29,492 R$ 21,533 R$ 13,270
[1]
(1) Includes the acquisition of the equity interest in Lenzing Aktiengesellschaft (note 1.2.5).
v3.25.1
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - BRL (R$)
R$ in Thousands
Total
Share Capital
Share issuance costs
Stock options granted
Treasury shares
Retained earnings, Tax incentives
Legal Reserve
Reserve for capital increase
Special statutory reserve
Investment reserve
Dividends proposed
Other reserves
Retained earnings (losses)
Total
Non-controlling interest
Beginning balances at Dec. 31, 2021 R$ 15,175,130 R$ 9,269,281 R$ (33,735) R$ 15,455 R$ (218,265) R$ 812,909 R$ 235,019 R$ 2,513,663 R$ 279,344 R$ 86,889 R$ 2,114,907 R$ 15,075,467 R$ 99,663
Total comprehensive income                              
Net income (loss) for the year 23,394,887                       23,381,617 23,381,617 13,270
Other comprehensive income for the year (262,382)                     (262,382)   (262,382)  
Transactions with shareholders:                              
Stock options granted 5,335     5,335                   5,335  
Shares granted     (2,365) 2,365                    
Shares repurchased 1,904,424       1,904,424                 1,904,424  
Unclaimed dividends forfeited 2,308                       2,308 2,308  
Proposed additional dividend payment 799,903             719,903 80,000         799,903  
Payment of supplementary dividends 86,986             97     86,889     86,986  
Proposed minimum mandatory dividends 2,256,367                       2,256,367 2,256,367  
Additional proposed dividend (93,633)                       (93,633) (93,633)  
Fair value attributable to non-controlling interests (7,600)                           (7,600)
Internal changes in equity:                              
Constitution of reserves           66,871 1,169,080 17,937,885 1,993,098       (21,166,934)    
Reversal of the tax incentive reserve           (502)   502              
Realization of deemed cost, net of taxes                       (133,009) 133,009    
Ending balances at Dec. 31, 2022 33,166,365 9,269,281 (33,735) 18,425 (2,120,324) 879,278 1,404,099 19,732,050 2,192,442 1,719,516 33,061,032 105,333
Total comprehensive income                              
Net income (loss) for the year 14,106,381                       14,084,848 14,084,848 21,533
Other comprehensive income for the year (80,515)                     (80,515)   (80,515)  
Transactions with shareholders:                              
Stock options granted 8,319     8,319                   8,319  
Shares repurchased (880,914)       (880,914)                 (880,914)  
Interest on own capital (1,500,000)                       (1,500,000) (1,500,000)  
Unclaimed dividends forfeited         1,517,224       (1,517,224)            
Fair value attributable to non-controlling interests (9,336)                           (9,336)
Internal changes in equity:                              
Constitution of reserves           118,959 443,010 10,911,226 1,212,358       (12,685,553)    
Constitution of investment reserve               (14,972,324)   14,972,324          
Realization of deemed cost, net of taxes                       (100,705) 100,705    
Ending balances at Dec. 31, 2023 44,810,300 9,269,281 (33,735) 26,744 (1,484,014) 998,237 1,847,109 15,670,952 1,887,576 14,972,324 1,538,296 44,692,770 117,530
Total comprehensive income                              
Net income (loss) for the year (7,044,706)                       (7,074,198) (7,074,198) 29,492
Other comprehensive income for the year (110,115)                     (110,115)   (110,115)  
Transactions with shareholders:                              
Stock options granted 81,276     81,276                   81,276  
Shares granted     (47,794) 47,794                    
Shares repurchased (2,806,764)       (2,806,764)                 (2,806,764)  
Treasury shares cancelled       2,903,787     (2,863,320) (40,467)            
Interest on own capital (2,500,000)                 (2,500,000)       (2,500,000)  
Unclaimed dividends forfeited 1,300                       1,300 1,300  
Fair value attributable to non-controlling interests (15,716)                           (15,716)
Internal changes in equity:                              
Constitution of reserves           321,671             (321,671)    
Realization of deemed cost, net of taxes                     (79,385) 79,385  
Loss absorption                   (7,315,184)     7,315,184    
Issued capital, ordinary shares 10,000,000             (10,000,000)              
Ending balances at Dec. 31, 2024 R$ 32,415,575 R$ 19,269,281 R$ (33,735) R$ 60,226 R$ (1,339,197) R$ 1,319,908 R$ 1,847,109 R$ 2,807,632 R$ 1,847,109 R$ 5,157,140 R$ 1,348,796 R$ 32,284,269 R$ 131,306
v3.25.1
CONSOLIDATED STATEMENTS OF CASH FLOW - BRL (R$)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
OPERATING ACTIVITIES      
Net income (loss) for the year R$ (7,044,706,000) R$ 14,106,381,000 R$ 23,394,887,000
Adjustment to      
Depreciation, depletion and amortization 8,874,931,000 6,999,839,000 7,206,125,000
Depreciation of right of use 349,064,000 321,271,000 231,966,000
Sublease of ships (11,314,000)
Interest expense on lease liabilities 451,148,000 441,596,000 433,613,000
Result from sale and disposal of property, plant and equipment and biological assets, net 163,033,000 331,285,000 509,000
Income (expense) from associates and joint ventures 13,845,000 19,379,000 (284,368,000)
Exchange rate and monetary variations, net 15,884,993,000 (3,087,727,000) (3,294,593,000)
Interest expenses on financing, loans and debentures, net 5,413,707,000 4,797,094,000 4,007,737,000
Capitalized loan cost (959,968,000) (1,160,364,000) (359,407,000)
Accrual of interest on marketable securities (1,254,424,000) (1,352,522,000) (707,211,000)
Amortization of transaction costs 80,099,000 67,353,000 69,881,000
Derivative losses, net 9,112,683,000 (5,526,714,000) (6,761,567,000)
Result on fair value adjustment of biological assets (1,431,530,000) (1,989,831,000) (1,199,759,000)
Deferred income tax and social contribution (7,431,946,000) 3,495,443,000 4,749,798,000
Interest on actuarial liabilities 75,850,000 69,231,000 59,258,000
Provision for judicial liabilities, net 138,318,000 139,934,000 88,198,000
(Reversal of) provision for allowance for doubtful accounts, net 2,585,000 35,202,000 1,652,000
Provision for inventory losses, net 77,353,000 31,419,000 56,060,000
Provision (reversal) for loss of ICMS credits, net 130,727,000 348,628,000 58,003,000
Other 69,535,000 66,938,000 4,118,000
Decrease (increase) in assets      
Trade accounts receivables (808,785,000) 2,155,448,000 (3,267,356,000)
Inventories (863,648,000) (48,673,000) (967,995,000)
Recoverable taxes (95,411,000) (666,681,000) (381,408,000)
Other assets 6,185,000 328,800,000 (95,382,000)
Increase (decrease) in liabilities      
Trade accounts payables 2,164,832,000 463,003,000 1,533,118,000
Taxes payable 296,169,000 329,556,000 422,591,000
Payroll and charges 364,817,000 73,096,000 83,742,000
Other liabilities (27,706,000) (277,538,000) (9,007,000)
Cash provided by operations 23,751,750,000 20,510,846,000 25,061,889,000
Payment of interest with financing, loans and debentures (5,241,389,000) (4,728,998,000) (4,019,072,000)
Finance costs paid, classified as operating activities 959,968,000 1,160,364,000 359,407,000
Interest received from marketable securities 1,500,437,000 681,268,000 544,849,000
Payment of income taxes (366,339,000) (308,002,000) (306,453,000)
Cash provided by operating activities 20,604,427,000 17,315,478,000 21,640,620,000
INVESTING ACTIVITIES      
Additions to property, plant and equipment (9,190,589,000) (11,674,183,000) (9,791,238,000)
Additions to intangible (162,042,000) (104,931,000) (90,499,000)
Additions to biological assets (7,180,450,000) (5,777,952,000) (4,957,380,000)
Proceeds from sale of property, plant and equipment 167,983,000 183,576,000 251,183,000
Capital increase in subsidiaries and affiliates (41,281,000) (48,462,000) (67,020,000)
Marketable securities, net 205,954,000 (5,296,370,000) 67,426,000
Advances for acquisition (receipt) of wood from operations with development and partnerships (294,952,000) (690,908,000) (355,362,000)
Dividends received 44,789,000 6,604,000
Asset acquisition (2,595,974,000) (1,615,140,000) (2,090,062,000)
Acquisition of subsidiaries (1,060,718,000)
Increase (decrease) through acquisition of other investments (1,440,503,000)
Cash and cash equivalents from asset acquisitions 19,113,000 5,002,000 10,590,000
Cash used in investing activities (20,512,741,000) (26,035,297,000) (17,015,758,000)
FINANCING ACTIVITIES      
Proceeds from loans, financing and debentures 15,692,905,000 10,944,794,000 1,335,715,000
Payment of derivative transactions (550,581,000) 3,559,286,000 282,225,000
Payment of loans, financing and debentures (9,410,807,000) (4,296,447,000) (2,517,934,000)
Payment of leases (1,325,398,000) (1,218,399,000) (1,044,119,000)
Interest paid, referring to interest on own capital, classified as financing activities (1,624,653,000) (192,532,000) (4,150,782,000)
Liabilities for assets acquisitions and associates (58,467,000) (116,924,000) (107,888,000)
Shares repurchased (2,806,764,000) (880,914,000) (1,904,424,000)
Cash provided (used) by financing activities (83,765,000) 7,798,864,000 (8,107,207,000)
EXCHANGE VARIATION ON CASH AND CASH EQUIVALENTS 665,026,000 (239,125,000) (602,480,000)
Increase (decrease) in cash and cash equivalents, net 672,947,000 (1,160,080,000) (4,084,825,000)
At the beginning of the year 8,345,871,000 9,505,951,000 13,590,776,000
At the end of the year R$ 9,018,818,000 R$ 8,345,871,000 R$ 9,505,951,000
v3.25.1
COMPANY'S OPERATIONS
12 Months Ended
Dec. 31, 2024
COMPANY'S OPERATIONS  
COMPANY'S OPERATIONS
1 COMPANY’S OPERATIONS
Suzano S.A. (“Suzano”) and its subsidiaries (collectively the “Company”) is a public company with its headquarters in Brazil, at Avenida Professor Magalhães Neto, No. 1,752 - 10th floor, rooms 1010 and 1011, Bairro Pituba, in the city of Salvador, State of Bahia, and its main business office in the city of São Paulo.
Suzano’s shares are traded on B3 S.A. (“Brasil, Bolsa, Balcão - “B3”), listed in the New Market under the ticker SUZB3, and its American Depositary Receipts (“ADRs”) in a ratio of 1 (one) per common share, Level II, are traded in the New York Stock Exchange (“NYSE”) under the ticker SUZ.
The Company has 16 industrial units, 14 located in Brazil in the cities of Cachoeiro de Itapemirim and Aracruz (Espírito Santo State), Belém (Pará State), Eunápolis and Mucuri (Bahia State), Maracanaú (Ceará State), Imperatriz (Maranhão State), Jacareí, Limeira, Mogi das Cruzes and two units in Suzano (São Paulo State) and Três Lagoas and Ribas do Rio Pardo (Mato Grosso do Sul State) and two units in United States located in the cities of Pine Bluff (Arkansas) and Waynesville (North Carolina). Additionally, it has seven technology centers, four located in Brazil, one in Canada, one in China and one in Israel, 28 distribution centers and four ports, all located in Brazil.
These units produce hardwood pulp from eucalyptus, coated paper, paperboard, uncoated paper and cut size paper and packages of sanitary paper (consumer goods - tissue) to serve the domestic and foreign markets.
Pulp and paper are sold in foreign markets by Suzano, as well as through its wholly-owned subsidiaries and/or its sales offices in Argentina, Austria, China, Ecuador, United States of America and Singapore.
The Company's operations also include the commercial management of eucalyptus forest for its own use, operation of port terminals, and holding of interests, as a partner or shareholder, in other companies or enterprises, and commercialization of electricity generated from its pulp production process.
The Company is controlled by Suzano Holding S.A., through a voting agreement whereby it holds 49.25% of the common shares of its share capital.
These financial statements were authorized by the Board of Directors on February 12, 2025.
1.1 Equity interests
The Company holds equity interests in the following entities:
% equity interest
Entity/Type of investment Main activityCountry12/31/202412/31/2023
Consolidated
F&E Tecnologia do Brasil S.A. (Direct)Biofuel production, except alcoholBrazil100.00 %100.00 %
Fibria Celulose (USA) Inc. (Direct)Business officeUnited States of America100.00 %100.00 %
Fibria Overseas Finance Ltd. (Direct) (1)
Financial fundraisingCayman Island 100.00 %
Fibria Terminal de Celulose de Santos SPE S.A. (Direct)Port operationsBrazil100.00 %100.00 %
FuturaGene Ltd.Biotechnology research and developmentEngland100.00 %100.00 %
FuturaGene Delaware Inc. (Indirect)Biotechnology research and developmentUnited States of America100.00 %100.00 %
FuturaGene Israel Ltd. (Indirect)Biotechnology research and developmentIsrael100.00 %100.00 %
FuturaGene Inc. (Indirect)Biotechnology research and developmentUnited States of America100.00 %100.00 %
Maxcel Empreendimentos e Participações S.A. (Direct)HoldingBrazil100.00 %100.00 %
Itacel - Terminal de Celulose de Itaqui S.A. (Indirect)Port operationsBrazil100.00 %100.00 %
Mucuri Energética S.A. (Direct)Power generation and distributionBrazil100.00 %100.00 %
Paineiras Logística e Transportes Ltda. (Direct)Road freight transportBrazil100.00 %100.00 %
Portocel - Terminal Espec. Barra do Riacho S.A. (Direct)Port operationsBrazil51.00 %51.00 %
Projetos Especiais e Investimentos Ltda. (Direct)Commercialization of equipment and partsBrazil100.00 %100.00 %
SFBC Participações Ltda. (Direct)Packaging productionBrazil100.00 %100.00 %
Stenfar S.A. Indl. Coml. Imp. Y. Exp. (Direct)Commercialization of paper and computer materialsArgentina100.00 %100.00 %
Suzano Austria GmbH. (Direct)Business officeAustria100.00 %100.00 %
Suzano Canada Inc. (Direct)Lignin research and developmentCanada100.00 %100.00 %
Suzano Ecuador S.A.S. (Direct) Business officeEcuador100.00 %100.00 %
Suzano Finland Oy (Direct)Industrialization and commercialization of cellulose, microfiber cellulose and paperFinland100.00 %100.00 %
Suzano International Finance B.V (Direct)Financial fundraisingNetherlands100.00 %100.00 %
Suzano International Holding B.V. (Direct)HoldingNetherlands100.00 %100.00 %
Suzano International Trade GmbH. (Direct)Business officeAustria100.00 %100.00 %
Suzano Packaging LLC (Indirect) (3)
Production of coated and uncoated paperboard, used in the production of Liquid Packaging Board and CupstockUnited States of America100.00 %
Suzano Material Technology Development Ltd. (Direct)Biotechnology research and developmentChina100.00 %100.00 %
Suzano Netherlands B.V. (Direct)Financial fundraisingNetherlands100.00 %100.00 %
Suzano Operações Industriais e Florestais S.A. (Direct)Industrialization, commercialization and exporting of pulpBrazil100.00 %100.00 %
Suzano Pulp and Paper America Inc. (Direct)Business officeUnited States of America100.00 %100.00 %
Suzano Pulp and Paper Europe S.A. (Direct)Business officeSwitzerland100.00 %100.00 %
Suzano Shanghai Ltd. (Direct)Business officeChina100.00 %100.00 %
Suzano Shanghai Trading Ltd. (Direct) Financial fundraisingChina100.00 %100.00 %
Suzano Singapura Pte. Ltd (Direct)Business officeSingapore100.00 %100.00 %
Suzano Trading International KFT(Direct)Business officeHungary100.00 %100.00 %
Suzano Ventures LLC (Direct)Corporate venture capitalUnited States of America100.00 %100.00 %
% equity interest
Entity/Type of investment Main activityCountry12/31/202412/31/2023
Joint operation
Veracel Celulose S.A. (Direct)Industrialization, commercialization and exporting of pulpBrazil50.00 %50.00 %
Equity
Biomas Serviços Ambientais, Restauração e Carbono S.A. (Direct) Restoration, conservation and preservation of forestsBrazil16.66 %16.66 %
Ensyn Corporation (Direct) (7)
Biofuel research and developmentUnited States of America24.80 %25.53 %
F&E Technologies LLC (Direct/Indirect)Biofuel production, except alcoholUnited States of America50.00 %50.00 %
Ibema Companhia Brasileira de Papel (Direct)Industrialization and commercialization of paperboardBrazil49.90 %49.90 %
Simplifyber, Inc (Indirect) (6)
Production of consumer goods through the transformation of cellulose-based liquidsUnited States of America13.91 %
Spinnova Plc (Direct) (“Spinnova”)Research of sustainable raw materials for the textile industryFinland18.77 %18.78 %
Woodspin Oy (Direct/Indirect) (“Woodspin”)Development and production of cellulose-based fibers, yarns and textile filamentsFinland50.00 %50.00 %
Fair value through other comprehensive income
Bem Agro Integração e Desenvolvimento S.A. (Indirect) (4)
Software solutions based on artificial intelligence and computer vision for agribusinessBrazil5.82 %
Celluforce Inc. (Direct)Nanocrystalline pulp research and developmentCanada8.28 %8.28 %
Lenzing Aktiengesellschaft (Indirect) (5)
Production of wood-based cellulose fibersAustria15.00 %
Nfinite Nanotechnology Inc. (Indirect) (2)
Research and development of smart nanocoatingsCanada5.00 %
(1)On March 27, 2024, the entity was liquidated.
(2)On March 8, 2024, Suzano Ventures LLC acquired an equity interest in the legal entity Nfinite Nanotechnology Inc., which is an associate of Suzano S.A.
(3)On July 9, 2024, establishment of legal entity with is a subsidiary of Suzano S.A
(4)On July 19, 2024, Suzano Ventures LLC acquired an equity interest in the legal entity Bem Agro Integração e Desenvolvimento S.A., which is an associate of Suzano S.A.
(5)On August 30, 2024, Suzano International Trade GmbH acquired an equity interest in the legal entity Lenzing Aktiengesellschaft (note 1.2.5), which is an associate of Suzano S.A.
(6)On December 13, 2024, Suzano Ventures LLC acquired an equity interest in the legal entity Simplifyber, Inc., which is an associate of Suzano S.A.
(7)On July 30, August 30 and December 31, 2024, there was a change in the percentage of participation due to the dilution of shares.

1.2 Major events in the year
1.2.1 Effects of the war between Russia and Ukraine, and Middle East conflict
The Company has continuously monitored the impacts of the current war between Russia and Ukraine, and the Middle East conflict, both direct and indirect, on society, the economy and markets (global and domestic), with the objective of evaluating possible impacts and risks for the business.
The Company's assessment has covered five main areas:
(i)Personnel: Suzano has local employees and facilities in the city of Rehovot in Israel, through its subsidiary, FuturaGene Israel Ltd. The Company continuously monitors the situation.

In the context of the conflict between Russia and Ukraine, Suzano does not have employees or facilities of any kind in locations related to the conflict.
(ii)Supply Chain: the Company did not identify any short-term or long-term risk of possible interruptions or shortages of materials for its industrial and forestry activities. So far, the only effects observed have been greater volatility in commodities and energy prices.
(iii)Logistics: internationally, there was no relevant change in the Company’s logistical operations, with all the routes used remaining substantially unchanged and the moorings in the planned locations being maintained. At the domestic level, no changes in logistical flows were identified.
(iv)Commercial: to date, the Company has continued with its transactions as planned, maintaining service to its customers in all its sectors of activity. Sales to a few customers located in Russia were suspended, without any significant financial impact.
(v)Continuity of operations: The conflict in Israel may result in disruptions to biotechnology research and development operations at FuturaGene Israel Ltd.
As a result of the current scenario, the Company has taken steps to expand its monitoring of the situation, together with its main stakeholders, in order to ensure any updates and information flows required for its global decision-making are available in a timely manner.
1.2.2 Cerrado Project
On July 21, 2024, the Cerrado Project started its operation. The plant has a nominal capacity of 2,550,000 tons of eucalyptus pulp production per year. The total investment is R$22,200,000, with substantial payments during the years of 2021 to 2025.
1.2.3 Cancellation of shares and new share buyback program
On January 26, 2024, the Board of Directors approved the cancellation of 20,000,000 common shares, with an average cost of R$42.69 per share, in the amount of R$853,725, which were held in treasury, without changing the share capital and against the balances of retained earnings reserves available.
Additionally, on August 9, 2024, the Board of Directors approved the cancellation of an additional 40,000,000 common shares, with an average cost of R$51.25 per share, valued at R$2,050,062, which were held in treasury, without changing the share capital and against the balances of available profit reserves.
After the cancellation of the shares and the events listed in the note 1.2.4, the share capital of R$19,269,281 is divided into 1,264,117,615 common shares, all nominative, book-entry and with no par value.
On the same date, the Company approved a new share buyback program, in which it may acquire up to a maximum of 40,000,000 common shares of its own issue with a maximum period of 18 months, which will end on February 9, 2026.
1.2.4 Share capital increase
On April 25, 2024, the Board of Directors approved the increase in the Company's share capital, in the amount of R$10,000,000, without the issuance of new shares, pursuant to article 169, paragraph 1, of the Brazilian Corporation Law, to be paid in through the capitalization of the balance of the Capital Increase Reserve, pursuant to Article 199 of the Brazilian Corporation Law.
1.2.5 Acquisition of equity interest in a specialty fibers business
On August 30, 2024, the Company acquired from B & C Alpha Zweite Holding GmbH & Co KG (“B&C”) 5,792,727 shares which represents 15% of the issued share capital of Lenzing Aktiengesellschaft (“Lenzing”), the “Lenzing Transaction”. The Lenzing Transaction was completed after all precedent conditions were fulfilled. The fair value of the cash consideration transferred was EUR 229,971 (equivalent to R$1,436,814), at a price of EUR 39.70 per share.
The main terms and conditions of the Lenzing Transaction are:
(i) the right of Suzano to hold two out of ten seats on Lenzing’s Supervisory Board; and
(ii) Suzano has a right to alter the controlling position by acquiring an additional 15% of the shares held by B&C as part of a mandatory takeover offer to be made by Suzano for all shares of Lenzing under Austrian Takeover Law at a price to be set in accordance with the requirements of the Austrian Takeover Law. Such right can be exercised by Suzano as from the day after the first anniversary of closing until the end of 2028;
Management assessed the Lenzing Transaction in accordance with CPC 18 (R3)/ IAS 28 and even though Suzano has two seats on Lenzing’s Supervisory Board, it was concluded that Suzano does not have significant influence over Lenzing since it has no power to participate in decision making, policy making and decisions about dividends or other distributions. Therefore, the investment was recorded at fair value through other comprehensive income (FVOCI), in accordance with CPC 48/IFRS 9 Financial Instruments.
1.2.6 Share purchase agreement - Timber
On July 31, 2024, the Company concluded the transaction to purchase 100% of the share capital of the Timber VII SPE S.A. and Timber XX SPE S.A. (the "Timber Transaction"), after completion of all precedent conditions. The fair value of consideration transferred in cash was R$2,143,821.
Considering the characteristics of the assets (substantially land and biological assets), the Company elected to apply the optional concentration test to identify a concentration of fair value under paragraph B7A of IFRS 3 and therefore the Timber Transaction was accounted for as an asset acquisition.
The impact of this acquisition is reflected in the line-item asset acquisition, net of cash, in the consolidated statement of cash flow. The cash of these companies was R$19,113.
On September 30, 2024, these companies were merged to the Company. The merger did not result in a capital increase, given that the Company already held, directly or indirectly, 100% of the share capital of these companies.
1.2.7 Acquisition of Pactiv Evergreen Inc. assets
On October 1, 2024, the Company, through its indirect subsidiary Suzano Packaging LLC, acquired the inventories and property, plant and e equipment comprising the integrated coated and uncoated paperboard manufacturing plants, used for the production of Liquid Packaging Board and Cupstock, located in the cities of Pine Bluff – Arkansas and Waynesville – North Carolina, both in the United States of America, previously owned by Pactiv Evergreen Inc. ("Pactiv Transaction"). The "Pactiv Transaction" was finalized after the fulfillment of all precedent conditions.
The fair value of the consideration transferred in cash was US$82.932 (equivalent to R$452,153), based on the composition of the assets received.
Considering the characteristics of the assets (substantially inventory), the Company elected to apply the optional concentration test to identify a concentration of fair value under paragraph B7A of IFRS 3 and therefore the Pactiv Transaction was accounted for as an asset acquisition.
The accounting effects of the transaction were reflected under the inventories line in the consolidated balance sheet.
1.2.8 Interest on own capital
On December 4, 2024, the Board of Directors approved the distribution of interest on equity by the Company, in the total gross amount of R$2,500,000, at the rate of BRL 2,017362506 per share, considering the number of “ex-treasury” shares on this date, as remuneration based on the profit shown in the Company's quarterly balance sheet dated September 30, 2024.
Interest on equity is subject to 15% withholding tax, except for shareholders who are demonstrably immune or exempt, in accordance with current legislation. This tax, amounting to R$306,327, was withheld and paid in December 2024.
1.2.9 Tax reform consumption
On December 20, 2023, Constitutional Amendment (“EC”) No. 132 was enacted, establishing the Tax Reform (“Reform”) on consumption. The Reform model is based on a split VAT (“dual VAT”) with two jurisdictions: a federal one (Contribution on Goods and Services - CBS), which will replace PIS and COFINS, and a subnational one (Tax on Goods and Services - IBS), which will replace ICMS and ISS.
A Selective Tax (“IS”) was also created – under federal jurisdiction, which will apply to the production, extraction, commercialization, or importation of goods and services harmful to health and the environment, as defined by a supplementary law.
In January 2025, Supplementary Law Bill (“PLP”) 68/24 was sanctioned and converted into Supplementary Law 214/25, which regulated part of the Tax Reform.
Although the regulation and establishment of the IBS Management Committee were initially addressed in PLP No. 108/2024, the second regulatory bill of the Reform, which is yet to be reviewed by the Federal Senate, part of the provisions has already been incorporated into PLP No. 68/2024, approved as mentioned above. Among other provisions, it determined the establishment of the Committee by December 31, 2025, which will be responsible for administering the said tax.
There will be a transition period between the years 2026 and 2032, in which the two tax systems – old and new – will coexist. The impacts of the Reform on the calculation of the aforementioned taxes, starting from the beginning of the transition period, will only be fully understood once the pending issues are regulated by supplementary law. Consequently, there is no effect of the Reform on the financial statements as of December 31, 2024.
v3.25.1
BASIS OF PREPARATION AND PRESENTATION OF FINANCIAL STATEMENTS
12 Months Ended
Dec. 31, 2024
BASIS OF PREPARATION AND PRESENTATION OF FINANCIAL STATEMENTS  
BASIS OF PREPARATION AND PRESENTATION OF FINANCIAL STATEMENTS
2 BASIS OF PREPARATION AND PRESENTATION OF FINANCIAL STATEMENTS
The Company’s consolidated financial statements have been prepared in compliance with the International Financial Reporting Standards as issued by the International Accounting Standards Board (“IFRS Accounting Standards”) and disclose all the applicable significant information related to the financial statements, which is consistent with the information used by Management in the performance of its duties.
The Company's consolidated financial statements are expressed in thousands of Brazilian Reais (“R$”) and disclosures of amounts in other currencies, when applicable, were also expressed in thousands, unless otherwise stated.
The preparation of consolidated financial statements requires Management to make judgments, use estimates and adopt policies in the process of applying accounting practices that affect the disclosed amounts of revenues, expenses, assets and liabilities, including the disclosure of contingent liabilities assumed. However, the uncertainty inherent to these judgements, assumptions and estimates could result in material adjustments to the carrying amount of certain assets and liabilities in future periods. The accounting practices requiring a higher level of judgment, and those which are more complex, as well as areas in which assumptions and estimates are significant, are disclosed in Note 3.2.34.
The consolidated financial statements were prepared on a historical costs basis, considering the historical cost as a value basis and adjusted to reflect the attributed cost of land and buildings on the date of transition to IFRS Accounting Standards, except for the following material items recognized:
(i)Derivative and non-derivative financial instruments measured at fair value;
(ii)Share-based payments and employee benefits measured at fair value; and
(iii)Biological assets measured at fair value;
The material accounting policies applied to the preparation of these consolidated financial statements are presented in Note 3.
The consolidated financial statements were prepared under the going concern assumption.
v3.25.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
12 Months Ended
Dec. 31, 2024
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
3 SUMMARY OF MATERIAL ACCOUNTING POLICIES
The consolidated financial statements were prepared based on the information of Suzano and its subsidiaries on the same base date, except for subsidiaries Futuragene and Suzano Packaging and associates Biomas, Ensyn, Simplifyber and Spinnova, as well as in accordance with consistent accounting policies and practices.
The accounting policies have been consistently applied to all consolidated companies.
There were no changes on such policies and estimates calculation methodologies, except for the application of the new accounting policies presented in note 3.1, adopted as of January 1, 2024.
3.1 New accounting policies and changes in accounting policies adopted
The new standards and interpretations issued, until the issuance of the Company’s consolidated financial statements, are described below.
3.1.1 Amendments to IFRS 7 – Supplier financing agreements and IAS 7 Statement of cash flow
The changes now require the entity to disclose additional information about its supplier financing arrangements that allows users to assess the effects of these arrangements on the entity's liabilities and cash flows and on the entity's exposure to liquidity risk.
The disclosures required by the amendments, which would allow understanding of the effects of these agreements on liabilities, cash flows and liquidity include:
(a) the terms and conditions of the agreements;
(b) at the beginning and end of the reporting period: (i) the carrying values, and the associated items presented in the entity's balance sheet, of the financial liabilities that form part of a supplier financing agreement; (ii) the carrying amounts, and associated items, of the financial liabilities disclosed in accordance with item (i) for which suppliers have already received payment from financiers; and (iii) the range of due dates.
(c) the type and effect of non-cash changes in the carrying values of financial liabilities disclosed in accordance with paragraph (b)(i).
The Company assessed the content of this pronouncement and did not identify the need to disclose additional information, since (a) the terms and conditions of the agreements have not changed compared to the original conditions; (b) (i) the accounting amounts subject to advance payment are disclosed in Note 17; (ii) the decision to adhere to this transaction is exclusive to the suppliers, and the Company has no influence or management over the amounts received by suppliers from financial institutions; (iii) there was no change in due dates; and (c) there were no non-cash modifications to the supplier advance payment agreements.
3.1.2 Amendments to IFRS 16 – Lease liability in a sale and leaseback transaction
The amendments specify that, in measuring the lease liability subsequent to the sale and leaseback, the seller-lessee determines ‘lease payments’ and ‘revised lease payments’ in a way that does not result in the seller-lessee recognising any amount of the gain or loss that relates to the right of use that it retains.
The Company assessed the content of this pronouncement and did not identify any impact.
3.1.3 Amendments to IAS 1: Classification of liabilities as current or non-current and non-current liabilities with covenants
The changes improve the information provided by the entity when its right to defer the settlement of a liability for at least twelve months is subject to compliance with covenants.
The classification of liabilities as current or non-current is based on compliance with covenants that are required on the reporting date or before that date, but never in relation to future events, in addition to requiring disclosure of information in the explanatory notes that allow Users of financial statements assess the risk that the liability may become due within twelve months, including the agreed conditions (for example, their nature and the date by which the entity must comply with them), whether the entity would have complied with the conditions based on its circumstances at the end of the reporting period and how the entity expects to comply with the conditions after the end of the reporting period.
The Company assessed the content of this pronouncement and did not identify any impact.
3.1.4 IFRIC agenda decision - disclosure of revenues and expenses for reportable segments (IFRS 8)
In July 2024, the IASB approved an IFRIC agenda decision in relation to segment reporting. The decision deals with how an entity applies the requirements in paragraph 23 of IFRS 8 to disclose for each reportable segment specified amounts related to segment profit or loss.
The Company assessed the content of this pronouncement and included the cost of the product sold in note 28.
3.2 Accounting policies adopted
3.2.1 Financial statements
3.2.1.1 Consolidated financial statements
They are prepared using information from Suzano and its subsidiaries on the same base date, except for the subsidiaries Futuragene and Suzano Packaging and the affiliates Biomas, Ensyn, Simplifyber, which have a lag of less than three months in relation to the base date of these financial statements, in accordance with the provisions of CPC 18/IAS 28 and do not have a material effect on the consolidated result and, if any significant event occurred until December 31, 2024, the effect would be adjusted in the consolidated financial statements, as well as consistent accounting policies.
On December 31, 2024, Suzano had an investment in the associate Spinnova, in the amount of R$95,254, representing 18.77% of the equity of this associate. Up to the date of this report, the latest financial statements published for this investment were more than three months out of date. In these circumstances, the investment is measured based on the latest information available, with the necessary adjustments being made as a result of the effects of significant transactions and events, which have no material effect on the consolidated result.
The Company consolidates all subsidiaries over which it has direct or indirect control, i.e. when it is exposed to or has the right to variable returns on its investment with the investee and has the ability to direct the relevant activities of the investee.
In addition, all transactions and balances between Suzano and its subsidiaries, associates and joint operations were eliminated in consolidation, as well as the unrealized profits or losses arising from these transactions, net of tax effects, investments and the respective equity results.
The participation of non-controlling shareholders is highlighted.
3.2.2 Subsidiaries
These include all entities for which the Company has the power to govern the financial and operating policies, generally through a majority of voting rights. The Company controls an entity when the Company is exposed to, or has rights to, variable returns on its investment in the investee, and has the ability to affect those returns through its power over the entity.
Subsidiaries are consolidated from the date on which control is obtained and consolidated from the date on which control ceases.
3.2.3 Joint operations
These include all entities for which the Company maintains contractually established control over its economic activity, and exists only when the strategic, financial and operational decisions regarding the activity requiring the unanimous consent of the parties sharing control.
In the consolidated financial statements, the balance of assets, liabilities, revenue and expenses are recognized proportionally to the interest in joint operations.
3.2.4 Associated and joint ventures
These include all entities initially recognized at cost and adjusted thereafter for the equity method, being increased or reduced from its interest in the investee's income after the acquisition date.
In the investments in associates, the Company must have significant influence, which means the power to participate in the financial and operating policy decisions of the investee, without having control or joint control over those policies. In investments in joint ventures, there is a contractually agreed sharing of control through an arrangement, which exists only when decisions about the relevant activities requiring the unanimous consent of the parties sharing control.
3.2.5 Translation of financial statements into the functional and presentation currency
The Company has defined that, for all its wholly owned subsidiaries, the functional and presentation currency is the Brazilian Real, except for subsidiary Suzano Packaging, whose functional currency is the US Dollar, and for investments in associates abroad related to Ensyn Corporation, F&E Technologies LLC and Simplifyber, whose functional currency is the US Dollar, Spinnova and Woodspin, whose functional currency is the Euro. The accumulated gains or losses of which affect the conversion of the financial statements, which are recorded in other comprehensive income, in equity.
The individual financial information of each of the subsidiaries, included in the consolidated financial statement, are prepared in the local currency in which the subsidiary operates and are translated into the Company’s functional and presentation currency.
3.2.5.1 Transactions and balances in foreign currency
These are translated using the following criteria:
(i)Monetary assets and liabilities are translated at the exchange rate in effect at year-end;
(ii)Non-monetary assets and liabilities are translated at the historical rate of the transaction;
(iii)Revenue and expenses are translated based on monthly average rate; and
(iv)The cumulative effects of gains or losses upon translation are recognized in the other comprehensive income.
The cumulative translation adjustment (“CTA”) arising from the translation of a foreign operation previously recognized in other comprehensive income are reclassified from equity to profit or loss at the disposal of the operations. The total or partial disposal of interest in wholly-owned subsidiaries occurs through sale or dissolution, of all or part of operation.
3.2.6 Hyperinflationary economies
Entities based in Argentina, a country considered to have a hyperinflationary economy, are subject to the requirements of IAS 29 - Financial Reporting in Hyperinflationary Economies. Non-monetary items, as well as income and expenses, are adjusted by the changes in the inflation index between the initial recognition and the closing date, so the balances are stated at their current value.
However, the Company's wholly-owned subsidiary, based in Argentina, has the Real as its functional currency, and therefore is not considered an entity with a hyperinflationary currency, and does not present its individual financial statements in accordance with IAS 29 - Financial Reporting in Hyperinflationary Economies. The financial statements are presented at historical cost.
3.2.7 Business combinations
These are accounted for using the acquisition method when control is transferred to the acquirer. The cost of an acquisition is the sum of the consideration paid, evaluated based on the fair value at the acquisition date, and the amount of any non-controlling interest in the acquiree. For each business combination, the Company recognizes any non-controlling interest in the acquiree either at fair value or at the non-controlling interest’s proportionate share of the acquirer’s net assets. The costs directly attributable to the acquisition are recorded as expenses when they are incurred, except for costs related to the issuance of debt instruments or equity instruments, which are presented as reductions in debt or equity, respectively.
In a business combination, assets acquired and liabilities assumed are evaluated in order to classify and allocate them, assessing the terms of the agreement, the economic circumstances and other conditions at the acquisition date.
Goodwill is initially measured as the excess of the consideration paid over the fair value of the net assets acquired. After initial recognition, goodwill is measured at cost, net of any accumulated impairment losses. For the purpose of impairment testing, the goodwill recognized in a business combination, as from the acquisition date, is allocated to each of the Company’s cash generating units.
Gains on an advantageous purchase are recognized immediately in the result. The borrowing costs are recorded in the income statement as they are incurred.
Contingent liabilities related to tax, civil and labor, classified in the acquired company as possible and remote risks, are recognized by the acquirer at their fair values.
Transactions involving the acquisition of shares with shared control over the net assets traded are evaluated in accordance with the complementary guidance to IFRS 3 - Business Combinations, IFRS 11 and IAS 28 - Investments in Associates and Joint Ventures to evaluate initial recognition criteria. For the investments defined based on the equity method, investments are initially recognized at cost. The carrying amount of the investment is adjusted for the recognition of changes in the Company's share of the acquirer's Shareholders' equity as at the acquisition date. Goodwill is measured and segregated from the carrying amount of the investment. Other intangible assets identified in the transaction shall be allocated in proportion to the interest acquired by the Company, based on the difference between the carrying amounts recorded in the acquired entity and its fair value assets, which may be amortized.
3.2.8 Segment information
An operating segment is a component of the Company that carries out business activities from which it can obtain revenue and incur expenses. The operating segments reflect how the Company’s management reviews the financial information used to make decisions. The Company’s management has identified two reportable segments, which meet the quantitative and qualitative disclosure requirements, in accordance with the current management model (note 28).
3.2.9 Cash and cash equivalents
Include cash on hand, bank deposits and highly liquid short-term investments with maturities, upon acquisition, of 90 days or less, which are readily convertible into known amounts of cash and subject to an insignificant risk of changes in value.
3.2.10 Financial instruments
3.2.10.1 Classification
Financial instruments are classified based on the purpose for which the financial instruments were acquired, as set forth below:
(i)Amortized cost;
(i)Fair value through other comprehensive income; and
(i)Fair value through profit or loss.
Regular purchases and sales of financial assets are recognized on the trade date, meaning the date on which the Company commits to purchase or sell the asset. Financial instruments are derecognized when the rights to receive cash flow from the investments have expired or have been transferred, substantially, all of the risks and rewards of ownership.
3.2.10.1.1 Financial instruments measured at amortized cost
Financial instruments held by the Company: (i) in order to receive their contractual cash flow and not to sell to realize a profit or loss; and (ii) whose contractual terms give rise, on specified dates, to cash flow that exclusively represents payments of principal and interest on the principal amount outstanding. Any changes are recognized under financial income (expenses) in the income statement.
It includes the balance of cash and cash equivalents, trade accounts receivable, dividends receivable and other assets, classified as financial assets and the balances of suppliers, loans, financing and debentures, lease payables, accounts payable for the acquisition of assets and subsidiaries, , dividends and interest on own capital payable and other liabilities, all of which are classified as financial liabilities.
3.2.10.1.2 Financial instruments at fair value through other comprehensive income
Financial instruments at fair value through other comprehensive income are financial assets held by the Company: (i) either to receive their contractual cash flow through sale with the realization of a profit or loss; and (ii) whose contractual terms give rise, on specified dates, to cash flows constituting, exclusively, repayments of principal and interest on the principal amount outstanding. In addition, this category includes investments in equity instruments where, upon initial recognition, the Company elected to present subsequent changes in its fair value within other comprehensive income. Any changes are recognized under net financial income (expenses) in the income statement, except for the fair value of investments in equity instruments, which are recognized in other comprehensive income.
Includes the balance presented in Note 14.1 as other investments evaluated at fair value through other comprehensive income.
3.2.10.1.3 Financial instruments at fair value through profit or loss
Financial instruments at fair value through profit or loss are either designated in this category or not classified in any of the other categories. Any changes are recognized within financial income (expenses) in the income statement for non-derivative financial instruments and for financial derivative instruments within income from derivative financial instruments.
This category includes the balance of marketable securities, classified as financial assets financial and derivative financial instruments, including embedded derivatives, stock options, classified as financial assets and liabilities.
3.2.10.2 Impairment of financial assets
3.2.10.2.1 Financial instruments measured at amortized cost
Annually, the Company assesses whether there is evidence that a financial asset is impaired. A financial is impaired only if there is evidence of impairment as a result of one or more events that occurred after the initial recognition of the asset, and that loss event has an impact on the estimated future cash flow of the financial asset that can be estimated reliably.
The criteria the Company uses to determine whether there is evidence of an impairment loss includes:
(i)Significant financial difficulty of the issuer or debtor;
(ii)Defaults on or late payment of interest or principal under the agreement;
(iii)Where the Company, for economic or legal reasons relating to the borrower's financial difficulty, grants to the borrower a concession that a lender would not otherwise consider;
(iv)It becomes probable that the borrower will enter bankruptcy or other financial reorganization;
(v)The disappearance of an active market for that financial asset because of financial difficulties; and
(vi)Observable data indicating a measurable decrease in the estimated future cash flow from a portfolio of financial assets after the initial recognition of those assets, although the decrease cannot yet be identified with the individual financial assets in the portfolio.
The amount of an impairment loss is measured at the difference between the carrying amount of the asset and the present value of estimated future cash flows, discounted at the financial asset's original effective interest rate. If the financial asset is impaired, the carrying amount of the asset is reduced and a loss is recognized in the income statement.
If, in a subsequent remeasurement, if there is an improvement in the asset rating, such as an improvement in the debtor's credit rating, the reversal of the previously recognized impairment loss is recognized in the income statement.
3.2.10.2.2 Financial assets at fair value through other comprehensive income
The Company periodically evaluates, when measuring fair value, whether there is evidence that a financial asset is impaired.
For such financial assets, a significant or prolonged decrease in the fair value of the security below its cost is evidence that the assets are impaired. If any such evidence exists, an impairment loss measured at the difference between the acquisition cost and the current fair value, less any loss previously recognized in other comprehensive income, shall be recognized in the income statement.
3.2.11 Derivative financial instruments and hedging activities
Derivative financial instruments are recognized at fair value on the date on which the derivative agreement is entered into and are subsequently remeasured at fair value. Changes in fair value are recorded within the results of derivative financial instruments in the income statement.
Embedded derivatives in non-derivative main contracts are required to be separated when their risks and characteristics are not closely related to those of the respective main contracts, and these are not measured at fair value through profit or loss.
Non-option embedded derivatives are separated from the respective main contracts in accordance with the stated or implied substantive terms, so they have a zero fair value upon initial recognition.
3.2.12 Trade accounts receivable
These are recorded at their invoiced amounts, in the normal course of the Company´s business, adjusted for exchange rate variations where denominated in foreign currency and, if applicable, net of expected credit losses.
The Company applies an aging-based provision matrix with appropriate groupings for its portfolio. When necessary, based on individual analyses, the provision for expected losses is supplemented.
The Company examines the maturity of receivables on a monthly basis and identifies those customers with overdue balances, assessing the specific situation of each client, including the risk of loss, the existence of contracted insurance, letters of credit, collateral and the customer’s financial situation. In the event of default, collection attempts are made, which include direct contact with customers and collection efforts through third parties. Should these efforts prove unsuccessful, legal measures are considered, and expected credit losses are recognized. The notes are written off from the credit expected loss when Management considers that they are not recoverable after taking all appropriate measures to collect them.
3.2.13 Inventories
These are evaluated at the average acquisition or formation cost of the finished products, net of recoverable taxes, not exceeding their net realizable value.
Finished products and work-in-process consist of raw materials, direct labor, production costs, freight, storage and general production expenses, which are related to the processes required to make the products available for sale.
Imports in transit are presented at the cost incurred up to the balance sheet date.
Raw materials derived from biological assets are measured based on their fair value, less costs to sell at the point of harvest and freight costs.
Provisions for obsolescence, adjustments to net realizable value, impaired items and slow-moving inventories are recorded when necessary. Usual production losses are recorded and are an integral part of the production costs for the respective month, whereas unusual losses, if any, are recorded directly as part of cost of sales.
3.2.14 Non-current assets held for sale
These are measured at their carrying amount or fair value less costs to sell, whichever is lower, and are not depreciated or amortized. Such items are only classified in this account when the sale is highly probable and the assets are available for immediate sale in their current condition.
3.2.15 Biological assets
The biological assets for production (mature and immature forests) are reforested eucalyptus forests, with a formation cycle between planting and harvest from 6 to 7 years, measured at fair value. Depletion is measured based on the amount of biological assets depleted (harvested) and measured at fair value at the time of harvest.
For the determination of the fair value, the income approach technique was applied, using the discounted cash flow model, according to the projected productivity cycle for these assets. The assumptions used to measure the fair value are reviewed every six months, as the Company considers that this interval is sufficient to ensure no significant gaps in the fair value balance of biological assets booked. Significant assumptions are presented in Note 13.
The gain or loss on the assessment of fair value is recognized in operating income (expenses), net.
Biological assets in the process of formation under the age of 2 (two) years are recorded for at their formation cost. Areas of permanent environmental preservation are not recorded, because these are not characterized as biological assets, and are not included in the measurement at fair value.
3.2.16 Property, plant and equipment
Stated at their cost of acquisition, formation, construction or dismantling, net of recoverable taxes. This cost is deducted from the accumulated depreciation and accumulated impairment losses, when incurred, at the higher of the value in use or the proceeds from sale less cost to sell. The borrowing costs are capitalized as a component of construction in progress, at the weighted average rate of the Company’s debt at the capitalization date, adjusted for the equalization of exchange rate effects.
Depreciation is recognized based on the estimated economic useful life of each asset on a straight-line basis. The estimated useful lives, residual values and depreciation methods are reviewed annually, and the effects of any changes in estimates are accounted for prospectively. Land is not depreciated.
The Company performs an annual analysis of impairment indicators of property, plant and equipment. Impairment for losses on property, plant and equipment are only recognized if the related cash-generating unit is devalued, or if the asset’s recoverable amount is less than its carrying amount. The recoverable amount of the asset or cash-generating unit is the higher of its value in use, and its fair value less costs to sell.
The cost of major renovations is capitalized if the future economic benefits exceed the performance standards initially estimated for the asset and are then depreciated over the remaining useful life of the related asset.
Repairs and maintenance are expensed as incurred.
Gains and losses on disposals of property, plant and equipment are measured by comparing the proceeds with the book value and are recognized as other operating income (expenses), net, at the disposal date.
3.2.17 Leases
A contract is, or contains, a lease if the right to control the use of an identified asset for a period of time is transferred in exchange for consideration, for which it is necessary to assess whether:
(i)The contract involves the use of an identifiable asset, which may be explicit or implicit, and may be physically distinct or represent almost the entire capacity of a physically distinct asset. If the supplier has a substantial right to replace the asset, then the asset is not identified;
(ii)The Company has the right to obtain substantially all the economic benefits from the use of the asset during the contract period; and
(iii)The Company has the right to direct the use of the asset, meaning the Company has the right to decide to change how and for what purpose the asset is used, if:
It has the right to operate the asset, or
It designed the asset, in a way that predetermines how and for what purpose it will be used.
At the beginning of the contract, the Company recognizes a right-of-use asset and a lease liability that represents the obligation to make payments related to the asset underlying the lease.
The right-to-use asset is initially measured at cost, which includes the initial amount of the lease liability adjusted for any payments made up to the contract start date, plus any direct initial costs incurred, and estimated costs of disassembly, removal, or restoration of the asset in the place where it is located, less any incentives received.
The right-to-use asset is subsequently depreciated using the straight-line method from the start date to the end of the useful life of the right to use, or the end of the lease term, whichever is shorter. Except for land agreements that are automatically extended for the same period through a notification to the lessor, other agreements are not allowed automatic renewals for an indefinite period, since both parties have the right to terminate the agreements.
The lease liability is initially measured at the present value of the payments not made, less the incremental loan rate.
The lease liability is measured at amortized cost using the effective interest method. It is remeasured when there is a change:
(i)In future payments resulting from a change in index or rate;
(ii)In the estimate of the expected amount to be paid, at the guaranteed residual value; or
(iii)In the assessment of whether the Company will exercise the purchase option, extension or termination.
When the lease liability is remeasured, the corresponding adjustment amount is recorded in the book value of the right-of-use asset, or in the statement of profit and loss, if the book value of the right-of-use asset has been reduced to zero.
The Company does not have lease agreements with clauses imposing:
(i)Variable payments that are based on the performance of the leased assets;
(ii)Guarantees of residual value; and
(iii)Restrictions, such as, for example, an obligation to maintain financial ratios.
Short-term or low-value contracts which are exempt from these standards are contracts where the individual value of the assets is lower than US$5, and for which the maturity date is shorter than 12 months, are expensed as incurred.
3.2.18 Intangible assets
These are measured at cost at the time when they are initially recognized. The cost of intangible assets acquired during a business combination corresponds to the fair value at the acquisition date. After initial recognition, intangible assets are presented at cost less accumulated amortization and impairment losses, when applicable.
The useful life of intangible assets are assessed as finite or indefinite.
Intangible assets with a finite life are amortized over the economically useful lives and reviewed for impairment whenever there is an indication that their carrying values may be impaired. The amortization period and method for intangible assets with finite useful lives are reviewed at least at the end of each fiscal year. The amortization of intangible assets with finite useful lives is recognized in the statement of income as an expense related to its use, and in line with the economically useful life of the intangible asset.
Intangible assets with indefinite useful lives are not amortized, but are tested annually for impairment losses, individually or at the CGU level. The allocation is made to the CGU or group of CGUs that represents the lowest level within the entity for which goodwill is monitored for management's internal purposes, that has benefited from the business combination. The Company mainly records in this subgroup goodwill for expected future profitability (goodwill) and easement of passage.
This testing involved the adoption of assumptions and judgments, disclosed in Note 16.
3.2.19 Current and deferred income tax and social contribution and uncertainty over income tax treatments (IFRIC 23)
Income taxes include income tax and social contribution on net income, current and deferred. These taxes are recognized in the income statement, except to the extent that they relate to items recognized directly in equity. In this case, they are recognized in equity under other reserves.
The current charge is calculated based on the tax laws enacted in the countries in which the Company and its subsidiaries and affiliates operate and generate taxable income. Management periodically evaluates the positions assumed in the income tax returns with respect to situations in which the applicable tax regulations give rise to interpretations and establishes provisions, when appropriate, based on the amounts that must be paid to the tax authorities.
Deferred tax and contribution liabilities are recognized on temporary differences between the tax bases of assets and liabilities and their carrying amounts in the financial statements. Deferred taxes and contributions are determined based on the rates in force on the balance sheet date, and which must be applied when they are realized or settled.
Deferred tax assets and contributions are recognized to the extent that it is probable that future taxable profits will be available for use to offset temporary differences, based on the projections of future results prepared and based on internal assumptions and future economic scenarios that may, therefore, undergo changes.
The projection for the realization of deferred tax assets was prepared based on Management's estimates that are based on significant judgments and assumptions relating to net average pulp and paper prices, and the transfer prices with the subsidiaries based in Austria. However, there are other assumptions that are not under the control of the Company, such as inflation rates, exchange rates, pulp prices in the international market, and other economic uncertainties in Brazil, which mean that future results may differ from those considered in the preparation of the consolidated projection.
Deferred income tax and social contribution are recognized on temporary differences arising from investments in subsidiaries and associates, except when the timing of the reversal of temporary differences is controlled by the Company, and if it is probable that the temporary differences will not be reversed in the foreseeable future.
Deferred tax and contribution assets and liabilities are offset and presented at their net amounts in the balance sheet whenever they are related to the same legal entity and the same tax authority.
3.2.20 Trade accounts payable and supplier finance arrangement
Corresponds to the obligations payable for goods or services acquired in the normal course of the Company´s business, recognized at fair value and subsequently measured at amortized cost using the effective interest rate method, adjusted to present value, plus exchange rate variations when denominated in foreign currency.
Supplier finance arrangements are made available for suppliers to anticipate receivables related to the Company's routine purchases. In this transaction, financial institutions pay suppliers who opted for early receipt in exchange for a discount and, when agreed upon between financial institutions and suppliers (the decision to adhere to this transaction is exclusive to the suppliers), the Company pays the financial institutions the total nominal amount of the original obligation on the original payment date. Therefore, these transactions do not change the amounts, nature and timing of the liabilities (including terms, prices and conditions previously agreed upon) and do not affect the Company with the financial charges charged by financial institutions. Additionally, payments made by the Company are directly related to supplier invoices and do not change cash flows. Accordingly, the Company continues to recognize suppliers who opted for drawdown risk in operating activities in the statements of cash flows.
3.2.21 Loans, financing and debentures
Loans and financing are initially recognized at fair value, net of costs incurred in the transaction, and are subsequently stated at amortized cost. Any difference between the amounts raised and settled is recognized in the statement of income during the period in which the loans and financing are outstanding, using the effective tax rate method.
General or specific borrowing costs, directly attributable to the acquisition, construction or production of a qualifying asset, are capitalized as a part of the cost of that asset when it is probable that they will provide future economic benefits for the entity, and that such cost can be measured with reliability. The Company does not have specific loans to obtain qualifying assets. Other loan costs are recognized as expenses in the period during which they are incurred.
3.2.22 Provisions, contingent assets and liabilities
Contingent assets are not recorded. Recognition is only performed when there are guarantees or favorable judicial decisions and the amounts of these can be measured reliably. Contingent assets for which such conditions are not met are only disclosed in the notes to the financial statements when their amounts are material.
Provisions are made to the extent that the Company expects that is probable that it will disburse cash, and the amount can be reliably estimated. Tax, civil, environmental and labor proceedings are accrued when losses are assessed as probable, and the amounts involved can be measured reliably, being recorded net of judicial deposits, under “provisions for judicial liabilities”. When the expectation of loss is possible, a description of the processes and amounts involved is disclosed in the notes to the financial statements. Contingent liabilities assessed as representing remote losses are neither accrued nor disclosed.
Contingent liabilities arising from business combinations are recognized if they arise from a present obligation as a result of from past events, and if their fair values can be measured reliably, and are subsequently measured at the higher of:
(i)The amount that would be recognized in accordance with the accounting policy for the provisions above that comply with IAS 37; or
(ii)The amount initially recognized less, where appropriate, revenue recognized in accordance with the accounting treatment of revenue from customer contracts under IFRS 15.
Principal and penalties amounts related to Tax, civil, environmental and labor proceedings are under other operating income and expenses and the interest is recognized in the net financial result.
The realization of provisions for judicial liabilities and contingent liabilities arising from business combinations, with possible and remote probability of loss, are recognized under other operating income and expenses or cash depending on the court decision.
3.2.23 Asset retirement obligations
These primarily relate to future costs for the decommissioning of industrial landfill sites and related assets. A provision is recorded as a long-term obligation within property, plant and equipment. The provision and the corresponding property, plant and equipment are initially recorded at fair value, based on the present value of the estimated cash flow for future cash payments discounted at an adjusted risk-free rate. The long-term obligation accrues interest using a long-term discount rate, recognized under other liabilities. Property, plant and equipment are depreciated on a straight-line basis over the useful life of the principal, against cost of sales in the income statement.
3.2.24 Share based payments
The Company’s executives and managers receive their compensation partially through share-based payment plans to be settled in cash and shares, or alternatively in cash only.
Plan-related expenses are recognized in the income statement as a corresponding entry within financial liabilities during the vesting period when the services will be rendered. The financial liability is measured at its fair value on every balance sheet date, and its variations are recorded in the income statement as administrative expenses.
At the option exercise date, if such options are exercised by the executive in order to receive shares in the Company, financial liabilities are reclassified under stock options granted in shareholders’ equity. In the case of options exercised in cash, the Company settles the related financial liability in favor of the Company’s executives.
3.2.25 Employee benefits
The Company offers benefits through a supplementary contribution plan to all employees, as well as medical assistance and life insurance for a determined group of former employees, and for the latter two benefits an annual actuarial appraisal is prepared by an independent actuary, and are reviewed by Management. The respective impact is recognized in employee benefit plans.
Actuarial gains and losses are recognized in other reserves when incurred. The interest incurred, resulting from changes in the present value of the actuarial liability, is recorded in the income statement within financial expenses.
3.2.26 Other assets and liabilities, current and non-current
Assets are recognized only when it is probable that the economic benefit associated with the transaction will flow to the entity, and its cost or value can be measured reliably.
A liability is recognized when the Company has a legal or constructive obligation arising from a past event, and it is probable that an economic resource will be required to settle this liability.
3.2.27 Government grants and assistance
Government grants and assistance are recognized at fair value when it is reasonably certain that the conditions established by the granting Governmental Authority were observed, and that these subsidies will be obtained. These are recorded as deductions expenses in the income statement for the period of enjoyment of the benefit, and subsequently allocated to the tax incentives reserve under shareholders’ equity, when applicable.
3.2.28 Dividends and interest on own capital
The distribution of dividends or interest on own capital is recognized as a liability, calculated based on the Corporate Law, the bylaws and the Company's Dividend Policy, which establishes that the minimum annual dividend is the lower of: (i) 25% of adjusted net income, or (ii) 10% the consolidated operating cash flow for the year, provided they are declared before the end of the year. Any portion in excess of the minimum mandatory dividends, if declared after the balance sheet date, must be recorded as part of the additional dividends proposed in shareholders' equity, until approved by the shareholders at a General Meeting. After approval, the reclassification to current liabilities is made.
The tax benefit of interest on own capital is recognized in the income statement under income tax.
3.2.29 Share capital
Common shares are classified in shareholders’ equity. Incremental costs directly attributable to a public offer are stated in shareholders’ equity as a deduction from the amount raised, net of taxes.
3.2.30 Revenue recognition
Revenue from contracts with customers is recognized at the time when control of the products is transferred to customers, represented by the ability to determine the use of products and obtain substantially all the remaining benefits from the products.
The Company follows the five-step model: (i) identification of contracts with customers; (ii) identification of performance obligations under the contracts; (iii) determining the transaction price; (iv) allocation of the transaction price to the performance obligations provided for in the contracts; and (v) recognition of revenue when the performance obligations have been met.
For the Pulp operating segment, revenue recognition occurs when control is transferred to the buyer who assumes the remaining benefits of the asset and is based on the parameters provided by: (i) International Commercial Terms (“Incoterms”), when destined for the foreign market; and (ii) lead times, when destined for the internal market.
For the operating segment Paper and Consumer Goods, revenue recognition occurs when control is transferred to the buyer who assumes the remaining benefits of the asset and is based on the parameters provided by: (i) the corresponding International Commercial Terms (“Incoterms”); and (ii) lead times, when destined for the external and internal markets.
Revenue is measured at the fair value of the consideration received or receivable, net of taxes, returns, rebates and discounts, and recognized in accordance with the accrual basis of accounting, when the amount can be reliably measured.
Accumulated experience is used to estimate and provide for rebates and discounts, using the expected value method, and revenue is only recognized to the extent that it is highly unlikely that a significant reversal will occur. A provision for reimbursement (included in trade accounts receivable) is recognized for expected rebates and discounts payable to customers in relation to sales made until the end of the reporting period. No significant element of financing is deemed to be present, as sales are made with short credit terms.
3.2.31 Financial income and expenses
Includes interest income on financial assets, at the effective interest rate, which includes the amortization of funding raising costs, gains and losses on derivative financial instruments, interest on loans and financing, exchange variations on loans and financing and other assets and financial liabilities and monetary variations on other assets and liabilities. Interest income and expenses are recognized in the statement of income using the effective interest method.
3.2.32 Earnings (losses) per share
Basic earnings (losses) per share are calculated by dividing the net profit (loss) attributable to the holders of ordinary shares of the Company to the weighted average number of ordinary shares during the year.
Diluted earnings per share are calculated by dividing the net profit attributable to the holders of ordinary shares of the Company by the weighted average number of ordinary shares during the year, plus the weighted average number of ordinary shares that would be issued when converting all potential dilutive ordinary shares into ordinary shares.
3.2.33 Employee and management profit sharing
Employees are entitled to profit sharing based on certain goals agreed annually. For the Administrators, the statutory provisions proposed by the Board of Directors and approved by the shareholders are used as a basis. Provisions for participation are recognized in the payroll and charges against to administrative expenses during the period in which the targets are attained.
3.2.34 Material accounting judgments, estimates and assumptions
As disclosed in Note 2, Management used judgments, estimates and accounting assumptions regarding the future, uncertainty in which may lead to results that require significant adjustments to the book values of certain assets, liabilities, income and expenses in future years, are presented below:
Control, significant influence and consolidation (Note 1.1);
Share-based payment transactions (Note 22);
Transfers to control for revenue recognition (Note 27);
Fair value of financial instruments (Note 4);
Annual analysis of the impairment of non-financial assets (Notes 15 and 16);
Expected credit losses in the accounts receivable (Note 7);
Net realizable value provision for inventory (Note 8);
Annual analyses of the recoverability of taxes (Notes 9 and 12);
Fair value of biological assets (Note 13);
Useful lives of property, plant and equipment and intangible assets with defined useful life (Notes 15 and 16);
Annual analysis recoverable amount of goodwill (Note 16);
Leases (Note 19);
Provision for legal liabilities (Note 20); and
Pension and post-employment plans (Note 21).
The Company reviews the estimates and underlying assumptions used in its accounting estimates on an annual basis. Revisions to the accounting estimates are recognized in the period during which the estimates are revised.
3.3 Accounting policies not yet adopted
The new and changed standards and interpretations issued, but not yet adopted up to December 31, 2024, are described below. The Company intends to adopt these new standards, changes and interpretations, if applicable, when they come into force, and does not expect them to have a material impact on the financial statements except for the IFRS 18 as disclosed below.
3.3.1 Amendments to IAS 21: Absence of interchangeability (applicable for annual on/or after January 1, 2025)
The changes will create requirements for the entity to apply a consistent approach to assessing whether a currency is exchangeable for another currency and, when it is not, to determining the appropriate exchange rate to use and the disclosures to be made.
In this context, exchangeability is considered non-existent when, for a given purpose, the entity is unable to obtain more than an insignificant amount of foreign currency. To this end, the entity evaluates:
(i)the timeliness of obtaining foreign currency;
(ii)the practical ability (and not the intention) to obtain foreign currency; It is
(iii)the available markets or exchange mechanisms that create enforceable rights and obligations.
3.3.2 Amendment to IFRS 9 and IFRS 7 - Classification and Measurement of Financial Instruments (applicable for annual on/or after January 1, 2026)
On 30 May 2024, the IASB issued targeted amendments to IFRS 9 and IFRS 7 to respond to recent questions arising in practice, and to include new requirements not only for financial institutions but also for corporate entities. These amendments:
clarify the date of recognition and derecognition of some financial assets and liabilities,with a new exception for some financial liabilities settled through an electronic cash transfer system;
clarify and add further guidance for assessing whether a financial asset meets the solely payments of principal and interest (SPPI) criterion;
add new disclosures for certain instruments with contractual terms that can change cash flows (such as some financial instruments with features linked to the achievement of environment, social and governance targets); and
update the disclosures for equity instruments designated at fair value through other comprehensive income (FVOCI).
3.3.3 IFRS 18 Presentation and Disclosure in Financial Statements (applicable for annual on/or after January 1, 2027)
IFRS 18 will replace IAS 1 Presentation of financial statements, introducing new requirements that will help to achieve comparability of the financial performance of similar entities and provide more relevant information and transparency to users. Even though IFRS 18 will not impact the recognition or measurement of items in the financial statements, its impacts on presentation and disclosure are expected to be pervasive, in particular those related to the statement of financial performance and providing management-defined performance measures within the financial statements.
Management is currently assessing the detailed implications of applying the new standard on the Company’s consolidated financial statements. From the high-level preliminary assessment performed, the following potential impacts have been identified:
(i) Although the adoption of IFRS 18 will have no impact on the Company’s net profit, the Company expects that grouping items of income and expenses in the statement of profit or loss into the new categories will impact how operating profit is calculated and reported. From the high-level impact assessment that the Company has performed, the following items might potentially impact operating profit:
Foreign exchange differences currently aggregated in the line item ‘other income and other gains/(losses) – net’ in operating profit might need to be disaggregated, with some foreign exchange gains or losses presented below operating profit.
IFRS 18 has specific requirements on the category in which derivative gains or losses are recognised – which is the same category as the income and expenses affected by the risk that the derivative is used to manage. Although the Company currently recognises some gains or losses in operating profit and others in finance costs, there might be a change to where these gains or losses are recognised, and the Company is currently evaluating the need for change.
(ii) The line items presented on the primary financial statements might change as a result of the application of the concept of ‘useful structured summary’ and the enhanced principles on aggregation and disaggregation. In addition, since goodwill will be required to be separately presented in the statement of financial position, the Company will disaggregate goodwill and other intangible assets and present them separately in the statement of financial position.
(iii) The Company does not expect there to be a significant change in the information that is currently disclosed in the notes because the requirement to disclose material information remains unchanged; however, the way in which the information is grouped might change as a result of the aggregation/disaggregation principles. In addition, there will be significant new disclosures required for:
management-defined performance measures;
a break-down of the nature of expenses for line items presented by function in the operating category of the statement of profit or loss – this break-down is only required for certain nature expenses; and
for the first annual period of application of IFRS 18, a reconciliation for each line item in the statement of profit or loss between the restated amounts presented by applying IFRS 18 and the amounts previously presented applying IAS 1.
(iv) From a cash flow statement perspective, there will be changes to how interest received and interest paid are presented. Interest paid will be presented as financing cash flows and interest received as investing cash flows, which is a change from current presentation as part of operating cash flows.
The Company will apply the new standard from its mandatory effective date of 1 January 2027. Retrospective application is required, and so the comparative information for the financial year ending 31 December 2026 will be restated in accordance with IFRS 18.
3.3.4 IFRS 19 Subsidiaries without Public Accountability: Disclosures (applicable for annual on/or after January 1, 2027)
Issued in May 2024, IFRS 19 allows for certain eligible subsidiaries of parent entities that report under IFRS Accounting Standards to apply reduced disclosure requirements.
v3.25.1
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT
12 Months Ended
Dec. 31, 2024
Disclosure of detailed information about financial instruments [abstract]  
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT
4 FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT
4.1 Financial risks management
4.1.1 Overview
As a result of its activities, the Company is exposed to various financial risks, which are managed in accordance with the Financial Risk Management, Counterparty and Issuer Risk, Debt, Derivative and Cash Management Policies (“Financial Policies”) approved at the Board of Directors' meeting.
The main factors considered by Management are:
(i)Liquidity;
(ii)Credit;
(iii)Exchange rate;
(iv)Interest rate;
(v)Fluctuations of pulp selling and commodity prices; and
(vi)Capital.

Management are focused on generating consistent and sustainable results over time, however, arising from external risk factors, unintended levels of volatility can influence the Company’s cash flow and income statement.
The Company has policies and procedures for managing market risk which aims to:
(i)Reduce, mitigate or transfer exposure with the aim of protecting the Company’s cash flow and assets against fluctuations in the market prices of raw material and products, exchange rates and interest rates, price and adjustment indices ("market risk") or other assets or instruments traded in liquid or illiquid markets to which the value of the assets, liabilities and cash flow are exposed;
(ii)Establish limits and instruments with the purpose of allocating the Company's cash to financial institutions falling within acceptable credit risk exposure parameters; and
(iii)Optimize the process of contracting financial instruments for protection against exposure to risk, drawing on natural hedges and correlations between the prices of different assets and markets, avoiding any waste of funds for inefficient transactions. All financial transactions entered into by the Company aim to protect existing exposures, with the assumption of new risks being prohibited, except those arising from its operating activities.
Hedging instruments are contracted exclusively for hedging purposes and are based on the following terms:
(i)Protection of cash flow against currency mismatches;
(ii)Protection of revenue flows for debt settlement and interest payments against fluctuations in interest rates and currencies; and
(iii)Protection against fluctuations in the prices of pulp and other supplies related to production.
The Treasury team is responsible for identification, evaluating and seeking protection against possible financial risks. The Board of Directors approves financial policies that establish the principles and guidance for global risk management, the areas involved in these activities, the use of derivative and non-derivative financial instruments, and the allocation of a cash surplus.
The Company only uses the most liquid financial instruments, and:
(i)Does not enter into leveraged transactions or other forms of embedded options that change the purpose of protection (hedge);
(ii)Does not have double-indexed debt or other forms of implied options; and
(iii)Does not have any transactions requiring margin deposits or other forms of collateral for counterparty credit risk.
The Company does not use hedge accounting. Therefore, gains and losses from derivative operations are fully recognized in the statements of income, as disclosed in Note 26.
4.1.2 Classification
All transactions with financial instruments are recognized for accounting purposes and classified in the following categories:
Note12/31/202412/31/2023
Assets
Amortized cost
Cash and cash equivalents59,018,818 8,345,871 
Marketable securities6 
Trade accounts receivable79,132,860 6,848,454 
Other assets (1)

628,275 737,222 

18,779,953 15,931,547
Fair value through other comprehensive income

Investments14.11,138,066 23,606 

1,138,066 23,606
Fair value through profit or loss

Derivative financial instruments4.5.13,887,100 4,430,454 
Marketable securities613,363,511 13,267,286 

17,250,611 17,697,740

37,168,630 33,652,893
Liabilities

Amortized cost

Trade accounts payable176,033,285 5,572,219 
Loans, financing and debentures18.1101,435,531 77,172,692 
Lease liabilities19.26,972,915 6,243,782 
Liabilities for assets acquisitions and subsidiaries23120,490 187,187 
Dividends and interests on own capital payable

2,200,917 1,316,528 
Other liabilities (1)

143,330 116,716 

116,906,468 90,609,124
Fair value through profit or loss

Derivative financial instruments4.5.110,454,820 2,436,072 

10,454,820 2,436,072

127,361,288 93,045,196

90,192,658 59,392,303
(1)Does not include items not classified as financial instruments.
4.1.3 Fair value of loans and financing
The financial instruments are recognized at their contractual amounts. In order to determine the market values of financial instruments traded in public and liquid markets, the market closing prices were used at the balance sheet dates. The fair values of interest rate and index swaps are calculated based on the present value of their future cash flow, discounted at the current interest rates available for transactions with similar remaining terms to maturity. This calculation is based on the quotations of B3 and ANBIMA for interest rate transactions in Brazilian Reais, and the Federal Reserve Bank of New York and Bloomberg for Secured Overnight Financing Rate (“SOFR”) transactions. The fair value of forward or forward exchange agreements is determined using the forward exchange rates prevailing at the balance sheet dates, in accordance with B3 prices.
In order to determine the fair values of financial instruments traded in over-the-counter or unliquidated markets, a number of assumptions and methods based on normal market conditions and not for liquidation or forced sale, are used at each balance sheet date, including the use of option pricing models such as Garman-Kohlhagen, and estimates of discounted future cash flow. The fair value of agreements for the fixing of oil bunker prices is obtained based on the Platts index.
The estimated fair values of loans and financing are set forth below:
Yield used to discount/methodology12/31/202412/31/2023
Quoted in the secondary market
In foreign currency

BondsSecondary Market48,734,909 38,703,379 
Estimated present value
In foreign currency
Export credits (“Prepayment”)SOFR22,740,891 17,783,760 
Assets FinancingSOFR422,115 278,107 
ECA - Export Credit AgencySOFR864,202 
IFC - International Finance CorporationSOFR6,261,715 3,198,761 
Panda Bonds - CNHFixed951,125 
In local currency
BNDES – TJLPDI 1171,109 215,458 
BNDES – TLPDI 13,275,012 2,712,762 
BNDES – FixedDI 1 3,903 
BNDES – TRDI 133,466 
BNDES – Selic (“Special Settlement and Custody System”)DI 1645,139 686,798 
BNDES – UMBNDESDI 2106,966 
Assets FinancingDI 160,566 75,622 
DebenturesDI 1/IPCA12,002,992 8,881,277 
NCE (“Export Credit Notes”) DI 1108,308 110,396 
NCR (“Rural Credit Notes”)DI 12,424,457 2,228,806 
Export credits (“Prepayment”)DI 1 824,035 
98,802,972 75,703,064
The book values of loans and financing are disclosed in Note 18.
Management considers that, for its other financial assets and liabilities measured at amortized cost, their book values approximate their fair values, and therefore the fair value information is not being presented.
4.2 Liquidity risk management
The Company’s purpose is to maintain a strong cash and marketable securities position to meet its financial and operating commitments. The amount held in cash is intended to cover the expected outflows in the normal course of its operations, while the cash surplus is generally invested in highly liquid financial investments according to the Cash Management Policy.
The cash position is monitored by the Company’s Management, by means of management reports and participation in performance meetings with determined frequencies.
In the year ended December 31, 2024, the variations in cash and marketable securities were as expected, and the cash generated from operations was mostly used for investments and debt service.
All derivative financial instruments were traded over the counter and do not require deposit guarantee margins.
The remaining contractual maturities of financial liabilities are presented as of the balance sheet date.
The amounts as set forth below consist of undiscounted cash flow, and include interest payments and exchange rate variations, and therefore may not reconcile with the amounts disclosed in the balance sheet.
12/31/2024
Book valueUndiscounted cash flowUp to 1 year1 - 2 years2 - 5 yearsMore than 5 years
Liabilities
Trade accounts payables6,033,285 6,033,285 6,033,285 
Loans, financing and debentures 101,435,531 142,028,543 13,599,011 14,235,170 50,858,667 63,335,695 
Lease liabilities6,972,915 12,099,294 1,302,590 1,176,832 3,094,493 6,525,379 
Liabilities for asset acquisitions and subsidiaries120,490 146,082 23,425 22,400 100,257 
Derivative financial instruments 10,454,820 13,878,150 1,676,180 957,540 1,489,357 9,755,073 
Dividends and interests on own capital payable2,200,917 2,200,917 2,200,917 
Other liabilities143,330 143,330 60,892 82,438 
127,361,288 176,529,601 24,896,300 16,474,380 55,542,774 79,616,147 
12/31/2023
Book
value
Undiscounted cash flowUp to 1 year1 - 2 years2 - 5 yearsMore than 5 years
Liabilities
Trade accounts payables5,572,219 5,572,219 5,572,219 
Loans, financing and debentures 77,172,692 105,526,852 7,648,237 12,983,542 31,355,362 53,539,711 
Lease liabilities6,243,782 11,021,519 1,172,568 1,045,795 2,743,793 6,059,363 
Liabilities for asset acquisitions and subsidiaries187,187 215,891 94,948 18,314 87,520 15,109 
Derivative financial instruments 2,436,072 2,801,258 66,433 1,278,953 1,191,014 264,858 
Dividends and interests on own capital payable1,316,528 1,316,528 1,316,528 
Other liabilities116,716 116,716 58,955 57,761 
93,045,196126,570,98315,929,88815,384,36535,377,68959,879,041
4.3 Credit risk management
Related to the possibility of non-compliance with the counterparties’ commitments as part of a transaction. Credit risk is managed on a group basis and arises from cash equivalents, marketable securities, derivative financial instruments, bank deposits, Bank Deposit Certificates ("CDB"), fixed income box, repurchase agreements, letters of credit, insurance, receivable terms of customers, and advances to suppliers for new projects, among others.
4.3.1 Trade accounts receivable
The Company has commercial and credit policies aimed at mitigating any risks arising from defaults by its customers, mainly through contracting credit insurance policies, bank guarantees provided by first-tier banks, and collateral based on liquidity. Moreover, portfolio customers are subject to internal credit analysis aimed at assessing the risks regarding payment performance, both for exports and for domestic sales.
For customer credit assessment, the Company applies a matrix based on the analysis of qualitative and quantitative aspects to determine the individual credit limits to each customer according to the identified risks. Each analysis is submitted for approval according to an established hierarchy and, if applicable, for approval at a Management meeting and by the Credit Committee.
The risk classification of trade accounts receivable is set forth below:
Consolidated
12/31/202412/31/2023
Low (1)
8,899,516 6,549,975 
Average (2)
174,048 156,883 
High (3)89,596 173,558 
9,163,160 6,880,416
1) Current and overdue up to 30 days.
2) Overdue between 30 and 90 days.
3) Overdue more than 90 days.

A portion of the amounts above does not consider the expected credit losses calculated based on the provision matrix of R$30,300 and R$31,962 as of December 31, 2024 and 2023, respectively.
4.3.2 Banks and financial institutions
The Company, in order to mitigate its credit risk, ensures its financial operations are diversified among banks, with a main focus on first-tier financial institutions classified as high-grade by the main risk rating agencies.
The book value of financial assets representing exposure to credit risk is set forth below:
Consolidated
12/31/202412/31/2023
Cash and cash equivalents9,018,818 8,345,871 
Marketable securities13,363,511 13,267,286 
Derivative financial instruments (1)
3,887,100 4,199,982 
26,269,429 25,813,139
1) Does not include the derivative embedded in a forest partnership agreement for the supply of standing wood, which is not a transaction with a financial institution.
The counterparties, mainly financial institutions, with whom the transactions are performed classified under cash and cash equivalents, marketable securities and derivatives financial instruments, are rated by the main ratings agencies. The risk ratings are set forth below:
Cash and cash equivalents and marketable securitiesDerivative financial instruments
12/31/202412/31/202312/31/202412/31/2023
Risk rating (1)
AAA232,908 878,241 
AA-286,906 1,007,537 
A+148,029 136,864 
A 55,547 
brAAA20,830,651 20,856,072 2,747,948 1,682,513 
brAA+658,880 511,589  439,280 
brAA755 6,565  
brAA-19 2,169  
brA31,504  
brBBB-3  
brBB710 1,132  
brBB-750,359 385 156,450 
Others109,448 235,242 314,859 
22,382,329 21,613,1573,887,100 4,199,982
1) We use the Brazilian Risk Ratings issued by the agencies Fitch Ratings, Standard & Poor’s and Moody’s.

4.4 Market risk management
The Company is exposed to several market risks, mainly related to fluctuations in exchange rate variations, interest rates, inflation rates, pulp selling prices and commodity prices that could affect its results and financial situation.
To mitigate the impacts, the Company has processes to monitor its exposure and policies that could support the implementation of risk management.
These policies establish the limits and the instruments to be implemented for the purpose of:
(i)Protecting cash flow due to currency mismatch;
(ii)Mitigating exposure to interest rates;
(iii)Reducing the impacts of fluctuations in commodity’s prices; and
(iv) Changes to debt indexes.
Market risk management involves the identification, assessment and implementation of the strategy, with the effective contracting of adequate financial instruments.
4.4.1 Exchange rate risk management
The fundraising, financing and currency hedging policies of the Company are guided by the fact that a substantial part of the net revenue arises from exports with prices negotiated in US Dollars, while a substantial part of the production costs are in Brazilian Reais. This structure allows the Company to enter into export financing arrangements in US Dollars, and to reconcile the financing payments with the cash flow of receivables from sales in foreign markets, using the international bond market as an important portion of its capital structure, and providing a natural cash hedge for these commitments.
Moreover, the Company enters into US$ selling transactions in the futures markets, including strategies involving options, to ensure attractive levels of operating margins for a portion of revenue. Such transactions are limited to a percentage of the net surplus foreign currency over a 24-months’ time horizon and therefore, are matched to the availability of currency for sale in the short term. The Company's Board of Directors approved the contracting of extraordinary hedge, in addition to the strategy mentioned above, for investments in the Cerrado Project, with a term of up to 36 months as of November 2021, in an amount of up to US$1,000,000. On July 27, 2022, the Board of Directors approved the expansion of the program, increasing the maximum amount (notional) to US$1,500,000, maintaining the previously established deadline. In order to provide transparency on the hedge program for the Cerrado Project, since December 31, 2021 the Company has started to prominently disclose the respective contracted operations.
The assets and liabilities that are exposed to foreign currency, substantially in US$, are set forth below:
12/31/202412/31/2023
Assets
Cash and cash equivalents6,496,039 6,432,557 
Marketable securities70,255 7,378,277 
Trade accounts receivable7,090,160 5,049,609 
Derivative financial instruments3,887,100 3,070,594 
17,543,554 21,931,037
Liabilities
Trade accounts payable(1,350,763)(1,625,011)
Loans and financing(83,004,915)(61,304,673)
Liabilities for asset acquisitions and subsidiaries(93,308)(127,598)
Derivative financial instruments(10,448,379)(1,867,882)
(94,897,365)(64,925,164)
(77,353,811)(42,994,127)
4.4.1.1 Sensitivity analysis – foreign exchange rate exposure – except for derivative financial instruments
For market risk analysis, the Company uses scenarios to evaluate both its asset and liability positions in foreign currency, and the possible effects on its results. The probable scenario represents the amounts recognized, as they reflect the conversion into Brazilian Reais on the balance sheet date (R$ to US$ = R$6.1923).
This analysis assumes that all other variables, particularly interest rates, remain constant. The other scenarios considered the depreciation of the Brazilian Real against the US$ at the rates of 25% and 50% before taxes.
The following table set forth the potential impacts at their absolute amounts:
12/31/2024
Effect on profit or loss
Probable (base value)Possible (25%)Remote (50%)
Cash and cash equivalents6,496,039 1,624,010 3,248,020 
Marketable securities70,255 17,564 35,128 
Trade accounts receivable7,090,160 1,772,540 3,545,080 
Trade accounts payable(1,350,763)(337,691)(675,382)
Loans and financing(83,004,915)(20,751,229)(41,502,458)
Liabilities for asset acquisitions and subsidiaries(93,308)(23,327)(46,654)
4.4.1.2 Sensitivity analysis – foreign exchange rate exposure – derivative financial instruments
The Company has sales operations in US$ in the futures markets, including strategies using options, to ensure attractive levels of operating margins for a portion of its revenue. These operations are limited to a percentage of the total exposure to US$ over a 24-month horizon, and are therefore pegged to the availability of ready-to-sell foreign exchange in the short term.
In addition to the transaction described above, the Company also taken out derivative instruments linked to the US$ and subject to exchange fluctuations, seeking to adjust the debt's currency indexation to the cash generation currency, as provided for in its financial policies.
For the calculation of the mark-to-market (“MtM”) price, the exchange rate of the last business day of the period is used. These market movements caused a negative impact on the mark-to-market position entered into by the Company.
This analysis below assumes that all other variables, particularly the interest rates, remain constant. The other scenarios considered the depreciation of the Brazilian Real against the US$ by 25% and 50%, before taxes, based on the base scenario on December 31, 2024.
The following table set out the possible impacts assuming these scenarios:
12/31/2024
Effect on profit or loss
Probable (base value)Possible 25%Remote 50%
Dollar/Real
Derivative financial instruments
Derivative options(4,328,970)(9,226,995)(19,121,860)
Derivative swaps(1,843,087)(2,604,422)(4,992,835)
Derivative Non-Deliverable Forward (‘NDF’) Contracts(331,876)(896,742)(1,788,477)
Embedded derivatives(80,759)(183,663)(367,326)
Commodity Derivatives16,973 4,236 8,478 
4.4.2 Interest rate risk management
Fluctuations in interest rates could increase or reduce the costs of new loans and existing contracted operations.
The Company is constantly looking for alternatives for the use of financial instruments in order to avoid negative impacts on its cash flow due to fluctuations in interest rates in Brazil or abroad.
4.4.2.1 Sensitivity analysis – exposure to interest rates – except for derivative financial instruments
For its market risk analysis, the Company uses scenarios to evaluate the sensitivity of changes in operations impacted by the following rates: Interbank Deposit Rate (“CDI”), Long Term Interest Rate (“TJLP”), Long Term Rate ("TLP"), Special System for Settlement and Custody (“SELIC”) and SOFR, which could impact the results.
The probable scenario represents the amounts already booked, as they reflect Management’s best estimates.
This analysis assumes that all other variables, particularly exchange rates, will remain constant. The other scenarios considered a depreciation of 25% and 50% in market interest rates.
The following table set forth the possible impacts assuming these scenarios in absolute amounts:
12/31/2024
Effect on profit or loss
ProbablePossible (25%)Remote (50%)
CDI/SELIC
Cash and cash equivalents2,422,308 73,578 147,155 
Marketable securities13,293,256 403,783 807,565 
Loans and financing9,290,595 282,202 564,404 
TJLP/TLP
Loans and financing202,961 3,770 7,540 
SOFR
Loans and financing28,534,005 320,294 640,588 
4.4.2.2 Sensitivity analysis – exposure to interest rates – derivative financial instruments
This analysis assumes that all other variables remain constant. The other scenarios considered a depreciation of 25% and 50% in market interest rates.
The following table sets out the possible impacts of these assumed scenarios:
12/31/2024
Effect on profit or loss
ProbableProbable 25%Remote 50%
CDI
Derivative financial instruments
Liabilities
Derivative options(4,328,970)(943,363)(1,868,091)
Derivative swaps(1,843,087)(91,012)(178,459)
SOFR
Derivative financial instruments
Liabilities
Derivative swaps(1,843,087)(136,036)(261,559)
4.4.2.3 Sensitivity analysis to changes in the consumer price indices of the US economy
For the measurement of the probable scenario, the United States Consumer Price Index (“US-CPI”) was considered on December 31, 2024. The probable scenario was extrapolated considering a depreciation of 25% and 50% in the US-CPI to define the possible and remote scenarios, respectively.
The following table sets out the possible impacts, assuming these scenarios in absolute amounts:
12/31/2024
Effect on profit or loss
Probable (base value)Possible (25%)Remote (50%)
Embedded derivative in a commitment to purchase standing wood, originating from a forest partnership agreement(80,759)(32,607)(66,859)
4.4.3 Pulp and commodity price risk management
The Company is exposed to the selling price of pulp and commodity prices in the international market. The dynamics of rising and falling production capacities in the global market and macroeconomic conditions may impact the Company´s operating results.
Through a specialized team, the Company monitors hardwood pulp prices and analyses future trends, adjusting the forecasts aimed at assisting with preventive measures to calculate the different scenarios. There is no sufficiently liquid financial market to mitigate the risk of a material portion of the Company’s operations. Hardwood pulp price protection instruments available on the market have low liquidity and low volume, and high levels of distortion in price formation.
The Company is also exposed to international oil prices, reflected in logistical costs for selling in the export market, and indirectly in the costs of other supply, logistics and service contracts. In such cases, the Company evaluates whether to contract derivative financial instruments to mitigate the risk of price variations in its results.
4.5 Derivative financial instruments
The Company determines the fair value of derivative contracts, which differ from the amounts realized in the event of early settlement due to bank spreads and market factors at the time of quotation. The amounts presented by the Company are based on an estimate using market factors and use data provided by third parties, measured internally and compared to calculations performed by external consultants and by counterparties.
The fair value does not represent an obligation to make an immediate disbursement or receipt of cash, given that such an effect will only occur on the dates of contractual fulfillment or upon the maturity of each transaction, when the result will be determined, depending on the case and on the market conditions on the agreed dates.
A summary of the methodologies used for the purpose of determining the fair value by type of instrument is presented below:
(i)Swaps: the future value of the asset and liability is estimated based on the cash flows projected using the market interest rate of the currency in which the tip of the swap is denominated. The present value of the US Dollar-denominated tip is measured using the discount based on the exchange coupon curve (the remuneration, in US Dollars, of the Reais invested in Brazil) and in the case of the R$-denominated tip, the discount is made using Brazil's interest curve, being the future curve of the DI, considering the credit risk of both the Company and the counterparty. The exception is pre-fixed contracts x US$, for which the present value of the tip denominated in US$ is measured through a discount using the SOFR curve disclosed by Bloomberg. The fair value of the contract is the difference between these two points. Interest rate curves were obtained from B3.
(ii)Options (Zero Cost Collar): the fair value was calculated based on the Garman Kohlhagen model, considering both the Company’s and the counterparty credit risk. Volatility information and interest rates are observable and obtained from the B3 exchange and are used to calculate the fair values.
(iii)Non-deliverable forward (“NDF”) contracts: a projection of the future currency quote is made, using the exchange coupon curves and the future DI curve for each maturity. Next, the difference between this quotation and the rate at which the operation was contracted is verified, considering the credit risk of the Company and the counterparty. This difference is multiplied by the notional value of each contract and brought to its present value based on the future DI curve. Interest rate curves were obtained from B3.
(iv)Swap US-CPI: liability cash flows are projected based on the US inflation curve US-CPI, obtained based on the implicit rates for inflation-linked US securities (Treasury Protected against Inflation – “TIPS”), disclosed by Bloomberg. Cash flows from the asset components are projected at the fixed rates implicit in the embedded derivatives. The fair value of an embedded derivative is the difference between the two components, adjusted to present value base on the curve of the exchange coupon obtained from B3.
(v)Swap VLSFO (marine fuel): a future projection of the asset price is made, using the future price curve disclosed by Bloomberg. Next, the difference between this projection and the rate at which the operation was contracted is verified, considering both of Company’s and the counterparty’s credit risk. This difference is multiplied by the notional value of each contract and adjusted to present value using the SOFR curve disclosed by Bloomberg.
The yield curves used to calculate the fair value as of December 31, 2024 are as set forth below:
Interest rate curves
Term
Brazil (1)
United States of America (2)
US Dollar coupon (1)
1M
12.15% p.a
4.33% p.a
8.46% p.a
6M
14.19% p.a
4.25% p.a
6.37% p.a
1Y
15.41% p.a
4.17% pa.
6.41% p.a
2Y
15.94% p.a
4.16% p.a
6.29% p.a
3Y
15.89% p.a
4.21% pa.
6.22% p.a
5Y
15.60% p.a
4.36% p.a
6.41% p.a
10Y
14.96% p.a
4.88% p.a
7.31% p.a
1) Source: B3
2) Source: Bloomberg
4.5.1 Outstanding derivatives by contract type, including embedded derivatives
The positions of outstanding derivatives are set forth below:
Notional value, net in U.S.$Fair value in R$
12/31/202412/31/202312/31/202412/31/2023
Instruments as part of cash flow protection strategy
Cash flow hedge
Zero Cost Collar6,852,200 4,500,200 (4,328,970)1,968,337 
NDF (R$ x US$)581,000 505,000 (331,876)162,776 
NDF (€ x US$)262,088 100,362 
Debt hedges
Swap SOFR to Fixed (US$)1,973,705 2,555,626 394,129 741,492 
Swap IPCA to CDI (notional in Brazilian Reais)8,128,395 4,274,397 (825,899)47,645 
Swap CNH to Fixed (US$)165,815 (6,440)
Swap CDI x Fixed (US$)909,612 1,025,000 (776,261)(1,081,964)
Pre-fixed Swap R$ to US$ (US$)200,000 (203,045)
Swap CDI x SOFR (US$)610,171 125,000 (590,764)25,774 
Swap SOFR to SOFR (US$)150,961 150,961 (37,850)(16,615)
Commodity Hedge
Swap US$ e US-CPI (1)
138,439 131,510 (80,759)230,471 
Zero Cost Collar (Brent)163,941 163,100 6,097 (3,148)
Swap VLSFO/Brent39,706 142,794 10,873 22,297 
(6,567,720)1,994,382
Current assets1,006,427 2,676,526 
Non-current assets2,880,673 1,753,928 
Current liabilities(2,760,273)(578,763)
Non-current liabilities(7,694,547)(1,857,309)
(6,567,720)1,994,382
(1)The embedded derivative refers to a swap contract for the sale of price variations in US$ and US-CPI within the term of a forest partnership with a standing wood supply contract.
The current contracts and the respective protected risks are set forth below:
(i)Swap CDI x Fixed US$: positions in conventional swaps exchanging the variation of the Interbank Deposit rate (“DI”) for a fixed rate in US$. The objective is to change the debt indexed in Brazilian Reais to US$, in compliance with the Company's natural exposure to US$ receivables.
(ii)Swap IPCA x CDI (notional in Brazilian Reais): positions in conventional swaps exchanging the variation of the Amplified Consumer Price Index (“IPCA”) for the DI rate. The objective is to change the debt indexed in reais, in compliance with the Company's cash position in Brazilian Reais, which is also indexed to DI.
(iii)Swap SOFR x Fixed US$: positions in conventional swaps exchanging a post-fixed rate (SOFR) for a fixed rate in US$. The objective is to protect the cash flow against changes in the US interest rate.
(iv)Pre-Fixed Swap R$ x Fixed US$: positions in conventional swaps of a fixed rate in Reais for a fixed rate in US$. The objective is to change the exposure of debts in Brazilian Reais to US$, in compliance with the Company's natural exposure to US$ receivables.
(v)SOFR x SOFR Swap: swap position exchanging a fixed rate added to SOFR for another fixed rate added to SOFR. The objective is to generate a fee discount for Prepayment with the banking institution, allowing for reversal mechanisms.
(vi)CDI x SOFR Swap: positions in conventional swaps exchanging the variation in the Interbank Deposit rate (“DI”) for a post-fixed rate (“SOFR”) US$. The objective is to change the debt index in reais to US$, aligning with the natural exposure of the Company's US$ receivables and capturing a lower cost of debt through the fluctuation of SOFR rate projections.
(vii)Swap CNH x USD: swap positions exchanging a fixed rate in Chinese yuan for a fixed rate in US$. The objective is to change the exposure of debts in yuan to US$, aligning with the natural exposure of the Company's receivables in US$.
(viii)Zero Cost Collar: positions in an instrument that consists of the simultaneous combination of a purchase of put options and the sale of call options in US$, with the same principal amount and maturity, with the objective of protecting the cash flow of exports. Under this strategy, an interval is established where there is no deposit or receipt of financial margin at the option maturity. The objective is to protect the cash flow of exports against the depreciation of the Brazilian Real.
(ix)Non-Deliverable Forward contracts (“NDF”): short positions in US$ futures contracts with the objective of protecting the cash flow from exports against the depreciation of the Brazilian Real.
(x)Swap US-CPI: The embedded derivative refers to the swap contracts for selling price variations in US$ and the US-CPI in forest partnership with a standing wood supply contract.
(xi)Non-Deliverable Forward contracts: EUR and US$: call positions at EUR/US$ parity to protect the Capex cash flow of the Cerrado project against the appreciation of the Euro.
(xii)Swap Very Low Sulphur Fuel Oil / Brent (“VLSFO”): Long positions in oil, aimed at hedging logistical costs related to maritime freight contracts against the increase in oil prices.
(xiii)Zero Cost Collar (Brent): positions in an instrument that consists of the simultaneous combination of buying call options and selling put options for oil - Brent, with the same principal value and maturity, with the objective of protecting input costs of oil derivatives. In this strategy, an interval is established where there is no deposit or receipt of financial margin at the expiration of the options. The objective is to protect costs against rising oil prices.
The variation in the fair values of derivatives on December 31, 2024 compared to the fair values measured on December 31, 2023 are explained substantially by the depreciation of the Brazilian Real against the US$ and by settlements during the year.
There were also impacts caused by the variations in the Pre Fixed, Foreign Exchange Coupon and SOFR curves in the operations.
It is important to highlight that the outstanding agreements on December 31, 2024 are over-the-counter market operations, without any type of collateral margin or forced early settlement clause due to variations from market marking.
4.5.2 Fair Value Maturity Schedule (net amounts)
12/31/202412/31/2023
2025(1,753,846)2,097,763 
2026(1,699,768)233,072 
2027(36,905)(574,871)
2028 onwards(3,077,201)238,418 
(6,567,720)1,994,382
4.5.3 Outstanding assets and liabilities derivatives positions
The outstanding derivatives positions are set forth below:
Notional valueFair value in R$
Currency12/31/202412/31/202312/31/202412/31/2023
Debt hedges
Assets
Swap CDI to FixedUS$4,748,394 3,898,011 1,482,759 223,776 
Swap Pre-Fixed to US$ US$ 738,800  
Swap SOFR to Fixed US$ 1,973,705 2,555,626 424,824 1,104,984 
Swap IPCA to CDIR$8,382,699 4,320,471 927,586 161,542 
Swap CDI to SOFRUS$3,117,625 644,850 754,173 32,560 
Swap CNH to FixedCNH1,200,000  
Swap SOFR to SOFRUS$150,961 150,961 4,949 6,681 
3,594,291 1,529,543
Liabilities
Swap CDI to Fixed US$ 909,612 1,025,000 (2,259,020)(1,305,740)
Swap Pre-Fixed to US$ US$  200,000  (203,045)
Swap SOFR to Fixed US$ 1,973,705 2,555,626 (30,695)(363,492)
Swap IPCA to CDIR$8,128,395 4,274,397 (1,753,485)(113,897)
Swap CDI to SOFRUS$610,171 125,000 (1,344,937)(6,786)
Swap CNH to FixedCNH165,815 (6,440)
Swap SOFR to SOFRUS$ 150,961 150,961 (42,799)(23,296)
(5,437,376)(2,016,256)
(1,843,085)(486,713)
Cash flow hedge
Zero Cost Collar (US$ x R$)US$ 6,852,200 4,500,200 (4,328,970)1,968,337 
NDF (R$ x US$)US$ 581,000 505,000 (331,876)162,776 
NDF (€ x US$)US$  262,088  100,362 
(4,660,846)2,231,475
 Commodity hedge
Swap US-CPI (standing wood) (1)US$138,439 131,510 (80,759)230,471 
Zero Cost Collar (Brent)US$163,941 163,100 6,097 (3,148)
Swap VLSFO/BrentUS$39,706 142,794 10,873 22,297 
(63,789)249,620
(6,567,720)1,994,382
(1)The embedded derivative refers to the swap contracts for selling price variations in US$ and the US-CPI in forest partnership with a standing wood supply contract.
4.5.4 Fair value settled amounts
The settled derivatives positions are set forth below:
12/31/202412/31/2023
Cash flow hedge
Zero Cost Collar (R$ x US$)645,759 2,987,953 
NDF (R$ x US$)(68,695)155,458 
NDF (€ x US$)73,781 84,332 

650,845 3,227,743

Commodity Hedge 89,327 80,516 
Swap VLSFO/other89,327 80,516

Debt hedges
Swap CDI to Fixed (US$)(1,635,058)(438,417)
Swap IPCA to CDI (Brazilian Reais)(59,243)256,683 
Swap IPCA to Fixed (US$) 21,139 
Swap Pre-Fixed to US$(221,462)(104,827)
Swap SOFR to SOFR2,199 
Swap CDI to SOFR (US$)19,074 7,729 
Swap SOFR to Fixed (US$)603,737 508,720 

(1,290,753)251,027

(550,581)3,559,286
4.6 Fair value hierarchy
Financial instruments are measured at fair value, which considers the fair value as the price that would be received from selling an asset or paid to transfer a liability in an unforced transaction between market participants at the measurement date.
Depending on the inputs used for measurement, the financial instruments at fair value may be classified into three hierarchical levels:
(i)Level 1 – Based on quoted prices (unadjusted) for identical assets or liabilities in active markets. A market is considered active if it trades frequently and at a sufficient volume to provide pricing information immediately and continuously, usually obtained from a commodity and stock exchange, pricing service or regulatory agency, and if the prices represent actual market transactions, which occur regularly on a commercial basis;
(ii)Level 2 - Based on the prices quoted in active markets for similar assets or liabilities, the prices quoted for identical or similar assets or liabilities in non-active markets, evaluation models for which inputs are observable , such as rates of interest and yield curves, credit volatilities and spreads, and market corroborated information. Assets and liabilities classified in this category are measured based on the discounted cash flow and interest accrual, respectively, for derivative financial instruments and marketable securities. The observable inputs include interest rates and curves, volatility factors and foreign exchange rates; and
(iii)Level 3 – Based on unquoted data for assets and liabilities, where the Company applies the income approach technique using the discounted cash flow model. The observable inputs used are the IMA, discount rate and eucalyptus average gross sales price.
For the year ended December 31, 2024, there were no changes between the levels of hierarchy and no transfers between levels 1, 2 and 3.
12/31/2024
Level 1Level 2Level 3Total
Assets
At fair value through profit or loss
Derivative financial instruments3,887,100 3,887,100 
Marketable securities1,203,776 12,159,735 13,363,511 
1,203,776 16,046,835  17,250,611 
At fair value through other comprehensive income



Other investments (note 14.1)1,138,066 1,138,066 
  1,138,066 1,138,066 






Biological assets 22,283,001 22,283,001 
  22,283,001 22,283,001 
Total assets1,203,776 16,046,835 23,421,067 40,671,678 
Liabilities






At fair value through profit or loss





Derivative financial instruments 10,454,820 10,454,820 
 10,454,820  10,454,820 
 10,454,820  10,454,820 
12/31/2023
Level 2Level 3Total
Assets
At fair value through profit or loss
Derivative financial instruments4,430,454  4,430,454 
Marketable securities13,267,286  13,267,286 
17,697,74017,697,740
At fair value through other comprehensive income



Other investments - (note 14.1) 23,606 23,606 
23,60623,606
Biological assets 18,278,582 18,278,582 
18,278,58218,278,582
Total assets17,697,74018,302,18835,999,928
Liabilities
At fair value through profit or loss
Derivative financial instruments2,436,072  2,436,072 
2,436,0722,436,072
Total liabilities2,436,0722,436,072
4.7 Cybersecurity
Suzano has a Public Information Security Policy, which aims to establish guidelines regarding cyber security management and controls at Suzano, seeking to mitigate vulnerabilities, preserve and protect assets, mainly information and personal data, in accordance with current laws, regulations and contractual obligations, covering the confidentiality, integrity, availability, authenticity and legality of information. The Policy establishes responsibilities to avoid damages, which may represent financial impacts, image and reputation, exposure of information, interruption of operations, among other damages due to cyber-attacks.
For the year ended December 31, 2024, no material incidents associated with cybersecurity were identified that could affect the confidentiality, integrity and/or availability of the systems used by the Company.
4.8 Climate change
4.8.1 Risks linked to climate change and the sustainability strategy
In view of the nature of the Company's operations, there is inherent exposure to risks related to climate change.
The Company's assets, notably biological assets, which are measured at fair value (Note 13), property, plant and equipment (Note 15) and intangible assets (Note 16), may be impacted by climate change, the risks of which were evaluated in the context of preparation of financial statements. For the year ended December 31, 2024, Management considered the main risk data and assumptions highlighted below:
(i)Possible impacts on the determination of fair value in biological assets due to: Effects of climate change, such as temperature rises and scarcity of water resources, could impact some of the assumptions used in accounting estimates related to the Company's biological assets, as follow:
Loss of biological assets due to fires and impacts arising from the greater presence and resistance of pests and other forest diseases favored by the gradual increase in temperature;
Reduction in productivity and expected growth (“IMA”) due to reduced availability of water resources in river basins and other atypical weather events such as droughts, frosts and torrential rains; and
Interruptions to the production chain due to adverse weather events.
(ii)Scarcity of water resources in the industry: although our units are efficient in the use of water, there are contingency plans for all units affected by possible water shortages and action plans to confront the water crisis in critical regions.
(iii)Structural changes in society and their impacts on business, such as:
Regulatory and legal: arising from changes in the Brazilian and/or international scope that require capital investment in new technologies and/or operating costs. Among the expected topics are carbon pricing, customs carbon taxation, trade barriers and/or commercial restrictions related to businesses’ alleged contributions, even if indirect, to the intensification of climate change, which increase the risk of litigation;
Technological: arising from the emergence of improvements and innovations towards an economy with greater energy efficiency and lower carbon. Suzano should continue investing in R&D to reduce greenhouse gas emissions;
Markets: arising from changes to the supply of and demand for certain products and services as climate-related issues begin to be considered in decision-making. The market should increasingly prioritize the reduction of carbon emissions and more sustainable business practices, which may lead to a drop in demand and revenue for Suzano's disposable products and an increase in demand for renewable forests and other sustainable products; and
Reputational: related to the perceptions of customers and society in general regarding the positive or negative contribution of an organization to a low carbon economy.
(iv)Natural storms, hurricanes, and cyclones: events exacerbated by climate change that can generate direct and/or indirect impacts on Suzano's industrial operations (material damage and operational disruptions) as well as on its logistics operations and value chain.
4.8.2 Compliance with contractual clauses related to sustainability in debt securities and sustainable loans (Sustainability Linked Bonds - “SLB” and Sustainability Linked Loans – “SLL”)
The Company issued debt securities and loans linked to sustainability performance targets ("Sustainability Performance Targets - SPT") related to the reduce the intensity of our greenhouse gas emissions, reduce the intensity of water capture for use in industrial processes and increase the percentage of women in leadership positions by December 31, 2025. Non-compliance with these targets may generate future increases in the cost of said debts, while the compliance with the targets may result in a reduction in the cost of SLL's, as provided for in the respective contracts.
In 2020, the company issued its first bond based on the SLB Principles. In 2021, Suzano issued two additional Sustainability Linked bonds that, for the first time, were linked to something other than an environmental or social target: a diversity, equity and inclusion target. The goals and their financial impacts on the instruments called SLBs are available in the public prospectus of each of the transactions. The Company's first Sustainability Linked Loan (SLL) was contracted in 2021 and, in 2022 and 2024, the company obtained new loans with the International Finance Corporation (IFC) and with commercial bank syndicates following the guidelines of the SLL Principles.
4.8.3 Climate risk management
The Company has a structure dedicated to corporate risk management, including risks related to climate change, with its own methodologies, tools and processes aimed at ensuring the identification, assessment and treatment of its main risks. This allows the continuous monitoring of risks and their eventual impacts, control of the variables involved, and the definition and implementation of mitigating measures, which aim to reduce the identified exposures. The Company's assessment of the potential physical impacts of climate change, as well as those arising from the transition to a low carbon economy is carried out on an ongoing basis, and will continue to evolve.
4.8.4 Opportunities linked to climate change and the sustainability strategy
4.8.4.1 Securities with clauses related to sustainability
As disclosed in note 4.8.2, Suzano has Sustainability Linked Bonds (SLB) and Sustainability Linked Loan (SLL) linked to environmental performance indicators associated with a goal to reduce greenhouse gases, intensity the capture of water resources, and aspects of diversity and inclusion, evidencing the Company's commitment as part of the solution to the global climate crisis and in convergence with the implementation of its goal. These funding linked to sustainability goals allow differentiated rates.
4.9 Capital management
The main objective is to strengthen the Company’s capital structure, aiming to maintain an appropriate level of financial leverage while mitigating risks that could affect the availability of capital for business development.
The Company continuously monitors significant indicators, such as consolidated financial leverage, which is the ratio of total net debt to adjusted Earnings Before Interest, Taxes, Depreciation, and Amortization (“Adjusted EBITDA”).
v3.25.1
CASH AND CASH EQUIVALENTS
12 Months Ended
Dec. 31, 2024
Cash and cash equivalents [abstract]  
CASH AND CASH EQUIVALENTS
5 CASH AND CASH EQUIVALENTS
Average yield p.a. %12/31/202412/31/2023
Cash and banks (1)
4.62%6,596,510 6,561,558 
 
Cash equivalents 
Local currency 
Fixed-term deposits (compromised) 100.96 % of CDI2,422,308 1,784,313 
9,018,818 8,345,871
(1)Refers mainly to investments in foreign currency under the Sweep Account modality, which is a remunerated account the balance of which is invested and made available automatically each day.
v3.25.1
MARKETABLE SECURITIES
12 Months Ended
Dec. 31, 2024
Disclosure of financial assets [abstract]  
MARKETABLE SECURITIES
6 MARKETABLE SECURITIES
Average yield p.a. %12/31/202412/31/2023
In local currency
Private funds97.76% of CDI552,635 1,295,296 
Public Securities (1)
IPCA + 6.10%1,203,776  
Private Securities ("CDBs")100.91% of CDI11,144,881 4,150,313 
CDBs - Escrow Account (2)
101.76% of CDI391,964 443,400 

13,293,256 5,889,009
Foreign currency

Time deposits (3)
 7,333,308 
Other

70,255 44,969 

70,255 7,378,277
13,363,511 13,267,286
Current12,971,547 12,823,886 
Non-Current391,964 443,400 
(1)Acquisition of Brazil National Treasury Notes indexed to IPCA (NTN-B).
(2)Includes escrow accounts, which will be released only after obtaining the applicable governmental approvals, and pending compliance by the Company with the conditions precedent in transactions involving the sale of rural properties.
(3)Refers to Time Deposit investments, with maturities over 90 days, which are remunerated bank deposits with specific maturity periods.
v3.25.1
TRADE ACCOUNTS RECEIVABLE
12 Months Ended
Dec. 31, 2024
Trade and other current receivables [abstract]  
TRADE ACCOUNTS RECEIVABLE
7 TRADE ACCOUNTS RECEIVABLE
7.1 Breakdown of balances
12/31/202412/31/2023
Domestic customers
Third parties1,989,455 1,785,157 
Related parties (Note 11.1) (1)
83,343 45,650 
Foreign customers
Third parties7,090,160 5,049,609 
Related parties (Note 11.1)202  
(-) Expected credit losses(30,300)(31,962)
9,132,860 6,848,454
(1)The balance refers to transactions with Ibema Companhia Brasileira de Papel.
The Company carries out factoring transactions for certain customer receivables where it transfers the control of all risks and rewards related to these receivables to the counterparty, so these receivables are derecognized from accounts receivable in the balance sheet. This transaction refers to an additional cash generation opportunity which can be discontinued at any time without significant impacts on the Company's operation and is therefore classified as a financial asset measured at amortized cost. The decision to assign the receivables is continuously reassessed based on market conditions and the Company's cash flow strategy, meaning that the volume of discounts may vary over time. The impact of these factoring transactions on the accounts receivable as of December 31, 2024, was R$6,821,539 (R$4,273,623 as of December 31, 2023).
7.2 Breakdown of trade accounts receivable by maturity
12/31/202412/31/2023
Current8,216,570 5,904,402 
Overdue
Up to 30 days682,142 644,644 
From 31 to 60 days134,674 57,395 
From 61 to 90 days38,187 97,639 
From 91 to 120 days17,701 40,533 
From 121 to 180 days12,402 34,708 
From 181 days31,184 69,133 
9,132,860 6,848,454
7.3 Roll-forward of expected credit losses
12/31/202412/31/2023
 Opening balance(31,962)(21,109)
(Provisions)/Reversals, net(2,585)(35,202)
Write-offs5,790 24,230 
Exchange rate variations (1,543)119 
 Closing balance(30,300)(31,962)
The Company maintains guarantees for overdue receivables as part of its commercial operations, through credit insurance policies, letters of credit and other guarantees. These guarantees avoid the need to recognize expected credit losses, in accordance with the Company's credit policy.
7.4 Main customers
On December 31, 2024, the Company doesn't have any customer responsible for more than 10% of the net sales of pulp operating segment or paper operating segment. On December 31, 2023 the Company had 1 (one) customer responsible for 10.27% of the net sales of pulp operating segment and no main customers in the paper operating segment.
v3.25.1
INVENTORIES
12 Months Ended
Dec. 31, 2024
Classes of current inventories [abstract]  
INVENTORIES
8 INVENTORIES
12/31/202412/31/2023
Finished goods
Pulp
Domestic (Brazil)801,623 576,774 
Foreign1,510,985 1,271,335 
Paper
Domestic (Brazil)561,409 569,771 
Foreign362,027 137,653 
Work in process135,380 93,325 
Raw materials
Wood2,287,406 1,666,817 
Operating supplies and packaging1,098,894 795,274 
Spare parts and other1,302,534 931,052 
(-) Expected losses(97,934)(95,053)

7,962,324 5,946,948
8.1 Roll-forward of estimated losses
12/31/202412/31/2023
Opening balance(95,053)(105,989)
Additions(83,705)(65,085)
Reversals6,352 33,666 
Write-offs74,472 42,355 
Closing balance(97,934)(95,053)
On December 31, 2024 and 2023, there were no inventory items pledged as collateral.
v3.25.1
RECOVERABLE TAXES
12 Months Ended
Dec. 31, 2024
RECOVERABLE TAXES  
RECOVERABLE TAXES
9 RECOVERABLE TAXES
12/31/202412/31/2023
IRPJ/CSLL – prepayments and withheld taxes227,464 464,188 
PIS/COFINS – on acquisitions of property, plant and equipment (1)
187,126 93,866 
PIS/COFINS – operations789,667 699,717 
PIS/COFINS – exclusions from ICMS (2)
405,407 443,210 
ICMS – on acquisitions of property, plant and equipment (3)
471,825 432,793 
ICMS – operations (4)
1,654,162 1,470,949 
Reintegra program (5)
70,610 64,077 
Other taxes and contributions64,444 45,821 
Provision for loss on ICMS credits (6)
(1,581,961)(1,452,435)
2,288,744 2,262,186
Current 1,109,619 888,539 
Non-current 1,179,125 1,373,647 
(1)Social Integration Program (“PIS”) and Social Security Funding Contribution (“COFINS”): Credits whose realization is based on the years of depreciation of the corresponding asset.
(2)The Company and its subsidiaries filed lawsuits over the years seeking the exclusion of ICMS from the PIS and COFINS contribution tax basis, in relation to certain transactions during various periods from March 1992.
(3)Tax on Sales and Services (“ICMS”): Credits from the acquisition of property, plant and equipment are recovered on a straight-line basis over a four-year period, from the acquisition date, in accordance with the relevant regulation, the ICMS Control on Property, Plant and Equipment (“CIAP”).
(4)ICMS credits accrued due to the volume of exports and credit generated from product import transactions: Credits are concentrated in the States of Espírito Santo, Maranhão, Mato Grosso do Sul e São Paulo, where the Company realizes the credits through the sale of credits to third parties, after approval from the State Ministry of Finance of each State. Credits are also being realized through the consumption of consumer goods (tissue) transactions in the domestic market.
(5)Special Regime of Tax Refunds for Export Companies ("Reintegra"): Reintegra is a program that aims to refund the residual costs of taxes paid throughout the export chain to taxpayers, to make them more competitive in foreign markets.
(6)Related to provisions for ICMS credit balances that are not probable to be recovered.
9.1 Roll-forward of provision for loss
ICMS
12/31/202412/31/2023
Opening balance(1,452,435)(1,103,807)
Addition (1)
(316,741)(399,838)
Reversal (2)
186,014 51,210 
Write-off1,201  
Closing balance(1,581,961)(1,452,435)
(1)Refers, substantially, to the accumulated ICMS credits of the state of Mato Grosso do Sul, arising from the construction operations of the Cerrado Project, and of the state of Espirito Santo, of the accumulated credits due to the volume of exports.
(2)Refers mainly to the reversal of the provision for loss resulting from the recovery of ICMS credits from the State of Espírito Santo through sale to third parties.
v3.25.1
ADVANCES TO SUPPLIERS
12 Months Ended
Dec. 31, 2024
ADVANCES TO SUPPLIERS  
ADVANCES TO SUPPLIERS
10 ADVANCES TO SUPPLIERS
12/31/202412/31/2023
Forestry development program and partnerships2,503,537 2,242,229 
Advance to suppliers - others92,133 113,743 
2,595,670 2,355,972
Current 92,133 113,743 
Non-current 2,503,537 2,242,229 
The forestry development program consists of an incentive partnership for regional forest production, where independent producers plant eucalyptus on their own land to supply agricultural wood products to the Company. Suzano provides eucalyptus seedlings, input subsidies and cash advances, and the latter are not subject to valuation at their present value since they will be settled in volume standing or cut wood. In addition, the Company supports producers by providing technical advice on forest management but does not have joint control over decisions effectively implemented. At the end of the production cycles, the Company has a contractually guaranteed right to make an offer to purchase the forest and/or wood at its market value. However, this right does not prevent producers from negotiating the sale of the forest and/or wood with other market participants, provided the incentive amounts are fully paid.
v3.25.1
RELATED PARTIES
12 Months Ended
Dec. 31, 2024
Disclosure of transactions between related parties [abstract]  
RELATED PARTIES
11 RELATED PARTIES
The Company's commercial and financial transactions with the controlling shareholder and Companies owned by the controlling shareholder Suzano Holding S.A. ("Suzano Group") were carried out at specific prices and conditions, as well as the corporate governance practices adopted by the Company, and those recommended and/or required by the applicable legislation.
The transactions refers mainly to:
Assets: (i) accounts receivable from the sale of pulp, paper, tissue and other products; (ii) interest on shareholder’s capital and dividends receivable; (iii) reimbursement for expenses; and (iv) social services;
Liabilities: (i) loan agreements;(ii) reimbursement for expenses; (iii) social services; (iv) real estate consulting; and (v) interest on shareholder’s capital and dividends payable.
Amounts in the statements of income: (i) sale of pulp, paper, tissue and other products; (ii) loan charges and exchange variation; (iii) social services and (viii) real estate consulting.
For the year ended December 31, 2024, there were no material changes in the terms of the agreements, deals and transactions entered into, nor were there any new contracts, agreements or transactions of any different nature entered into between the Company and its related parties.
11.1 Balances recognized in assets and liabilities and amounts of transactions during the year
AssetsLiabilitiesSales (purchases), net
12/31/202412/31/202312/31/202412/31/202312/31/202412/31/202312/31/2022
Transactions with majority shareholders
Suzano Holding S.A. (1)
4 24 (630,387)(363,520)66 91 
Controller (1)
  (336,205)(193,883)  
Management and related persons (1)
  (55,627)(31,748)  
Alden Fundo de Investimento em Ações (1)
  (52,764)(30,428)  
4 24(1,074,983)(619,579)66 991
Transactions with companies of the Suzano Group and other related parties
Management (expect compensation – Note 11.2)61 61   538 (906)(47)
Bexma Participações Ltda    7 38 
Bizma Investimentos Ltda.10 
Civelec Participações Ltda3,860 4,575    4,825 
Fundação Arymax    5 
Ibema Companhia Brasileira de Papel (2)
83,343 45,659 (1,413)(1,023)211,482 168,621 218,226 
Instituto Ecofuturo - Futuro para o Desenvolvimento Sustentável21   (5,173)(5,549)(4,603)
IPLF Holding S.A.1    10 38 
Mabex Representações e Participações Ltda.  (23) (915)(817)
Nemonorte Imóveis e Participações Ltda    (177)(178)(194)
87,489 50,297(1,436)(1,023)206,640 166,020213,472
87,493 50,321(1,076,419)(620,602)206,706 166,029213,563
Assets
Trade accounts receivable (Note 7)83,545 45,650   
Other assets3,948 4,671   
Liabilities
Trade accounts payable (Note 18)  (1,457)(1,023)
Dividends and interest on own capital payable (3)
(1,074,962)(619,579)
87,493 50,321(1,076,419)(620,602)
(1)Refers to dividends and interest on own capital payable.
(2)Refers mainly to the sale of pulp.
(3)The amount of R$1,074,962 refers to interest on own capital payable to the controlling shareholders and the amount of R$1,125,955 refers to other non-controlling shareholders, totaling R$2,200,917 (Note 1.2.8).
11.2 Management compensation
Expenses related to the compensation of key management personnel, which include the Board of Directors, Fiscal Council and Board of Statutory Executive Officers, recognized in the statement of income for the year, are set out below:
12/31/202412/31/202312/31/2022
Short-term benefits
Salary or compensation48,469 49,165 50,228 
Direct and indirect benefits1,896 2,286 1,099 
Bonus14,881 10,829 7,031 
65,246 62,28058,358
Long-term benefits
Share-based compensation plan99,051 42,130 36,390 
99,051 42,13036,390
164,297 104,41094,748
Short-term benefits include fixed compensation (salaries and fees, vacation pay, mandatory bonus and “13th month’s salary” bonus), payroll charges (Company’s share of contributions to social security – “INSS”) and variable compensation such as profit sharing, bonuses and benefits (company car, health plan, meal voucher, market voucher, life insurance and private pension plan).
Long-term benefits include the stock option plan and phantom shares for executives and key members of Management, in accordance with the specific regulations disclosed in Note 22.
v3.25.1
INCOME AND SOCIAL CONTRIBUTION TAXES
12 Months Ended
Dec. 31, 2024
Major components of tax expense (income) [abstract]  
INCOME AND SOCIAL CONTRIBUTION TAXES
12 INCOME AND SOCIAL CONTRIBUTION TAXES
The Company calculates income tax and social contribution taxes, current and deferred, based on the following rates: (i) 15% plus an additional 10% on taxable income in excess of R$240 for IRPJ; and (ii) 9% for CSLL, on the net income. Balances are recognized in the Company's income on an accrual basis.
Subsidiaries domiciled in Brazil have their taxes calculated and provisioned in accordance with the current legislation and their specific tax regime, including, in some cases, the presumed profit method. Subsidiaries domiciled abroad are subject to taxation in their respective jurisdictions, according to local regulations.
Deferred income and social contribution taxes are recognized at the net amounts in non-current assets or liabilities.
In Brazil, Law nº. 12,973/14 revoked article 74 of Provisional Measure nº. 2,158/01 and determines that the parcel of the adjustment of the value of the investment in subsidiaries, direct and indirect, domiciled abroad, equivalent to the profit earned by them before income tax, except for exchange rate variation, must be added in the determination of taxable income and the social contribution calculation basis of the controlling entity domiciled in Brazil, at each year ended.
The Company management believes in the validity of the provisions of international treaties entered by Brazil to avoid double taxation. In order to ensure its right to non-double taxation, the Company filed a lawsuit in April 2019, which aims to exempt the double taxation in Brazil, of profits earned by its subsidiary located in Austria, according to Law No. 12,973/14. Due to the preliminary injunction granted in favor of the Company in the aforementioned lawsuit, the Company decided not to add the profit from Suzano International Trading GmbH, located in Austria, when determining its taxable income and social contribution basis of the net profit of the Company for the year ended December 31, 2024. There is no provision for tax related to the non-double taxation profits of such subsidiary in 2024. Disclosures about uncertain tax positions for income tax and social contribution (IFRIC 23) are presented in Note 20.2.
12.1 Deferred taxes
12.1.1 Deferred income and social contribution taxes
12/31/202412/31/2023
Tax loss796,831 1,209,968 
Negative tax basis of social contribution307,143 457,030 
Assets - temporary differences
Provision for judicial liabilities324,873 324,158 
Operating provisions and other losses1,308,352 1,214,807 
Exchange rate variations 7,385,034 2,384,153 
Derivatives losses (“MtM”)(2)
2,230,835 
Amortization of fair value adjustments arising from business combinations625,745 654,358 
Unrealized profit on inventories539,157 151,578 
Leases (2)
606,944 356,110 
14,124,914 6,752,162
 Liabilities - temporary differences
Goodwill - tax benefit on unamortized goodwill1,589,887 1,301,654 
Property, plant and equipment - deemed cost1,066,883 1,137,483 
Depreciation for tax-incentive reason (1)
733,640 799,857 
Capitalized loan costs947,482 640,063 
Fair value of biological assets1,317,095 1,115,432 
Deferred taxes, net of fair value adjustments 342,141 370,947 
Tax credits - gains from tax lawsuit (exclusion of ICMS from the PIS and COFINS basis)137,928 150,691 
Derivatives gains (“MtM”) (2)
 678,090 
Other temporary differences18,439 24,109 
6,153,495 6,218,326
Non-current assets7,984,015 545,213 
Non-current liabilities12,596 11,377 
(1)Tax depreciation is taken as a benefit only in the income tax calculation bases.
(2)The Company presents a net balance of derivatives and leases, as gains and losses from deferred taxes are offset simultaneously. For the derivatives line, the passive temporary difference was R$1,321,614 and asset temporary difference of R$3,552,449 (passive temporary difference of R$1,506,354 and asset temporary difference of R$828,264 as of December 31, 2023). For the lease line, the passive temporary difference was R$1,763,847 and asset temporary difference was R$2,370,791 (passive temporary difference of R$1,766,776 and asset temporary difference of R$2,122,886 as of December 31, 2023).
12.1.2 Breakdown of accumulated tax losses and social contribution tax losses carried forward
 12/31/202412/31/2023
Tax loss carried forward3,187,324 4,839,872 
Negative tax basis of social contribution carried forward3,412,700 5,078,111 
12.1.3 Roll-forward of deferred tax assets
12/31/202412/31/2023
Opening balance533,836 3,985,297 
Tax loss(413,137)2,872 
Negative tax basis of social contribution(149,887)11,780 
Provision for judicial liabilities715 55,562 
Operating provisions and other losses93,545 215,779 
Exchange rate variation 5,000,881 (1,913,350)
Derivative (gains) losses (“MtM”)2,908,925 (668,926)
Amortization of fair value adjustments arising from business combinations 193 2,219 
Unrealized profit on inventories387,579 (211,474)
Leases250,834 (8,728)
Goodwill - tax benefit on unamortized goodwill(288,233)(278,551)
Property, plant and equipment - deemed cost70,600 79,866 
Depreciation accelerated for tax-incentive reason 66,217 70,140 
Capitalized loan costs(307,419)(429,229)
Fair value of biological assets(201,663)(412,158)
Credits on exclusion of ICMS from the PIS/COFINS tax base12,763 43,430 
Other temporary differences5,670 (10,693)
Closing balance7,971,419 533,836
12.2 Reconciliation of the effects of income tax and social contribution on profit or loss
12/31/202412/31/202312/31/2022
Net income (loss) before taxes(13,111,053)17,997,21628,655,581
Income tax and social contribution benefit (expense) at statutory nominal rate of 34%4,457,758(6,119,053)(9,742,898)
Tax effect on permanent differences
Taxation (difference) on profit of associates in Brazil and abroad (1)
484,7171,688,6564,915,243
Equity method(4,707)(6,589)96,685
Thin capitalization (2)
(46,796)(505,553)
Interest on own capital850,000510,000
Credit related to Reintegra Program11,8967,1767,829
Director bonuses(9,587)(4,907)(12,208)
Tax incentives (Note 12.3) (3)
336,541128,65051,839
Donations/Fines – Other(60,271)(47,972)(71,631)
6,066,347(3,890,835)(5,260,694)
Income tax
Current(999,421)(352,577)(464,312)
Deferred5,482,647(2,561,991)(3,485,267)
4,483,226(2,914,568)(3,949,579)
Social Contribution
Current(366,178)(42,815)(46,584)
Deferred1,949,299(933,452)(1,264,531)
1,583,121(976,267)(1,311,115)
Income and social contribution benefits (expenses) on the year6,066,347(3,890,835)(5,260,694)
(1)The difference in the taxation of subsidiaries is substantially due to the differences between the nominal tax rates in Brazil and those of subsidiaries located abroad.
(2)The Brazilian thin capitalization rules establish that interest paid or credited by a Brazilian entity to a related party abroad may only be deducted for income tax and social contribution purposes if the interest expense is viewed as necessary for the activities of the local entity, and when certain limits and requirements are met. On December 31, 2024, all limits and requirements were met, and on December 31, 2023 and 2022, the Company did not meet all of the limits and requirements, and therefore the expense is not deductible for the period.
(3)Income tax and social contribution deduction on profit or loss referring to the use of tax incentives: (i) exploitation profits, (ii) expenses with research and development, (iii) PAT benefits ("Worker Food Program"), (iv) donations made in cultural projects, (v) children and adolescents rights funds, (vi) sports incentives, (vii) funds for the elderly and (viii) extensions to maternity and paternity leave.

12.3 Tax incentives
The Company benefits from a tax incentive for partial reduction of the income tax obtained from operations carried out in areas under the jurisdiction of the Northeast Development Superintendence (“SUDENE”) and the Superintendence of Amazon Development (“SUDAM”). The IRPJ reduction incentive is calculated based on the activity profits (exploitation profits) and considers the allocation of the operating profit based on the incentive production levels for each product.
Area/RegionsCompanyMaturity
Northeast Development Superintendence (“SUDENE”)


Aracruz (ES)

Portocel2030
Aracruz (ES)

Suzano2031
Imperatriz (MA)

Suzano2032
Mucuri (BA)

Suzano2032
São Luís (MA)

Itacel2033
Eunápolis (BA)
Veracel2033
Superintendence of Amazon Development (“SUDAM”)


Belém (PA)

Suzano2025
On June 13, 2024, the tax incentive for exploitation profits was approved for the company Terminal de Celulose de Itaqui S/A and on July 22, 2024, the tax incentive request was renewed for the company Veracel Celulose S/A in areas under the jurisdiction of the SUDENE, granting a 75% reduction in Corporate Income Tax (IRPJ), with a validity of 10 years for utilizing this tax benefit.
These incentives aim to promote regional development by encouraging investments in strategic areas.
12.4 OECD PILLAR TWO MODEL RULES
In December 2021, the Organization for Economic Co-operation and Development (“OECD”) announced the guidelines for the Pillar Two model, aiming for a reform in international corporate taxation to ensure that multinational economic groups, covered by such regulations, contribute an effective minimum tax at a rate of 15% on profits. Each country's effective profit tax rate, as calculated by this model, is called the GloBE (Global Anti-Base Erosion Rules) effective tax rate. These rules await approval in the local legislation of each country. In the context of Suzano, compliance with OECD guidelines on international taxation is a strategic priority.
Many countries have already released legislation or plans on the adoption of Pillar Two rules and the calculation of GloBE revenue, considering the global minimum rate of 15% for multinationals with consolidated revenue above EUR750 million.
From 2024, the Company is subject to the OECD Pillar Two model rules in certain European jurisdictions where it operates, with Austria standing out as a relevant operation. To date, there has been no material impact on the financial statements due to this topic.
In December 2024, Law 15.079/2024 was published, establishing the Additional Social Contribution on Net Income (CSLL) in the process of adapting Brazilian legislation to the GloBE rules, whose application comes into effect as of January 1, 2025. The main impact is the need to adapt compliance structures and the calculation of any additional CSLL (Top-up Tax).
The Company reaffirms its commitment to tax compliance and is already taking the necessary actions to ensure the proper implementation of the new rule in Brazil, in line with global best practices and current legislation.
The Company also continually assesses legislative developments in the jurisdictions in which it operates in order to map potential effects on its operations.
v3.25.1
BIOLOGICAL ASSETS
12 Months Ended
Dec. 31, 2024
Disclosure of detailed information about biological assets [abstract]  
BIOLOGICAL ASSETS
13 BIOLOGICAL ASSETS
The roll-forward of biological assets is as set forth below:
12/31/202412/31/2023
Opening balance18,278,582 14,632,186 
Additions 7,180,450 5,777,952 
Additions of merged companies (1)
366,785  
Depletions (4,831,916)(3,680,997)
Transfers102,790 (136,297)
Gain on fair value adjustments1,431,530 1,989,831 
Disposals(130,922)(128,370)
Write-offs(114,298)(175,723)
Closing balance22,283,001 18,278,582
(1) Refers to the acquisition and merger of 100% of the share capital of the companies Timber VII and Timber XX (note 1.2.6).
The calculation of fair value of the biological assets is determined using unobservable data, therefore it falls under Level 3 in the hierarchy set forth in IFRS 13 — Measurement of Fair Value.
In our model, the assumptions regarding the average annual growth rate (IMA) and average gross selling price of eucalyptus are particularly sensitive. Any increase or decrease in these assumptions could lead to significant gains or losses in the fair value measurement.
The assumptions used in the measurement of the fair value of biological assets were as follow:
(i)Average cycle of forest formation between 6 and 7 years;
(ii)Effective area of forest from the 3rd year of planting;
(iii)The IMA consists of the estimated volume of production of wood with bark in m3 per hectare, ascertained based on the genetic material used in each region, silvicultural practices and forest management, production potential, climate factors and soil conditions;
(iv)The estimated average standard cost per hectare includes silvicultural and forest management expenses, applied to each year of formation of the biological cycle of the forests, plus the costs of land lease agreements and the opportunity cost of owning land;
(v)The average gross selling prices of eucalyptus were based on specialized research on transactions carried out by the Company with independent third parties; and
(vi)The discount rate corresponds to the Weighted Average Cost of Capital (“WACC”).
The table below discloses the measurement of the premises adopted:
12/31/202412/31/2023
Useful productive planted area (hectare)1,243,1911,094,611
Mature assets (6 to 7 years)191,737144,942
Immature assets (1 to 5 years)1,051,454949,669
Average annual growth (IMA) – m3/hectare/year
37.6237.92
Average gross sale price of eucalyptus – R$/m3
101.3896.04
Discount rate (post-tax)8.80 %8.80 %
The pricing model considers the net cash flows, after the deduction of taxes on profit at the applicable rates.
The fair value adjustment justified by the combined variations of the indicators mentioned above resulted in a positive variation of R$1,431,530 recognized in other operating income (expenses), net (Note 29).
12/31/202412/31/2023
Physical changes and discount rate (1)
609,2591,575,017
Price822,271414,814
1,431,5301,989,831
1) Includes the variation of indicators: IMA, discount rate and area.
The Company manages the financial and climate risks related to its agricultural activities in a preventive manner. To reduce the risks arising from edaphoclimatic factors, the weather is monitored through meteorological stations and, in the event of pests and diseases, our Department of Forestry Research and Development, an area specialized in physiological and phytosanitary aspects, has procedures to diagnose and act rapidly against any occurrences and losses (Note 4.8).
The Company has no biological assets pledged as collateral on December 31, 2024 and 2023.
v3.25.1
INVESTMENTS
12 Months Ended
Dec. 31, 2024
Investments in subsidiaries, joint ventures and associates reported in separate financial statements [abstract]  
INVESTMENTS
14 INVESTMENTS
14.1 Investments breakdown
12/31/202412/31/2023
Investments in associates and joint ventures453,371 355,520 
Goodwill 225,486 228,887 
Other investments evaluated at fair value through other comprehensive income (1)
1,138,066 23,606 
1,816,923 608,013
(1) Includes the acquisition of the equity interest in Lenzing Aktiengesellschaft (note 1.2.5). On December 31, 2024, the value of the investment was R$1,099,870 in the consolidated accounts.

14.2 Investments in associates and joint ventures
Information of investees as at
Company Participation
12/31/2024Carrying amountIn the income (expenses) for the year
EquityIncome (expenses) of the yearParticipation equity (%)12/31/202412/31/202312/31/202412/31/2023
Associate
Foreign
Ensyn Corporation6 (17,776)24.80 %2 387 (6,966)(12,448)
Spinnova Plc (1)
507,482 (56,117)18.77 %95,254 95,736 (19,690)(20,109)
Simplifyber, Inc. (2)
13.91 %30,060 
125,316 96,123(26,656)(32,557)
Joint ventures
Domestic (Brazil)
Biomas - Serviços Ambientais, Restauração e Carbono Ltda.17,536 (30,151)16.66 %2,923 2,797 (4,874)(2,203)
Ibema Companhia Brasileira de Papel388,580 74,547 49.90 %193,901 156,703 37,199 35,161 
Foreign
F&E Technologies LLC 12,756  50.00 %6,378 4,987   
Woodspin Oy249,706 (38,665)50.00 %124,853 94,910 (19,514)(19,780)
328,055 259,39712,811 13,178
Other investments evaluated at fair value through other comprehensive income
Bem Agro Integração e Desenvolvimento S.A.5.82 %4,026   
Celluforce Inc.8.28 %27,823 23,606 
Nfinite Nanotechnology Inc.5.00 %6,347   
Lenzing Aktiengesellschaft (3)
15.00 %1,099,870   
1,138,066 23,606 
1,591,437 379,126(13,845)(19,379)
(1)The average share price quoted on the Nasdaq First North Growth Market (NFNGM) was EUR0.95 on December 31, 2024 and EUR2.40 in December 31, 2023.
(2)On December 13, 2024, Suzano Ventures LLC acquired an equity interest in the legal entity Simplifyber, Inc., which is an indirect subsidiary of Suzano S.A.
(3)Includes the acquisition of the equity interest in Lenzing Aktiengesellschaft (note 1.2.5).
v3.25.1
PROPERTY, PLANT AND EQUIPMENT
12 Months Ended
Dec. 31, 2024
Disclosure of detailed information about property, plant and equipment [abstract]  
PROPERTY, PLANT AND EQUIPMENT
15 PROPERTY, PLANT AND EQUIPMENT    
LandBuildingsMachinery,
equipment and facilities
Work in progress
Other (1)
Total
Average rate %  3.34 6.78  19.38  
Accumulated cost14,486,408 9,644,875 45,160,365 10,373,151 1,281,328 80,946,127 
Accumulated depreciation (3,879,898)(25,541,712) (867,883)(30,289,493)
Balance as of December 31, 202214,486,408 5,764,977 19,618,653 10,373,151 413,445 50,656,634 
Additions54,027 15 467,032 10,742,118 17,949 11,281,141 
Additions of merged companies4,572 111,495 453,617 8,306 11,175 589,165 
Write-offs(25,090)(36,184)(133,249) (56,869)(251,392)
Depreciation (313,304)(2,570,734) (145,092)(3,029,130)
Transfers and other339,272 379,495 2,702,633 (3,638,466)259,717 42,651 
Accumulated cost14,859,189 10,032,317 48,456,537 17,485,109 1,491,663 92,324,815 
Accumulated depreciation (4,125,823)(27,918,585) (991,338)(33,035,746)
Balance as of December 31, 202314,859,189 5,906,494 20,537,952 17,485,109 500,325 59,289,069 
Additions (2)
697 558 415,147 7,490,762 28,904 7,936,068 
Additions of merged companies (3)
1,699,588 775 413  1,992 1,702,768 
Write-offs(10,724)(7,455)(118,499) (9,324)(146,002)
Depreciation (366,398)(3,214,550) (222,993)(3,803,941)
Transfers and other (4)
226,598 3,988,619 16,660,035 (21,465,336)598,162 8,078 
Accumulated cost16,775,348 13,816,631 62,822,096 3,510,535 1,806,592 98,731,202 
Accumulated depreciation (4,294,038)(28,541,598) (909,526)(33,745,162)
Balance as of December 31, 202416,775,348 9,522,593 34,280,498 3,510,535 897,066 64,986,040 
(1)Includes vehicles, furniture and utensils and computer equipment.
(2)The addition of work in progress refers, mainly to the Cerrado Project, of which R$1,254,521 is a cash effect in the previous periods (R$393,042 as of December 31, 2023).
(3)Refers to the acquisition and merger of 100% of the share capital of the companies Timber VII and Timber XX (note 1.2.6).
(4)Refers, basically, to the activation of the Cerrado Project, that started its operation on July 21, 2024 (note 1.2.2).

On December 31, 2024, the Company evaluated the business, market and climate impacts, and did not identify any event that indicated the need to perform an impairment test and to record any impairment provision for property, plant and equipment.
15.1 Items pledged as collateral
On December 31, 2024, property, plant and equipment items pledged as collateral, consisting mainly of the units of Ribas do Rio Pardo, Três Lagoas and Imperatriz are set forth below:
Type of collateral12/31/202412/31/2023
LandFinancial/Legal24,427 3,198,674 
BuildingsFinancial1,755,082 1,947,075 
Machinery, equipment and facilitiesFinancial20,442,189 10,393,344 
Work in progressFinancial427,998 649,081 
OtherFinancial43,487 144,273 
22,693,183 16,332,447 
15.2 Capitalized expenses
For the year ended December 31, 2024, the Company capitalized loan costs in the amount of R$959,967 (R$1,160,364 as of December 31, 2023). The weighted average interest rate, adjusted by the equalization of the exchange rate effects, utilized to determine the capitalized amount was 11.17% p.a. (10.98% p.a. as of December 31, 2023).
15.3 Asset Retirement Obligation (ARO)
For the year ended December 31, 2024, the Company has provisioned the amount of R$65,327 (R$52,566 as of December 31, 2023) arising asset retirement obligation of industrial landfills.
v3.25.1
INTANGIBLE
12 Months Ended
Dec. 31, 2024
Disclosure of detailed information about intangible assets [abstract]  
INTANGIBLE
16 INTANGIBLE
16.1 Goodwill and intangible assets with indefinite useful lives
12/31/202412/31/2023
Goodwill - Facepa119,332 119,332 
Goodwill - Fibria7,897,051 7,897,051 
Goodwill - MMC Brasil (1)
170,859 170,859 
Other (2)
5,097 4,834 
8,192,339 8,192,076
(1)Refers to the goodwill of the MMC Brasil business combination.
(2)Refers to other intangible assets with indefinite useful lives such as servitude of passage and electricity.
The goodwill is based on expected future profitability supported by valuation reports, after the purchase price allocation.
Goodwill is allocated to cash-generating units as presented in Note 28.4.
For the pulp cash-generating unit (“CGU”), the calculation of the value in use of non-financial assets is performed annually using the discounted cash flow method. In 2024 the Company used the strategic plan and the annual budget with projected increases to 2029 and the average rate in perpetuity of the cash generating units considering a nominal rate of 3.6% p.a. from this date, based on historical information for previous years, economic and financial projections from each specific market in which the Company has operations, and additionally include official information disclosed by independent institutions and government agencies.
The discount rate, after taxes, adopted by Management was 8.91% p.a., calculated based on the Weighted Average Cost of Capital (“WACC”).
The assumptions in the table set forth below were also adopted:
Net average pulp price – Foreign market (US$/t)684.9
Net average pulp price – Internal market (US$/t)735.5
Average exchange rate (R$/US$)5.40
Discount rate (pos-tax)
8.91% p.a.
Discount rate (pre-tax)
12.50% p.a.
For the year ended December 31, 2024, the Company did not identify the need to record any impairment provision for intangible assets.
If the post-tax discount rate applied to the cash flow projections of both cash-generating units had been 1% higher than management’s estimates (9.91% instead of 8.91%), the Company would still not need to record an impairment provision.
The Company have considered and assessed possible changes for other key assumptions and have not identified any instances that could cause the carrying amount of the cash generating units to exceed its recoverable amount.
For the paper cash-generating unit (“CGU”), the asset recoverability test is carried out annually based on the EV/EBITDA multiple method. For the year ended December 31, 2024, the Company did not identify the need to record any impairment provision for intangible assets.

16.2 Intangible assets with limited useful lives
12/31/202412/31/2023
Opening balance6,557,009 7,173,183 
Additions161,779 104,931 
Fair value adjustment MMC Brasil  189,655 
Write-offs (2)
Amortization(1,008,824)(990,432)
Transfers and others 79,674 
Closing balance5,709,964 6,557,009
Represented byAverage rate %
Non-competition agreements5.00 4,508 4,818 
Port concessions3.94 632,253 537,179 
Lease agreements16.90  6,875 
Supplier agreements12.66 25,925 40,739 
Port service contracts4.23 520,459 549,821 
Cultivars14.28 20,391 40,784 
Trademarks and patents8.35 170,306 188,723 
Customer portfolio9.09 4,104,900 4,925,879 
Supplier agreements17.64 295 10,861 
Software20.80 201,476 141,178 
Other10.00 29,451 110,152 
5,709,964 6,557,009
Cost12,540,497 12,378,761 
Amortization(6,830,533)(5,821,752)
Closing balance5,709,964 6,557,009
v3.25.1
TRADE ACCOUNTS PAYABLE
12 Months Ended
Dec. 31, 2024
Trade and other payables [abstract]  
TRADE ACCOUNTS PAYABLE
17 TRADE ACCOUNTS PAYABLE
12/31/202412/31/2023
In local currency
Third party (1) (2)

4,681,065 3,946,185 
Related party (Note 11.1) (3)

1,457 1,023 
In foreign currency
Third party (2)

1,350,763 1,625,011 
6,033,285 5,572,219
(1)Within the balance of suppliers, there are values under supplier finance arrangement that were subject to anticipation with financial institutions at the exclusive option of certain suppliers, without changing the originally defined purchase conditions (payment terms and negotiated prices). The balance related to such operations on December 31, 2024 was R$555,063 (R$281,350 at December 31, 2023).
(2)Within the balance of suppliers, the following balances refer to the Cerrado Project, R$107,418 (R$523,408 on December 31, 2023) in local currency and R$241,497 (R$1,080,028 on December 31, 2023) in foreign currency.
(3)The balance refers mainly to transactions with Ibema Companhia Brasileira de Papel.




17.1 Long-term commitments
The Company entered into long-term take-or-pay agreements with chemicals, transportation and natural gas suppliers. These agreements contain termination and supply interruption clauses in the event of defaults on certain essential obligations. Generally, the Company purchases the minimum amounts agreed under the agreements, and hence there is no liability recorded in the amount that is recognized each month. The total contractual obligations assumed on December 31, 2024 were R$26,239,939 (R$14,606,380 at December 31, 2023).
v3.25.1
LOANS, FINANCING AND DEBENTURES
12 Months Ended
Dec. 31, 2024
Disclosure of detailed information about borrowings [abstract]  
LOANS, FINANCING AND DEBENTURES
18 LOANS, FINANCING AND DEBENTURES
18.1 Breakdown by type
CurrentNon-currentTotal
TypeCurrencyInterest rateAverage annual interest rate - %12/31/202412/31/202312/31/202412/31/202312/31/202412/31/2023
In foreign currency
BondsUSDFixed5.0 %3,229,641 841,625 49,166,804 40,122,749 52,396,445 40,964,374 
Panda BondsCNYFixed2.8 %4,224 1,016,331 1,020,555 
Export credits (“export prepayments”)USDSOFR/Fixed5.4 %6,236,806 2,690,891 16,283,736 14,487,252 22,520,542 17,178,143 
Assets financingUSDSOFR3.7 %137,300 61,924 298,252 220,199 435,552 282,123 
ECA - Export Credit AgencyUSDSOFR6.3 %7,297  769,702  776,999  
IFC - International Finance Corporation (1)
USDSOFR6.0 %(12,051)731 5,858,208 2,871,399 5,846,157 2,872,130 
EDC - Export Development CanadaEURFixed1.0 %4,210 7,903 4,455  8,665 7,903 
9,607,427 3,603,07473,397,488 57,701,59983,004,915 61,304,673
In local currency
BNDESBRLUMBNDES7.2 %157 157,555 157,712 
BNDESBRLTJLP8.6 %100,556 49,348 101,587 199,988 202,143 249,336 
BNDESBRLTLP14.8 %94,903 57,060 4,607,102 3,123,727 4,702,005 3,180,787 
BNDESBRLFixed4,020  4,020 
BNDESBRLSELIC14.5 %243,223 65,013 704,825 857,419 948,048 922,432 
BNDESBRLTR2.2 %84 70,015 70,099 
Assets financingBRLCDI18.1 %18,427 17,037 56,956 71,235 75,383 88,272 
NCE (“Export credit notes”)BRLCDI18.5 %3,027 3,114 100,000 100,000 103,027 103,114 
NCR (“Rural producer certificates”)BRLCDI14.8 %312,652 101,739 2,000,000 1,998,270 2,312,652 2,100,009 
Export credits (“export prepayments”)BRLFixed791,306  791,306 
DebenturesBRLCDI/IPCA15.4 %120,931 66,536 9,738,616 8,362,207 9,859,547 8,428,743 
893,960 1,155,17317,536,656 14,712,84618,430,616 15,868,019
10,501,387 4,758,24790,934,144 72,414,445101,435,531 77,172,692
Interest on financing1,541,312 1,232,810  1,541,312 1,232,810 
Non-current funding8,960,075 3,525,437 90,934,144 72,414,445 99,894,219 75,939,882 
10,501,387 4,758,24790,934,144 72,414,445101,435,531 77,172,692
(1) The balances shown as negative correspond to fundraising costs
18.2 Breakdown by maturity - non-current
202620272028202920302031 onwards Total
In foreign currency
Bonds3,074,751 4,318,390 3,083,311 10,758,081 6,150,231 21,782,040 49,166,804 
Panda Bonds (1)
(1,211)1,017,542     1,016,331 
Export credits (“export prepayments”)5,668,270 4,889,574 3,832,090 1,893,802   16,283,736 
Assets financing110,452 112,204 69,012 6,584   298,252 
ECA - Export Credit Agency (1)
(670)(845)(780)(912)(847)773,756 769,702 
EDC - Export Development Canada  1,114 1,114 1,114 1,113 4,455 
IFC - International Finance Corporation (1)
(6,668)305,291 1,587,751 2,613,047 1,358,787  5,858,208 
8,844,924 10,642,156 8,572,498 15,271,716 7,509,285 22,556,909 73,397,488 
In local currency
BNDES – TJLP90,078 3,634 3,634 3,634 607  101,587 
BNDES – TLP98,668 158,812 155,980 141,823 366,249 3,685,570 4,607,102 
BNDES – SELIC254,966 33,888 33,933 33,979 34,024 314,035 704,825 
BNDES – TR4,178 4,734 4,734 4,734 4,734 46,901 70,015 
BNDES - UMBNDES4,258 8,516 8,516 8,516 8,516 119,233 157,555 
Assets financing18,741 19,114 19,034 67   56,956 
NCE (“Export credit notes”) 25,000 25,000 25,000 25,000  100,000 
NCR (“Rural producer certificates”)    2,000,000  2,000,000 
Debentures (1)
(7,431)(11,767)738,297 (11,477)518,399 8,512,595 9,738,616 
463,458 241,931 989,128 206,276 2,957,529 12,678,334 17,536,656 
9,308,382 10,884,087 9,561,626 15,477,992 10,466,814 35,235,243 90,934,144 
(1) The balances shown as negative correspond to fundraising costs, which are amortized on a straight-line basis.                                                
18.3 Roll-forward of loans, financing and debentures
12/31/202412/31/2023
Opening balance77,172,692 74,574,591 
Fundraising, net of issuance costs 15,692,905 10,944,794 
Interest accrued 5,413,707 4,797,094 
Monetary and exchange rate variation, net17,728,324 (4,185,675)
Settlement of principal (9,410,807)(4,296,447)
Settlement of interest (5,241,389)(4,728,998)
Amortization of fundraising costs 80,099 67,333 
Closing balance101,435,531 77,172,692
18.4 Fundraising costs
The fundraising costs are amortized based on the terms of agreements and the effective interest rate.
Balance to be amortized
TypeCostAmortization12/31/202412/31/2023
Bonds434,970 266,520 168,450 164,825 
NCE125,222 125,222  2,696 
Export credits (“export prepayments”)219,946 156,866 63,080 52,162 
Debentures159,675 34,012 125,663 102,235 
BNDES 81,730 55,953 25,777 9,854 
IFC - International Finance Corporation81,726 3,007 78,719 38,911 
Others20,912 14,113 6,799 598 
1,124,181 655,693 468,488 371,281
18.5 Guarantees
Some loan and financing agreements have guarantees clauses, in which the financed equipment or other property, plant and equipment is offered as collateral by the Company, as disclosed in Note 15.1.
The Company does not have contracts with restrictive financial clauses (financial covenants) which must be complied with.
18.6 Relevant transactions entered into during the year
18.6.1 Export Prepayment
On February 15, 2024, the Company raised, with several banks (a syndicated operation), an export prepayment ("EPP") in the amount of US$780,000 (equivalent to R$3,877,380), at a floating rate based on SOFR + 1.65% p.a (increasing by 0.05% p.a until maturity), with final maturity in February 2029, as part of the rollover process of a partially settled EPP on the same date.
18.6.2 Rural Credit Note
On March 28, 2024, the Company raised, with Safra Bank, a Rural Credit Note in the amount of R$200,000, with a post-fixed interest rate of 100% of the CDI, with final maturity in March 2025.
18.6.3 Export Development Canada (“EDC”)
On April 30, 2024, the Company raised with from EDC in the amount of US$125,000 (equivalent to R$646,475) at a floating rate of SOFR + 1.74%, with final maturity in April 2031.
18.6.4 Debentures
On May 29, 2024, the Company issued simple, non-convertible debentures, unsecured, in three series, totaling R$5,900,000, as part of a debt rollover strategy. The debenture consists of three parts: (i) R$1,000,000 at a cost of CDI + 0.80% p.a., with a total term of eight years and equal amortizations in May 2031 and May 2032; (ii) R$4,000,000 at a cost of CDI + 1% p.a., with a total term of ten years and equal amortizations in May 2033 and May 2034; and (iii) R$900,000 (incentivized debenture) at a cost of IPCA + 6.11% p.a., with a total term of twelve years and equal amortizations in May 2035 and May 2036.
18.6.5 BNDES
On June 27, 2024, the Company raised with from BNDES in the amount of R$65,000, indexed by the Long-Term Interest Rate (TLP - 5.56% p.a.), plus fixed interest of 1.75% p.a., with a one-year principal grace period and final maturity in December 2043. The funds were allocated to industrial projects.
On August 26, 2024, the Company raised from BNDES in the amount of R$1,110,000, indexed by the Long-Term Rate (TLP = IPCA + 5.48% p.a.), plus fixed interest of 1.75% p.a., with a 7-year principal grace period and final maturity in May 2044. The funds were allocated to forestry projects.
On October 16, 2024, the Company raised from BNDES in the amount of R$32,000, indexed by the Long-Term Rate (TLP - 5.27% p.a.), plus fixed interest of 1.75% p.a., with final maturity in October 2042. The funds were allocated to industrial projects.
On November 8, 2024, the Company raised from BNDES in the amount of R$154,000, indexed by the Long-Term Rate (TLP - 5.23% p.a.), plus fixed interest of 1.65% p.a., with final maturity in December 2037. The funds were allocated to forestry projects.
On December 20, 2024, the Company raised from the BNDES in the amount of R$61,000, indexed by the reference rate (“TR”), plus fixed interest of 2.24% p.a., with a grace period of 1 year and final maturity in December 2040. The funds were allocated to technological innovation projects.
On December 26, 2024, the Company raised from the BNDES in the amount of R$208,981, indexed by the exchange rate variation of the US dollar against the Real, plus fixed interest of 1.65% p.a., with a grace period of one and a half years and final maturity in December 2044. The funds were allocated for industrial projects.
18.6.6 Advance of exchange contract (“ACC”)
On May 17, 2024, the Company rolled over an ACC of US$100,000 (equivalent to R$555,890), indexed at a fixed rate of 6% p.a. and originally maturing on May 17, 2024, to a new rate of 6.46% p.a. with a new maturity on May 19, 2025.
On June 5, 2024, the Company raised an ACC from BNP bank in the amount of US$15,000 (equivalent to R$83,383), indexed at a fixed rate of 6.43% p.a., with a maturity on June 9, 2025.
On June 21, 2024, the Company rolled over an ACC of US$35,000 (equivalent to R$194,561), indexed at a fixed rate of 6.52% p.a. and originally maturing on June 21, 2024, to a new rate of 6.54% p.a. with a new maturity on May 21, 2025.
18.6.7 Panda Bonds
On November 15, 2024, the Company issued a panda bond in China in the amount of CNY1,200,000 (equivalent to US$166,000 and R$960,891) at a fixed cost of 2.8% with a final term of three years.
The Panda Bonds have been certified as green bonds according to the analysis of the China Green Bond Standard Committee. Suzano has also voluntarily obtained an independent Second Party Opinion from Sustainalytics US Inc., which ensures that the allocation of funds under this operation is in line with the Green Bond Principles published by the International Capital Markets Association (ICMA).
18.6.8 International Finance Corporation (“IFC”)
On December 10, 2024, the Company drew down the amount available under a credit line with the IFC and a syndicate of commercial banks, in the amount of US$350,000 (equivalent to R$2,118,515).
The financing is made up of the following parts: (i) “B-loan - tranche 1”, in the amount of US$105,000 (equivalent to R$635,554), at a cost of Term SOFR + 1.60% p.a. and a total term of five years. and a total term of five years, with a principal grace period of three years; and (ii) “B-Loan - tranche 2”, in the amount of US$245,000 (equivalent to R$1,482,961) at a cost of Term SOFR + 1.80% p.a. and a total term of six years, with a principal grace period of four years.
The credit operation has sustainability performance indicators (KPIs) associated with targets for: (a) reducing the intensity of greenhouse gas (GHG) emissions; and (b) increasing the representation of women in leadership positions in the company. The funds will be allocated to the Cerrado Project.
18.7 Significant transactions settled during the year
18.7.1 Export Prepayment
On February 15, 2024, the Company partially settled, in advance, a pre-export facility with several banks (a syndicated operation), in the total amount of US$620,000 (equivalent to R$3,209,057 (principal and interest)). The residual amount of this operation maintained its original maturity in February 2026, with a floating rate based on SOFR + 1.41% p.a.
On June 7, 2024, the Company early settled a debenture with Bradesco bank in the total amount of R$4,926,631 (principal and interest) as part of a debt rollover strategy. The original maturity of the debenture was in June 2025 and June 2026, with an annual rate of 112.5% of CDI.
v3.25.1
LEASES
12 Months Ended
Dec. 31, 2024
Presentation of leases for lessee [abstract]  
LEASES
19 LEASES
19.1 Right of use
The balances rolled-forward are set out below:
 Lands Machinery and equipment BuildingsShips and boatsVehicles Total
Balances at December 31, 20223,283,156 112,553 85,756 1,623,118 4,643 5,109,226 
Additions/updates496,236 206,847 101,124 9,702 813,909 
Depreciation (1)
(386,436)(134,587)(59,448)(124,890)(2,346)(707,707)
Write-offs (2)
(12,658)(6,139)(18,797)
Balances at December 31, 20233,380,298 184,813 127,432 1,498,228 5,860 5,196,631 
Additions/updates506,373 157,542 41,235  39,076 744,226 
Depreciation (1)
(408,000)(167,312)(54,275)(124,890)(2,587)(757,064)
Write-offs (2)
(3,102)    (3,102)
Balances at December 31, 20243,475,569 175,043 114,392 1,373,338 42,349 5,180,691 
(1)The amount of depreciation related to land is substantially reclassified to biological assets to make up the formation costs.
(2)Write-off due to cancellation of contracts.

On December 31, 2024 and 2023, the Company does not have commitments to lease agreements not yet in force.
19.2 Lease liabilities
The balance of lease payables on December 31, 2024, measured at present value and discounted at the respective discount rates are set forth below:
Nature of agreement
Average rate - % p.a. (1)
Maturity (2)
Present value of liabilities
Lands and farms

12.27 October/20523,951,880 
Machinery and equipment

11.19 April/2035273,019 
Buildings

10.75 May/2031117,387 
Ships and boats

11.25 February/20392,626,083 
Vehicles

11.10 November/20284,546 
6,972,915 
(i)To determine the discount rates, quotes were obtained from financial institutions for agreements with characteristics and average terms similar to the lease agreements.
(ii)Refers to the original maturities of the agreements and, therefore, does not consider eventual renewal clauses.
The balances rolled-forward are set out below:
12/31/202412/31/2023
Opening balance6,243,782 6,182,530 
Additions744,226 813,909 
Write-offs (2)
(3,102)(18,797)
Payments(1,325,398)(1,218,399)
Accrual of financial charges (1)
700,283 664,651 
Exchange rate variations613,124 (180,112)
Closing balance6,972,915 6,243,782
Current872,228 753,399 
Non-current6,100,687 5,490,383 
(1)On December 31, 2024, the amount of R$249,135 related to interest expenses on leased lands was capitalized to biological assets to represent the formation cost (R$223,055 as of December 31, 2023).
(2)Write-off due to cancellation of contracts.
The maturity schedule for future payments not discounted to present value related to lease liabilities is disclosed in Note 4.2.
19.2.1 Amounts recognized in the statement of income for the year
The amounts recognized are set out below:
12/31/202412/31/2023
Expenses relating to short-term assets6,477 8,005 
Expenses relating to low-value assets4,083 2,611 
10,560 10,616
v3.25.1
PROVISION FOR JUDICIAL LIABILITIES
12 Months Ended
Dec. 31, 2024
Disclosure of other provisions [abstract]  
PROVISION FOR JUDICIAL LIABILITIES
20 PROVISION FOR JUDICIAL LIABILITIES
The Company is involved in certain legal proceedings arising in the normal course of its business, which include tax, social security, labor, civil, environment and real estate.
The Company classifies the risk of unfavorable decisions in legal proceedings, based on legal advice, which reflects the estimated probable losses.
The Company’s Management believes that, based on the available information as of the date of these consolidated financial statements, its provisions for tax, social security, labor, civil, environment and real estate risks, accounted for according to IAS 37 are sufficient to cover estimated losses related to its legal proceedings, as set forth below:
20.1 Roll-forward and changes in the provisions for probable losses based on the nature of the proceedings, net of judicial deposits
12/31/2024
Tax and
social security
LaborCivil, environment and real estate
Contingent liabilities assumed (1) (2)
Total
Provision balance at the beginning of the year468,839 349,058 139,435 2,155,545 3,112,877 
Payments(60,081)(89,221)(6,795) (156,097)
Reversal(9,540)(89,941)(1,951)(27,820)(129,252)
Additions4,689 162,456 72,605  239,750 
Monetary adjustment 4,057 21,574 12,259  37,890 
Provision balance407,964 353,926 215,553 2,127,725 3,105,168 
Judicial deposits(66,746)(91,596)(20,076)(178,418)
Provision balance at the end of the year341,218 262,330 195,477 2,127,725 2,926,750 
(1)Amounts arising from tax-related lawsuits with a possible or remote probability of loss in the amount of R$1,994,444 and civil lawsuits in the amount of R$133,281, measured and recorded at the estimated fair value resulting from the business combination with Fibria.
(2)Reversal due to a change in likelihood, cancellation and/or due to settlement.
12/31/2023
Tax and
social security
LaborCivil, environment and real estate
Contingent liabilities assumed (1) (2)
Total
Provision balance at the beginning of the year419,915255,805118,7292,645,7053,440,154
Payments(1,717)(37,172)(3,014)(41,903)
Reversal(18,035)(101,375)(11,337)(490,160)(620,907)
Additions37,656 211,690 21,335 270,681 
Monetary adjustment31,020 20,110 13,722 64,852 
Provision balance468,839349,058139,4352,155,5453,112,877
Judicial deposits(154,469)(82,305)(15,694)(252,468)
Provision balance at the end of the year314,370266,753123,7412,155,5452,860,409
(1)Amounts arising from tax-related lawsuits with a possible or remote probability of loss in the amount of R$2,015,075 and civil lawsuits in the amount of R$140,470, measured and recorded at the estimated fair value resulting from the business combination with Fibria.
(2)Reversal due to a change in likelihood, cancellation and/or due to settlement. The amount of R$372,541 refers to the penalty cancellation of the contingent liability assumed on the business combination with Fibria, described in note 20.2.1 (i).

20.1.1 Tax and social security
On December 31, 2024, the Company has 58 (32 as of December 31, 2023) administrative and judicial proceedings of a tax or social security nature in which the disputed matters are related to IRPJ, CSLL, PIS, COFINS, ICMS among others, whose amounts are provisioned when the likelihood of loss is deemed probable by the Company’s external legal counsel and by Management.
20.1.2 Labor
On December 31, 2024, the Company has 1,178 (1,241 as of December 31, 2023) labor lawsuits.
In general, the provisioned labor proceedings are related primarily to matters frequently contested by employees of agribusiness companies, such as wages and/or severance payments, in addition to suits filed by outsourced employees of the Company.
20.1.3 Civil, environment and real estate
On December 31, 2024, the Company has 97 (76 as at December 31, 2023) civil, environmental and real estate proceedings.
The provisioned Civil, environment and real estate proceedings are related primarily to the payment of damages, including those arising from contractual obligations, traffic-related injuries, possessory actions, environmental restoration obligations, claims and others.
20.2 Contingencies with possible losses
The Company is involved in tax, civil and labor lawsuits, whose losses have been assessed as possible by Management, supported by legal counsel, and therefore no provision was recorded:
12/31/202412/31/2023
Taxes and social security (1)
9,837,082 9,775,068 
Labor171,480 194,883 
Civil and environmental (1)
5,065,714 4,462,964 
15,074,276 14,432,915
(1)The amounts above do not include the fair value adjustments allocated to possible loss risk contingencies representing R$R$2,108,635 (R$2,135,869 as of December 31, 2023), which were recorded at fair value resulting from business combinations with Fibria, as presented in Note 20.1.1 above.
20.2.1 Tax and social securities

For the year ended December 31, 2024, the Company had 673 (733 as of December 31, 2023) tax proceedings whose likelihood of loss is considered possible, in the total amount of R$9,837,082 (R$9,775,068 as of December 31, 2023) for which no provision was recorded.
The other tax and social security lawsuits involve various taxes, such as IRPJ, CSLL, PIS, COFINS, ICMS, ISS, IRRF. These disputes primarily arise from differing interpretations of the applicable tax regulations and the information provided in the ancillary obligations.
The most significant tax cases are outlined below:
(i)Income Tax Assessment - IRPJ/CSLL - Swaps of Industrial and Forestry Assets: In December 2012, the Company received a tax assessment for income tax and social contribution, alleging unpaid tax on a capital gain in February 2007, the closing date of the transaction, when the Company executed an agreement with International Paper regarding a swap of industrial and forestry assets. On January 19, 2016, the Tax Federal Administrative Court (“CARF”) rejected, as per the casting vote of the CARF’s President, the appeal filed by the Company in the administrative process. The Company was notified of the decision on May 25, 2016 and, given the impossibility of further appeals and the consequent closure of the case at the administrative level, decided to pursue the discussion in the Judiciary. The lawsuit was ruled in favor of the Company's interests and the National Treasury's appeal is currently awaiting judgment at the lower court. In December 2023, pursuant to article 25, § 9ºA, of Law No. 14,689/23, the Active Debt Certificates were rectified to definitively cancel the amounts related to the tax assessment penalty and its charges. According to the Company and its external legal advisors the probability of loss in this case is possible, except for the provisioning of the amount equivalent to the contingent liability assumed arising from the business combination. For the year ended December 31, 2024, the estimated amount of the possible exposure is R$1,688,690 (R$1,630,537 as of December 31, 2023).
(ii)Income tax assessment - IRPJ/CSLL: This refers to an administrative proceeding initiated in October 2023, resulting from tax assessments for IRPJ and CSLL issued against Suzano S.A., for the calendar year of 2019. The infractions alleged include: (i) nondeductible expenses; (ii) improper deduction of operating expenses; (iii) profits earned by the subsidiaries abroad; (iv) goodwill amortization; (v) lack of addition of bonus paid to directors to the CSLL calculation basis, and (vi) tax loss and negative CSLL basis. The Company filed an administrative objection, which was partially upheld. Currently, the voluntary appeal filed by the Company and the ex officio appeal filed by the National Treasury are awaiting judgment. For the year ended December 31, 2024, the total amount of the possible exposure is R$920,628 (R$845,164 as of December 31, 2023).
(iii)Income Tax Assessment - IRPJ/CSLL - Disallowance of Depreciation, Amortization and Depletion Expenses – 2010 period: In December 2015, the Company received a tax assessment demanding the payment of IRPJ and CSLL. The assessment challenges the deductibility of depreciation, amortization and depletion expenses of 2010, which the Company had included in its income tax calculations. The Company filed an administrative appeal, which was partially upheld. This decision was subject to a voluntary appeal, filed by the Company in November 2017. The judgment was converted into a due diligence process, and currently, the Company is awaiting the completion of the due diligence. For the year ended December 31, 2024 the total amount of the possible exposure is R$875,466 (R$827,186 as of December 31, 2023).
(iv)Tax Assessment - IRPJ/CSLL: On October 5, 2020, the Company was notified of a Tax Assessment issued by the Brazilian Internal Revenue Service ("RFB") claiming the payment of IRPJ and CSLL credits, resulting from the remeasurement of the profit of its subsidiary Suzano Trading Ltd in the years ended December 31, 2014, 2015 and 2016. In addition to the Company, the statutory executive officers of Suzano Trading were also included as co-defendants. Based on the legal advisors hired to present the defense, the Company classifies, the risk of loss as possible with reference to the Company and, with reference to the Officers, also possible but with a higher chance of winning (possible to remote). The Company presented the administrative defense and, currently, through Resolution No.104000033, the judgment was converted into a diligence. Currently awaiting the conclusion of the due diligence. In the year ended December 31, 2024 the total amount of the possible exposure is R$609,548 (R$563,723 as of December 31, 2023).
(v)PIS/COFINS – Goods and Services – Period of 2009 to 2011: In December 2013, the Company was assessed by the RFB demanding the collection of PIS and COFINS credits disallowed for allegedly not being linked to its operational activities. In the first instance, the objection filed by the Company was dismissed. A voluntary appeal was filed and it was partially upheld in April 2016. From this decision, the Company filed a special appeal, and certain divergences were admitted for consideration by the Superior Chamber of Tax Appeals (“CSRF”). The National Treasury also filed a special appeal with the Superior Chamber. Currently, the partial settlement of the ruling is being discussed, and the special appeal is awaiting judgment by the CSRF. For the year ended December 31, 2024 the total amount of the possible exposure is R$201,199 (R$190,875 as of December 31, 2023).
(vi)Tax Assessment - Taxation on a universal basis – Period of 2015: On November 3, 2020, the Company was notified of a Tax Assessment issued by the RFB under the accusation that it had failed to pay IRPJ and CSLL for the 2015 calendar year. The infraction was based on the lack of addition, in determining the real profit and the CSLL calculation base, of the profits earned by its foreign subsidiaries. Based on the legal advisors hired to present the defense, the Company classified the risk of loss as possible. The Company filed an administrative defense, which was partially upheld in the first instance. Following this decision, the Company filed a voluntary appeal on June 8, 2024, which was partially upheld on May 14, 2024, resulting in the cancellation of the majority of the tax assessment. For the remaining portion, the Company filed a special appeal, which is currently awaiting judgment. For the year ended December 31, 2024 the total amount of exposure is R$4,712 (R$176,917 as of December 31, 2023).
(vii)Tax incentive - Agency for the Development of Northeastern Brazil (“ADENE”): In 2002, the Company applied for and was granted by the RFB the right to benefit from a reduction in the IRPJ and non-refundable additional taxes calculated on operating profit, for plants A and B (period from 2003 to 2013) and plant C (period from 2003 to 2012), all located in the Aracruz unit, under the condition of making new investments in its units located in the area covered by ADENE. In 2004, the Company received a notice from the extrajudicial administrator of the extinct Superintendency for the Development of the Northeast (“SUDENE”), informing it that the right to enjoy the benefit previously granted was deemed unfounded and would be revoked. In 2005, a tax assessment was issued demanding alleged amounts relating to the tax incentive enjoyed up to that point. After administrative discussion, the tax assessment was partially upheld recognizing the Company's right to benefit from the tax incentive until 2003. The Company's management, advised by its legal advisors, believes that the decision to cancel the referred tax benefits is incorrect and should not prevail, whether concerning the benefits already enjoyed or those not yet enjoyed until their respective final terms. Currently, the contingency is being discussed in the judicial sphere. The Company is awaiting the judgment of the appeal filed against the unfavorable decision. For the year ended December 31, 2024 the total amount of the possible exposure is R$150,869 (R$143,912 as of December 31, 2023).
(viii)Offsetting - IRRF - Period 2000: The Company filed a process to offset IRRF credits for the year ended December 31, 2000 against debts owed to the RFB. In April 2008, the Brazilian Federal Revenue Service partially recognized the credit in favor of the Company. The Company filed a Voluntary Appeal with CARF against this decision and the judgment was converted into a due diligence process. The Voluntary Appeal is currently awaiting judgment. For the year ended December 31, 2024 the total amount of the possible exposure is R$125,489 (R$120,871 as of December 31, 2023).
(ix)IRPJ/CSLL - Partial Approval – 1997 Period: The Company filed a process to offset credits arising from tax losses for the year 1997 against debts owed to the RFB . In March 2009, the tax authorities approved only R$83,000, resulting in a difference of R$51,000. The Company is still awaiting the conclusion of the analysis of the credits under administrative review following a favorable decision by CARF in August 2019, which upheld the voluntary appeal filed by the Company. For the remaining portion of the credit, the Company filed a lawsuit to discuss the matter which is currently awaiting judgment in the second instance of its appeal, filed after an unfavorable ruling. For the year ended December 31, 2024, the total amount of the possible exposure is R$122,319 (R$117,130 as of December 31, 2023).
(x)Tax Assessment - IRPJ/CSLL: Administrative proceeding demanding the collection of IRPJ and CSLL for the 2015 calendar year. The infractions alleged include (i) transfer pricing; and (ii) non-deductible expenses. The Company filed an objection in January 2020, which was partially upheld. Following this decision, the Company filed a voluntary appeal, and the judgment was converted into a due diligence process. Currently, the Company is awaiting the beginning of the due diligence process. For the year ended December 31, 2024, the total amount of the possible exposure is R$112,168 (R$106,477 as of December 31, 2023).
(xi)Tax Assessment - IRPJ and Negative Balance: This refers to a Decision Dispatch that partially approved the offsetting carried out by the Company, due to the use of credits from a Negative Balance, arising from withholding tax, calculated for the period from January 2016 to December 2016. The Company filed an administrative objection, which was fully upheld in its favor. For the year ended December 31, 2024, there is no estimated amount of exposure due to the favorable outcome (R$102,496 as of December 31, 2023).
(xii)IRPJ/CSLL - Partial Approval – 2000 Period: In 2024, the Company submitted a request to offset credits arising from the negative balance calculated in the year 2000 against debts owed to the Brazilian Federal Revenue Service (“RFB”). The RFB fully disallowed the tax credit. After presenting the defense and the appropriate appeals, the process ended unfavorably for the Company at the administrative level. The Attorney General's Office of the National Treasury (“PGFN”) filed a tax execution to collect the amounts, at which time the Company filed the appropriate motions to stay the tax execution, which were partially upheld. The Company has filed an Appeal, which is awaiting judgment. For the year ended December 31, 2024, the estimated amount of exposure is R$101,654.
20.2.2 Labor
On December 31, 2024, the Company was a defendant in 1,135 labor lawsuits, totaling R$171,480 (1,034 labor lawsuits, totaling R$194,883 as of December 31, 2023).
The Company also has several lawsuits in which employees’ unions in the states of Bahia, Espírito Santo, Maranhão, São Paulo and Mato Grosso do Sul are included.
20.2.3 Civil, environmental and real estate
On December 31, 2024, the Company was a defendant in approximately 201 civil, environmental and real estate lawsuits, totaling R$5,065,714 (219 lawsuits totaling R$4,462,964 as of December 31, 2023).
In general, the civil and environmental proceedings in which the Company, including its subsidiaries, is a defendant, are mainly related to discussions regarding eligibility for environmental licenses, repair of environmental damage, matters relating to indemnities, including those arising from discussions about contractual obligations, precautionary measures, possessory actions, damage repair and revision actions, actions aimed at the recovery of credits (collection actions, monitoring, execution, credit qualifications related to bankruptcy and judicial recovery), actions of social movements interest, such as landless workers, quilombola communities, indigenous people and fishers, and actions resulting from traffic accidents. The Company has a general civil liability insurance policy that aims to cover, within the limits contracted in the policy, any legal convictions arising from damages to third parties (including employees).
The most relevant civil cases are set forth below:
(i)The Company is involved in 3 Public Civil Actions (“ACPs”) filed by the Federal Public Prosecutor's Office (“MPF”) in which it requests (i) an injunction that the Company's trucks stop transporting wood on federal highways above the legal weight restrictions (ii) an increase in the fine for excess weight to be applied to Suzano and (iii) compensation for material damage caused to federal highways, the environment and the economic order and compensation for moral damage. One of the ACPs was judged partially well-founded and the Company filed an appeal to the competent court with a request to suspend the effects of the judgment, which is still pending assessment. The other two lawsuits were dismissed and an appeal is pending. In September 2021, both were suspended due to a decision by the STJ to evaluate the points of discussion in the form of a repetitive appeal. In December 2024, the STJ judged the repetitive appeals to allow the application of a double penalty (administrative and judicial), establishing a thesis authorizing the imposition of injunctive relief and civil liability. At the moment, the União Comércio and CNT have filed motions for clarification to highlight various gaps and omissions identified in the judgment.
(ii)The company sued a competitor in the central-western region over the improper and unauthorized use of a variety of eucalyptus protected by intellectual property rights (cultivar) of the incorporated subsidiary Fibria. The prohibition on the cultivation of this biological asset by the competitor was protected by an injunction, which was confirmed in a judgment in favor of the Company, with the Company initiating the liquidation of the judgment. However, at the appeal stage and in an extended trial, there was a ruling against the Company recognizing a supposed incidental nullity of the cultivar, a decision that is currently subject to a motion for clarification. It should be noted that, in parallel, there is also a lawsuit in the Federal Court in which the competitor filed an action to annul the registration of the cultivar, but, to date, there has been no decision in this process determining the nullity or restricting the Company's right.
v3.25.1
EMPLOYEE BENEFIT PLANS
12 Months Ended
Dec. 31, 2024
Disclosure of information about defined benefit plans [abstract]  
EMPLOYEE BENEFIT PLANS
21 EMPLOYEE BENEFIT PLANS
The Company provides supplementary pension plan and defined benefit plan, such as medical assistance and life insurance, as set forth below:
21.1 Pension plan
The Company has current supplementary retirement plans, as disclosed below.
21.1.1 Pension plan – Suzano Prev
In 2005, the Company established the Suzano Prev pension plan, managed by BrasilPrev, an open private pension entity, which serves the employees of Suzano Group Companies, in the form of a defined contribution plan.
Under the terms of the benefit plan agreement, for employees who have a salary above 10 Suzano reference units (“URS”), in addition to the 0.5% contribution, the contributions of the Company matches the employees' contributions, and affect the portion of the salary that exceeds 10 URS, which can vary between 1% and 6% of the nominal salary. This plan is called Basic Contribution 1.
The Company's contributions to the employees are 0.5% of the nominal salary that does not exceed 10 URS, even though there is no contribution by the employees. This plan is called Basic Contribution 2.
From August 2020, employees who have a salary lower than 10 URS will be able to invest 0.5% or 1% of their nominal salary, and the Company will monitor the employee's contributions. The employee can choose to invest up to 12% of their salary in the Suzano Prev pension plan, and the excess of Basic Contribution 1 or 2 may be invested in the supplementary contribution, where there is no counter-entry from the Company, and the employee must consider the two contributions within the limit of 12% of their salary.
Access to the balance constituted by the Company's contributions only occurs upon dismissal, and is directly related to the length of the employment relationship.
Contributions made by the Company, for Suzano Prev pension plan managed by Brasilprev Seguros e Previdência S.A., for the year ended December 31, 2024 amounted R$21,719 (R$18,342 as of December 31, 2023) recognized under the cost of sales, selling and general and administrative expenses.
21.2 Defined benefits plan
The Company offers the medical assistance and life insurance in addition to the pension plans, which are measured based on actuarial calculations and recognized in the financial statement, as detailed below.
21.2.1 Medical assistance
The Company guarantees healthcare program cost coverage for a group of former employees who retired up to 2007, as well as their spouses for life and underage dependents.
For other groups of former employees, who exceptionally, according to the Company’s criteria and resolutions or based on rights related to compliance with pertinent legislation, the Company ensures the healthcare program.
The main actuarial risks related are: (i) lower interest rates; (ii) longer than expected mortality tables; (iii) higher than expected turnover; and (iv) higher than expected growth in medical costs.
21.2.2 Life insurance
The Company offers the life insurance benefit to the group of former employees who retired up to 2005 at the Suzano and São Paulo administrative offices, and did not opt for the supplementary retirement plan.
The main actuarial risks are: (i) lower interest rates; and (ii) higher than expected mortality.
21.2.3 Roll-forward of actuarial liability
The roll-forward of actuarial liabilities prepared based on actuarial report is set forth below:
12/31/202412/31/2023
Opening balance833,683 691,424 
Interest on actuarial liabilities73,853 67,272 
Current service cost1,997 1,959 
Actuarial loss – experience(125)57,765 
Actuarial loss (gain) – financial assumptions(137,649)70,762 
Benefits paid directly by entity(50,199)(55,499)
Closing balance721,560 833,683
21.2.4 Economic actuarial assumptions and biometric data
12/31/202412/31/2023
Economic
Nominal discount rate – medical assistance and life insurance
11.16% p.a.
9.14% p.a.
Medical cost growth rate
6.86% p.a.
6.86% p.a.
Nominal inflation
3.50% p.a.
3.50% p.a.
Aging factor
0 to 24 years: 1.50% p.a.
0 to 24 years: 1.50% p.a.
25 to 54 years: 2.50% p.a.
25 to 54 years: 2.50% p.a.
55 to 79 years: 4.50% p.a.
55 to 79 years: 4.50% p.a.
Above 80 years: 2.50% p.a.
Above 80 years: 2.50% p.a.
Biometric
Table of general mortalityAT-2000AT-2000
Table of mortality of disabled personsIAPB 57IAPB 57
Turnover
1.00% p.a.
1.00% p.a.
Other
Retirement age
65 years
65 years
Family composition
Men 4 years + older
Men 4 years + older
and 90% married
and 90% married
Permanency in the plan100%100%
21.2.5 Sensitivity analysis
The sensitivity analysis regarding the relevant assumptions of the plans show the impact on the liability balance:
Discount rateMedical costs growth rate
+0.50%691,494 +1.00%788,124 
21.2.6 Forecast amounts and average duration of payments of obligations
The expected benefit payments for future years (ten years), from the obligation of benefits granted and the average duration of the plan obligations are as set forth below:
PaymentsMedical assistance and life insurance
202553,601 
202657,267 
202760,995 
202864,862 
202968,645 
2029 to 2034397,704 
v3.25.1
SHARE-BASED COMPENSATION PLAN
12 Months Ended
Dec. 31, 2024
Disclosure of terms and conditions of share-based payment arrangement [abstract]  
SHARE-BASED COMPENSATION PLAN
22 SHARE-BASED COMPENSATION PLAN
The Company grants members of the statutory and non-statutory board of directors, key employees and members of the Board of Directors (“Beneficiaries”) long-term share-based incentive plans, approved at the General Meeting with the objectives of: (i) aligning the interests of the beneficiaries with the interests of the Company and its shareholders, (ii) attracting, rewarding, retaining and incentivizing the beneficiaries to conduct the Company's business in a sustainable manner, within appropriate risk limits and aligned with the interests of the shareholders, and (iii) granting a financial incentive to the beneficiaries.
The plans granted by the Company are: (i) Phantom Shares Plan (“PS”), settled in in local currency and (ii) Restrict Shares Plan ("Performance Shares"), settled in shares.
The characteristics and measurement criteria of each plan are disclosed below:
22.1 Phantom shares plan (“PS”)
The number of phantom shares to be granted to each beneficiary is calculated based on a fixed financial amount per beneficiary.
The beneficiary may only exercise the rights to the phantom shares once the vesting period has been completed, lasting up to 5 (five) years from the date of grant, in accordance with the characteristics of each plan.
The settlement of the phantom shares is in cash, and the amount will be calculated by multiplying the number of shares granted by the value of the share measured based on the average price of the last 90 (ninety) trading sessions.
Since phantom stock option plans are settled in cash, their fair values are measured at the end of each reporting period.
If the beneficiaries leave the Company during the vesting period, they lose the right to exercise the phantom shares.
The plan transactions are presented below:
Number of shares
Year of grantFair value on grant date31/12/2023Granted during of the yearCancelledExercised (1)31/12/2024Available for completionRestricted year for transfer of shares
2025202620272028
2019R$42.81 39,461 903 (40,364) 
2020R$38.36 984,160 22,525 (204,963)(768,338)33,384 33,384 
2021R$62.15 1,724,020 39,387 (66,231)(822,696)874,480 425,280 449,200 
2022R$57.54 3,686,722 84,207 (286,478)(23,014)3,461,437 3,113,607 324,611 23,219 
2023R$48.79 3,294,062 74,647 (283,548)(32,982)3,052,179 28,333 2,721,535 302,311 
2024R$56.52 2,759,878 (81,947)(2,914)2,675,017 2,893 2,467,693 204,431 
Number of stock options9,728,4252,981,547 (923,167)(1,690,308)10,096,497 458,664 3,591,140 3,049,039 2,793,223 204,431 
Book value268,489 173,486 (80,001)361,974 
Book value of the previous year162,117154,318(47,946)268,489
(1)The average price of the share options exercised and exercised due to termination of employment on December 31, 2024 was R$42.36 (forty-two reais and thirty-six cents) (R$58.07 (fifty-eight reais and seven cents) as at December 31, 2023).
22.2 Restricted shares plan (“Performance Shares”)
Each performance share corresponds to 1 (one) common, registered, book-entry share with no par value issued by the Company, to be delivered to the beneficiary once the conditions established in this plan have been met.
The acquisition of rights to the beneficiaries is subject to: (i) continued permanence of the beneficiaries as directors of the Company during the vesting period, (ii) achievement of the goals assigned in the programs and (iii) any other conditions determined by the Board of Directors in each grant made.
The vesting period may last up to 5 (five) years, starting from the date of grant, according to the characteristics of each plan.
The number of performance shares to be effectively delivered to each beneficiary will depend on the achievement of the goals linked to the respective programs and contracts, and will be determined after the vesting period. This calculation will also consider the Total Shareholder Return (“TSR”), which is an indicator used to measure the performance of the shares of the group of companies characterized as competitors of Suzano.
If beneficiaries leave the Company before fulfilling the conditions for obtaining rights, they lose the right to exercise the restricted share option.
The plan transactions are presented below:
Number of stock options
Year of grantFair value on grant date31/12/2023Shares granted/provisionedExercised31/12/2024Restricted year for transfer of shares
2025202620272029
2021R$51.70 111,685 2,559 (114,244) 
2022R$53.81 113,161 2,639 115,800 115,800 
2023R$51.45 367,903 15,665 383,568 268,534 115,034 
2024R$55.27 3,371,612 (890,869)2,480,743 337,465 220,540 302,738 1,620,000 
Number of stock options592,7493,392,475 (1,005,113)2,980,111 453,265 489,074 417,772 1,620,000 
Book value26,744 81,276 (47,794)60,226 
Book value of the previous year18,4258,31926,744
v3.25.1
LIABILITIES FOR ASSETS ACQUISITIONS AND ASSOCIATES
12 Months Ended
Dec. 31, 2024
LIABILITIES FOR ASSETS ACQUISITIONS AND ASSOCIATES  
LIABILITIES FOR ASSETS ACQUISITIONS AND ASSOCIATES
23 LIABILITIES FOR ASSETS ACQUISITIONS AND SUBSIDIARIES
12/31/202412/31/2023
Business combinations
Facepa (1)
27,182 25,924 
Vale Florestar Fundo de Investimento em Participações ("VFFIP") (2)
93,308 161,263 
120,490 187,187
Current 21,166 93,405 
Non-current99,324 93,782 
(1)Acquired in March 2018, for the amount of R$307,876, upon the payment of R$267,876, with the remainder updated at the IPCA, adjusted for possible losses incurred up to the payment date, with maturity in March 2028.
(2)On August 2014, the Company acquired Vale Florestar S.A. through VFFIP, with maturity up to August 2029. The annual settlements, carried out in the month of August, are subject to interest and updated by the variations of the US$ exchange rate, and partially updated by the IPCA.
v3.25.1
SHAREHOLDERS' EQUITY
12 Months Ended
Dec. 31, 2024
Disclosure of classes of share capital [abstract]  
SHAREHOLDERS' EQUITY
24 SHAREHOLDERS’ EQUITY
24.1 Share capital
On December 31, 2024, Suzano’s share capital was R$19,269,281 divided into 1,264,117,615 common shares, all nominative, book-entry shares without par value. Expenses related to the public offering were R$33,735, totaling a net share capital of R$19,235,546. The breakdown of the share capital is as set out below:
12/31/202412/31/2023
Quantity(%)Quantity(%)
Controlling Shareholders
Suzano Holding S.A.367,612,329 29.08 367,612,32927.76 
Controller196,065,636 15.51 196,065,63614.81 
Managements and related persons32,784,440 2.59 32,105,7832.42 
Alden Fundo de Investimento em Ações26,154,744 2.07 26,154,7441.98 
622,617,149 49.25 621,938,49246.97
Treasury (Note 24.2)24,875,787 1.97 34,765,6002.63 
Other shareholders616,624,679 48.78 667,413,52350.40 
1,264,117,615 100.00 1,324,117,615100.00
For the year ended December 31, 2024, SUZB3 common shares ended the period quoted at R$61.78 and R$55.63 on December 31, 2023.
On April 25, 2024, the Board of Directors approved an increase in the Company's share capital in the amount of R$10,000,000, as described in note 1.2.4.
24.2 Dividends and reserve calculations
The Company´s bylaws establishes that the minimum annual dividend shall be the lower of:
(i)25% of the adjusted net income for the year pursuant to Article 202 of Brazilian Law No. 6,404/76; or
(ii)10% of the Company's consolidated operating cash generation (“GCO”) for the year.
In the year ended December 31, 2024, no dividends were distributed as a result of the loss for the year.
On December 4, 2024, the Board of Directors approved the payment of interest on equity by the Company, in the total gross amount of R$2,500,000, as described in note 1.2.8.
In the year ended December 31, 2023, based on the criteria defined in the bylaws, mandatory minimum dividends were determined in accordance with item (ii) above, as set forth below:
12/31/2023
Accounting EBITDA19,537,398 
Adjustments to EBITDA(1,264,428)
Adjusted EBTIDA18,272,970
Capex Maintenance (Sustain) (6,706,367)
GCO = Adjusted EBTIDA - Capex Maintenance11,566,603
Dividends (10%) - Art. 26, "c" of the Bylaws1,156,660
Interest on own capital distributed and dividends1,500,000 
Withholding income tax(190,119)
Interest on own capital distributed in excess (1)
(153,221)
(1) Considering that the distribution of Interest on own capital in the year ending in 2023 exceeded the minimum mandatory dividends, the Company does not expect to propose additional dividends at the next shareholders' meeting.
24.3 Reserves
24.3.1 Capital reserve
They consist of amounts received by the Company arising from transactions with shareholders that do not pass through the income statement and may be used to absorb losses when they exceed profit reserves and redemptions, reimbursements and purchases of shares.
24.3.2 Income reserves
Reserves are constituted by the allocation of the Company's profits, after the allocation for the payment of the minimum mandatory dividends and after the allocation to the various profit reserves, as set forth below:
(i)Legal: measured based on 5% (five percent) of the net profit of each fiscal year as specified in Article 193 of Brazilian Law No. 6,404/76, which shall not exceed 20% of the share capital, whereas in the year in which the balance of the legal reserve plus the capital reserve amounts exceeds 30% (thirty percent) of the share capital, the allocation of part of the profit will not be mandatory. The use of this reserve is restricted to loss compensation and capital increases, and aims to ensure the integrity of the share capital. For the year ended December 31, 2024, the balance of this reserve is R$1,847,109 (R$1,847,109 as of December 31, 2023).
(ii)Capital increase: measured on the basis of up to 90% (ninety percent) of the remaining balance of the net income for the year, limited to 80% (eighty percent) of the share capital, pursuant to the Company's bylaws, after the allocation to the legal reserve and minimum mandatory dividends. The constitution of this reserve aims to ensure the Company has adequate operating conditions. For the year ended December 31, 2024, the balance of this reserve is R$2,807,632 (R$15,670,952 as of December 31, 2023).
(iii)Special statutory: measured on the basis of up to 10% (ten percent) of the remaining balance of net income for the year, and aims to ensure the continuity of the distribution of dividends, up to the limit of 20% of the share capital. For the year ended December 31, 2024, the balance of this reserve is R$1,847,109 (R$1,887,576 as of December 31, 2023).
(iv)Tax incentives: set up under the terms of article 195-A of Law 6,404/76, amended by Law 11,638/07 and at the proposal of the management bodies, the company will allocate the portion of net income arising from donations or government subsidies to investments, this portion being excluded from the basis for calculating the mandatory dividend. For the year ended December 31, 2024, the balance of this reserve is R$1,319,908 (R$998,237 as of December 31, 2023). This increase can be explained by the reserve relating to the benefits of Operating Profit (note 12.3) and Reinvestment. The Operating Profit, applicable to the plants in the states of Espírito Santo, Maranhão and Bahia (under Sudene's approval), in addition to the plant in Belém do Pará (under Sudam's approval), contributed to a reserve of R$299,515 in the year ended December 31, 2024. With regard to the Reinvestment incentive, used only for the Aracruz (ES), Mucuri (BA) and Imperatriz (MA) units, which are located in the region administered by Sudene, the use of the benefit resulted in an increase of R$14,574 to the reserve for the year. With regard to the investment subsidy tax incentive, in accordance with Law 14.789/2023, the Company taxed the results equivalent to these amounts, and there was no creation of a reserve for this tax incentive for the current year, only the creation of R$7,582, referring to the benefit of the previous year, under the rules prior to Law 14.789/2023.
(v)Investment reserve: constituted in accordance with article 196 of Law No. 6,404/76, modified by Law No. 11,638/07, profit retention is carried out based on a capital budget. This practice aims to meet the needs of the Company's investment plan, previously approved at the Ordinary General Meeting. In the year ended December 31, 2024, the Company absorbed the loss for the year in the amount of R$(7,315,184), ending the year ended 2024 with a balance of R$5,157,140 (R$14,972,324 as of at December 31, 2023).
24.4 Other reserves
These are changes that occur in shareholders' equity arising from transactions and other events that do not originate with shareholders and are disclosed net of tax effects, as set forth below:
Debenture conversion 5th issueActuarial lossExchange variation and fair value of financial assetsExchange variation on conversion of financial statements of foreign subsidiariesDeemed costTotal
Balances at December 31, 2022(45,746)(144,799)2,163 3,218 1,904,680 1,719,516 
Actuarial loss (84,828)   (84,828)
Loss on conversion of financial assets and fair value  (865)  (865)
Gain on conversion of financial statements and on foreign investments   5,178  5,178 
Partial realization of deemed cost, net of taxes    (100,705)(100,705)
Balances at December 31, 2023(45,746)(229,627)1,298 8,396 1,803,975 1,538,296 
Actuarial loss 90,931    90,931 
Loss on conversion of financial assets and fair value  (364,231)  (364,231)
Gain on conversion of financial statements and on foreign investments   163,185  163,185 
Partial realization of deemed cost, net of taxes    (79,385)(79,385)
Balances at December 31, 2024(45,746)(138,696)(362,933)171,580 1,724,590 1,348,796 
24.5 Treasury shares
On December 31, 2024, the Company had 24,875,787 (34,765,600 as of December 31, 2023) of its own common shares held in treasury, with an average cost of R$53.84 per share, with a historical value of R$1,339,197 (R$1,484,014 as at December 31, 2023) and the market corresponding to R$1,536,826 (R$1,934,010 as at December 31, 2023).
On January 26, 2024, 20,000,000 common shares held in treasury were canceled. Additionally, on August 9, 2024, another 40,000,000 common shares held in treasury were canceled, as described in Note 1.2.3. On the same date, the Company approved a new share buyback program, under which it may acquire up to 40,000,000 common shares of its own issue, with a maximum term of 18 months, ending on February 9, 2026, of which 11,115,300 have already been repurchased up to the year ended December 31, 2024.
Quantity Average cost
per share
Historical
value
Market
value
Balances at December 31, 202251,911,56940.842,120,3242,504,214
Repurchase

20,000,000 44.05 880,914 880,914 
Canceled

(37,145,969)40.84 (1,517,224)(1,570,532)
Balances at December 31, 202334,765,60042.691,484,0141,934,010
Exercised (note 22.2)(1,005,113)47.55 (47,794)(54,213)
Repurchase51,115,300 54.91 2,806,764 2,806,764 
Canceled(60,000,000)48.40 (2,903,787)(3,238,200)
Balances at December 31, 202424,875,787 53.84 1,339,197 1,536,826 
24.6 Distribution of results
Limit on share capital %Distribution of resultsReserve balances
12/31/202412/31/202312/31/202412/31/2023
Realization of deemed cost, net of taxes(79,385)(100,705)  
Tax incentive reserve321,671 118,959 1,319,908 998,237 
Legal reserve20.00 % 443,010 1,847,109 1,847,109 
Capital increase reserve80.00 % 10,911,226 2,807,632 15,670,952 
Special statutory reserve20.00 % 1,212,358 1,847,109 1,887,576 
Investments reserve(7,315,184) 5,157,140 14,972,324 
Capital reserve  60,226 26,744 
Dividends forfeited(1,300)
Interest on own capital 1,500,000   
(7,074,198)14,084,848 13,039,124 35,402,942 
v3.25.1
EARNINGS (LOSS) PER SHARE
12 Months Ended
Dec. 31, 2024
Earnings per share [abstract]  
EARNINGS (LOSS) PER SHARE
25 EARNINGS (LOSS) PER SHARE
25.1 Basic
The basic earnings (loss) per share is measured by dividing the profit attributable to the Company’s shareholders by the weighted average number of common shares issued during the period, excluding the common shares acquired by the Company and held as treasury shares.
12/31/202412/31/202312/31/2022
Net income (loss) for the year attributed to Controlling shareholders'(7,074,198)14,084,848 23,381,617 
Weighted average number of shares in the year – in thousands1,289,637 1,330,020 1,361,264 
Weighted average treasury shares – in thousands(24,836)(32,827)(31,043)
Weighted average number of outstanding shares – in thousands1,264,801 1,297,193 1,330,221 
Basic earnings (loss) per common share – R$(5.59313)10.8579417.57724
25.2 Diluted
The diluted earnings (loss) per share is measured by adjusting the weighted average of outstanding common shares, assuming the conversion of all common shares with dilutive effects.
12/31/202412/31/202312/31/2022
Net income (loss) for the year attributed to Controlling shareholders'(7,074,198)14,084,848 23,381,617 
Weighted average number of shares during the year (except treasury shares) – in thousands1,264,801 1,297,193 1,330,221 
Average number of potential shares (stock options) - in thousands487 317 
Weighted average number of shares (diluted) – in thousands1,264,801 1,297,680 1,330,538 
Diluted earnings (loss) per common share – R$(5.59313)10.8538717.57305
The average number of dilutive potential ordinary shares (stock option) is 2,980 thousand shares. Due to the loss on December 31, 2024, the Company does not consider the dilution effect in the measurement.
v3.25.1
NET FINANCIAL RESULT
12 Months Ended
Dec. 31, 2024
NET FINANCIAL RESULT  
NET FINANCIAL RESULT
26 NET FINANCIAL RESULT
12/31/202412/31/202312/31/2022
Financial expenses
Interest on loans, financing and debentures (1)

(4,453,739)(3,636,730)(3,648,330)
Amortization of transaction costs (2)

(80,099)(67,353)(69,881)
Interest expenses on lease liabilities (3)

(451,148)(441,596)(433,613)
Amortization of fair value adjustment

 (18,887)
Other

(556,917)(513,483)(419,659)
(5,541,903)(4,659,162)(4,590,370)
Financial income

Cash and cash equivalents and marketable securities

1,598,111 1,668,408 818,780 
Other139,323 157,241 148,230 
1,737,434 1,825,649 967,010 
Results from derivative financial instruments

Income

2,669,394 10,149,730 11,969,288 
Expenses(11,782,077)(4,623,016)(5,207,721)
(9,112,683)5,526,714 6,761,567 
Monetary and exchange rate variations, net

Exchange rate variations on loans, financing and debentures

(17,728,324)4,185,675 3,949,020 
Leases(613,124)180,112 186,241 
Other assets and liabilities (4)
2,456,455 (1,278,060)(840,668)
(15,884,993)3,087,727 3,294,593 
Net financial result(28,802,145)5,780,9286,432,800
(1)Excludes R$959,968 arising from capitalized loan costs, substantially related to property, plant and equipment in progress of the Cerrado Project for the year ended December 31, 2024 (R$1,160,364 as at December 31, 2023).
(2)On December 31, 2023, in the consolidated statements, the balance of R$19 relating to transaction costs with loans and financing was recognized directly in the income statement.
(3)Includes R$249,135 referring to the reclassification to the biological assets item for the composition of the formation cost (R$223,055 as of December 31, 2023).
(4)Includes effects of exchange rate variations of trade accounts receivable, trade accounts payable, cash and cash equivalents, marketable securities and others.
v3.25.1
NET SALES
12 Months Ended
Dec. 31, 2024
Disclosure of disaggregation of revenue from contracts with customers [abstract]  
NET SALES
27 NET SALES
12/31/202412/31/202312/31/2022
Gross sales57,017,142 47,601,020 59,550,424 
Sales deductions
Returns and cancellations(234,643)(155,950)(91,291)
Discounts and rebates(6,936,630)(5,526,032)(7,459,520)
49,845,869 41,919,038 51,999,613 
Taxes on sales(2,442,587)(2,163,463)(2,168,667)
Net sales 47,403,282 39,755,57549,830,946
v3.25.1
SEGMENT INFORMATION
12 Months Ended
Dec. 31, 2024
Disclosure of operating segments [abstract]  
SEGMENT INFORMATION
28 SEGMENT INFORMATION
28.1 Criteria for identifying operating segments
The Board of Directors and Board of Statutory Executive Officers evaluate the performance of the Company’s business segments through the Adjusted EBITDA. The Company has revised the segment note to present Adjusted EBITDA as its performance measure.
The operating segments defined by the Company’s management are set forth below:
(i)Pulp: comprised of the production and sale of hardwood eucalyptus pulp and fluff pulp, mainly to supply the foreign market.
(ii)Paper: comprises the production and sale of paper to meet the demands of both the domestic and foreign markets. Consumer goods (tissue) sales are classified under this segment due to their immateriality.
Information related to total assets by reportable segment is not disclosed, as it is not included in the set of information made available to the Company’s management, which makes investment decisions and determines the allocation of resources on a consolidated basis.
In addition, with respect to geographical information related to non-current assets, the Company does not disclose such information, as all property, plant and equipment, biological and intangible assets are substantially in Brazil.
28.2 Information of operating segments
12/31/2024
PulpPaperTotal
Net sales 37,593,462 9,809,820 47,403,282 
Domestic market (Brazil)2,295,258 7,278,586 9,573,844 
Foreign market35,298,204 2,531,234 37,829,438 
Asia15,760,800 24,767 15,785,567 
Europe11,895,394 355,784 12,251,178 
North America6,965,731 914,234 7,879,965 
South America and Central670,157 1,179,840 1,849,997 
Africa6,122 56,608 62,730 
Cost of sales(21,261,705)(6,139,822)(27,401,527)
Adjusted EBITDA20,866,160 2,983,040 23,849,200 
Adjustments to EBITDA (*)1,065,887 
Depreciation, depletion and amortization(9,223,995)
Financial result(28,802,145)
Net income (loss) before taxes(13,111,053)
12/31/2023
PulpPaperTotal
Net sales30,677,2659,078,31039,755,575
Domestic market (Brazil)2,144,199 6,719,093 8,863,292 
Foreign market28,533,066 2,359,217 30,892,283 
Asia13,588,032 72,133 13,660,165 
Europe8,701,141 302,131 9,003,272 
North America5,682,010 476,429 6,158,439 
South America and Central558,601 1,437,181 1,995,782 
Africa3,282 71,343 74,625 
Cost of sales(19,694,674)(5,382,001)(25,076,675)
Adjusted EBITDA15,194,660 3,078,310 18,272,970 
Adjustments to EBITDA (*)1,264,428 
Depreciation, depletion and amortization  (7,321,110)
Financial result5,780,928 
Net income (loss) before taxes  17,997,216
12/31/2022
PulpPaperTotal
Net sales41,384,3228,446,62449,830,946
Domestic market (Brazil)2,665,746 5,858,892 8,524,638 
Foreign market38,718,576 2,587,732 41,306,308 
Asia18,294,046 4,059 18,298,105 
Europe12,768,321 325,503 13,093,824 
North America7,055,625 608,734 7,664,359 
South America and Central592,360 1,641,277 2,233,637 
Africa8,224 8,159 16,383 
Cost of sales(19,958,000)(4,863,288)(24,821,288)
Adjusted EBITDA25,098,535 3,096,367 28,194,902 
Adjustments to EBITDA (*)1,435,769 
Depreciation, depletion and amortization(7,407,890)
Financial result6,432,800 
Net income (loss) before taxes28,655,581
12/31/202412/31/202312/31/2022
(*) Adjustments to EBITDA
Fair Value Update - Biological Asset 1,431,532 1,989,831 1,199,759 
Income from disposal and write-off of property, plant and equipment and biological assets(169,284)(232,143)19,436 
Accruals for losses on ICMS credits (130,726)(348,628)(58,003)
Others (1)
(65,635)(144,632)274,577 
1,065,887 1,264,4281,435,769
(1) It includes items with specific, non-cash and exceptional adjustments, such as: i) COVID-19 - Expenses related to social actions to combat the virus, ii) write-off of wood inventory, iii) tax credits - exclusion of ICMS from the PIS and COFINS calculation basis, iv) donations for catastrophes and pandemics, v) equity equivalence, vi) extension of the PCHM grant, vii) extinction of the packaging business line, viii) fines and cancellation of contracts, ix) expenses with the acquisition of assets and business combinations, and x) effective loss of the development contract advance program.

28.3 Net sales by product
12/31/202412/31/202312/31/2022
Products
Market pulp (1)
37,593,462 30,677,265 41,384,322 
Printing and writing paper (2)
8,478,489 7,567,320 6,912,984 
Paperboard1,270,872 1,417,075 1,421,338 
Other60,459 93,915 112,302 
47,403,282 39,755,57549,830,946
(1)Net sales of fluff pulp represent 0.7% of total net sales, and therefore were included in market pulp net sales. (0.8% as at December 31, 2023).
(2)Net sales of tissue represent 5.8% of total net sales, and therefore were included in printing and writing paper net sales. (5.1% as at December 31, 2023).

With regard to the foreign market revenues of the pulp operating segment, China and the USA are the main countries in terms of net revenue, 36.92% and 16.08%, respectively, for the year ended December 31, 2024 (China and the USA represented 41.36% and 15.32%, respectively, on December 31, 2023).
With regard to the foreign market revenues of the paper operating segment, Argentina and USA, are the main countries in terms of net revenue, 10.96% and 22.50%, respectively, for the year ended December 31, 2024 (Argentina and USA represented 23.68% and 19.49% respectively, on December 31, 2023).
There is no other individual foreign country that represents more than 10% of net revenue in the foreign market for the years ended December 31, 2024 and December 31, 2023.
28.4 Goodwill based on expected future profitability
The goodwill based on expected future profitability arising from the business combination was allocated to the disclosable segments, which correspond to the Company's cash-generating units (“CGUs”), considering the economic benefits generated by such intangible assets. The allocation of goodwill is set out below:
12/31/202412/31/2023
Pulp7,897,051 7,897,051 
Paper290,191 290,191 
8,187,242 8,187,242
v3.25.1
RESULTS BY NATURE
12 Months Ended
Dec. 31, 2024
Expenses by nature [abstract]  
RESULTS BY NATURE
29 INCOME (EXPENSES) BY NATURE
12/31/202412/31/202312/31/2022
Cost of sales
Personnel expenses(1,741,347)(1,450,428)(1,467,896)
Costs of raw materials, materials and services(11,468,545)(10,981,883)(11,463,862)
Logistics cost(5,186,872)(4,341,369)(4,795,161)
Depreciation, depletion and amortization(8,135,016)(6,718,474)(6,406,610)
Other (1)
(869,747)(1,584,521)(687,759)
(27,401,527)(25,076,675)(24,821,288)
Selling expenses
Personnel expenses(330,178)(281,673)(244,681)
Services(247,585)(173,494)(146,184)
Logistics cost(1,288,670)(1,067,031)(1,065,416)
Depreciation and amortization(955,201)(952,033)(951,626)
Other (2)
(116,913)(122,146)(75,287)
(2,938,547)(2,596,377)(2,483,194)
General and administrative expenses
Personnel expenses(1,661,843)(1,172,538)(1,039,733)
Services(503,086)(406,001)(378,986)
Depreciation and amortization(143,600)(118,771)(101,764)
Other (3)
(311,315)(225,918)(189,284)
(2,619,844)(1,923,228)(1,709,767)
Other operating (expenses) income, net
Rents and leases2,188 3,971 2164
Results from sales of other products, net77,817 79,046 58,880 
Results from sales and disposals of property, plant and equipment, intangible and biological assets, net(163,033)(331,285)(509)
Result on fair value adjustment of biological assets1,431,530 1,989,831 1,199,759 
Depletion, amortization and other PPA realizations (4)
9,822 468,168 52,110 
Tax credits - gains in tax lawsuits (exclusion of ICMS from the PIS/COFINS calculation basis)(1,324)
Provision for judicial liabilities(148,952)(167,563)(156,243)
Other operating income (expenses), net52,201 34,204 (33,121)
1,261,573 2,076,3721,121,716
(i)Includes R$587,345 related to maintenance downtime, costing (R$650,592 as at December 31, 2023).
(ii)Includes expected credit losses, insurance, materials for use and consumption, travel, accommodation, trade fairs and events.
(iii)Includes, substantially, corporate expenses, insurance, materials for use and consumption, social programs and donations, travel and accommodation.
(iv)Refers, substantially, to the write-off of contingent liabilities assumed in Fibria's PPA as disclosed in note 20.1.
v3.25.1
INSURANCE COVERAGE
12 Months Ended
Dec. 31, 2024
INSURANCE COVERAGE  
INSURANCE COVERAGE
30 INSURANCE COVERAGE
The Company has insurance coverage for operational risks, with a maximum coverage of US$1,000,000 corresponding to R$6,192,300. Additionally, the Company has insurance coverage for civil general liabilities in the amount of US$20,000 corresponding to R$123,846 as of December 31, 2024.
The Company's Management considers these amounts adequate to cover any potential liabilities, risks and damage to its assets, and any loss of profits. The Company does not have insurance coverage for its forests. To mitigate the risk of fire, the Company maintains internal fire brigades, a watchtower network, and a fleet of fire trucks. There is no history of material losses arising from forest fires.
The Company has a domestic transportation insurance policy with a maximum coverage of R$60,000 and international policy in the amount of US$75,000 corresponding to R$464,423, effective through November 2025, and renewable for an additional 18 months.
In addition, it has insurance coverage for civil responsibility of Directors and Executives (“D&O”).
v3.25.1
Insider Trading Policies and Procedures
12 Months Ended
Dec. 31, 2024
Insider Trading Policies and Procedures [Line Items]  
Insider Trading Policies and Procedures Adopted true
v3.25.1
Cybersecurity Risk Management and Strategy Disclosure
12 Months Ended
Dec. 31, 2024
Cybersecurity Risk Management, Strategy, and Governance [Line Items]  
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]
We maintain a comprehensive process to assess, identify, and manage risks arising from vulnerabilities, including risks related to disruptions to business operations or financial reporting systems, intellectual property theft, fraud, extortion, harm to employees or customers, privacy law violations, and other legal disputes and risks, as part of our overall risk management system and processes.
Cybersecurity Risk Management Processes Integrated [Flag] true
Cybersecurity Risk Management Processes Integrated [Text Block] We frequently conduct training and awareness campaigns on information security and cybersecurity so that everyone receives guidance and can identify and report information security events or incidents, both in the corporate and industrial environments. These actions are intended to promote familiarity with our Information Security Policy. We also leverage internal communications to raise awareness and conduct phishing simulation exercises.
We regularly review, test, and update our information security and cybersecurity processes by conducting penetration testing, vulnerability assessments, and attack simulations. Measures are implemented to deter, prevent, detect, and respond to unauthorized activities in our systems.
Cybersecurity Risk Management Third Party Engaged [Flag] true
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] false
Cybersecurity Risk Board of Directors Oversight [Text Block] There is monitoring and reporting to the company's Audit team and Corporate Risk team, where Cybersecurity is also overseen by the Board on their respective agendas.
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]
Cybersecurity is periodically on the agenda of our Board of Directors, in addition to specific Cyber Committees within the company alongside executives. There is monitoring and reporting to the company's Audit team and Corporate Risk team, where Cybersecurity is also overseen by the Board on their respective agendas.
Cybersecurity Risk Role of Management [Text Block]
We have an internally formalized process, based on the ISO 27005 framework, that defines the management of cybersecurity risks, aiming to identify, monitor, and communicate information security risks that may impact the business through a systematic approach and a continuous process, monitoring and, whenever possible, reducing the likelihood of causing any type of damage to our assets. Risks are periodically reported to management, as well as relevant information security incidents.
Cybersecurity Risk Management Positions or Committees Responsible [Flag] true
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]
At Suzano, she leads a robust Information Technology team, where one of the managements is responsible for Cybersecurity. In the position of Cybersecurity Manager, we have a leader with expertise in the subject and over 14 years of experience in Cybersecurity, having led the topic in various industries.
Cybersecurity Risk Management Expertise of Management Responsible [Text Block] we have a leader with expertise in the subject and over 14 years of experience in Cybersecurity, having led the topic in various industries.
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]
To fulfill this responsibility, it is equipped with information from established information security processes and controls, periodically reporting strategic indicators to the security committee, and to the audit and executive committees as requested.
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag] true
v3.25.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
12 Months Ended
Dec. 31, 2024
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
New accounting policies and changes in accounting policies adopted
3.1 New accounting policies and changes in accounting policies adopted
The new standards and interpretations issued, until the issuance of the Company’s consolidated financial statements, are described below.
3.1.1 Amendments to IFRS 7 – Supplier financing agreements and IAS 7 Statement of cash flow
The changes now require the entity to disclose additional information about its supplier financing arrangements that allows users to assess the effects of these arrangements on the entity's liabilities and cash flows and on the entity's exposure to liquidity risk.
The disclosures required by the amendments, which would allow understanding of the effects of these agreements on liabilities, cash flows and liquidity include:
(a) the terms and conditions of the agreements;
(b) at the beginning and end of the reporting period: (i) the carrying values, and the associated items presented in the entity's balance sheet, of the financial liabilities that form part of a supplier financing agreement; (ii) the carrying amounts, and associated items, of the financial liabilities disclosed in accordance with item (i) for which suppliers have already received payment from financiers; and (iii) the range of due dates.
(c) the type and effect of non-cash changes in the carrying values of financial liabilities disclosed in accordance with paragraph (b)(i).
The Company assessed the content of this pronouncement and did not identify the need to disclose additional information, since (a) the terms and conditions of the agreements have not changed compared to the original conditions; (b) (i) the accounting amounts subject to advance payment are disclosed in Note 17; (ii) the decision to adhere to this transaction is exclusive to the suppliers, and the Company has no influence or management over the amounts received by suppliers from financial institutions; (iii) there was no change in due dates; and (c) there were no non-cash modifications to the supplier advance payment agreements.
3.1.2 Amendments to IFRS 16 – Lease liability in a sale and leaseback transaction
The amendments specify that, in measuring the lease liability subsequent to the sale and leaseback, the seller-lessee determines ‘lease payments’ and ‘revised lease payments’ in a way that does not result in the seller-lessee recognising any amount of the gain or loss that relates to the right of use that it retains.
The Company assessed the content of this pronouncement and did not identify any impact.
3.1.3 Amendments to IAS 1: Classification of liabilities as current or non-current and non-current liabilities with covenants
The changes improve the information provided by the entity when its right to defer the settlement of a liability for at least twelve months is subject to compliance with covenants.
The classification of liabilities as current or non-current is based on compliance with covenants that are required on the reporting date or before that date, but never in relation to future events, in addition to requiring disclosure of information in the explanatory notes that allow Users of financial statements assess the risk that the liability may become due within twelve months, including the agreed conditions (for example, their nature and the date by which the entity must comply with them), whether the entity would have complied with the conditions based on its circumstances at the end of the reporting period and how the entity expects to comply with the conditions after the end of the reporting period.
The Company assessed the content of this pronouncement and did not identify any impact.
3.1.4 IFRIC agenda decision - disclosure of revenues and expenses for reportable segments (IFRS 8)
In July 2024, the IASB approved an IFRIC agenda decision in relation to segment reporting. The decision deals with how an entity applies the requirements in paragraph 23 of IFRS 8 to disclose for each reportable segment specified amounts related to segment profit or loss.
The Company assessed the content of this pronouncement and included the cost of the product sold in note 28.
Consolidated financial statements
3.2 Accounting policies adopted
3.2.1 Financial statements
3.2.1.1 Consolidated financial statements
They are prepared using information from Suzano and its subsidiaries on the same base date, except for the subsidiaries Futuragene and Suzano Packaging and the affiliates Biomas, Ensyn, Simplifyber, which have a lag of less than three months in relation to the base date of these financial statements, in accordance with the provisions of CPC 18/IAS 28 and do not have a material effect on the consolidated result and, if any significant event occurred until December 31, 2024, the effect would be adjusted in the consolidated financial statements, as well as consistent accounting policies.
On December 31, 2024, Suzano had an investment in the associate Spinnova, in the amount of R$95,254, representing 18.77% of the equity of this associate. Up to the date of this report, the latest financial statements published for this investment were more than three months out of date. In these circumstances, the investment is measured based on the latest information available, with the necessary adjustments being made as a result of the effects of significant transactions and events, which have no material effect on the consolidated result.
The Company consolidates all subsidiaries over which it has direct or indirect control, i.e. when it is exposed to or has the right to variable returns on its investment with the investee and has the ability to direct the relevant activities of the investee.
In addition, all transactions and balances between Suzano and its subsidiaries, associates and joint operations were eliminated in consolidation, as well as the unrealized profits or losses arising from these transactions, net of tax effects, investments and the respective equity results.
The participation of non-controlling shareholders is highlighted.
Subsidiaries
3.2.2 Subsidiaries
These include all entities for which the Company has the power to govern the financial and operating policies, generally through a majority of voting rights. The Company controls an entity when the Company is exposed to, or has rights to, variable returns on its investment in the investee, and has the ability to affect those returns through its power over the entity.
Subsidiaries are consolidated from the date on which control is obtained and consolidated from the date on which control ceases.
Joint operations
3.2.3 Joint operations
These include all entities for which the Company maintains contractually established control over its economic activity, and exists only when the strategic, financial and operational decisions regarding the activity requiring the unanimous consent of the parties sharing control.
In the consolidated financial statements, the balance of assets, liabilities, revenue and expenses are recognized proportionally to the interest in joint operations.
Associated and joint ventures
3.2.4 Associated and joint ventures
These include all entities initially recognized at cost and adjusted thereafter for the equity method, being increased or reduced from its interest in the investee's income after the acquisition date.
In the investments in associates, the Company must have significant influence, which means the power to participate in the financial and operating policy decisions of the investee, without having control or joint control over those policies. In investments in joint ventures, there is a contractually agreed sharing of control through an arrangement, which exists only when decisions about the relevant activities requiring the unanimous consent of the parties sharing control.
Translation of financial statements to functional and presentation currency
3.2.5 Translation of financial statements into the functional and presentation currency
The Company has defined that, for all its wholly owned subsidiaries, the functional and presentation currency is the Brazilian Real, except for subsidiary Suzano Packaging, whose functional currency is the US Dollar, and for investments in associates abroad related to Ensyn Corporation, F&E Technologies LLC and Simplifyber, whose functional currency is the US Dollar, Spinnova and Woodspin, whose functional currency is the Euro. The accumulated gains or losses of which affect the conversion of the financial statements, which are recorded in other comprehensive income, in equity.
The individual financial information of each of the subsidiaries, included in the consolidated financial statement, are prepared in the local currency in which the subsidiary operates and are translated into the Company’s functional and presentation currency.
3.2.5.1 Transactions and balances in foreign currency
These are translated using the following criteria:
(i)Monetary assets and liabilities are translated at the exchange rate in effect at year-end;
(ii)Non-monetary assets and liabilities are translated at the historical rate of the transaction;
(iii)Revenue and expenses are translated based on monthly average rate; and
(iv)The cumulative effects of gains or losses upon translation are recognized in the other comprehensive income.
The cumulative translation adjustment (“CTA”) arising from the translation of a foreign operation previously recognized in other comprehensive income are reclassified from equity to profit or loss at the disposal of the operations. The total or partial disposal of interest in wholly-owned subsidiaries occurs through sale or dissolution, of all or part of operation.
Hyperinflationary economies
3.2.6 Hyperinflationary economies
Entities based in Argentina, a country considered to have a hyperinflationary economy, are subject to the requirements of IAS 29 - Financial Reporting in Hyperinflationary Economies. Non-monetary items, as well as income and expenses, are adjusted by the changes in the inflation index between the initial recognition and the closing date, so the balances are stated at their current value.
However, the Company's wholly-owned subsidiary, based in Argentina, has the Real as its functional currency, and therefore is not considered an entity with a hyperinflationary currency, and does not present its individual financial statements in accordance with IAS 29 - Financial Reporting in Hyperinflationary Economies. The financial statements are presented at historical cost.
Business combinations
3.2.7 Business combinations
These are accounted for using the acquisition method when control is transferred to the acquirer. The cost of an acquisition is the sum of the consideration paid, evaluated based on the fair value at the acquisition date, and the amount of any non-controlling interest in the acquiree. For each business combination, the Company recognizes any non-controlling interest in the acquiree either at fair value or at the non-controlling interest’s proportionate share of the acquirer’s net assets. The costs directly attributable to the acquisition are recorded as expenses when they are incurred, except for costs related to the issuance of debt instruments or equity instruments, which are presented as reductions in debt or equity, respectively.
In a business combination, assets acquired and liabilities assumed are evaluated in order to classify and allocate them, assessing the terms of the agreement, the economic circumstances and other conditions at the acquisition date.
Goodwill is initially measured as the excess of the consideration paid over the fair value of the net assets acquired. After initial recognition, goodwill is measured at cost, net of any accumulated impairment losses. For the purpose of impairment testing, the goodwill recognized in a business combination, as from the acquisition date, is allocated to each of the Company’s cash generating units.
Gains on an advantageous purchase are recognized immediately in the result. The borrowing costs are recorded in the income statement as they are incurred.
Contingent liabilities related to tax, civil and labor, classified in the acquired company as possible and remote risks, are recognized by the acquirer at their fair values.
Transactions involving the acquisition of shares with shared control over the net assets traded are evaluated in accordance with the complementary guidance to IFRS 3 - Business Combinations, IFRS 11 and IAS 28 - Investments in Associates and Joint Ventures to evaluate initial recognition criteria. For the investments defined based on the equity method, investments are initially recognized at cost. The carrying amount of the investment is adjusted for the recognition of changes in the Company's share of the acquirer's Shareholders' equity as at the acquisition date. Goodwill is measured and segregated from the carrying amount of the investment. Other intangible assets identified in the transaction shall be allocated in proportion to the interest acquired by the Company, based on the difference between the carrying amounts recorded in the acquired entity and its fair value assets, which may be amortized.
Segment information
3.2.8 Segment information
An operating segment is a component of the Company that carries out business activities from which it can obtain revenue and incur expenses. The operating segments reflect how the Company’s management reviews the financial information used to make decisions. The Company’s management has identified two reportable segments, which meet the quantitative and qualitative disclosure requirements
Cash and cash equivalents
3.2.9 Cash and cash equivalents
Include cash on hand, bank deposits and highly liquid short-term investments with maturities, upon acquisition, of 90 days or less, which are readily convertible into known amounts of cash and subject to an insignificant risk of changes in value.
Financial instruments
3.2.10 Financial instruments
3.2.10.1 Classification
Financial instruments are classified based on the purpose for which the financial instruments were acquired, as set forth below:
(i)Amortized cost;
(i)Fair value through other comprehensive income; and
(i)Fair value through profit or loss.
Regular purchases and sales of financial assets are recognized on the trade date, meaning the date on which the Company commits to purchase or sell the asset. Financial instruments are derecognized when the rights to receive cash flow from the investments have expired or have been transferred, substantially, all of the risks and rewards of ownership.
3.2.10.1.1 Financial instruments measured at amortized cost
Financial instruments held by the Company: (i) in order to receive their contractual cash flow and not to sell to realize a profit or loss; and (ii) whose contractual terms give rise, on specified dates, to cash flow that exclusively represents payments of principal and interest on the principal amount outstanding. Any changes are recognized under financial income (expenses) in the income statement.
It includes the balance of cash and cash equivalents, trade accounts receivable, dividends receivable and other assets, classified as financial assets and the balances of suppliers, loans, financing and debentures, lease payables, accounts payable for the acquisition of assets and subsidiaries, , dividends and interest on own capital payable and other liabilities, all of which are classified as financial liabilities.
3.2.10.1.2 Financial instruments at fair value through other comprehensive income
Financial instruments at fair value through other comprehensive income are financial assets held by the Company: (i) either to receive their contractual cash flow through sale with the realization of a profit or loss; and (ii) whose contractual terms give rise, on specified dates, to cash flows constituting, exclusively, repayments of principal and interest on the principal amount outstanding. In addition, this category includes investments in equity instruments where, upon initial recognition, the Company elected to present subsequent changes in its fair value within other comprehensive income. Any changes are recognized under net financial income (expenses) in the income statement, except for the fair value of investments in equity instruments, which are recognized in other comprehensive income.
Includes the balance presented in Note 14.1 as other investments evaluated at fair value through other comprehensive income.
3.2.10.1.3 Financial instruments at fair value through profit or loss
Financial instruments at fair value through profit or loss are either designated in this category or not classified in any of the other categories. Any changes are recognized within financial income (expenses) in the income statement for non-derivative financial instruments and for financial derivative instruments within income from derivative financial instruments.
This category includes the balance of marketable securities, classified as financial assets financial and derivative financial instruments, including embedded derivatives, stock options, classified as financial assets and liabilities.
3.2.10.2 Impairment of financial assets
3.2.10.2.1 Financial instruments measured at amortized cost
Annually, the Company assesses whether there is evidence that a financial asset is impaired. A financial is impaired only if there is evidence of impairment as a result of one or more events that occurred after the initial recognition of the asset, and that loss event has an impact on the estimated future cash flow of the financial asset that can be estimated reliably.
The criteria the Company uses to determine whether there is evidence of an impairment loss includes:
(i)Significant financial difficulty of the issuer or debtor;
(ii)Defaults on or late payment of interest or principal under the agreement;
(iii)Where the Company, for economic or legal reasons relating to the borrower's financial difficulty, grants to the borrower a concession that a lender would not otherwise consider;
(iv)It becomes probable that the borrower will enter bankruptcy or other financial reorganization;
(v)The disappearance of an active market for that financial asset because of financial difficulties; and
(vi)Observable data indicating a measurable decrease in the estimated future cash flow from a portfolio of financial assets after the initial recognition of those assets, although the decrease cannot yet be identified with the individual financial assets in the portfolio.
The amount of an impairment loss is measured at the difference between the carrying amount of the asset and the present value of estimated future cash flows, discounted at the financial asset's original effective interest rate. If the financial asset is impaired, the carrying amount of the asset is reduced and a loss is recognized in the income statement.
If, in a subsequent remeasurement, if there is an improvement in the asset rating, such as an improvement in the debtor's credit rating, the reversal of the previously recognized impairment loss is recognized in the income statement.
3.2.10.2.2 Financial assets at fair value through other comprehensive income
The Company periodically evaluates, when measuring fair value, whether there is evidence that a financial asset is impaired.
For such financial assets, a significant or prolonged decrease in the fair value of the security below its cost is evidence that the assets are impaired. If any such evidence exists, an impairment loss measured at the difference between the acquisition cost and the current fair value, less any loss previously recognized in other comprehensive income, shall be recognized in the income statement.
Derivative financial instruments and hedging activities
3.2.11 Derivative financial instruments and hedging activities
Derivative financial instruments are recognized at fair value on the date on which the derivative agreement is entered into and are subsequently remeasured at fair value. Changes in fair value are recorded within the results of derivative financial instruments in the income statement.
Embedded derivatives in non-derivative main contracts are required to be separated when their risks and characteristics are not closely related to those of the respective main contracts, and these are not measured at fair value through profit or loss.
Non-option embedded derivatives are separated from the respective main contracts in accordance with the stated or implied substantive terms, so they have a zero fair value upon initial recognition.
Trade accounts receivables
3.2.12 Trade accounts receivable
These are recorded at their invoiced amounts, in the normal course of the Company´s business, adjusted for exchange rate variations where denominated in foreign currency and, if applicable, net of expected credit losses.
The Company applies an aging-based provision matrix with appropriate groupings for its portfolio. When necessary, based on individual analyses, the provision for expected losses is supplemented.
The Company examines the maturity of receivables on a monthly basis and identifies those customers with overdue balances, assessing the specific situation of each client, including the risk of loss, the existence of contracted insurance, letters of credit, collateral and the customer’s financial situation. In the event of default, collection attempts are made, which include direct contact with customers and collection efforts through third parties. Should these efforts prove unsuccessful, legal measures are considered, and expected credit losses are recognized. The notes are written off from the credit expected loss when Management considers that they are not recoverable after taking all appropriate measures to collect them.
Inventories
3.2.13 Inventories
These are evaluated at the average acquisition or formation cost of the finished products, net of recoverable taxes, not exceeding their net realizable value.
Finished products and work-in-process consist of raw materials, direct labor, production costs, freight, storage and general production expenses, which are related to the processes required to make the products available for sale.
Imports in transit are presented at the cost incurred up to the balance sheet date.
Raw materials derived from biological assets are measured based on their fair value, less costs to sell at the point of harvest and freight costs.
Provisions for obsolescence, adjustments to net realizable value, impaired items and slow-moving inventories are recorded when necessary. Usual production losses are recorded and are an integral part of the production costs for the respective month, whereas unusual losses, if any, are recorded directly as part of cost of sales.
Non-current assets held for sale
3.2.14 Non-current assets held for sale
These are measured at their carrying amount or fair value less costs to sell, whichever is lower, and are not depreciated or amortized. Such items are only classified in this account when the sale is highly probable and the assets are available for immediate sale in their current condition.
Biological assets
3.2.15 Biological assets
The biological assets for production (mature and immature forests) are reforested eucalyptus forests, with a formation cycle between planting and harvest from 6 to 7 years, measured at fair value. Depletion is measured based on the amount of biological assets depleted (harvested) and measured at fair value at the time of harvest.
For the determination of the fair value, the income approach technique was applied, using the discounted cash flow model, according to the projected productivity cycle for these assets. The assumptions used to measure the fair value are reviewed every six months, as the Company considers that this interval is sufficient to ensure no significant gaps in the fair value balance of biological assets booked. Significant assumptions are presented in Note 13.
The gain or loss on the assessment of fair value is recognized in operating income (expenses), net.
Biological assets in the process of formation under the age of 2 (two) years are recorded for at their formation cost. Areas of permanent environmental preservation are not recorded, because these are not characterized as biological assets, and are not included in the measurement at fair value.
Property, plant and equipment
3.2.16 Property, plant and equipment
Stated at their cost of acquisition, formation, construction or dismantling, net of recoverable taxes. This cost is deducted from the accumulated depreciation and accumulated impairment losses, when incurred, at the higher of the value in use or the proceeds from sale less cost to sell. The borrowing costs are capitalized as a component of construction in progress, at the weighted average rate of the Company’s debt at the capitalization date, adjusted for the equalization of exchange rate effects.
Depreciation is recognized based on the estimated economic useful life of each asset on a straight-line basis. The estimated useful lives, residual values and depreciation methods are reviewed annually, and the effects of any changes in estimates are accounted for prospectively. Land is not depreciated.
The Company performs an annual analysis of impairment indicators of property, plant and equipment. Impairment for losses on property, plant and equipment are only recognized if the related cash-generating unit is devalued, or if the asset’s recoverable amount is less than its carrying amount. The recoverable amount of the asset or cash-generating unit is the higher of its value in use, and its fair value less costs to sell.
The cost of major renovations is capitalized if the future economic benefits exceed the performance standards initially estimated for the asset and are then depreciated over the remaining useful life of the related asset.
Repairs and maintenance are expensed as incurred.
Gains and losses on disposals of property, plant and equipment are measured by comparing the proceeds with the book value and are recognized as other operating income (expenses), net, at the disposal date.
Leases
3.2.17 Leases
A contract is, or contains, a lease if the right to control the use of an identified asset for a period of time is transferred in exchange for consideration, for which it is necessary to assess whether:
(i)The contract involves the use of an identifiable asset, which may be explicit or implicit, and may be physically distinct or represent almost the entire capacity of a physically distinct asset. If the supplier has a substantial right to replace the asset, then the asset is not identified;
(ii)The Company has the right to obtain substantially all the economic benefits from the use of the asset during the contract period; and
(iii)The Company has the right to direct the use of the asset, meaning the Company has the right to decide to change how and for what purpose the asset is used, if:
It has the right to operate the asset, or
It designed the asset, in a way that predetermines how and for what purpose it will be used.
At the beginning of the contract, the Company recognizes a right-of-use asset and a lease liability that represents the obligation to make payments related to the asset underlying the lease.
The right-to-use asset is initially measured at cost, which includes the initial amount of the lease liability adjusted for any payments made up to the contract start date, plus any direct initial costs incurred, and estimated costs of disassembly, removal, or restoration of the asset in the place where it is located, less any incentives received.
The right-to-use asset is subsequently depreciated using the straight-line method from the start date to the end of the useful life of the right to use, or the end of the lease term, whichever is shorter. Except for land agreements that are automatically extended for the same period through a notification to the lessor, other agreements are not allowed automatic renewals for an indefinite period, since both parties have the right to terminate the agreements.
The lease liability is initially measured at the present value of the payments not made, less the incremental loan rate.
The lease liability is measured at amortized cost using the effective interest method. It is remeasured when there is a change:
(i)In future payments resulting from a change in index or rate;
(ii)In the estimate of the expected amount to be paid, at the guaranteed residual value; or
(iii)In the assessment of whether the Company will exercise the purchase option, extension or termination.
When the lease liability is remeasured, the corresponding adjustment amount is recorded in the book value of the right-of-use asset, or in the statement of profit and loss, if the book value of the right-of-use asset has been reduced to zero.
The Company does not have lease agreements with clauses imposing:
(i)Variable payments that are based on the performance of the leased assets;
(ii)Guarantees of residual value; and
(iii)Restrictions, such as, for example, an obligation to maintain financial ratios.
Short-term or low-value contracts which are exempt from these standards are contracts where the individual value of the assets is lower than US$5, and for which the maturity date is shorter than 12 months, are expensed as incurred.
Intangible assets
3.2.18 Intangible assets
These are measured at cost at the time when they are initially recognized. The cost of intangible assets acquired during a business combination corresponds to the fair value at the acquisition date. After initial recognition, intangible assets are presented at cost less accumulated amortization and impairment losses, when applicable.
The useful life of intangible assets are assessed as finite or indefinite.
Intangible assets with a finite life are amortized over the economically useful lives and reviewed for impairment whenever there is an indication that their carrying values may be impaired. The amortization period and method for intangible assets with finite useful lives are reviewed at least at the end of each fiscal year. The amortization of intangible assets with finite useful lives is recognized in the statement of income as an expense related to its use, and in line with the economically useful life of the intangible asset.
Intangible assets with indefinite useful lives are not amortized, but are tested annually for impairment losses, individually or at the CGU level. The allocation is made to the CGU or group of CGUs that represents the lowest level within the entity for which goodwill is monitored for management's internal purposes, that has benefited from the business combination. The Company mainly records in this subgroup goodwill for expected future profitability (goodwill) and easement of passage.
This testing involved the adoption of assumptions and judgments, disclosed in Note 16.
Current and deferred income tax and social contribution
3.2.19 Current and deferred income tax and social contribution and uncertainty over income tax treatments (IFRIC 23)
Income taxes include income tax and social contribution on net income, current and deferred. These taxes are recognized in the income statement, except to the extent that they relate to items recognized directly in equity. In this case, they are recognized in equity under other reserves.
The current charge is calculated based on the tax laws enacted in the countries in which the Company and its subsidiaries and affiliates operate and generate taxable income. Management periodically evaluates the positions assumed in the income tax returns with respect to situations in which the applicable tax regulations give rise to interpretations and establishes provisions, when appropriate, based on the amounts that must be paid to the tax authorities.
Deferred tax and contribution liabilities are recognized on temporary differences between the tax bases of assets and liabilities and their carrying amounts in the financial statements. Deferred taxes and contributions are determined based on the rates in force on the balance sheet date, and which must be applied when they are realized or settled.
Deferred tax assets and contributions are recognized to the extent that it is probable that future taxable profits will be available for use to offset temporary differences, based on the projections of future results prepared and based on internal assumptions and future economic scenarios that may, therefore, undergo changes.
The projection for the realization of deferred tax assets was prepared based on Management's estimates that are based on significant judgments and assumptions relating to net average pulp and paper prices, and the transfer prices with the subsidiaries based in Austria. However, there are other assumptions that are not under the control of the Company, such as inflation rates, exchange rates, pulp prices in the international market, and other economic uncertainties in Brazil, which mean that future results may differ from those considered in the preparation of the consolidated projection.
Deferred income tax and social contribution are recognized on temporary differences arising from investments in subsidiaries and associates, except when the timing of the reversal of temporary differences is controlled by the Company, and if it is probable that the temporary differences will not be reversed in the foreseeable future.
Deferred tax and contribution assets and liabilities are offset and presented at their net amounts in the balance sheet whenever they are related to the same legal entity and the same tax authority.
Trade accounts payable
3.2.20 Trade accounts payable and supplier finance arrangement
Corresponds to the obligations payable for goods or services acquired in the normal course of the Company´s business, recognized at fair value and subsequently measured at amortized cost using the effective interest rate method, adjusted to present value, plus exchange rate variations when denominated in foreign currency.
Supplier finance arrangements are made available for suppliers to anticipate receivables related to the Company's routine purchases. In this transaction, financial institutions pay suppliers who opted for early receipt in exchange for a discount and, when agreed upon between financial institutions and suppliers (the decision to adhere to this transaction is exclusive to the suppliers), the Company pays the financial institutions the total nominal amount of the original obligation on the original payment date. Therefore, these transactions do not change the amounts, nature and timing of the liabilities (including terms, prices and conditions previously agreed upon) and do not affect the Company with the financial charges charged by financial institutions. Additionally, payments made by the Company are directly related to supplier invoices and do not change cash flows. Accordingly, the Company continues to recognize suppliers who opted for drawdown risk in operating activities in the statements of cash flows.
Loans and financing
3.2.21 Loans, financing and debentures
Loans and financing are initially recognized at fair value, net of costs incurred in the transaction, and are subsequently stated at amortized cost. Any difference between the amounts raised and settled is recognized in the statement of income during the period in which the loans and financing are outstanding, using the effective tax rate method.
General or specific borrowing costs, directly attributable to the acquisition, construction or production of a qualifying asset, are capitalized as a part of the cost of that asset when it is probable that they will provide future economic benefits for the entity, and that such cost can be measured with reliability. The Company does not have specific loans to obtain qualifying assets. Other loan costs are recognized as expenses in the period during which they are incurred.
Provision, contingent assets and liabilities
3.2.22 Provisions, contingent assets and liabilities
Contingent assets are not recorded. Recognition is only performed when there are guarantees or favorable judicial decisions and the amounts of these can be measured reliably. Contingent assets for which such conditions are not met are only disclosed in the notes to the financial statements when their amounts are material.
Provisions are made to the extent that the Company expects that is probable that it will disburse cash, and the amount can be reliably estimated. Tax, civil, environmental and labor proceedings are accrued when losses are assessed as probable, and the amounts involved can be measured reliably, being recorded net of judicial deposits, under “provisions for judicial liabilities”. When the expectation of loss is possible, a description of the processes and amounts involved is disclosed in the notes to the financial statements. Contingent liabilities assessed as representing remote losses are neither accrued nor disclosed.
Contingent liabilities arising from business combinations are recognized if they arise from a present obligation as a result of from past events, and if their fair values can be measured reliably, and are subsequently measured at the higher of:
(i)The amount that would be recognized in accordance with the accounting policy for the provisions above that comply with IAS 37; or
(ii)The amount initially recognized less, where appropriate, revenue recognized in accordance with the accounting treatment of revenue from customer contracts under IFRS 15.
Principal and penalties amounts related to Tax, civil, environmental and labor proceedings are under other operating income and expenses and the interest is recognized in the net financial result.
The realization of provisions for judicial liabilities and contingent liabilities arising from business combinations, with possible and remote probability of loss, are recognized under other operating income and expenses or cash depending on the court decision.
Asset retirement obligations
3.2.23 Asset retirement obligations
These primarily relate to future costs for the decommissioning of industrial landfill sites and related assets. A provision is recorded as a long-term obligation within property, plant and equipment. The provision and the corresponding property, plant and equipment are initially recorded at fair value, based on the present value of the estimated cash flow for future cash payments discounted at an adjusted risk-free rate. The long-term obligation accrues interest using a long-term discount rate, recognized under other liabilities. Property, plant and equipment are depreciated on a straight-line basis over the useful life of the principal, against cost of sales in the income statement.
Share based payments
3.2.24 Share based payments
The Company’s executives and managers receive their compensation partially through share-based payment plans to be settled in cash and shares, or alternatively in cash only.
Plan-related expenses are recognized in the income statement as a corresponding entry within financial liabilities during the vesting period when the services will be rendered. The financial liability is measured at its fair value on every balance sheet date, and its variations are recorded in the income statement as administrative expenses.
At the option exercise date, if such options are exercised by the executive in order to receive shares in the Company, financial liabilities are reclassified under stock options granted in shareholders’ equity. In the case of options exercised in cash, the Company settles the related financial liability in favor of the Company’s executives.
Employee benefits
3.2.25 Employee benefits
The Company offers benefits through a supplementary contribution plan to all employees, as well as medical assistance and life insurance for a determined group of former employees, and for the latter two benefits an annual actuarial appraisal is prepared by an independent actuary, and are reviewed by Management. The respective impact is recognized in employee benefit plans.
Actuarial gains and losses are recognized in other reserves when incurred. The interest incurred, resulting from changes in the present value of the actuarial liability, is recorded in the income statement within financial expenses.
Other assets and liabilities current and non-current
3.2.26 Other assets and liabilities, current and non-current
Assets are recognized only when it is probable that the economic benefit associated with the transaction will flow to the entity, and its cost or value can be measured reliably.
A liability is recognized when the Company has a legal or constructive obligation arising from a past event, and it is probable that an economic resource will be required to settle this liability.
Government grants and assistance
3.2.27 Government grants and assistance
Government grants and assistance are recognized at fair value when it is reasonably certain that the conditions established by the granting Governmental Authority were observed, and that these subsidies will be obtained. These are recorded as deductions expenses in the income statement for the period of enjoyment of the benefit, and subsequently allocated to the tax incentives reserve under shareholders’ equity, when applicable.
Dividend and interest on own capital
3.2.28 Dividends and interest on own capital
The distribution of dividends or interest on own capital is recognized as a liability, calculated based on the Corporate Law, the bylaws and the Company's Dividend Policy, which establishes that the minimum annual dividend is the lower of: (i) 25% of adjusted net income, or (ii) 10% the consolidated operating cash flow for the year, provided they are declared before the end of the year. Any portion in excess of the minimum mandatory dividends, if declared after the balance sheet date, must be recorded as part of the additional dividends proposed in shareholders' equity, until approved by the shareholders at a General Meeting. After approval, the reclassification to current liabilities is made.
The tax benefit of interest on own capital is recognized in the income statement under income tax.
Share capital
3.2.29 Share capital
Common shares are classified in shareholders’ equity. Incremental costs directly attributable to a public offer are stated in shareholders’ equity as a deduction from the amount raised, net of taxes.
Revenue recognition
3.2.30 Revenue recognition
Revenue from contracts with customers is recognized at the time when control of the products is transferred to customers, represented by the ability to determine the use of products and obtain substantially all the remaining benefits from the products.
The Company follows the five-step model: (i) identification of contracts with customers; (ii) identification of performance obligations under the contracts; (iii) determining the transaction price; (iv) allocation of the transaction price to the performance obligations provided for in the contracts; and (v) recognition of revenue when the performance obligations have been met.
For the Pulp operating segment, revenue recognition occurs when control is transferred to the buyer who assumes the remaining benefits of the asset and is based on the parameters provided by: (i) International Commercial Terms (“Incoterms”), when destined for the foreign market; and (ii) lead times, when destined for the internal market.
For the operating segment Paper and Consumer Goods, revenue recognition occurs when control is transferred to the buyer who assumes the remaining benefits of the asset and is based on the parameters provided by: (i) the corresponding International Commercial Terms (“Incoterms”); and (ii) lead times, when destined for the external and internal markets.
Revenue is measured at the fair value of the consideration received or receivable, net of taxes, returns, rebates and discounts, and recognized in accordance with the accrual basis of accounting, when the amount can be reliably measured.
Accumulated experience is used to estimate and provide for rebates and discounts, using the expected value method, and revenue is only recognized to the extent that it is highly unlikely that a significant reversal will occur. A provision for reimbursement (included in trade accounts receivable) is recognized for expected rebates and discounts payable to customers in relation to sales made until the end of the reporting period. No significant element of financing is deemed to be present, as sales are made with short credit terms.
Financial income and expenses
3.2.31 Financial income and expenses
Includes interest income on financial assets, at the effective interest rate, which includes the amortization of funding raising costs, gains and losses on derivative financial instruments, interest on loans and financing, exchange variations on loans and financing and other assets and financial liabilities and monetary variations on other assets and liabilities. Interest income and expenses are recognized in the statement of income using the effective interest method.
Earnings (losses) per share
3.2.32 Earnings (losses) per share
Basic earnings (losses) per share are calculated by dividing the net profit (loss) attributable to the holders of ordinary shares of the Company to the weighted average number of ordinary shares during the year.
Diluted earnings per share are calculated by dividing the net profit attributable to the holders of ordinary shares of the Company by the weighted average number of ordinary shares during the year, plus the weighted average number of ordinary shares that would be issued when converting all potential dilutive ordinary shares into ordinary shares.
Employee and management profit sharing
3.2.33 Employee and management profit sharing
Employees are entitled to profit sharing based on certain goals agreed annually. For the Administrators, the statutory provisions proposed by the Board of Directors and approved by the shareholders are used as a basis. Provisions for participation are recognized in the payroll and charges against to administrative expenses during the period in which the targets are attained.
Material accounting judgments, estimates and assumptions
3.2.34 Material accounting judgments, estimates and assumptions
As disclosed in Note 2, Management used judgments, estimates and accounting assumptions regarding the future, uncertainty in which may lead to results that require significant adjustments to the book values of certain assets, liabilities, income and expenses in future years, are presented below:
Control, significant influence and consolidation (Note 1.1);
Share-based payment transactions (Note 22);
Transfers to control for revenue recognition (Note 27);
Fair value of financial instruments (Note 4);
Annual analysis of the impairment of non-financial assets (Notes 15 and 16);
Expected credit losses in the accounts receivable (Note 7);
Net realizable value provision for inventory (Note 8);
Annual analyses of the recoverability of taxes (Notes 9 and 12);
Fair value of biological assets (Note 13);
Useful lives of property, plant and equipment and intangible assets with defined useful life (Notes 15 and 16);
Annual analysis recoverable amount of goodwill (Note 16);
Leases (Note 19);
Provision for legal liabilities (Note 20); and
Pension and post-employment plans (Note 21).
The Company reviews the estimates and underlying assumptions used in its accounting estimates on an annual basis. Revisions to the accounting estimates are recognized in the period during which the estimates are revised.
Accounting policies not yet adopted
3.3 Accounting policies not yet adopted
The new and changed standards and interpretations issued, but not yet adopted up to December 31, 2024, are described below. The Company intends to adopt these new standards, changes and interpretations, if applicable, when they come into force, and does not expect them to have a material impact on the financial statements except for the IFRS 18 as disclosed below.
3.3.1 Amendments to IAS 21: Absence of interchangeability (applicable for annual on/or after January 1, 2025)
The changes will create requirements for the entity to apply a consistent approach to assessing whether a currency is exchangeable for another currency and, when it is not, to determining the appropriate exchange rate to use and the disclosures to be made.
In this context, exchangeability is considered non-existent when, for a given purpose, the entity is unable to obtain more than an insignificant amount of foreign currency. To this end, the entity evaluates:
(i)the timeliness of obtaining foreign currency;
(ii)the practical ability (and not the intention) to obtain foreign currency; It is
(iii)the available markets or exchange mechanisms that create enforceable rights and obligations.
v3.25.1
COMPANY'S OPERATIONS (Tables)
12 Months Ended
Dec. 31, 2024
COMPANY'S OPERATIONS  
Summary of equity interest in the entities
The Company holds equity interests in the following entities:
% equity interest
Entity/Type of investment Main activityCountry12/31/202412/31/2023
Consolidated
F&E Tecnologia do Brasil S.A. (Direct)Biofuel production, except alcoholBrazil100.00 %100.00 %
Fibria Celulose (USA) Inc. (Direct)Business officeUnited States of America100.00 %100.00 %
Fibria Overseas Finance Ltd. (Direct) (1)
Financial fundraisingCayman Island 100.00 %
Fibria Terminal de Celulose de Santos SPE S.A. (Direct)Port operationsBrazil100.00 %100.00 %
FuturaGene Ltd.Biotechnology research and developmentEngland100.00 %100.00 %
FuturaGene Delaware Inc. (Indirect)Biotechnology research and developmentUnited States of America100.00 %100.00 %
FuturaGene Israel Ltd. (Indirect)Biotechnology research and developmentIsrael100.00 %100.00 %
FuturaGene Inc. (Indirect)Biotechnology research and developmentUnited States of America100.00 %100.00 %
Maxcel Empreendimentos e Participações S.A. (Direct)HoldingBrazil100.00 %100.00 %
Itacel - Terminal de Celulose de Itaqui S.A. (Indirect)Port operationsBrazil100.00 %100.00 %
Mucuri Energética S.A. (Direct)Power generation and distributionBrazil100.00 %100.00 %
Paineiras Logística e Transportes Ltda. (Direct)Road freight transportBrazil100.00 %100.00 %
Portocel - Terminal Espec. Barra do Riacho S.A. (Direct)Port operationsBrazil51.00 %51.00 %
Projetos Especiais e Investimentos Ltda. (Direct)Commercialization of equipment and partsBrazil100.00 %100.00 %
SFBC Participações Ltda. (Direct)Packaging productionBrazil100.00 %100.00 %
Stenfar S.A. Indl. Coml. Imp. Y. Exp. (Direct)Commercialization of paper and computer materialsArgentina100.00 %100.00 %
Suzano Austria GmbH. (Direct)Business officeAustria100.00 %100.00 %
Suzano Canada Inc. (Direct)Lignin research and developmentCanada100.00 %100.00 %
Suzano Ecuador S.A.S. (Direct) Business officeEcuador100.00 %100.00 %
Suzano Finland Oy (Direct)Industrialization and commercialization of cellulose, microfiber cellulose and paperFinland100.00 %100.00 %
Suzano International Finance B.V (Direct)Financial fundraisingNetherlands100.00 %100.00 %
Suzano International Holding B.V. (Direct)HoldingNetherlands100.00 %100.00 %
Suzano International Trade GmbH. (Direct)Business officeAustria100.00 %100.00 %
Suzano Packaging LLC (Indirect) (3)
Production of coated and uncoated paperboard, used in the production of Liquid Packaging Board and CupstockUnited States of America100.00 %
Suzano Material Technology Development Ltd. (Direct)Biotechnology research and developmentChina100.00 %100.00 %
Suzano Netherlands B.V. (Direct)Financial fundraisingNetherlands100.00 %100.00 %
Suzano Operações Industriais e Florestais S.A. (Direct)Industrialization, commercialization and exporting of pulpBrazil100.00 %100.00 %
Suzano Pulp and Paper America Inc. (Direct)Business officeUnited States of America100.00 %100.00 %
Suzano Pulp and Paper Europe S.A. (Direct)Business officeSwitzerland100.00 %100.00 %
Suzano Shanghai Ltd. (Direct)Business officeChina100.00 %100.00 %
Suzano Shanghai Trading Ltd. (Direct) Financial fundraisingChina100.00 %100.00 %
Suzano Singapura Pte. Ltd (Direct)Business officeSingapore100.00 %100.00 %
Suzano Trading International KFT(Direct)Business officeHungary100.00 %100.00 %
Suzano Ventures LLC (Direct)Corporate venture capitalUnited States of America100.00 %100.00 %
% equity interest
Entity/Type of investment Main activityCountry12/31/202412/31/2023
Joint operation
Veracel Celulose S.A. (Direct)Industrialization, commercialization and exporting of pulpBrazil50.00 %50.00 %
Equity
Biomas Serviços Ambientais, Restauração e Carbono S.A. (Direct) Restoration, conservation and preservation of forestsBrazil16.66 %16.66 %
Ensyn Corporation (Direct) (7)
Biofuel research and developmentUnited States of America24.80 %25.53 %
F&E Technologies LLC (Direct/Indirect)Biofuel production, except alcoholUnited States of America50.00 %50.00 %
Ibema Companhia Brasileira de Papel (Direct)Industrialization and commercialization of paperboardBrazil49.90 %49.90 %
Simplifyber, Inc (Indirect) (6)
Production of consumer goods through the transformation of cellulose-based liquidsUnited States of America13.91 %
Spinnova Plc (Direct) (“Spinnova”)Research of sustainable raw materials for the textile industryFinland18.77 %18.78 %
Woodspin Oy (Direct/Indirect) (“Woodspin”)Development and production of cellulose-based fibers, yarns and textile filamentsFinland50.00 %50.00 %
Fair value through other comprehensive income
Bem Agro Integração e Desenvolvimento S.A. (Indirect) (4)
Software solutions based on artificial intelligence and computer vision for agribusinessBrazil5.82 %
Celluforce Inc. (Direct)Nanocrystalline pulp research and developmentCanada8.28 %8.28 %
Lenzing Aktiengesellschaft (Indirect) (5)
Production of wood-based cellulose fibersAustria15.00 %
Nfinite Nanotechnology Inc. (Indirect) (2)
Research and development of smart nanocoatingsCanada5.00 %
(1)On March 27, 2024, the entity was liquidated.
(2)On March 8, 2024, Suzano Ventures LLC acquired an equity interest in the legal entity Nfinite Nanotechnology Inc., which is an associate of Suzano S.A.
(3)On July 9, 2024, establishment of legal entity with is a subsidiary of Suzano S.A
(4)On July 19, 2024, Suzano Ventures LLC acquired an equity interest in the legal entity Bem Agro Integração e Desenvolvimento S.A., which is an associate of Suzano S.A.
(5)On August 30, 2024, Suzano International Trade GmbH acquired an equity interest in the legal entity Lenzing Aktiengesellschaft (note 1.2.5), which is an associate of Suzano S.A.
(6)On December 13, 2024, Suzano Ventures LLC acquired an equity interest in the legal entity Simplifyber, Inc., which is an associate of Suzano S.A.
(7)On July 30, August 30 and December 31, 2024, there was a change in the percentage of participation due to the dilution of shares.
v3.25.1
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT (Tables)
12 Months Ended
Dec. 31, 2024
Disclosure of detailed information about financial instruments [abstract]  
Schedule of financial instruments by category
All transactions with financial instruments are recognized for accounting purposes and classified in the following categories:
Note12/31/202412/31/2023
Assets
Amortized cost
Cash and cash equivalents59,018,818 8,345,871 
Marketable securities6 
Trade accounts receivable79,132,860 6,848,454 
Other assets (1)

628,275 737,222 

18,779,953 15,931,547
Fair value through other comprehensive income

Investments14.11,138,066 23,606 

1,138,066 23,606
Fair value through profit or loss

Derivative financial instruments4.5.13,887,100 4,430,454 
Marketable securities613,363,511 13,267,286 

17,250,611 17,697,740

37,168,630 33,652,893
Liabilities

Amortized cost

Trade accounts payable176,033,285 5,572,219 
Loans, financing and debentures18.1101,435,531 77,172,692 
Lease liabilities19.26,972,915 6,243,782 
Liabilities for assets acquisitions and subsidiaries23120,490 187,187 
Dividends and interests on own capital payable

2,200,917 1,316,528 
Other liabilities (1)

143,330 116,716 

116,906,468 90,609,124
Fair value through profit or loss

Derivative financial instruments4.5.110,454,820 2,436,072 

10,454,820 2,436,072

127,361,288 93,045,196

90,192,658 59,392,303
(1)Does not include items not classified as financial instruments.
Summary of estimated fair value of loans and financing
The estimated fair values of loans and financing are set forth below:
Yield used to discount/methodology12/31/202412/31/2023
Quoted in the secondary market
In foreign currency

BondsSecondary Market48,734,909 38,703,379 
Estimated present value
In foreign currency
Export credits (“Prepayment”)SOFR22,740,891 17,783,760 
Assets FinancingSOFR422,115 278,107 
ECA - Export Credit AgencySOFR864,202 
IFC - International Finance CorporationSOFR6,261,715 3,198,761 
Panda Bonds - CNHFixed951,125 
In local currency
BNDES – TJLPDI 1171,109 215,458 
BNDES – TLPDI 13,275,012 2,712,762 
BNDES – FixedDI 1 3,903 
BNDES – TRDI 133,466 
BNDES – Selic (“Special Settlement and Custody System”)DI 1645,139 686,798 
BNDES – UMBNDESDI 2106,966 
Assets FinancingDI 160,566 75,622 
DebenturesDI 1/IPCA12,002,992 8,881,277 
NCE (“Export Credit Notes”) DI 1108,308 110,396 
NCR (“Rural Credit Notes”)DI 12,424,457 2,228,806 
Export credits (“Prepayment”)DI 1 824,035 
98,802,972 75,703,064
Schedule of contractual maturities of financial liabilities
12/31/2024
Book valueUndiscounted cash flowUp to 1 year1 - 2 years2 - 5 yearsMore than 5 years
Liabilities
Trade accounts payables6,033,285 6,033,285 6,033,285 
Loans, financing and debentures 101,435,531 142,028,543 13,599,011 14,235,170 50,858,667 63,335,695 
Lease liabilities6,972,915 12,099,294 1,302,590 1,176,832 3,094,493 6,525,379 
Liabilities for asset acquisitions and subsidiaries120,490 146,082 23,425 22,400 100,257 
Derivative financial instruments 10,454,820 13,878,150 1,676,180 957,540 1,489,357 9,755,073 
Dividends and interests on own capital payable2,200,917 2,200,917 2,200,917 
Other liabilities143,330 143,330 60,892 82,438 
127,361,288 176,529,601 24,896,300 16,474,380 55,542,774 79,616,147 
12/31/2023
Book
value
Undiscounted cash flowUp to 1 year1 - 2 years2 - 5 yearsMore than 5 years
Liabilities
Trade accounts payables5,572,219 5,572,219 5,572,219 
Loans, financing and debentures 77,172,692 105,526,852 7,648,237 12,983,542 31,355,362 53,539,711 
Lease liabilities6,243,782 11,021,519 1,172,568 1,045,795 2,743,793 6,059,363 
Liabilities for asset acquisitions and subsidiaries187,187 215,891 94,948 18,314 87,520 15,109 
Derivative financial instruments 2,436,072 2,801,258 66,433 1,278,953 1,191,014 264,858 
Dividends and interests on own capital payable1,316,528 1,316,528 1,316,528 
Other liabilities116,716 116,716 58,955 57,761 
93,045,196126,570,98315,929,88815,384,36535,377,68959,879,041
Analysis of credit exposures using internal credit grading system
The risk classification of trade accounts receivable is set forth below:
Consolidated
12/31/202412/31/2023
Low (1)
8,899,516 6,549,975 
Average (2)
174,048 156,883 
High (3)89,596 173,558 
9,163,160 6,880,416
1) Current and overdue up to 30 days.
2) Overdue between 30 and 90 days.
3) Overdue more than 90 days.
Schedule of the book value of financial assets representing the exposure to credit risk
The book value of financial assets representing exposure to credit risk is set forth below:
Consolidated
12/31/202412/31/2023
Cash and cash equivalents9,018,818 8,345,871 
Marketable securities13,363,511 13,267,286 
Derivative financial instruments (1)
3,887,100 4,199,982 
26,269,429 25,813,139
1) Does not include the derivative embedded in a forest partnership agreement for the supply of standing wood, which is not a transaction with a financial institution.
Analysis Of Credit Exposures Using External Credit Grading System Explanatory
The counterparties, mainly financial institutions, with whom the transactions are performed classified under cash and cash equivalents, marketable securities and derivatives financial instruments, are rated by the main ratings agencies. The risk ratings are set forth below:
Cash and cash equivalents and marketable securitiesDerivative financial instruments
12/31/202412/31/202312/31/202412/31/2023
Risk rating (1)
AAA232,908 878,241 
AA-286,906 1,007,537 
A+148,029 136,864 
A 55,547 
brAAA20,830,651 20,856,072 2,747,948 1,682,513 
brAA+658,880 511,589  439,280 
brAA755 6,565  
brAA-19 2,169  
brA31,504  
brBBB-3  
brBB710 1,132  
brBB-750,359 385 156,450 
Others109,448 235,242 314,859 
22,382,329 21,613,1573,887,100 4,199,982
1) We use the Brazilian Risk Ratings issued by the agencies Fitch Ratings, Standard & Poor’s and Moody’s.
Schedule of net exposure of assets and liabilities in foreign currency
The assets and liabilities that are exposed to foreign currency, substantially in US$, are set forth below:
12/31/202412/31/2023
Assets
Cash and cash equivalents6,496,039 6,432,557 
Marketable securities70,255 7,378,277 
Trade accounts receivable7,090,160 5,049,609 
Derivative financial instruments3,887,100 3,070,594 
17,543,554 21,931,037
Liabilities
Trade accounts payable(1,350,763)(1,625,011)
Loans and financing(83,004,915)(61,304,673)
Liabilities for asset acquisitions and subsidiaries(93,308)(127,598)
Derivative financial instruments(10,448,379)(1,867,882)
(94,897,365)(64,925,164)
(77,353,811)(42,994,127)
Summary of sensitivity analysis
The following table set forth the potential impacts at their absolute amounts:
12/31/2024
Effect on profit or loss
Probable (base value)Possible (25%)Remote (50%)
Cash and cash equivalents6,496,039 1,624,010 3,248,020 
Marketable securities70,255 17,564 35,128 
Trade accounts receivable7,090,160 1,772,540 3,545,080 
Trade accounts payable(1,350,763)(337,691)(675,382)
Loans and financing(83,004,915)(20,751,229)(41,502,458)
Liabilities for asset acquisitions and subsidiaries(93,308)(23,327)(46,654)
The following table set out the possible impacts assuming these scenarios:
12/31/2024
Effect on profit or loss
Probable (base value)Possible 25%Remote 50%
Dollar/Real
Derivative financial instruments
Derivative options(4,328,970)(9,226,995)(19,121,860)
Derivative swaps(1,843,087)(2,604,422)(4,992,835)
Derivative Non-Deliverable Forward (‘NDF’) Contracts(331,876)(896,742)(1,788,477)
Embedded derivatives(80,759)(183,663)(367,326)
Commodity Derivatives16,973 4,236 8,478 
The following table set forth the possible impacts assuming these scenarios in absolute amounts:
12/31/2024
Effect on profit or loss
ProbablePossible (25%)Remote (50%)
CDI/SELIC
Cash and cash equivalents2,422,308 73,578 147,155 
Marketable securities13,293,256 403,783 807,565 
Loans and financing9,290,595 282,202 564,404 
TJLP/TLP
Loans and financing202,961 3,770 7,540 
SOFR
Loans and financing28,534,005 320,294 640,588 
The following table sets out the possible impacts of these assumed scenarios:
12/31/2024
Effect on profit or loss
ProbableProbable 25%Remote 50%
CDI
Derivative financial instruments
Liabilities
Derivative options(4,328,970)(943,363)(1,868,091)
Derivative swaps(1,843,087)(91,012)(178,459)
SOFR
Derivative financial instruments
Liabilities
Derivative swaps(1,843,087)(136,036)(261,559)
The following table sets out the possible impacts, assuming these scenarios in absolute amounts:
12/31/2024
Effect on profit or loss
Probable (base value)Possible (25%)Remote (50%)
Embedded derivative in a commitment to purchase standing wood, originating from a forest partnership agreement(80,759)(32,607)(66,859)
Summary of yield curves used to calculate fair value of derivative financial instruments
The yield curves used to calculate the fair value as of December 31, 2024 are as set forth below:
Interest rate curves
Term
Brazil (1)
United States of America (2)
US Dollar coupon (1)
1M
12.15% p.a
4.33% p.a
8.46% p.a
6M
14.19% p.a
4.25% p.a
6.37% p.a
1Y
15.41% p.a
4.17% pa.
6.41% p.a
2Y
15.94% p.a
4.16% p.a
6.29% p.a
3Y
15.89% p.a
4.21% pa.
6.22% p.a
5Y
15.60% p.a
4.36% p.a
6.41% p.a
10Y
14.96% p.a
4.88% p.a
7.31% p.a
1) Source: B3
2) Source: Bloomberg
Schedule of derivatives by type of contract
The positions of outstanding derivatives are set forth below:
Notional value, net in U.S.$Fair value in R$
12/31/202412/31/202312/31/202412/31/2023
Instruments as part of cash flow protection strategy
Cash flow hedge
Zero Cost Collar6,852,200 4,500,200 (4,328,970)1,968,337 
NDF (R$ x US$)581,000 505,000 (331,876)162,776 
NDF (€ x US$)262,088 100,362 
Debt hedges
Swap SOFR to Fixed (US$)1,973,705 2,555,626 394,129 741,492 
Swap IPCA to CDI (notional in Brazilian Reais)8,128,395 4,274,397 (825,899)47,645 
Swap CNH to Fixed (US$)165,815 (6,440)
Swap CDI x Fixed (US$)909,612 1,025,000 (776,261)(1,081,964)
Pre-fixed Swap R$ to US$ (US$)200,000 (203,045)
Swap CDI x SOFR (US$)610,171 125,000 (590,764)25,774 
Swap SOFR to SOFR (US$)150,961 150,961 (37,850)(16,615)
Commodity Hedge
Swap US$ e US-CPI (1)
138,439 131,510 (80,759)230,471 
Zero Cost Collar (Brent)163,941 163,100 6,097 (3,148)
Swap VLSFO/Brent39,706 142,794 10,873 22,297 
(6,567,720)1,994,382
Current assets1,006,427 2,676,526 
Non-current assets2,880,673 1,753,928 
Current liabilities(2,760,273)(578,763)
Non-current liabilities(7,694,547)(1,857,309)
(6,567,720)1,994,382
(1)The embedded derivative refers to a swap contract for the sale of price variations in US$ and US-CPI within the term of a forest partnership with a standing wood supply contract.
Schedule of fair value by maturity
12/31/202412/31/2023
2025(1,753,846)2,097,763 
2026(1,699,768)233,072 
2027(36,905)(574,871)
2028 onwards(3,077,201)238,418 
(6,567,720)1,994,382
Schedule of long and short positions of outstanding derivatives
The outstanding derivatives positions are set forth below:
Notional valueFair value in R$
Currency12/31/202412/31/202312/31/202412/31/2023
Debt hedges
Assets
Swap CDI to FixedUS$4,748,394 3,898,011 1,482,759 223,776 
Swap Pre-Fixed to US$ US$ 738,800  
Swap SOFR to Fixed US$ 1,973,705 2,555,626 424,824 1,104,984 
Swap IPCA to CDIR$8,382,699 4,320,471 927,586 161,542 
Swap CDI to SOFRUS$3,117,625 644,850 754,173 32,560 
Swap CNH to FixedCNH1,200,000  
Swap SOFR to SOFRUS$150,961 150,961 4,949 6,681 
3,594,291 1,529,543
Liabilities
Swap CDI to Fixed US$ 909,612 1,025,000 (2,259,020)(1,305,740)
Swap Pre-Fixed to US$ US$  200,000  (203,045)
Swap SOFR to Fixed US$ 1,973,705 2,555,626 (30,695)(363,492)
Swap IPCA to CDIR$8,128,395 4,274,397 (1,753,485)(113,897)
Swap CDI to SOFRUS$610,171 125,000 (1,344,937)(6,786)
Swap CNH to FixedCNH165,815 (6,440)
Swap SOFR to SOFRUS$ 150,961 150,961 (42,799)(23,296)
(5,437,376)(2,016,256)
(1,843,085)(486,713)
Cash flow hedge
Zero Cost Collar (US$ x R$)US$ 6,852,200 4,500,200 (4,328,970)1,968,337 
NDF (R$ x US$)US$ 581,000 505,000 (331,876)162,776 
NDF (€ x US$)US$  262,088  100,362 
(4,660,846)2,231,475
 Commodity hedge
Swap US-CPI (standing wood) (1)US$138,439 131,510 (80,759)230,471 
Zero Cost Collar (Brent)US$163,941 163,100 6,097 (3,148)
Swap VLSFO/BrentUS$39,706 142,794 10,873 22,297 
(63,789)249,620
(6,567,720)1,994,382
(1)The embedded derivative refers to the swap contracts for selling price variations in US$ and the US-CPI in forest partnership with a standing wood supply contract.
Schedule of fair value settled derivatives
The settled derivatives positions are set forth below:
12/31/202412/31/2023
Cash flow hedge
Zero Cost Collar (R$ x US$)645,759 2,987,953 
NDF (R$ x US$)(68,695)155,458 
NDF (€ x US$)73,781 84,332 

650,845 3,227,743

Commodity Hedge 89,327 80,516 
Swap VLSFO/other89,327 80,516

Debt hedges
Swap CDI to Fixed (US$)(1,635,058)(438,417)
Swap IPCA to CDI (Brazilian Reais)(59,243)256,683 
Swap IPCA to Fixed (US$) 21,139 
Swap Pre-Fixed to US$(221,462)(104,827)
Swap SOFR to SOFR2,199 
Swap CDI to SOFR (US$)19,074 7,729 
Swap SOFR to Fixed (US$)603,737 508,720 

(1,290,753)251,027

(550,581)3,559,286
Disclosure of Fair Value Hierarchy
For the year ended December 31, 2024, there were no changes between the levels of hierarchy and no transfers between levels 1, 2 and 3.
12/31/2024
Level 1Level 2Level 3Total
Assets
At fair value through profit or loss
Derivative financial instruments3,887,100 3,887,100 
Marketable securities1,203,776 12,159,735 13,363,511 
1,203,776 16,046,835  17,250,611 
At fair value through other comprehensive income



Other investments (note 14.1)1,138,066 1,138,066 
  1,138,066 1,138,066 






Biological assets 22,283,001 22,283,001 
  22,283,001 22,283,001 
Total assets1,203,776 16,046,835 23,421,067 40,671,678 
Liabilities






At fair value through profit or loss





Derivative financial instruments 10,454,820 10,454,820 
 10,454,820  10,454,820 
 10,454,820  10,454,820 
12/31/2023
Level 2Level 3Total
Assets
At fair value through profit or loss
Derivative financial instruments4,430,454  4,430,454 
Marketable securities13,267,286  13,267,286 
17,697,74017,697,740
At fair value through other comprehensive income



Other investments - (note 14.1) 23,606 23,606 
23,60623,606
Biological assets 18,278,582 18,278,582 
18,278,58218,278,582
Total assets17,697,74018,302,18835,999,928
Liabilities
At fair value through profit or loss
Derivative financial instruments2,436,072  2,436,072 
2,436,0722,436,072
Total liabilities2,436,0722,436,072
v3.25.1
CASH AND CASH EQUIVALENTS (Tables)
12 Months Ended
Dec. 31, 2024
Cash and cash equivalents [abstract]  
Schedule of cash and cash equivalents
Average yield p.a. %12/31/202412/31/2023
Cash and banks (1)
4.62%6,596,510 6,561,558 
 
Cash equivalents 
Local currency 
Fixed-term deposits (compromised) 100.96 % of CDI2,422,308 1,784,313 
9,018,818 8,345,871
(1)Refers mainly to investments in foreign currency under the Sweep Account modality, which is a remunerated account the balance of which is invested and made available automatically each day
v3.25.1
MARKETABLE SECURITIES (Tables)
12 Months Ended
Dec. 31, 2024
Disclosure of financial assets [abstract]  
Schedule of marketable securities
Average yield p.a. %12/31/202412/31/2023
In local currency
Private funds97.76% of CDI552,635 1,295,296 
Public Securities (1)
IPCA + 6.10%1,203,776  
Private Securities ("CDBs")100.91% of CDI11,144,881 4,150,313 
CDBs - Escrow Account (2)
101.76% of CDI391,964 443,400 

13,293,256 5,889,009
Foreign currency

Time deposits (3)
 7,333,308 
Other

70,255 44,969 

70,255 7,378,277
13,363,511 13,267,286
Current12,971,547 12,823,886 
Non-Current391,964 443,400 
(1)Acquisition of Brazil National Treasury Notes indexed to IPCA (NTN-B).
(2)Includes escrow accounts, which will be released only after obtaining the applicable governmental approvals, and pending compliance by the Company with the conditions precedent in transactions involving the sale of rural properties.
(3)Refers to Time Deposit investments, with maturities over 90 days, which are remunerated bank deposits with specific maturity periods.
v3.25.1
TRADE ACCOUNTS RECEIVABLE (Tables)
12 Months Ended
Dec. 31, 2024
Trade and other current receivables [abstract]  
Schedule of trade accounts receivable by type of customer
12/31/202412/31/2023
Domestic customers
Third parties1,989,455 1,785,157 
Related parties (Note 11.1) (1)
83,343 45,650 
Foreign customers
Third parties7,090,160 5,049,609 
Related parties (Note 11.1)202  
(-) Expected credit losses(30,300)(31,962)
9,132,860 6,848,454
(1)The balance refers to transactions with Ibema Companhia Brasileira de Papel.
12/31/202412/31/2023
Current8,216,570 5,904,402 
Overdue
Up to 30 days682,142 644,644 
From 31 to 60 days134,674 57,395 
From 61 to 90 days38,187 97,639 
From 91 to 120 days17,701 40,533 
From 121 to 180 days12,402 34,708 
From 181 days31,184 69,133 
9,132,860 6,848,454
Schedule of rollforward of expected credit losses, trade accounts receivable
12/31/202412/31/2023
 Opening balance(31,962)(21,109)
(Provisions)/Reversals, net(2,585)(35,202)
Write-offs5,790 24,230 
Exchange rate variations (1,543)119 
 Closing balance(30,300)(31,962)
v3.25.1
INVENTORIES (Tables)
12 Months Ended
Dec. 31, 2024
Classes of current inventories [abstract]  
Schedule of inventories
12/31/202412/31/2023
Finished goods
Pulp
Domestic (Brazil)801,623 576,774 
Foreign1,510,985 1,271,335 
Paper
Domestic (Brazil)561,409 569,771 
Foreign362,027 137,653 
Work in process135,380 93,325 
Raw materials
Wood2,287,406 1,666,817 
Operating supplies and packaging1,098,894 795,274 
Spare parts and other1,302,534 931,052 
(-) Expected losses(97,934)(95,053)

7,962,324 5,946,948
Schedule of changes in expected losses
12/31/202412/31/2023
Opening balance(95,053)(105,989)
Additions(83,705)(65,085)
Reversals6,352 33,666 
Write-offs74,472 42,355 
Closing balance(97,934)(95,053)
v3.25.1
RECOVERABLE TAXES (Tables)
12 Months Ended
Dec. 31, 2024
RECOVERABLE TAXES  
Schedule of recoverable taxes
12/31/202412/31/2023
IRPJ/CSLL – prepayments and withheld taxes227,464 464,188 
PIS/COFINS – on acquisitions of property, plant and equipment (1)
187,126 93,866 
PIS/COFINS – operations789,667 699,717 
PIS/COFINS – exclusions from ICMS (2)
405,407 443,210 
ICMS – on acquisitions of property, plant and equipment (3)
471,825 432,793 
ICMS – operations (4)
1,654,162 1,470,949 
Reintegra program (5)
70,610 64,077 
Other taxes and contributions64,444 45,821 
Provision for loss on ICMS credits (6)
(1,581,961)(1,452,435)
2,288,744 2,262,186
Current 1,109,619 888,539 
Non-current 1,179,125 1,373,647 
(1)Social Integration Program (“PIS”) and Social Security Funding Contribution (“COFINS”): Credits whose realization is based on the years of depreciation of the corresponding asset.
(2)The Company and its subsidiaries filed lawsuits over the years seeking the exclusion of ICMS from the PIS and COFINS contribution tax basis, in relation to certain transactions during various periods from March 1992.
(3)Tax on Sales and Services (“ICMS”): Credits from the acquisition of property, plant and equipment are recovered on a straight-line basis over a four-year period, from the acquisition date, in accordance with the relevant regulation, the ICMS Control on Property, Plant and Equipment (“CIAP”).
(4)ICMS credits accrued due to the volume of exports and credit generated from product import transactions: Credits are concentrated in the States of Espírito Santo, Maranhão, Mato Grosso do Sul e São Paulo, where the Company realizes the credits through the sale of credits to third parties, after approval from the State Ministry of Finance of each State. Credits are also being realized through the consumption of consumer goods (tissue) transactions in the domestic market.
(5)Special Regime of Tax Refunds for Export Companies ("Reintegra"): Reintegra is a program that aims to refund the residual costs of taxes paid throughout the export chain to taxpayers, to make them more competitive in foreign markets.
(6)Related to provisions for ICMS credit balances that are not probable to be recovered.
Schedule of changes in provision for loss
ICMS
12/31/202412/31/2023
Opening balance(1,452,435)(1,103,807)
Addition (1)
(316,741)(399,838)
Reversal (2)
186,014 51,210 
Write-off1,201  
Closing balance(1,581,961)(1,452,435)
(1)Refers, substantially, to the accumulated ICMS credits of the state of Mato Grosso do Sul, arising from the construction operations of the Cerrado Project, and of the state of Espirito Santo, of the accumulated credits due to the volume of exports.
(2)Refers mainly to the reversal of the provision for loss resulting from the recovery of ICMS credits from the State of Espírito Santo through sale to third parties.
v3.25.1
ADVANCES TO SUPPLIERS (Tables)
12 Months Ended
Dec. 31, 2024
ADVANCES TO SUPPLIERS  
Schedule of advances to suppliers
12/31/202412/31/2023
Forestry development program and partnerships2,503,537 2,242,229 
Advance to suppliers - others92,133 113,743 
2,595,670 2,355,972
Current 92,133 113,743 
Non-current 2,503,537 2,242,229 
v3.25.1
RELATED PARTIES (Tables)
12 Months Ended
Dec. 31, 2024
Disclosure of transactions between related parties [abstract]  
Schedule of related party transactions
AssetsLiabilitiesSales (purchases), net
12/31/202412/31/202312/31/202412/31/202312/31/202412/31/202312/31/2022
Transactions with majority shareholders
Suzano Holding S.A. (1)
4 24 (630,387)(363,520)66 91 
Controller (1)
  (336,205)(193,883)  
Management and related persons (1)
  (55,627)(31,748)  
Alden Fundo de Investimento em Ações (1)
  (52,764)(30,428)  
4 24(1,074,983)(619,579)66 991
Transactions with companies of the Suzano Group and other related parties
Management (expect compensation – Note 11.2)61 61   538 (906)(47)
Bexma Participações Ltda    7 38 
Bizma Investimentos Ltda.10 
Civelec Participações Ltda3,860 4,575    4,825 
Fundação Arymax    5 
Ibema Companhia Brasileira de Papel (2)
83,343 45,659 (1,413)(1,023)211,482 168,621 218,226 
Instituto Ecofuturo - Futuro para o Desenvolvimento Sustentável21   (5,173)(5,549)(4,603)
IPLF Holding S.A.1    10 38 
Mabex Representações e Participações Ltda.  (23) (915)(817)
Nemonorte Imóveis e Participações Ltda    (177)(178)(194)
87,489 50,297(1,436)(1,023)206,640 166,020213,472
87,493 50,321(1,076,419)(620,602)206,706 166,029213,563
Assets
Trade accounts receivable (Note 7)83,545 45,650   
Other assets3,948 4,671   
Liabilities
Trade accounts payable (Note 18)  (1,457)(1,023)
Dividends and interest on own capital payable (3)
(1,074,962)(619,579)
87,493 50,321(1,076,419)(620,602)
(1)Refers to dividends and interest on own capital payable.
(2)Refers mainly to the sale of pulp.
(3)The amount of R$1,074,962 refers to interest on own capital payable to the controlling shareholders and the amount of R$1,125,955 refers to other non-controlling shareholders, totaling R$2,200,917 (Note 1.2.8).
Schedule of management compensation
Expenses related to the compensation of key management personnel, which include the Board of Directors, Fiscal Council and Board of Statutory Executive Officers, recognized in the statement of income for the year, are set out below:
12/31/202412/31/202312/31/2022
Short-term benefits
Salary or compensation48,469 49,165 50,228 
Direct and indirect benefits1,896 2,286 1,099 
Bonus14,881 10,829 7,031 
65,246 62,28058,358
Long-term benefits
Share-based compensation plan99,051 42,130 36,390 
99,051 42,13036,390
164,297 104,41094,748
v3.25.1
INCOME AND SOCIAL CONTRIBUTION TAXES (Tables)
12 Months Ended
Dec. 31, 2024
Major components of tax expense (income) [abstract]  
Schedule of deferred income and social contribution taxes
12/31/202412/31/2023
Tax loss796,831 1,209,968 
Negative tax basis of social contribution307,143 457,030 
Assets - temporary differences
Provision for judicial liabilities324,873 324,158 
Operating provisions and other losses1,308,352 1,214,807 
Exchange rate variations 7,385,034 2,384,153 
Derivatives losses (“MtM”)(2)
2,230,835 
Amortization of fair value adjustments arising from business combinations625,745 654,358 
Unrealized profit on inventories539,157 151,578 
Leases (2)
606,944 356,110 
14,124,914 6,752,162
 Liabilities - temporary differences
Goodwill - tax benefit on unamortized goodwill1,589,887 1,301,654 
Property, plant and equipment - deemed cost1,066,883 1,137,483 
Depreciation for tax-incentive reason (1)
733,640 799,857 
Capitalized loan costs947,482 640,063 
Fair value of biological assets1,317,095 1,115,432 
Deferred taxes, net of fair value adjustments 342,141 370,947 
Tax credits - gains from tax lawsuit (exclusion of ICMS from the PIS and COFINS basis)137,928 150,691 
Derivatives gains (“MtM”) (2)
 678,090 
Other temporary differences18,439 24,109 
6,153,495 6,218,326
Non-current assets7,984,015 545,213 
Non-current liabilities12,596 11,377 
(1)Tax depreciation is taken as a benefit only in the income tax calculation bases.
(2)The Company presents a net balance of derivatives and leases, as gains and losses from deferred taxes are offset simultaneously. For the derivatives line, the passive temporary difference was R$1,321,614 and asset temporary difference of R$3,552,449 (passive temporary difference of R$1,506,354 and asset temporary difference of R$828,264 as of December 31, 2023). For the lease line, the passive temporary difference was R$1,763,847 and asset temporary difference was R$2,370,791 (passive temporary difference of R$1,766,776 and asset temporary difference of R$2,122,886 as of December 31, 2023).
Schedule of accumulated tax losses and social contribution tax loss carryforwards
 12/31/202412/31/2023
Tax loss carried forward3,187,324 4,839,872 
Negative tax basis of social contribution carried forward3,412,700 5,078,111 
Schedule of changes in net balance of deferred income tax
12/31/202412/31/2023
Opening balance533,836 3,985,297 
Tax loss(413,137)2,872 
Negative tax basis of social contribution(149,887)11,780 
Provision for judicial liabilities715 55,562 
Operating provisions and other losses93,545 215,779 
Exchange rate variation 5,000,881 (1,913,350)
Derivative (gains) losses (“MtM”)2,908,925 (668,926)
Amortization of fair value adjustments arising from business combinations 193 2,219 
Unrealized profit on inventories387,579 (211,474)
Leases250,834 (8,728)
Goodwill - tax benefit on unamortized goodwill(288,233)(278,551)
Property, plant and equipment - deemed cost70,600 79,866 
Depreciation accelerated for tax-incentive reason 66,217 70,140 
Capitalized loan costs(307,419)(429,229)
Fair value of biological assets(201,663)(412,158)
Credits on exclusion of ICMS from the PIS/COFINS tax base12,763 43,430 
Other temporary differences5,670 (10,693)
Closing balance7,971,419 533,836
Schedule of changes in the effects of income tax and social contribution on profit or loss
12/31/202412/31/202312/31/2022
Net income (loss) before taxes(13,111,053)17,997,21628,655,581
Income tax and social contribution benefit (expense) at statutory nominal rate of 34%4,457,758(6,119,053)(9,742,898)
Tax effect on permanent differences
Taxation (difference) on profit of associates in Brazil and abroad (1)
484,7171,688,6564,915,243
Equity method(4,707)(6,589)96,685
Thin capitalization (2)
(46,796)(505,553)
Interest on own capital850,000510,000
Credit related to Reintegra Program11,8967,1767,829
Director bonuses(9,587)(4,907)(12,208)
Tax incentives (Note 12.3) (3)
336,541128,65051,839
Donations/Fines – Other(60,271)(47,972)(71,631)
6,066,347(3,890,835)(5,260,694)
Income tax
Current(999,421)(352,577)(464,312)
Deferred5,482,647(2,561,991)(3,485,267)
4,483,226(2,914,568)(3,949,579)
Social Contribution
Current(366,178)(42,815)(46,584)
Deferred1,949,299(933,452)(1,264,531)
1,583,121(976,267)(1,311,115)
Income and social contribution benefits (expenses) on the year6,066,347(3,890,835)(5,260,694)
(1)The difference in the taxation of subsidiaries is substantially due to the differences between the nominal tax rates in Brazil and those of subsidiaries located abroad.
(2)The Brazilian thin capitalization rules establish that interest paid or credited by a Brazilian entity to a related party abroad may only be deducted for income tax and social contribution purposes if the interest expense is viewed as necessary for the activities of the local entity, and when certain limits and requirements are met. On December 31, 2024, all limits and requirements were met, and on December 31, 2023 and 2022, the Company did not meet all of the limits and requirements, and therefore the expense is not deductible for the period.
(3)Income tax and social contribution deduction on profit or loss referring to the use of tax incentives: (i) exploitation profits, (ii) expenses with research and development, (iii) PAT benefits ("Worker Food Program"), (iv) donations made in cultural projects, (v) children and adolescents rights funds, (vi) sports incentives, (vii) funds for the elderly and (viii) extensions to maternity and paternity leave.
Schedule of tax incentives
The Company benefits from a tax incentive for partial reduction of the income tax obtained from operations carried out in areas under the jurisdiction of the Northeast Development Superintendence (“SUDENE”) and the Superintendence of Amazon Development (“SUDAM”). The IRPJ reduction incentive is calculated based on the activity profits (exploitation profits) and considers the allocation of the operating profit based on the incentive production levels for each product.
Area/RegionsCompanyMaturity
Northeast Development Superintendence (“SUDENE”)


Aracruz (ES)

Portocel2030
Aracruz (ES)

Suzano2031
Imperatriz (MA)

Suzano2032
Mucuri (BA)

Suzano2032
São Luís (MA)

Itacel2033
Eunápolis (BA)
Veracel2033
Superintendence of Amazon Development (“SUDAM”)


Belém (PA)

Suzano2025
v3.25.1
BIOLOGICAL ASSETS (Tables)
12 Months Ended
Dec. 31, 2024
Disclosure of detailed information about biological assets [abstract]  
Schedule of changes in balances of biological assets
The roll-forward of biological assets is as set forth below:
12/31/202412/31/2023
Opening balance18,278,582 14,632,186 
Additions 7,180,450 5,777,952 
Additions of merged companies (1)
366,785  
Depletions (4,831,916)(3,680,997)
Transfers102,790 (136,297)
Gain on fair value adjustments1,431,530 1,989,831 
Disposals(130,922)(128,370)
Write-offs(114,298)(175,723)
Closing balance22,283,001 18,278,582
(1) Refers to the acquisition and merger of 100% of the share capital of the companies Timber VII and Timber XX (note 1.2.6).
Schedule of assumptions used in calculation of fair value of biological assets
The table below discloses the measurement of the premises adopted:
12/31/202412/31/2023
Useful productive planted area (hectare)1,243,1911,094,611
Mature assets (6 to 7 years)191,737144,942
Immature assets (1 to 5 years)1,051,454949,669
Average annual growth (IMA) – m3/hectare/year
37.6237.92
Average gross sale price of eucalyptus – R$/m3
101.3896.04
Discount rate (post-tax)8.80 %8.80 %
Schedule of fair value adjustment
12/31/202412/31/2023
Physical changes and discount rate (1)
609,2591,575,017
Price822,271414,814
1,431,5301,989,831
1) Includes the variation of indicators: IMA, discount rate and area.
v3.25.1
INVESTMENTS (Tables)
12 Months Ended
Dec. 31, 2024
Investments in subsidiaries, joint ventures and associates reported in separate financial statements [abstract]  
Schedule of investments by type
12/31/202412/31/2023
Investments in associates and joint ventures453,371 355,520 
Goodwill 225,486 228,887 
Other investments evaluated at fair value through other comprehensive income (1)
1,138,066 23,606 
1,816,923 608,013
(1) Includes the acquisition of the equity interest in Lenzing Aktiengesellschaft (note 1.2.5). On December 31, 2024, the value of the investment was R$1,099,870 in the consolidated accounts.
Schedule of investments in associates and joint ventures
Information of investees as at
Company Participation
12/31/2024Carrying amountIn the income (expenses) for the year
EquityIncome (expenses) of the yearParticipation equity (%)12/31/202412/31/202312/31/202412/31/2023
Associate
Foreign
Ensyn Corporation6 (17,776)24.80 %2 387 (6,966)(12,448)
Spinnova Plc (1)
507,482 (56,117)18.77 %95,254 95,736 (19,690)(20,109)
Simplifyber, Inc. (2)
13.91 %30,060 
125,316 96,123(26,656)(32,557)
Joint ventures
Domestic (Brazil)
Biomas - Serviços Ambientais, Restauração e Carbono Ltda.17,536 (30,151)16.66 %2,923 2,797 (4,874)(2,203)
Ibema Companhia Brasileira de Papel388,580 74,547 49.90 %193,901 156,703 37,199 35,161 
Foreign
F&E Technologies LLC 12,756  50.00 %6,378 4,987   
Woodspin Oy249,706 (38,665)50.00 %124,853 94,910 (19,514)(19,780)
328,055 259,39712,811 13,178
Other investments evaluated at fair value through other comprehensive income
Bem Agro Integração e Desenvolvimento S.A.5.82 %4,026   
Celluforce Inc.8.28 %27,823 23,606 
Nfinite Nanotechnology Inc.5.00 %6,347   
Lenzing Aktiengesellschaft (3)
15.00 %1,099,870   
1,138,066 23,606 
1,591,437 379,126(13,845)(19,379)
(1)The average share price quoted on the Nasdaq First North Growth Market (NFNGM) was EUR0.95 on December 31, 2024 and EUR2.40 in December 31, 2023.
(2)On December 13, 2024, Suzano Ventures LLC acquired an equity interest in the legal entity Simplifyber, Inc., which is an indirect subsidiary of Suzano S.A.
(3)Includes the acquisition of the equity interest in Lenzing Aktiengesellschaft (note 1.2.5).
v3.25.1
PROPERTY, PLANT AND EQUIPMENT (Tables)
12 Months Ended
Dec. 31, 2024
Disclosure of detailed information about property, plant and equipment [abstract]  
Schedule of property, plant and equipment
LandBuildingsMachinery,
equipment and facilities
Work in progress
Other (1)
Total
Average rate %  3.34 6.78  19.38  
Accumulated cost14,486,408 9,644,875 45,160,365 10,373,151 1,281,328 80,946,127 
Accumulated depreciation (3,879,898)(25,541,712) (867,883)(30,289,493)
Balance as of December 31, 202214,486,408 5,764,977 19,618,653 10,373,151 413,445 50,656,634 
Additions54,027 15 467,032 10,742,118 17,949 11,281,141 
Additions of merged companies4,572 111,495 453,617 8,306 11,175 589,165 
Write-offs(25,090)(36,184)(133,249) (56,869)(251,392)
Depreciation (313,304)(2,570,734) (145,092)(3,029,130)
Transfers and other339,272 379,495 2,702,633 (3,638,466)259,717 42,651 
Accumulated cost14,859,189 10,032,317 48,456,537 17,485,109 1,491,663 92,324,815 
Accumulated depreciation (4,125,823)(27,918,585) (991,338)(33,035,746)
Balance as of December 31, 202314,859,189 5,906,494 20,537,952 17,485,109 500,325 59,289,069 
Additions (2)
697 558 415,147 7,490,762 28,904 7,936,068 
Additions of merged companies (3)
1,699,588 775 413  1,992 1,702,768 
Write-offs(10,724)(7,455)(118,499) (9,324)(146,002)
Depreciation (366,398)(3,214,550) (222,993)(3,803,941)
Transfers and other (4)
226,598 3,988,619 16,660,035 (21,465,336)598,162 8,078 
Accumulated cost16,775,348 13,816,631 62,822,096 3,510,535 1,806,592 98,731,202 
Accumulated depreciation (4,294,038)(28,541,598) (909,526)(33,745,162)
Balance as of December 31, 202416,775,348 9,522,593 34,280,498 3,510,535 897,066 64,986,040 
(1)Includes vehicles, furniture and utensils and computer equipment.
(2)The addition of work in progress refers, mainly to the Cerrado Project, of which R$1,254,521 is a cash effect in the previous periods (R$393,042 as of December 31, 2023).
(3)Refers to the acquisition and merger of 100% of the share capital of the companies Timber VII and Timber XX (note 1.2.6).
(4)Refers, basically, to the activation of the Cerrado Project, that started its operation on July 21, 2024 (note 1.2.2).
Disclosure of Property, Plant and Equipment Pledged as Collateral
On December 31, 2024, property, plant and equipment items pledged as collateral, consisting mainly of the units of Ribas do Rio Pardo, Três Lagoas and Imperatriz are set forth below:
Type of collateral12/31/202412/31/2023
LandFinancial/Legal24,427 3,198,674 
BuildingsFinancial1,755,082 1,947,075 
Machinery, equipment and facilitiesFinancial20,442,189 10,393,344 
Work in progressFinancial427,998 649,081 
OtherFinancial43,487 144,273 
22,693,183 16,332,447 
v3.25.1
INTANGIBLE (Tables)
12 Months Ended
Dec. 31, 2024
Disclosure of detailed information about intangible assets [abstract]  
Schedule of goodwill and intangible assets with indefinite useful life
16.1 Goodwill and intangible assets with indefinite useful lives
12/31/202412/31/2023
Goodwill - Facepa119,332 119,332 
Goodwill - Fibria7,897,051 7,897,051 
Goodwill - MMC Brasil (1)
170,859 170,859 
Other (2)
5,097 4,834 
8,192,339 8,192,076
(1)Refers to the goodwill of the MMC Brasil business combination.
(2)Refers to other intangible assets with indefinite useful lives such as servitude of passage and electricity.
Summary of assumptions used in valuation of cash-generating units
The assumptions in the table set forth below were also adopted:
Net average pulp price – Foreign market (US$/t)684.9
Net average pulp price – Internal market (US$/t)735.5
Average exchange rate (R$/US$)5.40
Discount rate (pos-tax)
8.91% p.a.
Discount rate (pre-tax)
12.50% p.a.
Schedule of intangible assets with determined useful life
16.2 Intangible assets with limited useful lives
12/31/202412/31/2023
Opening balance6,557,009 7,173,183 
Additions161,779 104,931 
Fair value adjustment MMC Brasil  189,655 
Write-offs (2)
Amortization(1,008,824)(990,432)
Transfers and others 79,674 
Closing balance5,709,964 6,557,009
Represented byAverage rate %
Non-competition agreements5.00 4,508 4,818 
Port concessions3.94 632,253 537,179 
Lease agreements16.90  6,875 
Supplier agreements12.66 25,925 40,739 
Port service contracts4.23 520,459 549,821 
Cultivars14.28 20,391 40,784 
Trademarks and patents8.35 170,306 188,723 
Customer portfolio9.09 4,104,900 4,925,879 
Supplier agreements17.64 295 10,861 
Software20.80 201,476 141,178 
Other10.00 29,451 110,152 
5,709,964 6,557,009
Cost12,540,497 12,378,761 
Amortization(6,830,533)(5,821,752)
Closing balance5,709,964 6,557,009
v3.25.1
TRADE ACCOUNTS PAYABLE (Tables)
12 Months Ended
Dec. 31, 2024
Trade and other payables [abstract]  
Schedule of trade accounts payable
12/31/202412/31/2023
In local currency
Third party (1) (2)

4,681,065 3,946,185 
Related party (Note 11.1) (3)

1,457 1,023 
In foreign currency
Third party (2)

1,350,763 1,625,011 
6,033,285 5,572,219
(1)Within the balance of suppliers, there are values under supplier finance arrangement that were subject to anticipation with financial institutions at the exclusive option of certain suppliers, without changing the originally defined purchase conditions (payment terms and negotiated prices). The balance related to such operations on December 31, 2024 was R$555,063 (R$281,350 at December 31, 2023).
(2)Within the balance of suppliers, the following balances refer to the Cerrado Project, R$107,418 (R$523,408 on December 31, 2023) in local currency and R$241,497 (R$1,080,028 on December 31, 2023) in foreign currency.
(3)The balance refers mainly to transactions with Ibema Companhia Brasileira de Papel.
v3.25.1
LOANS, FINANCING AND DEBENTURES (Tables)
12 Months Ended
Dec. 31, 2024
Disclosure of detailed information about borrowings [abstract]  
Schedule of loans, financing and debentures by type
18.1 Breakdown by type
CurrentNon-currentTotal
TypeCurrencyInterest rateAverage annual interest rate - %12/31/202412/31/202312/31/202412/31/202312/31/202412/31/2023
In foreign currency
BondsUSDFixed5.0 %3,229,641 841,625 49,166,804 40,122,749 52,396,445 40,964,374 
Panda BondsCNYFixed2.8 %4,224 1,016,331 1,020,555 
Export credits (“export prepayments”)USDSOFR/Fixed5.4 %6,236,806 2,690,891 16,283,736 14,487,252 22,520,542 17,178,143 
Assets financingUSDSOFR3.7 %137,300 61,924 298,252 220,199 435,552 282,123 
ECA - Export Credit AgencyUSDSOFR6.3 %7,297  769,702  776,999  
IFC - International Finance Corporation (1)
USDSOFR6.0 %(12,051)731 5,858,208 2,871,399 5,846,157 2,872,130 
EDC - Export Development CanadaEURFixed1.0 %4,210 7,903 4,455  8,665 7,903 
9,607,427 3,603,07473,397,488 57,701,59983,004,915 61,304,673
In local currency
BNDESBRLUMBNDES7.2 %157 157,555 157,712 
BNDESBRLTJLP8.6 %100,556 49,348 101,587 199,988 202,143 249,336 
BNDESBRLTLP14.8 %94,903 57,060 4,607,102 3,123,727 4,702,005 3,180,787 
BNDESBRLFixed4,020  4,020 
BNDESBRLSELIC14.5 %243,223 65,013 704,825 857,419 948,048 922,432 
BNDESBRLTR2.2 %84 70,015 70,099 
Assets financingBRLCDI18.1 %18,427 17,037 56,956 71,235 75,383 88,272 
NCE (“Export credit notes”)BRLCDI18.5 %3,027 3,114 100,000 100,000 103,027 103,114 
NCR (“Rural producer certificates”)BRLCDI14.8 %312,652 101,739 2,000,000 1,998,270 2,312,652 2,100,009 
Export credits (“export prepayments”)BRLFixed791,306  791,306 
DebenturesBRLCDI/IPCA15.4 %120,931 66,536 9,738,616 8,362,207 9,859,547 8,428,743 
893,960 1,155,17317,536,656 14,712,84618,430,616 15,868,019
10,501,387 4,758,24790,934,144 72,414,445101,435,531 77,172,692
Interest on financing1,541,312 1,232,810  1,541,312 1,232,810 
Non-current funding8,960,075 3,525,437 90,934,144 72,414,445 99,894,219 75,939,882 
10,501,387 4,758,24790,934,144 72,414,445101,435,531 77,172,692
(1) The balances shown as negative correspond to fundraising costs
Schedule of non-current portion of loans, financing and debentures by maturity
18.2 Breakdown by maturity - non-current
202620272028202920302031 onwards Total
In foreign currency
Bonds3,074,751 4,318,390 3,083,311 10,758,081 6,150,231 21,782,040 49,166,804 
Panda Bonds (1)
(1,211)1,017,542     1,016,331 
Export credits (“export prepayments”)5,668,270 4,889,574 3,832,090 1,893,802   16,283,736 
Assets financing110,452 112,204 69,012 6,584   298,252 
ECA - Export Credit Agency (1)
(670)(845)(780)(912)(847)773,756 769,702 
EDC - Export Development Canada  1,114 1,114 1,114 1,113 4,455 
IFC - International Finance Corporation (1)
(6,668)305,291 1,587,751 2,613,047 1,358,787  5,858,208 
8,844,924 10,642,156 8,572,498 15,271,716 7,509,285 22,556,909 73,397,488 
In local currency
BNDES – TJLP90,078 3,634 3,634 3,634 607  101,587 
BNDES – TLP98,668 158,812 155,980 141,823 366,249 3,685,570 4,607,102 
BNDES – SELIC254,966 33,888 33,933 33,979 34,024 314,035 704,825 
BNDES – TR4,178 4,734 4,734 4,734 4,734 46,901 70,015 
BNDES - UMBNDES4,258 8,516 8,516 8,516 8,516 119,233 157,555 
Assets financing18,741 19,114 19,034 67   56,956 
NCE (“Export credit notes”) 25,000 25,000 25,000 25,000  100,000 
NCR (“Rural producer certificates”)    2,000,000  2,000,000 
Debentures (1)
(7,431)(11,767)738,297 (11,477)518,399 8,512,595 9,738,616 
463,458 241,931 989,128 206,276 2,957,529 12,678,334 17,536,656 
9,308,382 10,884,087 9,561,626 15,477,992 10,466,814 35,235,243 90,934,144 
(1) The balances shown as negative correspond to fundraising costs, which are amortized on a straight-line basis.
Schedule of changes in loans, financing and debentures
18.3 Roll-forward of loans, financing and debentures
12/31/202412/31/2023
Opening balance77,172,692 74,574,591 
Fundraising, net of issuance costs 15,692,905 10,944,794 
Interest accrued 5,413,707 4,797,094 
Monetary and exchange rate variation, net17,728,324 (4,185,675)
Settlement of principal (9,410,807)(4,296,447)
Settlement of interest (5,241,389)(4,728,998)
Amortization of fundraising costs 80,099 67,333 
Closing balance101,435,531 77,172,692
Schedule of fundraising costs and premiums of securities
The fundraising costs are amortized based on the terms of agreements and the effective interest rate.
Balance to be amortized
TypeCostAmortization12/31/202412/31/2023
Bonds434,970 266,520 168,450 164,825 
NCE125,222 125,222  2,696 
Export credits (“export prepayments”)219,946 156,866 63,080 52,162 
Debentures159,675 34,012 125,663 102,235 
BNDES 81,730 55,953 25,777 9,854 
IFC - International Finance Corporation81,726 3,007 78,719 38,911 
Others20,912 14,113 6,799 598 
1,124,181 655,693 468,488 371,281
v3.25.1
LEASES (Tables)
12 Months Ended
Dec. 31, 2024
Presentation of leases for lessee [abstract]  
Schedule of right of use assets
The balances rolled-forward are set out below:
 Lands Machinery and equipment BuildingsShips and boatsVehicles Total
Balances at December 31, 20223,283,156 112,553 85,756 1,623,118 4,643 5,109,226 
Additions/updates496,236 206,847 101,124 9,702 813,909 
Depreciation (1)
(386,436)(134,587)(59,448)(124,890)(2,346)(707,707)
Write-offs (2)
(12,658)(6,139)(18,797)
Balances at December 31, 20233,380,298 184,813 127,432 1,498,228 5,860 5,196,631 
Additions/updates506,373 157,542 41,235  39,076 744,226 
Depreciation (1)
(408,000)(167,312)(54,275)(124,890)(2,587)(757,064)
Write-offs (2)
(3,102)    (3,102)
Balances at December 31, 20243,475,569 175,043 114,392 1,373,338 42,349 5,180,691 
(1)The amount of depreciation related to land is substantially reclassified to biological assets to make up the formation costs.
(2)Write-off due to cancellation of contracts.
Schedule of present value of lease liabilities
The balance of lease payables on December 31, 2024, measured at present value and discounted at the respective discount rates are set forth below:
Nature of agreement
Average rate - % p.a. (1)
Maturity (2)
Present value of liabilities
Lands and farms

12.27 October/20523,951,880 
Machinery and equipment

11.19 April/2035273,019 
Buildings

10.75 May/2031117,387 
Ships and boats

11.25 February/20392,626,083 
Vehicles

11.10 November/20284,546 
6,972,915 
(i)To determine the discount rates, quotes were obtained from financial institutions for agreements with characteristics and average terms similar to the lease agreements.
(ii)Refers to the original maturities of the agreements and, therefore, does not consider eventual renewal clauses.
Summary of changes in lease liabilities
The balances rolled-forward are set out below:
12/31/202412/31/2023
Opening balance6,243,782 6,182,530 
Additions744,226 813,909 
Write-offs (2)
(3,102)(18,797)
Payments(1,325,398)(1,218,399)
Accrual of financial charges (1)
700,283 664,651 
Exchange rate variations613,124 (180,112)
Closing balance6,972,915 6,243,782
Current872,228 753,399 
Non-current6,100,687 5,490,383 
(1)On December 31, 2024, the amount of R$249,135 related to interest expenses on leased lands was capitalized to biological assets to represent the formation cost (R$223,055 as of December 31, 2023).
(2)Write-off due to cancellation of contracts.
Schedule of expenses recognised in profit or loss
The amounts recognized are set out below:
12/31/202412/31/2023
Expenses relating to short-term assets6,477 8,005 
Expenses relating to low-value assets4,083 2,611 
10,560 10,616
v3.25.1
PROVISION FOR JUDICIAL LIABILITIES (Tables)
12 Months Ended
Dec. 31, 2024
Disclosure of other provisions [abstract]  
Disclosure of provisions
20.1 Roll-forward and changes in the provisions for probable losses based on the nature of the proceedings, net of judicial deposits
12/31/2024
Tax and
social security
LaborCivil, environment and real estate
Contingent liabilities assumed (1) (2)
Total
Provision balance at the beginning of the year468,839 349,058 139,435 2,155,545 3,112,877 
Payments(60,081)(89,221)(6,795) (156,097)
Reversal(9,540)(89,941)(1,951)(27,820)(129,252)
Additions4,689 162,456 72,605  239,750 
Monetary adjustment 4,057 21,574 12,259  37,890 
Provision balance407,964 353,926 215,553 2,127,725 3,105,168 
Judicial deposits(66,746)(91,596)(20,076)(178,418)
Provision balance at the end of the year341,218 262,330 195,477 2,127,725 2,926,750 
(1)Amounts arising from tax-related lawsuits with a possible or remote probability of loss in the amount of R$1,994,444 and civil lawsuits in the amount of R$133,281, measured and recorded at the estimated fair value resulting from the business combination with Fibria.
(2)Reversal due to a change in likelihood, cancellation and/or due to settlement.
12/31/2023
Tax and
social security
LaborCivil, environment and real estate
Contingent liabilities assumed (1) (2)
Total
Provision balance at the beginning of the year419,915255,805118,7292,645,7053,440,154
Payments(1,717)(37,172)(3,014)(41,903)
Reversal(18,035)(101,375)(11,337)(490,160)(620,907)
Additions37,656 211,690 21,335 270,681 
Monetary adjustment31,020 20,110 13,722 64,852 
Provision balance468,839349,058139,4352,155,5453,112,877
Judicial deposits(154,469)(82,305)(15,694)(252,468)
Provision balance at the end of the year314,370266,753123,7412,155,5452,860,409
(1)Amounts arising from tax-related lawsuits with a possible or remote probability of loss in the amount of R$2,015,075 and civil lawsuits in the amount of R$140,470, measured and recorded at the estimated fair value resulting from the business combination with Fibria.
(2)Reversal due to a change in likelihood, cancellation and/or due to settlement. The amount of R$372,541 refers to the penalty cancellation of the contingent liability assumed on the business combination with Fibria, described in note 20.2.1 (i).
Schedule of possible losses for which no provision has been recorded
The Company is involved in tax, civil and labor lawsuits, whose losses have been assessed as possible by Management, supported by legal counsel, and therefore no provision was recorded:
12/31/202412/31/2023
Taxes and social security (1)
9,837,082 9,775,068 
Labor171,480 194,883 
Civil and environmental (1)
5,065,714 4,462,964 
15,074,276 14,432,915
(1)The amounts above do not include the fair value adjustments allocated to possible loss risk contingencies representing R$R$2,108,635 (R$2,135,869 as of December 31, 2023), which were recorded at fair value resulting from business combinations with Fibria, as presented in Note 20.1.1 above.
v3.25.1
EMPLOYEE BENEFIT PLANS (Tables)
12 Months Ended
Dec. 31, 2024
Disclosure of information about defined benefit plans [abstract]  
Schedule of changes in actuarial liabilities
The roll-forward of actuarial liabilities prepared based on actuarial report is set forth below:
12/31/202412/31/2023
Opening balance833,683 691,424 
Interest on actuarial liabilities73,853 67,272 
Current service cost1,997 1,959 
Actuarial loss – experience(125)57,765 
Actuarial loss (gain) – financial assumptions(137,649)70,762 
Benefits paid directly by entity(50,199)(55,499)
Closing balance721,560 833,683
Schedule of key actuarial economic and biometric assumptions used in the calculations of liability
21.2.4 Economic actuarial assumptions and biometric data
12/31/202412/31/2023
Economic
Nominal discount rate – medical assistance and life insurance
11.16% p.a.
9.14% p.a.
Medical cost growth rate
6.86% p.a.
6.86% p.a.
Nominal inflation
3.50% p.a.
3.50% p.a.
Aging factor
0 to 24 years: 1.50% p.a.
0 to 24 years: 1.50% p.a.
25 to 54 years: 2.50% p.a.
25 to 54 years: 2.50% p.a.
55 to 79 years: 4.50% p.a.
55 to 79 years: 4.50% p.a.
Above 80 years: 2.50% p.a.
Above 80 years: 2.50% p.a.
Biometric
Table of general mortalityAT-2000AT-2000
Table of mortality of disabled personsIAPB 57IAPB 57
Turnover
1.00% p.a.
1.00% p.a.
Other
Retirement age
65 years
65 years
Family composition
Men 4 years + older
Men 4 years + older
and 90% married
and 90% married
Permanency in the plan100%100%
Summary of sensitivity analysis of actuarial liabilities
The sensitivity analysis regarding the relevant assumptions of the plans show the impact on the liability balance:
Discount rateMedical costs growth rate
+0.50%691,494 +1.00%788,124 
Schedule of expected benefit obligation payments for future years
The expected benefit payments for future years (ten years), from the obligation of benefits granted and the average duration of the plan obligations are as set forth below:
PaymentsMedical assistance and life insurance
202553,601 
202657,267 
202760,995 
202864,862 
202968,645 
2029 to 2034397,704 
v3.25.1
SHARE-BASED COMPENSATION PLAN (Tables)
12 Months Ended
Dec. 31, 2024
Disclosure of terms and conditions of share-based payment arrangement [abstract]  
Schedule of changes in long term compensation plans
The plan transactions are presented below:
Number of shares
Year of grantFair value on grant date31/12/2023Granted during of the yearCancelledExercised (1)31/12/2024Available for completionRestricted year for transfer of shares
2025202620272028
2019R$42.81 39,461 903 (40,364) 
2020R$38.36 984,160 22,525 (204,963)(768,338)33,384 33,384 
2021R$62.15 1,724,020 39,387 (66,231)(822,696)874,480 425,280 449,200 
2022R$57.54 3,686,722 84,207 (286,478)(23,014)3,461,437 3,113,607 324,611 23,219 
2023R$48.79 3,294,062 74,647 (283,548)(32,982)3,052,179 28,333 2,721,535 302,311 
2024R$56.52 2,759,878 (81,947)(2,914)2,675,017 2,893 2,467,693 204,431 
Number of stock options9,728,4252,981,547 (923,167)(1,690,308)10,096,497 458,664 3,591,140 3,049,039 2,793,223 204,431 
Book value268,489 173,486 (80,001)361,974 
Book value of the previous year162,117154,318(47,946)268,489
(1)The average price of the share options exercised and exercised due to termination of employment on December 31, 2024 was R$42.36 (forty-two reais and thirty-six cents) (R$58.07 (fifty-eight reais and seven cents) as at December 31, 2023).
The plan transactions are presented below:
Number of stock options
Year of grantFair value on grant date31/12/2023Shares granted/provisionedExercised31/12/2024Restricted year for transfer of shares
2025202620272029
2021R$51.70 111,685 2,559 (114,244) 
2022R$53.81 113,161 2,639 115,800 115,800 
2023R$51.45 367,903 15,665 383,568 268,534 115,034 
2024R$55.27 3,371,612 (890,869)2,480,743 337,465 220,540 302,738 1,620,000 
Number of stock options592,7493,392,475 (1,005,113)2,980,111 453,265 489,074 417,772 1,620,000 
Book value26,744 81,276 (47,794)60,226 
Book value of the previous year18,4258,31926,744
Disclosure of number and weighted average exercise prices of other equity instruments
The plan transactions are presented below:
Number of shares
Year of grantFair value on grant date31/12/2023Granted during of the yearCancelledExercised (1)31/12/2024Available for completionRestricted year for transfer of shares
2025202620272028
2019R$42.81 39,461 903 (40,364) 
2020R$38.36 984,160 22,525 (204,963)(768,338)33,384 33,384 
2021R$62.15 1,724,020 39,387 (66,231)(822,696)874,480 425,280 449,200 
2022R$57.54 3,686,722 84,207 (286,478)(23,014)3,461,437 3,113,607 324,611 23,219 
2023R$48.79 3,294,062 74,647 (283,548)(32,982)3,052,179 28,333 2,721,535 302,311 
2024R$56.52 2,759,878 (81,947)(2,914)2,675,017 2,893 2,467,693 204,431 
Number of stock options9,728,4252,981,547 (923,167)(1,690,308)10,096,497 458,664 3,591,140 3,049,039 2,793,223 204,431 
Book value268,489 173,486 (80,001)361,974 
Book value of the previous year162,117154,318(47,946)268,489
(1)The average price of the share options exercised and exercised due to termination of employment on December 31, 2024 was R$42.36 (forty-two reais and thirty-six cents) (R$58.07 (fifty-eight reais and seven cents) as at December 31, 2023).
The plan transactions are presented below:
Number of stock options
Year of grantFair value on grant date31/12/2023Shares granted/provisionedExercised31/12/2024Restricted year for transfer of shares
2025202620272029
2021R$51.70 111,685 2,559 (114,244) 
2022R$53.81 113,161 2,639 115,800 115,800 
2023R$51.45 367,903 15,665 383,568 268,534 115,034 
2024R$55.27 3,371,612 (890,869)2,480,743 337,465 220,540 302,738 1,620,000 
Number of stock options592,7493,392,475 (1,005,113)2,980,111 453,265 489,074 417,772 1,620,000 
Book value26,744 81,276 (47,794)60,226 
Book value of the previous year18,4258,31926,744
Summary of activity for common stock options
The plan transactions are presented below:
Number of stock options
Year of grantFair value on grant date31/12/2023Shares granted/provisionedExercised31/12/2024Restricted year for transfer of shares
2025202620272029
2021R$51.70 111,685 2,559 (114,244) 
2022R$53.81 113,161 2,639 115,800 115,800 
2023R$51.45 367,903 15,665 383,568 268,534 115,034 
2024R$55.27 3,371,612 (890,869)2,480,743 337,465 220,540 302,738 1,620,000 
Number of stock options592,7493,392,475 (1,005,113)2,980,111 453,265 489,074 417,772 1,620,000 
Book value26,744 81,276 (47,794)60,226 
Book value of the previous year18,4258,31926,744
v3.25.1
LIABILITIES FOR ASSETS ACQUISITIONS AND ASSOCIATES (Tables)
12 Months Ended
Dec. 31, 2024
LIABILITIES FOR ASSETS ACQUISITIONS AND ASSOCIATES  
Disclosure of Liabilities for Assets Acquisitions
12/31/202412/31/2023
Business combinations
Facepa (1)
27,182 25,924 
Vale Florestar Fundo de Investimento em Participações ("VFFIP") (2)
93,308 161,263 
120,490 187,187
Current 21,166 93,405 
Non-current99,324 93,782 
(1)Acquired in March 2018, for the amount of R$307,876, upon the payment of R$267,876, with the remainder updated at the IPCA, adjusted for possible losses incurred up to the payment date, with maturity in March 2028.
(2)On August 2014, the Company acquired Vale Florestar S.A. through VFFIP, with maturity up to August 2029. The annual settlements, carried out in the month of August, are subject to interest and updated by the variations of the US$ exchange rate, and partially updated by the IPCA.
v3.25.1
SHAREHOLDERS' EQUITY (Tables)
12 Months Ended
Dec. 31, 2024
Disclosure of classes of share capital [abstract]  
Schedule of share capital The breakdown of the share capital is as set out below:
12/31/202412/31/2023
Quantity(%)Quantity(%)
Controlling Shareholders
Suzano Holding S.A.367,612,329 29.08 367,612,32927.76 
Controller196,065,636 15.51 196,065,63614.81 
Managements and related persons32,784,440 2.59 32,105,7832.42 
Alden Fundo de Investimento em Ações26,154,744 2.07 26,154,7441.98 
622,617,149 49.25 621,938,49246.97
Treasury (Note 24.2)24,875,787 1.97 34,765,6002.63 
Other shareholders616,624,679 48.78 667,413,52350.40 
1,264,117,615 100.00 1,324,117,615100.00
Schedule of calculation of mandatory minimum dividends
In the year ended December 31, 2023, based on the criteria defined in the bylaws, mandatory minimum dividends were determined in accordance with item (ii) above, as set forth below:
12/31/2023
Accounting EBITDA19,537,398 
Adjustments to EBITDA(1,264,428)
Adjusted EBTIDA18,272,970
Capex Maintenance (Sustain) (6,706,367)
GCO = Adjusted EBTIDA - Capex Maintenance11,566,603
Dividends (10%) - Art. 26, "c" of the Bylaws1,156,660
Interest on own capital distributed and dividends1,500,000 
Withholding income tax(190,119)
Interest on own capital distributed in excess (1)
(153,221)
(1) Considering that the distribution of Interest on own capital in the year ending in 2023 exceeded the minimum mandatory dividends, the Company does not expect to propose additional dividends at the next shareholders' meeting.
Schedule of other reserves
These are changes that occur in shareholders' equity arising from transactions and other events that do not originate with shareholders and are disclosed net of tax effects, as set forth below:
Debenture conversion 5th issueActuarial lossExchange variation and fair value of financial assetsExchange variation on conversion of financial statements of foreign subsidiariesDeemed costTotal
Balances at December 31, 2022(45,746)(144,799)2,163 3,218 1,904,680 1,719,516 
Actuarial loss (84,828)   (84,828)
Loss on conversion of financial assets and fair value  (865)  (865)
Gain on conversion of financial statements and on foreign investments   5,178  5,178 
Partial realization of deemed cost, net of taxes    (100,705)(100,705)
Balances at December 31, 2023(45,746)(229,627)1,298 8,396 1,803,975 1,538,296 
Actuarial loss 90,931    90,931 
Loss on conversion of financial assets and fair value  (364,231)  (364,231)
Gain on conversion of financial statements and on foreign investments   163,185  163,185 
Partial realization of deemed cost, net of taxes    (79,385)(79,385)
Balances at December 31, 2024(45,746)(138,696)(362,933)171,580 1,724,590 1,348,796 
Schedule of treasury shares
Quantity Average cost
per share
Historical
value
Market
value
Balances at December 31, 202251,911,56940.842,120,3242,504,214
Repurchase

20,000,000 44.05 880,914 880,914 
Canceled

(37,145,969)40.84 (1,517,224)(1,570,532)
Balances at December 31, 202334,765,60042.691,484,0141,934,010
Exercised (note 22.2)(1,005,113)47.55 (47,794)(54,213)
Repurchase51,115,300 54.91 2,806,764 2,806,764 
Canceled(60,000,000)48.40 (2,903,787)(3,238,200)
Balances at December 31, 202424,875,787 53.84 1,339,197 1,536,826 
Schedule of result absorption
24.6 Distribution of results
Limit on share capital %Distribution of resultsReserve balances
12/31/202412/31/202312/31/202412/31/2023
Realization of deemed cost, net of taxes(79,385)(100,705)  
Tax incentive reserve321,671 118,959 1,319,908 998,237 
Legal reserve20.00 % 443,010 1,847,109 1,847,109 
Capital increase reserve80.00 % 10,911,226 2,807,632 15,670,952 
Special statutory reserve20.00 % 1,212,358 1,847,109 1,887,576 
Investments reserve(7,315,184) 5,157,140 14,972,324 
Capital reserve  60,226 26,744 
Dividends forfeited(1,300)
Interest on own capital 1,500,000   
(7,074,198)14,084,848 13,039,124 35,402,942 
v3.25.1
EARNINGS (LOSS) PER SHARE (Tables)
12 Months Ended
Dec. 31, 2024
Earnings per share [abstract]  
Schedule of basic earnings (losses) per share
The basic earnings (loss) per share is measured by dividing the profit attributable to the Company’s shareholders by the weighted average number of common shares issued during the period, excluding the common shares acquired by the Company and held as treasury shares.
12/31/202412/31/202312/31/2022
Net income (loss) for the year attributed to Controlling shareholders'(7,074,198)14,084,848 23,381,617 
Weighted average number of shares in the year – in thousands1,289,637 1,330,020 1,361,264 
Weighted average treasury shares – in thousands(24,836)(32,827)(31,043)
Weighted average number of outstanding shares – in thousands1,264,801 1,297,193 1,330,221 
Basic earnings (loss) per common share – R$(5.59313)10.8579417.57724
Schedule of diluted earnings (losses) per share
The diluted earnings (loss) per share is measured by adjusting the weighted average of outstanding common shares, assuming the conversion of all common shares with dilutive effects.
12/31/202412/31/202312/31/2022
Net income (loss) for the year attributed to Controlling shareholders'(7,074,198)14,084,848 23,381,617 
Weighted average number of shares during the year (except treasury shares) – in thousands1,264,801 1,297,193 1,330,221 
Average number of potential shares (stock options) - in thousands487 317 
Weighted average number of shares (diluted) – in thousands1,264,801 1,297,680 1,330,538 
Diluted earnings (loss) per common share – R$(5.59313)10.8538717.57305
v3.25.1
NET FINANCIAL RESULT (Tables)
12 Months Ended
Dec. 31, 2024
NET FINANCIAL RESULT  
Schedule of net financial result
12/31/202412/31/202312/31/2022
Financial expenses
Interest on loans, financing and debentures (1)

(4,453,739)(3,636,730)(3,648,330)
Amortization of transaction costs (2)

(80,099)(67,353)(69,881)
Interest expenses on lease liabilities (3)

(451,148)(441,596)(433,613)
Amortization of fair value adjustment

 (18,887)
Other

(556,917)(513,483)(419,659)
(5,541,903)(4,659,162)(4,590,370)
Financial income

Cash and cash equivalents and marketable securities

1,598,111 1,668,408 818,780 
Other139,323 157,241 148,230 
1,737,434 1,825,649 967,010 
Results from derivative financial instruments

Income

2,669,394 10,149,730 11,969,288 
Expenses(11,782,077)(4,623,016)(5,207,721)
(9,112,683)5,526,714 6,761,567 
Monetary and exchange rate variations, net

Exchange rate variations on loans, financing and debentures

(17,728,324)4,185,675 3,949,020 
Leases(613,124)180,112 186,241 
Other assets and liabilities (4)
2,456,455 (1,278,060)(840,668)
(15,884,993)3,087,727 3,294,593 
Net financial result(28,802,145)5,780,9286,432,800
(1)Excludes R$959,968 arising from capitalized loan costs, substantially related to property, plant and equipment in progress of the Cerrado Project for the year ended December 31, 2024 (R$1,160,364 as at December 31, 2023).
(2)On December 31, 2023, in the consolidated statements, the balance of R$19 relating to transaction costs with loans and financing was recognized directly in the income statement.
(3)Includes R$249,135 referring to the reclassification to the biological assets item for the composition of the formation cost (R$223,055 as of December 31, 2023).
(4)Includes effects of exchange rate variations of trade accounts receivable, trade accounts payable, cash and cash equivalents, marketable securities and others.
v3.25.1
NET SALES (Tables)
12 Months Ended
Dec. 31, 2024
Disclosure of disaggregation of revenue from contracts with customers [abstract]  
Schedule of reconciliation from gross sales to net sales revenue
12/31/202412/31/202312/31/2022
Gross sales57,017,142 47,601,020 59,550,424 
Sales deductions
Returns and cancellations(234,643)(155,950)(91,291)
Discounts and rebates(6,936,630)(5,526,032)(7,459,520)
49,845,869 41,919,038 51,999,613 
Taxes on sales(2,442,587)(2,163,463)(2,168,667)
Net sales 47,403,282 39,755,57549,830,946
v3.25.1
SEGMENT INFORMATION (Tables)
12 Months Ended
Dec. 31, 2024
Disclosure of operating segments [abstract]  
Schedule of operating segments
12/31/2024
PulpPaperTotal
Net sales 37,593,462 9,809,820 47,403,282 
Domestic market (Brazil)2,295,258 7,278,586 9,573,844 
Foreign market35,298,204 2,531,234 37,829,438 
Asia15,760,800 24,767 15,785,567 
Europe11,895,394 355,784 12,251,178 
North America6,965,731 914,234 7,879,965 
South America and Central670,157 1,179,840 1,849,997 
Africa6,122 56,608 62,730 
Cost of sales(21,261,705)(6,139,822)(27,401,527)
Adjusted EBITDA20,866,160 2,983,040 23,849,200 
Adjustments to EBITDA (*)1,065,887 
Depreciation, depletion and amortization(9,223,995)
Financial result(28,802,145)
Net income (loss) before taxes(13,111,053)
12/31/2023
PulpPaperTotal
Net sales30,677,2659,078,31039,755,575
Domestic market (Brazil)2,144,199 6,719,093 8,863,292 
Foreign market28,533,066 2,359,217 30,892,283 
Asia13,588,032 72,133 13,660,165 
Europe8,701,141 302,131 9,003,272 
North America5,682,010 476,429 6,158,439 
South America and Central558,601 1,437,181 1,995,782 
Africa3,282 71,343 74,625 
Cost of sales(19,694,674)(5,382,001)(25,076,675)
Adjusted EBITDA15,194,660 3,078,310 18,272,970 
Adjustments to EBITDA (*)1,264,428 
Depreciation, depletion and amortization  (7,321,110)
Financial result5,780,928 
Net income (loss) before taxes  17,997,216
12/31/2022
PulpPaperTotal
Net sales41,384,3228,446,62449,830,946
Domestic market (Brazil)2,665,746 5,858,892 8,524,638 
Foreign market38,718,576 2,587,732 41,306,308 
Asia18,294,046 4,059 18,298,105 
Europe12,768,321 325,503 13,093,824 
North America7,055,625 608,734 7,664,359 
South America and Central592,360 1,641,277 2,233,637 
Africa8,224 8,159 16,383 
Cost of sales(19,958,000)(4,863,288)(24,821,288)
Adjusted EBITDA25,098,535 3,096,367 28,194,902 
Adjustments to EBITDA (*)1,435,769 
Depreciation, depletion and amortization(7,407,890)
Financial result6,432,800 
Net income (loss) before taxes28,655,581
12/31/202412/31/202312/31/2022
(*) Adjustments to EBITDA
Fair Value Update - Biological Asset 1,431,532 1,989,831 1,199,759 
Income from disposal and write-off of property, plant and equipment and biological assets(169,284)(232,143)19,436 
Accruals for losses on ICMS credits (130,726)(348,628)(58,003)
Others (1)
(65,635)(144,632)274,577 
1,065,887 1,264,4281,435,769
(1) It includes items with specific, non-cash and exceptional adjustments, such as: i) COVID-19 - Expenses related to social actions to combat the virus, ii) write-off of wood inventory, iii) tax credits - exclusion of ICMS from the PIS and COFINS calculation basis, iv) donations for catastrophes and pandemics, v) equity equivalence, vi) extension of the PCHM grant, vii) extinction of the packaging business line, viii) fines and cancellation of contracts, ix) expenses with the acquisition of assets and business combinations, and x) effective loss of the development contract advance program.
Schedule of net sales by product
12/31/202412/31/202312/31/2022
Products
Market pulp (1)
37,593,462 30,677,265 41,384,322 
Printing and writing paper (2)
8,478,489 7,567,320 6,912,984 
Paperboard1,270,872 1,417,075 1,421,338 
Other60,459 93,915 112,302 
47,403,282 39,755,57549,830,946
(1)Net sales of fluff pulp represent 0.7% of total net sales, and therefore were included in market pulp net sales. (0.8% as at December 31, 2023).
(2)Net sales of tissue represent 5.8% of total net sales, and therefore were included in printing and writing paper net sales. (5.1% as at December 31, 2023).
Goodwill based on expected future profitability
The goodwill based on expected future profitability arising from the business combination was allocated to the disclosable segments, which correspond to the Company's cash-generating units (“CGUs”), considering the economic benefits generated by such intangible assets. The allocation of goodwill is set out below:
12/31/202412/31/2023
Pulp7,897,051 7,897,051 
Paper290,191 290,191 
8,187,242 8,187,242
v3.25.1
RESULTS BY NATURE (Tables)
12 Months Ended
Dec. 31, 2024
Expenses by nature [abstract]  
Schedule of results by nature
12/31/202412/31/202312/31/2022
Cost of sales
Personnel expenses(1,741,347)(1,450,428)(1,467,896)
Costs of raw materials, materials and services(11,468,545)(10,981,883)(11,463,862)
Logistics cost(5,186,872)(4,341,369)(4,795,161)
Depreciation, depletion and amortization(8,135,016)(6,718,474)(6,406,610)
Other (1)
(869,747)(1,584,521)(687,759)
(27,401,527)(25,076,675)(24,821,288)
Selling expenses
Personnel expenses(330,178)(281,673)(244,681)
Services(247,585)(173,494)(146,184)
Logistics cost(1,288,670)(1,067,031)(1,065,416)
Depreciation and amortization(955,201)(952,033)(951,626)
Other (2)
(116,913)(122,146)(75,287)
(2,938,547)(2,596,377)(2,483,194)
General and administrative expenses
Personnel expenses(1,661,843)(1,172,538)(1,039,733)
Services(503,086)(406,001)(378,986)
Depreciation and amortization(143,600)(118,771)(101,764)
Other (3)
(311,315)(225,918)(189,284)
(2,619,844)(1,923,228)(1,709,767)
Other operating (expenses) income, net
Rents and leases2,188 3,971 2164
Results from sales of other products, net77,817 79,046 58,880 
Results from sales and disposals of property, plant and equipment, intangible and biological assets, net(163,033)(331,285)(509)
Result on fair value adjustment of biological assets1,431,530 1,989,831 1,199,759 
Depletion, amortization and other PPA realizations (4)
9,822 468,168 52,110 
Tax credits - gains in tax lawsuits (exclusion of ICMS from the PIS/COFINS calculation basis)(1,324)
Provision for judicial liabilities(148,952)(167,563)(156,243)
Other operating income (expenses), net52,201 34,204 (33,121)
1,261,573 2,076,3721,121,716
(i)Includes R$587,345 related to maintenance downtime, costing (R$650,592 as at December 31, 2023).
(ii)Includes expected credit losses, insurance, materials for use and consumption, travel, accommodation, trade fairs and events.
(iii)Includes, substantially, corporate expenses, insurance, materials for use and consumption, social programs and donations, travel and accommodation.
(iv)Refers, substantially, to the write-off of contingent liabilities assumed in Fibria's PPA as disclosed in note 20.1.
v3.25.1
COMPANY'S OPERATIONS - Summary (Details)
R$ in Thousands
12 Months Ended
Dec. 31, 2024
BRL (R$)
item
Dec. 31, 2023
COMPANY'S OPERATIONS    
Number of industrial units 16  
Number of technology centers 7,000  
Percentage of ownership interest in subsidiary 100.00% 100.00%
Issued capital, ordinary shares | R$ R$ 10,000,000  
Controlling Shareholders    
COMPANY'S OPERATIONS    
Percentage of ownership interest in subsidiary 49.25% 46.97%
BRAZIL    
COMPANY'S OPERATIONS    
Number of technology centers 4,000  
Number of distribution centers 28  
BRAZIL | Fibria    
COMPANY'S OPERATIONS    
Number of ports 4  
CANADA    
COMPANY'S OPERATIONS    
Number of technology centers 1,000  
CHINA    
COMPANY'S OPERATIONS    
Number of technology centers 1,000  
ISRAEL    
COMPANY'S OPERATIONS    
Number of technology centers 1,000  
Suzano Industrial | State of Sao Paulo    
COMPANY'S OPERATIONS    
Number of industrial units 2  
Suzano Industrial | BRAZIL    
COMPANY'S OPERATIONS    
Number of industrial units 14  
Suzano Packaging LLC    
COMPANY'S OPERATIONS    
Percentage of ownership interest in subsidiary 100.00%  
Suzano Packaging LLC | Waynesville    
COMPANY'S OPERATIONS    
Number of industrial units 2  
Suzano Packaging LLC | UNITED STATES    
COMPANY'S OPERATIONS    
Number of industrial units 2  
Suzano Packaging LLC | Pine Bluff    
COMPANY'S OPERATIONS    
Number of industrial units 2  
v3.25.1
COMPANY'S OPERATIONS - Equity interest (Details)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
COMPANY'S OPERATIONS    
Percentage of ownership interest in subsidiary 100.00% 100.00%
F&E Tecnologia do Brasil S.A.    
COMPANY'S OPERATIONS    
Main activity Biofuel production, except alcohol  
Country Brazil  
Percentage of ownership interest in subsidiary 100.00% 100.00%
Fibria Celulose (USA) Inc.    
COMPANY'S OPERATIONS    
Main activity Business office  
Country United States of America  
Percentage of ownership interest in subsidiary 100.00% 100.00%
Fibria Overseas Finance Ltd.    
COMPANY'S OPERATIONS    
Main activity Financial fundraising  
Country Cayman Island  
Percentage of ownership interest in subsidiary 100.00%
Fibria Terminal de Celulose de Santos SPE S.A.    
COMPANY'S OPERATIONS    
Main activity Port operations  
Country Brazil  
Percentage of ownership interest in subsidiary 100.00% 100.00%
FuturaGene Ltd.    
COMPANY'S OPERATIONS    
Main activity Biotechnology research and development  
Country England  
Percentage of ownership interest in subsidiary 100.00% 100.00%
FuturaGene Delaware Inc.    
COMPANY'S OPERATIONS    
Main activity Biotechnology research and development  
Country United States of America  
Percentage of ownership interest in subsidiary 100.00% 100.00%
FuturaGene Israel Ltd.    
COMPANY'S OPERATIONS    
Main activity Biotechnology research and development  
Country Israel  
Percentage of ownership interest in subsidiary 100.00% 100.00%
FuturaGene Inc.    
COMPANY'S OPERATIONS    
Main activity Biotechnology research and development  
Country United States of America  
Percentage of ownership interest in subsidiary 100.00% 100.00%
Maxcel Empreendimentos e Participacoes S.A.    
COMPANY'S OPERATIONS    
Main activity Holding  
Country Brazil  
Percentage of ownership interest in subsidiary 100.00% 100.00%
Itacel - Terminal de Celulose de Itaqui S.A.    
COMPANY'S OPERATIONS    
Main activity Port operations  
Country Brazil  
Percentage of ownership interest in subsidiary 100.00% 100.00%
Mucuri Energetica S.A    
COMPANY'S OPERATIONS    
Main activity Power generation and distribution  
Country Brazil  
Percentage of ownership interest in subsidiary 100.00% 100.00%
Paineiras Logistica e Transportes Ltda.    
COMPANY'S OPERATIONS    
Main activity Road freight transport  
Country Brazil  
Percentage of ownership interest in subsidiary 100.00% 100.00%
Portocel - Terminal Espec. Barra do Riacho S.A.    
COMPANY'S OPERATIONS    
Main activity Port operations  
Country Brazil  
Percentage of ownership interest in subsidiary 51.00% 51.00%
Projetos Especiais e Investimentos Ltda.    
COMPANY'S OPERATIONS    
Main activity Commercialization of equipment and parts  
Country Brazil  
Percentage of ownership interest in subsidiary 100.00% 100.00%
SFBC Participacoes Ltda.    
COMPANY'S OPERATIONS    
Main activity Packaging production  
Country Brazil  
Percentage of ownership interest in subsidiary 100.00% 100.00%
Stenfar S.A. Indl. Coml. Imp. Y. Exp.    
COMPANY'S OPERATIONS    
Main activity Commercialization of paper and computer materials  
Country Argentina  
Percentage of ownership interest in subsidiary 100.00% 100.00%
Suzano Austria GmbH    
COMPANY'S OPERATIONS    
Main activity Business office  
Country Austria  
Percentage of ownership interest in subsidiary 100.00% 100.00%
Suzano Canada Inc.    
COMPANY'S OPERATIONS    
Main activity Lignin research and development  
Country Canada  
Percentage of ownership interest in subsidiary 100.00% 100.00%
Suzano Ecuador S.A.S.    
COMPANY'S OPERATIONS    
Main activity Business office  
Country Ecuador  
Percentage of ownership interest in subsidiary 100.00% 100.00%
Suzano Finland Oy    
COMPANY'S OPERATIONS    
Main activity Industrialization and commercialization of cellulose, microfiber cellulose and paper  
Country Finland  
Percentage of ownership interest in subsidiary 100.00% 100.00%
Suzano International Finance B.V    
COMPANY'S OPERATIONS    
Main activity Financial fundraising  
Country Netherlands  
Percentage of ownership interest in subsidiary 100.00% 100.00%
Suzano International Holding B.V    
COMPANY'S OPERATIONS    
Main activity Holding  
Country Netherlands  
Percentage of ownership interest in subsidiary 100.00% 100.00%
Suzano International Trade GmbH    
COMPANY'S OPERATIONS    
Main activity Business office  
Country Austria  
Percentage of ownership interest in subsidiary 100.00% 100.00%
Suzano Packaging LLC    
COMPANY'S OPERATIONS    
Main activity Production of coated and uncoated paperboard, used in the production of Liquid Packaging Board and Cupstock  
Country United States of America  
Percentage of ownership interest in subsidiary 100.00%  
Suzano Material Technology Development Ltd.    
COMPANY'S OPERATIONS    
Main activity Biotechnology research and development  
Country China  
Percentage of ownership interest in subsidiary 100.00% 100.00%
Suzano Netherlands B.V.    
COMPANY'S OPERATIONS    
Main activity Financial fundraising  
Country Netherlands  
Percentage of ownership interest in subsidiary 100.00% 100.00%
Suzano Operacoes Industriais e Florestais S.A.    
COMPANY'S OPERATIONS    
Main activity Industrialization, commercialization and exporting of pulp  
Country Brazil  
Percentage of ownership interest in subsidiary 100.00% 100.00%
Suzano Pulp and Paper America Inc.    
COMPANY'S OPERATIONS    
Main activity Business office  
Country United States of America  
Percentage of ownership interest in subsidiary 100.00% 100.00%
Suzano Pulp and Paper Europe S.A.    
COMPANY'S OPERATIONS    
Main activity Business office  
Country Switzerland  
Percentage of ownership interest in subsidiary 100.00% 100.00%
Suzano Shanghai Ltd.    
COMPANY'S OPERATIONS    
Main activity Business office  
Country China  
Percentage of ownership interest in subsidiary 100.00% 100.00%
Suzano Trading Ltd.    
COMPANY'S OPERATIONS    
Main activity Financial fundraising  
Country China  
Percentage of ownership interest in subsidiary 100.00% 100.00%
Suzano Singapore Pte. Ltd    
COMPANY'S OPERATIONS    
Main activity Business office  
Country Singapore  
Percentage of ownership interest in subsidiary 100.00% 100.00%
Suzano Trading International KFT    
COMPANY'S OPERATIONS    
Main activity Business office  
Country Hungary  
Percentage of ownership interest in subsidiary 100.00% 100.00%
Suzano Ventures LLC    
COMPANY'S OPERATIONS    
Main activity Corporate venture capital  
Country United States of America  
Percentage of ownership interest in subsidiary 100.00% 100.00%
Veracel Celulose S.A.    
COMPANY'S OPERATIONS    
Main activity Industrialization, commercialization and exporting of pulp  
Country Brazil  
Percentage of ownership equity interests, Accounting method, Fair value through other comprehensive income 50.00% 50.00%
Biomas Serviços Ambientais, Restauração e Carbono S.A.    
COMPANY'S OPERATIONS    
Main activity Restoration, conservation and preservation of forests  
Country Brazil  
Percentage of ownership equity interests, Accounting method, Equity 16.66% 16.66%
Ensyn Corporation    
COMPANY'S OPERATIONS    
Main activity Biofuel research and development  
Country United States of America  
Percentage of ownership equity interests, Accounting method, Equity 24.80% 25.53%
F&E Technologies LLC    
COMPANY'S OPERATIONS    
Main activity Biofuel production, except alcohol  
Country United States of America  
Percentage of ownership equity interests, Accounting method, Equity 50.00% 50.00%
Ibema Companhia Brasileira de Papel    
COMPANY'S OPERATIONS    
Main activity Industrialization and commercialization of paperboard  
Country Brazil  
Percentage of ownership equity interests, Accounting method, Equity 49.90% 49.90%
Simplifyber, Inc    
COMPANY'S OPERATIONS    
Main activity Production of consumer goods through the transformation of cellulose-based liquids  
Country United States of America  
Percentage of ownership equity interests, Accounting method, Equity 13.91%  
Spinnova Plc    
COMPANY'S OPERATIONS    
Main activity Research of sustainable raw materials for the textile industry  
Country Finland  
Percentage of ownership equity interests, Accounting method, Equity 18.77% 18.78%
Woodspin Oy    
COMPANY'S OPERATIONS    
Main activity Development and production of cellulose-based fibers, yarns and textile filaments  
Country Finland  
Percentage of ownership equity interests, Accounting method, Equity 50.00% 50.00%
Bem Agro Integração e Desenvolvimento S.A    
COMPANY'S OPERATIONS    
Main activity Software solutions based on artificial intelligence and computer vision for agribusiness  
Country Brazil  
Percentage of ownership equity interests, Accounting method, Equity 5.82%  
Celluforce Inc.    
COMPANY'S OPERATIONS    
Main activity Nanocrystalline pulp research and development  
Country Canada  
Percentage of ownership equity interests, Accounting method, Fair value through other comprehensive income 8.28% 8.28%
Lenzing Aktiengesellschft    
COMPANY'S OPERATIONS    
Main activity Production of wood-based cellulose fibers  
Country Austria  
Percentage of ownership equity interests, Accounting method, Equity 15.00%  
Nfinite Nanotechnology Inc. (Indirect)    
COMPANY'S OPERATIONS    
Main activity Research and development of smart nanocoatings  
Country Canada  
Percentage of ownership equity interests, Accounting method, Fair value through other comprehensive income 5.00%  
v3.25.1
COMPANY'S OPERATIONS - Cerrado Project (Details) - Cerrado Project
R$ in Thousands
Oct. 28, 2021
BRL (R$)
T
COMPANY'S OPERATIONS  
New Construction Facility, Annual Capacity To Produce Eucalyptus Pulp (in tons) | T 2,550,000
Aggregate amount of industrial capital investment | R$ R$ 22,200
v3.25.1
COMPANY'S OPERATIONS - Cancellation of shares and new share buyback program (Details) - BRL (R$)
12 Months Ended
Aug. 09, 2024
Jan. 26, 2024
Dec. 31, 2024
Dec. 31, 2023
Aug. 30, 2024
COMPANY'S OPERATIONS [Line Items]          
Stock canceled during period, shares     (60,000,000,000) (37,145,969,000)  
Treasury shares cancelled        
Share capital     19,235,546,000 R$ 9,235,546,000  
Treasury shares cancelled          
COMPANY'S OPERATIONS [Line Items]          
Stock canceled during period, shares 40,000,000 20,000,000      
Average price of common shares R$ 51.25 R$ 42.69      
Treasury shares cancelled R$ 2,050,062 R$ 853,725,000      
Share repurchase program authorized         40,000,000
Period for shares to be held as treasury shares   18 months      
Share Capital          
COMPANY'S OPERATIONS [Line Items]          
Share capital     19,269,281,000   R$ 19,269,281
Treasury shares          
COMPANY'S OPERATIONS [Line Items]          
Treasury shares cancelled     R$ 2,903,787,000    
Number of shares outstanding         1,264,117,615
v3.25.1
COMPANY'S OPERATIONS - Acquisition of equity interest in a specialty fibers business (Details)
1 Months Ended
Aug. 31, 2024
EUR (€)
Aug. 31, 2024
BRL (R$)
Dec. 31, 2024
BRL (R$)
Dec. 04, 2024
BRL (R$)
R$ / shares
Oct. 01, 2024
BRL (R$)
Oct. 01, 2024
$ / shares
Aug. 30, 2024
€ / shares
shares
Jul. 31, 2024
BRL (R$)
COMPANY'S OPERATIONS [Line Items]                
Number Of Shares Acquired | shares             5,792,727  
Purchase and acquisition of shares € 229,971 R$ 1,436,814            
Par value per share | € / shares             € 39.70  
Fair value of consideration transferred in Asset Acquisition               R$ 2,143,821,000
Amount of cash payment for acquisition               R$ 19,113
Percentage Of Owner ship Interest Held Before Asset Acquisition     100.00%          
Interest on own capital distributed       R$ 2,500,000        
Interest on own capital                
COMPANY'S OPERATIONS [Line Items]                
Interest on own capital distributed       R$ 2,500,000,000        
Amount to be distributed as interest on own capital per share | R$ / shares       R$ 2,017,362,506        
Percentage of income tax on interest on own capital     15.00%          
Amount of income tax withheld and paid     R$ 306,327,000          
Timber XX SPE S.A.                
COMPANY'S OPERATIONS [Line Items]                
Percentage of shares purchase transaction     100.00%         100.00%
Timber VII SPE S.A.                
COMPANY'S OPERATIONS [Line Items]                
Percentage of shares purchase transaction     100.00%         100.00%
Suzano Packaging LLC                
COMPANY'S OPERATIONS [Line Items]                
Par value per share | $ / shares           $ 82.932    
Fair value of consideration transferred in Asset Acquisition         R$ 452,153      
AUSTRIA | Lenzing Aktiengesellschft                
COMPANY'S OPERATIONS [Line Items]                
Acquisition of minority shares             15.00%  
Additional acquisition through a public offering procedure             15.00%  
v3.25.1
COMPANY'S OPERATIONS - Share purchase agreement - Timber (Details) - BRL (R$)
Dec. 31, 2024
Jul. 31, 2024
COMPANY'S OPERATIONS [Line Items]    
Fair value of consideration transferred in Asset Acquisition   R$ 2,143,821,000
Amount of cash payment for acquisition   R$ 19,113
Percentage Of Owner ship Interest Held Before Asset Acquisition 100.00%  
Timber XX SPE S.A.    
COMPANY'S OPERATIONS [Line Items]    
Percentage of shares purchase transaction 100.00% 100.00%
Timber VII SPE S.A.    
COMPANY'S OPERATIONS [Line Items]    
Percentage of shares purchase transaction 100.00% 100.00%
v3.25.1
COMPANY'S OPERATIONS - Acquisition of Pactiv Evergreen Inc. assets (Details)
Aug. 30, 2024
€ / shares
Jul. 31, 2024
BRL (R$)
COMPANY'S OPERATIONS    
Par value per share | € / shares € 39.70  
Fair value of consideration transferred in Asset Acquisition | R$   R$ 2,143,821,000
v3.25.1
COMPANY'S OPERATIONS - Interest on own capital (Details) - BRL (R$)
Dec. 31, 2024
Dec. 04, 2024
COMPANY'S OPERATIONS [Line Items]    
Interest on own capital distributed   R$ 2,500,000
Interest on own capital    
COMPANY'S OPERATIONS [Line Items]    
Interest on own capital distributed   R$ 2,500,000,000
Amount to be distributed as interest on own capital per share   R$ 2,017,362,506
Percentage of income tax on interest on own capital 15.00%  
Amount of income tax withheld and paid R$ 306,327,000  
v3.25.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)
12 Months Ended
Dec. 31, 2024
segment
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
Number of Reportable Segments 2
Biological assets for production [Domain]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
Age of biological assets in formation accounted for at the formation cost 2 years
v3.25.1
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT - Rating (Details) - Financial risks management - BRL (R$)
R$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Assets R$ 37,168,630 R$ 33,652,893
Liabilities 127,361,288 93,045,196
Total 90,192,658 59,392,303
Amortized cost    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities 116,906,468 90,609,124
Amortized cost | Trade accounts payable    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities 6,033,285 5,572,219
Amortized cost | Loans, financing and debentures    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities 101,435,531 77,172,692
Amortized cost | Lease liabilities    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities 6,972,915 6,243,782
Amortized cost | Liabilities for asset acquisitions and associates    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities 120,490 187,187
Amortized cost | Dividends payable    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities 2,200,917 1,316,528
Amortized cost | Other liabilities    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities 143,330 116,716
Fair value through profit or loss    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities 10,454,820 2,436,072
Fair value through profit or loss | Derivative financial instruments    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities 10,454,820 2,436,072
Amortized cost    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Assets 18,779,953 15,931,547
Amortized cost | Cash and cash equivalents    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Assets 9,018,818 8,345,871
Amortized cost | Trade accounts receivable    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Assets 9,132,860 6,848,454
Amortized cost | Other assets    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Assets 628,275 737,222
Fair value through other comprehensive income    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Assets 1,138,066 23,606
Fair value through other comprehensive income | Investments - Celluforce    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Assets 1,138,066 23,606
Fair value through profit or loss    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Assets 17,250,611 17,697,740
Fair value through profit or loss | Derivative financial instruments    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Assets 3,887,100 4,430,454
Fair value through profit or loss | Marketable securities    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Assets R$ 13,363,511 R$ 13,267,286
v3.25.1
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT - Estimated fair value of loans and financing (Details) - Loans, financing and debentures - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Estimated fair values financial liabilities R$ 98,802,972 R$ 75,703,064
Foreign | Bonds | Fixed    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Yield used to discount/methodology Secondary Market  
Estimated fair values financial liabilities R$ 48,734,909 38,703,379
Foreign | Export credits ("export prepayment") | SOFR    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Yield used to discount/methodology SOFR  
Estimated fair values financial liabilities R$ 22,740,891 17,783,760
Foreign | Assets Financing | SOFR    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Yield used to discount/methodology SOFR  
Estimated fair values financial liabilities R$ 422,115 278,107
Foreign | ECA - Export Credit Agency | SOFR    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Yield used to discount/methodology SOFR  
Estimated fair values financial liabilities R$ 864,202  
Foreign | IFC - International Finance Corporation | SOFR    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Yield used to discount/methodology SOFR  
Estimated fair values financial liabilities R$ 6,261,715 3,198,761
Foreign | Panda Bonds - CNH | Fixed    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Yield used to discount/methodology Fixed  
Estimated fair values financial liabilities R$ 951,125
Domestic (Brazil) | Export credits ("export prepayment") | Fixed    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Yield used to discount/methodology DI 1  
Estimated fair values financial liabilities 824,035
Domestic (Brazil) | Assets Financing | SOFR    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Yield used to discount/methodology DI 1  
Estimated fair values financial liabilities R$ 60,566 75,622
Domestic (Brazil) | BNDES – TJLP | TJLP    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Yield used to discount/methodology DI 1  
Estimated fair values financial liabilities R$ 171,109 215,458
Domestic (Brazil) | BNDES – TLP | TLP    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Yield used to discount/methodology DI 1  
Estimated fair values financial liabilities R$ 3,275,012 2,712,762
Domestic (Brazil) | BNDES | Fixed    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Yield used to discount/methodology DI 1  
Estimated fair values financial liabilities 3,903
Domestic (Brazil) | BNDES | SELIC    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Yield used to discount/methodology DI 1  
Estimated fair values financial liabilities R$ 645,139 686,798
Domestic (Brazil) | BNDES –TR | BNDES –TR    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Yield used to discount/methodology DI 1  
Estimated fair values financial liabilities R$ 33,466  
Domestic (Brazil) | BNDES - US$ | BNDES - US$    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Yield used to discount/methodology DI 2  
Estimated fair values financial liabilities R$ 106,966
Domestic (Brazil) | Debentures | CDI/IPCA    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Yield used to discount/methodology DI 1/IPCA  
Estimated fair values financial liabilities R$ 12,002,992 8,881,277
Domestic (Brazil) | NCE ("Export Credit Notes") | CDI    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Yield used to discount/methodology DI 1  
Estimated fair values financial liabilities R$ 108,308 110,396
Domestic (Brazil) | NCR ("Rural Credit Notes") | CDI    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Yield used to discount/methodology DI 1  
Estimated fair values financial liabilities R$ 2,424,457 R$ 2,228,806
v3.25.1
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT - Contractual maturities of financial liabilities (Details) - Liquidity risk - BRL (R$)
R$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities R$ 127,361,288 R$ 93,045,196
Liabilities, Future Value 176,529,601 126,570,983
Trade accounts payable    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities 6,033,285 5,572,219
Liabilities, Future Value 6,033,285 5,572,219
Loans, financing and debentures    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities 101,435,531 77,172,692
Liabilities, Future Value 142,028,543 105,526,852
Leases    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities 6,972,915 6,243,782
Liabilities, Future Value 12,099,294 11,021,519
Liabilities for asset acquisitions and associates    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities 120,490 187,187
Liabilities, Future Value 146,082 215,891
Derivative Liabilities    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities 10,454,820 2,436,072
Liabilities, Future Value 13,878,150 2,801,258
Dividends payable    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities 2,200,917 1,316,528
Liabilities, Future Value 2,200,917 1,316,528
Other liabilities    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities 143,330 116,716
Liabilities, Future Value 143,330 116,716
Up to 1 year    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities, Future Value 24,896,300 15,929,888
Up to 1 year | Trade accounts payable    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities, Future Value 6,033,285 5,572,219
Up to 1 year | Loans, financing and debentures    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities, Future Value 13,599,011 7,648,237
Up to 1 year | Leases    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities, Future Value 1,302,590 1,172,568
Up to 1 year | Liabilities for asset acquisitions and associates    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities, Future Value 23,425 94,948
Up to 1 year | Derivative Liabilities    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities, Future Value 1,676,180 66,433
Up to 1 year | Dividends payable    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities, Future Value 2,200,917 1,316,528
Up to 1 year | Other liabilities    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities, Future Value 60,892 58,955
1 - 2 years    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities, Future Value 16,474,380 15,384,365
1 - 2 years | Loans, financing and debentures    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities, Future Value 14,235,170 12,983,542
1 - 2 years | Leases    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities, Future Value 1,176,832 1,045,795
1 - 2 years | Liabilities for asset acquisitions and associates    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities, Future Value 22,400 18,314
1 - 2 years | Derivative Liabilities    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities, Future Value 957,540 1,278,953
1 - 2 years | Other liabilities    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities, Future Value 82,438 57,761
2 - 5 years    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities, Future Value 55,542,774 35,377,689
2 - 5 years | Loans, financing and debentures    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities, Future Value 50,858,667 31,355,362
2 - 5 years | Leases    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities, Future Value 3,094,493 2,743,793
2 - 5 years | Liabilities for asset acquisitions and associates    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities, Future Value 100,257 87,520
2 - 5 years | Derivative Liabilities    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities, Future Value 1,489,357 1,191,014
More than 5 years    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities, Future Value 79,616,147 59,879,041
More than 5 years | Loans, financing and debentures    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities, Future Value 63,335,695 53,539,711
More than 5 years | Leases    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities, Future Value 6,525,379 6,059,363
More than 5 years | Liabilities for asset acquisitions and associates    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities, Future Value 15,109
More than 5 years | Derivative Liabilities    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities, Future Value R$ 9,755,073 R$ 264,858
v3.25.1
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT - Risk classification of trade accounts receivable (Details) - BRL (R$)
R$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT      
Allowance Account For Credit Losses Financial Assets R$ 97,934 R$ 95,053 R$ 105,989
Trade accounts receivable      
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT      
Allowance Account For Credit Losses Financial Assets 30,300 31,962 R$ 21,109
Credit risk | Trade accounts receivable      
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT      
Credit Risk Management Practices Explanatory 9,163,160 6,880,416  
Allowance Account For Credit Losses Financial Assets 30,300 31,962  
Credit risk | Trade accounts receivable | Low Risk member | Current and overdue to up 30 days member      
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT      
Credit Risk Management Practices Explanatory 8,899,516 6,549,975  
Credit risk | Trade accounts receivable | Average Risk member | Later than one month and not later than three months      
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT      
Credit Risk Management Practices Explanatory 174,048 156,883  
Credit risk | Trade accounts receivable | High Risk member | Overdue more than 90 days member      
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT      
Credit Risk Management Practices Explanatory R$ 89,596 R$ 173,558  
v3.25.1
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT - Book value of financial assets representing exposure to credit risk (Details) - Credit risk - BRL (R$)
R$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Assets R$ 26,269,429 R$ 25,813,139
Cash and cash equivalents    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Assets 9,018,818 8,345,871
Marketable securities    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Assets 13,363,511 13,267,286
Derivative financial instruments    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Assets R$ 3,887,100 R$ 4,199,982
v3.25.1
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT - Risk Rating (Details) - Credit risk - BRL (R$)
R$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Derivative financial instruments    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Rated Credit Exposures 2024 R$ 3,887,100 R$ 4,199,982
Derivative financial instruments | AAA    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Rated Credit Exposures 2024 232,908 878,241
Derivative financial instruments | AA-    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Rated Credit Exposures 2024 286,906 1,007,537
Derivative financial instruments | A+    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Rated Credit Exposures 2024 148,029 136,864
Derivative financial instruments | A    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Rated Credit Exposures 2024   55,547
Derivative financial instruments | brAAA    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Rated Credit Exposures 2024 2,747,948 1,682,513
Derivative financial instruments | brAA+    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Rated Credit Exposures 2024   439,280
Derivative financial instruments | brBB-    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Rated Credit Exposures 2024 156,450  
Derivative financial instruments | Other risk ratings    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Rated Credit Exposures 2024 314,859  
Cash and cash equivalents and marketable securities    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Rated Credit Exposures 2024 22,382,329 21,613,157
Cash and cash equivalents and marketable securities | brAAA    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Rated Credit Exposures 2024 20,830,651 20,856,072
Cash and cash equivalents and marketable securities | brAA+    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Rated Credit Exposures 2024 658,880 511,589
Cash and cash equivalents and marketable securities | brAA    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Rated Credit Exposures 2024 755 6,565
Cash and cash equivalents and marketable securities | brAA-    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Rated Credit Exposures 2024 19 2,169
Cash and cash equivalents and marketable securities | brA    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Rated Credit Exposures 2024 31,504  
Cash and cash equivalents and marketable securities | brBBB-    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Rated Credit Exposures 2024 3 3
Cash and cash equivalents and marketable securities | brBB    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Rated Credit Exposures 2024 710 1,132
Cash and cash equivalents and marketable securities | brBB-    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Rated Credit Exposures 2024 750,359 385
Cash and cash equivalents and marketable securities | Other risk ratings    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Rated Credit Exposures 2024 R$ 109,448 R$ 235,242
v3.25.1
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT - Exchange rate risk management (Details)
R$ in Thousands, $ in Thousands
1 Months Ended 12 Months Ended
Nov. 30, 2021
USD ($)
Dec. 31, 2024
BRL (R$)
Dec. 31, 2023
BRL (R$)
Jul. 27, 2022
USD ($)
Cerrado Project Investments        
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT        
Value at risk time horizon 36 years      
Maximum investment | $ $ 1,000,000     $ 1,500,000
Currency risk | Selling transactions in the futures markets        
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT        
Value at risk time horizon   24 years 24 years  
Currency risk | US Dollars        
Assets and liabilities exposed to foreign currency        
Assets   R$ 17,543,554 R$ 21,931,037  
Liabilities   (94,897,365) (64,925,164)  
Net liability exposure   (77,353,811) (42,994,127)  
Currency risk | US Dollars | Trade accounts payable        
Assets and liabilities exposed to foreign currency        
Liabilities   (1,350,763) (1,625,011)  
Currency risk | US Dollars | Loans and financing        
Assets and liabilities exposed to foreign currency        
Liabilities   (83,004,915) (61,304,673)  
Currency risk | US Dollars | Liabilities for asset acquisitions and associates        
Assets and liabilities exposed to foreign currency        
Liabilities   (93,308) (127,598)  
Currency risk | US Dollars | Derivative financial instruments        
Assets and liabilities exposed to foreign currency        
Liabilities   (10,448,379) (1,867,882)  
Currency risk | US Dollars | Cash and cash equivalents        
Assets and liabilities exposed to foreign currency        
Assets   6,496,039 6,432,557  
Currency risk | US Dollars | Marketable securities        
Assets and liabilities exposed to foreign currency        
Assets   70,255 7,378,277  
Currency risk | US Dollars | Trade accounts receivable        
Assets and liabilities exposed to foreign currency        
Assets   7,090,160 5,049,609  
Currency risk | US Dollars | Derivative financial instruments        
Assets and liabilities exposed to foreign currency        
Assets   R$ 3,887,100 R$ 3,070,594  
v3.25.1
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT - Sensitivity analysis - foreign exchange rate exposure (Details)
R$ in Thousands
12 Months Ended
Dec. 31, 2024
BRL (R$)
shares
Cash and cash equivalents | Probable (base value)  
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT  
Assets R$ 6,496,039
Cash and cash equivalents | Possible 25%  
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT  
Assets 1,624,010
Cash and cash equivalents | Remote 50%  
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT  
Assets 3,248,020
Marketable securities | Probable (base value)  
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT  
Assets 70,255
Marketable securities | Possible 25%  
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT  
Assets 17,564
Marketable securities | Remote 50%  
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT  
Assets 35,128
Trade accounts receivable | Probable (base value)  
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT  
Assets 7,090,160
Trade accounts receivable | Possible 25%  
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT  
Assets 1,772,540
Trade accounts receivable | Remote 50%  
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT  
Assets 3,545,080
Trade accounts payable | Probable (base value)  
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT  
Liabilities (1,350,763)
Trade accounts payable | Possible 25%  
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT  
Liabilities (337,691)
Trade accounts payable | Remote 50%  
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT  
Liabilities (675,382)
Loans and financing | Probable (base value)  
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT  
Liabilities (83,004,915)
Loans and financing | Possible 25%  
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT  
Liabilities (20,751,229)
Loans and financing | Remote 50%  
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT  
Liabilities (41,502,458)
Liabilities for asset acquisitions and associates | Probable (base value)  
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT  
Liabilities (93,308)
Liabilities for asset acquisitions and associates | Possible 25%  
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT  
Liabilities (23,327)
Liabilities for asset acquisitions and associates | Remote 50%  
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT  
Liabilities R$ (46,654)
Currency risk | Possible 25%  
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT  
Percentage change in foreign exchange rate 25.00%
Currency risk | Remote 50%  
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT  
Percentage change in foreign exchange rate 50.00%
Currency risk | Probable  
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT  
Closing foreign exchange rate | shares 6.1923
v3.25.1
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT - Sensitivity analysis - exposure to interest rates (Details) - Currency risk - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Possible 25%    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Percentage change in foreign exchange rate 25.00%  
Remote 50%    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Percentage change in foreign exchange rate 50.00%  
Selling transactions in the futures markets    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Value at risk time horizon 24 years 24 years
Option contract | Probable (base value) | Dollar/Real    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Derivative options R$ (4,328,970)  
Option contract | Possible 25% | Dollar/Real    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Derivative options (9,226,995)  
Option contract | Remote 50% | Dollar/Real    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Derivative options (19,121,860)  
Swap contract | Probable (base value) | Dollar/Real    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Derivative options (1,843,087)  
Swap contract | Possible 25% | Dollar/Real    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Derivative options (2,604,422)  
Swap contract | Remote 50% | Dollar/Real    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Derivative options (4,992,835)  
Forward contract | Probable (base value) | Dollar/Real    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Derivative options (331,876)  
Forward contract | Possible 25% | Dollar/Real    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Derivative options (896,742)  
Forward contract | Remote 50% | Dollar/Real    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Derivative options (1,788,477)  
Embedded derivatives | Probable (base value) | Dollar/Real    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Derivative options (80,759)  
Embedded derivatives | Possible 25% | Dollar/Real    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Derivative options (183,663)  
Embedded derivatives | Remote 50% | Dollar/Real    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Derivative options (367,326)  
Commodity Derivatives | Probable (base value) | Dollar/Real    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Derivative options 16,973  
Commodity Derivatives | Possible 25% | Dollar/Real    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Derivative options 4,236  
Commodity Derivatives | Remote 50% | Dollar/Real    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Derivative options R$ 8,478  
v3.25.1
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT - Sensitivity analysis - foreign exchange rate exposure - derivative financial instruments (Details) - Currency risk - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Selling transactions in the futures markets    
Financial Instruments and Risks    
Value at risk time horizon 24 years 24 years
Probable (base value) | Option contract | Dollar/Real    
Financial Instruments and Risks    
Derivative options R$ (4,328,970)  
Probable (base value) | Swap contract | Dollar/Real    
Financial Instruments and Risks    
Derivative options (1,843,087)  
Probable (base value) | Forward contract | Dollar/Real    
Financial Instruments and Risks    
Derivative options (331,876)  
Probable (base value) | Embedded derivatives | Dollar/Real    
Financial Instruments and Risks    
Derivative options (80,759)  
Probable (base value) | Commodity Derivatives | Dollar/Real    
Financial Instruments and Risks    
Derivative options R$ 16,973  
Possible 25%    
Financial Instruments and Risks    
Percentage change in foreign exchange rate 25.00%  
Possible 25% | Option contract | Dollar/Real    
Financial Instruments and Risks    
Derivative options R$ (9,226,995)  
Possible 25% | Swap contract | Dollar/Real    
Financial Instruments and Risks    
Derivative options (2,604,422)  
Possible 25% | Forward contract | Dollar/Real    
Financial Instruments and Risks    
Derivative options (896,742)  
Possible 25% | Embedded derivatives | Dollar/Real    
Financial Instruments and Risks    
Derivative options (183,663)  
Possible 25% | Commodity Derivatives | Dollar/Real    
Financial Instruments and Risks    
Derivative options R$ 4,236  
Remote 50%    
Financial Instruments and Risks    
Percentage change in foreign exchange rate 50.00%  
Remote 50% | Option contract | Dollar/Real    
Financial Instruments and Risks    
Derivative options R$ (19,121,860)  
Remote 50% | Swap contract | Dollar/Real    
Financial Instruments and Risks    
Derivative options (4,992,835)  
Remote 50% | Forward contract | Dollar/Real    
Financial Instruments and Risks    
Derivative options (1,788,477)  
Remote 50% | Embedded derivatives | Dollar/Real    
Financial Instruments and Risks    
Derivative options (367,326)  
Remote 50% | Commodity Derivatives | Dollar/Real    
Financial Instruments and Risks    
Derivative options R$ 8,478  
v3.25.1
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT - Sensitivity analysis – exposure to interest rates – except for derivative financial instruments (Details)
R$ in Thousands
12 Months Ended
Dec. 31, 2024
BRL (R$)
Possible 25% | Cash and cash equivalents  
Financial Instruments and Risks  
Assets R$ 1,624,010
Possible 25% | Marketable securities  
Financial Instruments and Risks  
Assets 17,564
Possible 25% | Loans and financing  
Financial Instruments and Risks  
Liabilities R$ (20,751,229)
Possible 25% | Interest rate risk  
Financial Instruments and Risks  
Percentage increase (decrease) in interest rate 25.00%
Possible 25% | Interest rate risk | Cash and cash equivalents | CDI/SELIC  
Financial Instruments and Risks  
Assets R$ 73,578
Possible 25% | Interest rate risk | Marketable securities | CDI/SELIC  
Financial Instruments and Risks  
Assets 403,783
Possible 25% | Interest rate risk | Loans and financing | CDI/SELIC  
Financial Instruments and Risks  
Liabilities 282,202
Possible 25% | Interest rate risk | Loans and financing | TJLP  
Financial Instruments and Risks  
Liabilities 3,770
Possible 25% | Interest rate risk | Loans and financing | SOFR  
Financial Instruments and Risks  
Liabilities 320,294
Remote 50% | Cash and cash equivalents  
Financial Instruments and Risks  
Assets 3,248,020
Remote 50% | Marketable securities  
Financial Instruments and Risks  
Assets 35,128
Remote 50% | Loans and financing  
Financial Instruments and Risks  
Liabilities R$ (41,502,458)
Remote 50% | Interest rate risk  
Financial Instruments and Risks  
Percentage increase (decrease) in interest rate 50.00%
Remote 50% | Interest rate risk | Cash and cash equivalents | CDI/SELIC  
Financial Instruments and Risks  
Assets R$ 147,155
Remote 50% | Interest rate risk | Marketable securities | CDI/SELIC  
Financial Instruments and Risks  
Assets 807,565
Remote 50% | Interest rate risk | Loans and financing | CDI/SELIC  
Financial Instruments and Risks  
Liabilities 564,404
Remote 50% | Interest rate risk | Loans and financing | TJLP  
Financial Instruments and Risks  
Liabilities 7,540
Remote 50% | Interest rate risk | Loans and financing | SOFR  
Financial Instruments and Risks  
Liabilities 640,588
Probable (base value) | Cash and cash equivalents  
Financial Instruments and Risks  
Assets 6,496,039
Probable (base value) | Marketable securities  
Financial Instruments and Risks  
Assets 70,255
Probable (base value) | Loans and financing  
Financial Instruments and Risks  
Liabilities (83,004,915)
Probable (base value) | Interest rate risk | Cash and cash equivalents | CDI/SELIC  
Financial Instruments and Risks  
Assets 2,422,308
Probable (base value) | Interest rate risk | Marketable securities | CDI/SELIC  
Financial Instruments and Risks  
Assets 13,293,256
Probable (base value) | Interest rate risk | Loans and financing | CDI/SELIC  
Financial Instruments and Risks  
Liabilities 9,290,595
Probable (base value) | Interest rate risk | Loans and financing | TJLP  
Financial Instruments and Risks  
Liabilities 202,961
Probable (base value) | Interest rate risk | Loans and financing | SOFR  
Financial Instruments and Risks  
Liabilities R$ 28,534,005
v3.25.1
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT - Sensitivity analysis – exposure to interest rates – derivative financial instruments (Details) - Interest rate risk
R$ in Thousands
12 Months Ended
Dec. 31, 2024
BRL (R$)
Possible 25%  
Financial Instruments and Risks  
Percentage increase (decrease) in interest rate 25.00%
Possible 25% | Option contract | CDI  
Financial Instruments and Risks  
Derivative financial liabilities R$ (943,363)
Possible 25% | Swap contract | CDI  
Financial Instruments and Risks  
Derivative financial liabilities (91,012)
Possible 25% | Swap contract | SOFR  
Financial Instruments and Risks  
Derivative financial liabilities R$ (136,036)
Remote 50%  
Financial Instruments and Risks  
Percentage increase (decrease) in interest rate 50.00%
Remote 50% | Option contract | CDI  
Financial Instruments and Risks  
Derivative financial liabilities R$ (1,868,091)
Remote 50% | Swap contract | CDI  
Financial Instruments and Risks  
Derivative financial liabilities (178,459)
Remote 50% | Swap contract | SOFR  
Financial Instruments and Risks  
Derivative financial liabilities (261,559)
Probable (base value) | Option contract | CDI  
Financial Instruments and Risks  
Derivative financial liabilities (4,328,970)
Probable (base value) | Swap contract | CDI  
Financial Instruments and Risks  
Derivative financial liabilities (1,843,087)
Probable (base value) | Swap contract | SOFR  
Financial Instruments and Risks  
Derivative financial liabilities R$ (1,843,087)
v3.25.1
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT - Sensitivity analysis to changes in the consumer price indices of the US economy (Details)
R$ in Thousands
Dec. 31, 2024
BRL (R$)
Possible 25%  
Financial Instruments and Risks  
Percentage change in sensitivity analysis scenario 25.00%
Possible 25% | Commodity price risk  
Financial Instruments and Risks  
Embedded derivative in a commitment to purchase standing wood, originating from a forest partnership agreement R$ (32,607)
Remote 50%  
Financial Instruments and Risks  
Percentage change in sensitivity analysis scenario 50.00%
Remote 50% | Commodity price risk  
Financial Instruments and Risks  
Embedded derivative in a commitment to purchase standing wood, originating from a forest partnership agreement R$ (66,859)
Probable (base value) | Commodity price risk  
Financial Instruments and Risks  
Embedded derivative in a commitment to purchase standing wood, originating from a forest partnership agreement R$ (80,759)
v3.25.1
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT - Derivative financial instruments (Details)
Dec. 31, 2024
Term, 1 month  
Financial Instruments and Risks  
Dollar coupon 8.46%
Term, 1 month | Brazil, Brazil Real  
Financial Instruments and Risks  
Derivative Instrument, Interest Rate, Effective Percentage 12.15%
Term, 1 month | US Dollars  
Financial Instruments and Risks  
Derivative Instrument, Interest Rate, Effective Percentage 4.33%
Term, 6 months  
Financial Instruments and Risks  
Dollar coupon 6.37%
Term, 6 months | Brazil, Brazil Real  
Financial Instruments and Risks  
Derivative Instrument, Interest Rate, Effective Percentage 14.19%
Term, 6 months | US Dollars  
Financial Instruments and Risks  
Derivative Instrument, Interest Rate, Effective Percentage 4.25%
Term, 1 year  
Financial Instruments and Risks  
Dollar coupon 6.41%
Term, 1 year | Brazil, Brazil Real  
Financial Instruments and Risks  
Derivative Instrument, Interest Rate, Effective Percentage 15.41%
Term, 1 year | US Dollars  
Financial Instruments and Risks  
Derivative Instrument, Interest Rate, Effective Percentage 4.17%
Term, 2 year  
Financial Instruments and Risks  
Dollar coupon 6.29%
Term, 2 year | Brazil, Brazil Real  
Financial Instruments and Risks  
Derivative Instrument, Interest Rate, Effective Percentage 15.94%
Term, 2 year | US Dollars  
Financial Instruments and Risks  
Derivative Instrument, Interest Rate, Effective Percentage 4.16%
Term, 3 year  
Financial Instruments and Risks  
Dollar coupon 6.22%
Term, 3 year | Brazil, Brazil Real  
Financial Instruments and Risks  
Derivative Instrument, Interest Rate, Effective Percentage 15.89%
Term, 3 year | US Dollars  
Financial Instruments and Risks  
Derivative Instrument, Interest Rate, Effective Percentage 4.21%
Term, 5 year  
Financial Instruments and Risks  
Dollar coupon 6.41%
Term, 5 year | Brazil, Brazil Real  
Financial Instruments and Risks  
Derivative Instrument, Interest Rate, Effective Percentage 15.60%
Term, 5 year | US Dollars  
Financial Instruments and Risks  
Derivative Instrument, Interest Rate, Effective Percentage 4.36%
Term, 10 year  
Financial Instruments and Risks  
Dollar coupon 7.31%
Term, 10 year | Brazil, Brazil Real  
Financial Instruments and Risks  
Derivative Instrument, Interest Rate, Effective Percentage 14.96%
Term, 10 year | US Dollars  
Financial Instruments and Risks  
Derivative Instrument, Interest Rate, Effective Percentage 4.88%
v3.25.1
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT - Outstanding derivatives by contract type, including embedded derivatives (Details)
R$ in Thousands, $ in Thousands
Dec. 31, 2024
BRL (R$)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
BRL (R$)
Dec. 31, 2023
USD ($)
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT        
Derivative fair value asset (liability), net R$ (6,567,720)   R$ 1,994,382  
Derivative financial instruments 1,006,427   2,676,526  
Derivative financial instruments 2,880,673   1,753,928  
Current derivative financial liabilities (2,760,273)   (578,763)  
Non-current derivative financial liabilities (7,694,547)   (1,857,309)  
Operational Hedge        
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT        
Derivative fair value asset (liability), net (4,660,846)   2,231,475  
Fair value hedges        
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT        
Derivative fair value asset (liability), net (1,843,085)   (486,713)  
Commodity Hedge        
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT        
Derivative fair value asset (liability), net (63,789)   249,620  
NDF (R$ x US$) | Operational Hedge        
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT        
Principle amount 581,000   505,000  
Derivative fair value asset (liability), net (331,876)   162,776  
NDF (Euro x US$) | Operational Hedge        
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT        
Principle amount   262,088  
Derivative fair value asset (liability), net   100,362  
Swap US-CPI (US$) | Commodity Hedge        
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT        
Principle amount 138,439   131,510  
Derivative fair value asset (liability), net (80,759)   230,471  
Swap VLSFO/Brent | Commodity Hedge        
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT        
Principle amount 39,706   142,794  
Derivative fair value asset (liability), net 10,873   22,297  
Interest rate swap contract | ZCC | Operational Hedge        
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT        
Principle amount | $   $ 6,852,200   $ 4,500,200
Derivative fair value asset (liability), net (4,328,970)   1,968,337  
Interest rate swap contract | ZCC | Commodity Hedge        
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT        
Principle amount | $   163,941   163,100
Derivative fair value asset (liability), net 6,097   (3,148)  
Interest rate swap contract | NDF (R$ x US$) | Operational Hedge        
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT        
Principle amount | $   581,000   505,000
Derivative fair value asset (liability), net (331,876)   162,776  
Interest rate swap contract | NDF (Euro x US$) | Operational Hedge        
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT        
Principle amount | $     262,088
Derivative fair value asset (liability), net   100,362  
Interest rate swap contract | Swap SOFR to Fixed (US$) | Fair value hedges        
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT        
Principle amount | $   1,973,705   2,555,626
Derivative fair value asset (liability), net 394,129   741,492  
Interest rate swap contract | Swap IPCA to CDI (notional in Brazilian Reais) | Fair value hedges        
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT        
Principle amount | $   8,128,395   4,274,397
Derivative fair value asset (liability), net (825,899)   47,645  
Interest rate swap contract | Swap CNH to Fixed (CNH) | Fair value hedges        
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT        
Principle amount | $   165,815    
Derivative fair value asset (liability), net (6,440)      
Interest rate swap contract | Swap CDI x Fixed (US$) | Fair value hedges        
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT        
Principle amount | $   909,612   1,025,000
Derivative fair value asset (liability), net (776,261)   (1,081,964)  
Interest rate swap contract | Pre-fixed Swap to US$ (US$) | Fair value hedges        
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT        
Principle amount | $     200,000
Derivative fair value asset (liability), net   (203,045)  
Interest rate swap contract | Swap CDI x SOFR (US$) | Fair value hedges        
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT        
Principle amount | $   610,171   125,000
Derivative fair value asset (liability), net (590,764)     25,774
Interest rate swap contract | Swap SOFR to SOFR (US$) | Fair value hedges        
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT        
Principle amount | $   150,961   150,961
Derivative fair value asset (liability), net (37,850)     (16,615)
Interest rate swap contract | Swap US-CPI (US$) | Commodity Hedge        
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT        
Principle amount | $   138,439   131,510
Derivative fair value asset (liability), net (80,759)   230,471  
Interest rate swap contract | Swap VLSFO/Brent | Commodity Hedge        
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT        
Principle amount | $   $ 39,706   $ 142,794
Derivative fair value asset (liability), net R$ 10,873   R$ 22,297  
v3.25.1
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT - Fair Value Maturity Schedule (net amounts) (Details) - BRL (R$)
R$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Derivative fair value asset (liability), net R$ (6,567,720) R$ 1,994,382
2025    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Derivative fair value asset (liability), net (1,753,846) 2,097,763
2026    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Derivative fair value asset (liability), net (1,699,768) 233,072
2027    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Derivative fair value asset (liability), net (36,905) (574,871)
More than 3 years    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Derivative fair value asset (liability), net R$ (3,077,201) R$ 238,418
v3.25.1
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT - Outstanding assets and liabilities derivatives positions (Details) - BRL (R$)
R$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Derivative fair value asset (liability), net R$ (6,567,720) R$ 1,994,382
Fair value hedges    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Derivative fair value asset (liability), net (1,843,085) (486,713)
Operational Hedge    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Derivative fair value asset (liability), net (4,660,846) 2,231,475
Commodity Hedge    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Derivative fair value asset (liability), net (63,789) 249,620
Zero cost collar (U.S.$ x R$) | Operational Hedge    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Principle amount 6,852,200 4,500,200
Derivative fair value asset (liability), net (4,328,970) 1,968,337
Zero cost collar (U.S.$ x R$) | Commodity Hedge    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Principle amount 163,941 163,100
Derivative fair value asset (liability), net 6,097 (3,148)
NDF (R$ x US$) | Operational Hedge    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Principle amount 581,000 505,000
Derivative fair value asset (liability), net (331,876) 162,776
NDF (Euro x US$) | Operational Hedge    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Principle amount 262,088
Derivative fair value asset (liability), net 100,362
Swap US-CPI (US$) | Commodity Hedge    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Principle amount 138,439 131,510
Derivative fair value asset (liability), net (80,759) 230,471
Swap VLSFO/Brent | Commodity Hedge    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Principle amount 39,706 142,794
Derivative fair value asset (liability), net 10,873 22,297
Derivative Assets | Fair value hedges    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Derivative fair value asset (liability), net 3,594,291 1,529,543
Derivative Assets | Swap CDI x Fixed (US$) | Fair value hedges    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Principle amount 4,748,394 3,898,011
Derivative fair value asset (liability), net 1,482,759 223,776
Derivative Assets | Swap Pre-Fixed to US$ | Fair value hedges    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Principle amount 738,800
Derivative fair value asset (liability), net
Derivative Assets | Swap SOFR to Fixed (US$) | Fair value hedges    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Principle amount 1,973,705 2,555,626
Derivative fair value asset (liability), net 424,824 1,104,984
Derivative Assets | Swap IPCA to CDI (notional in Brazilian Reais) | Fair value hedges    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Principle amount 8,382,699 4,320,471
Derivative fair value asset (liability), net 927,586 161,542
Derivative Assets | Swap CDI x SOFR (US$) | Fair value hedges    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Principle amount 3,117,625 644,850
Derivative fair value asset (liability), net 754,173 32,560
Derivative Assets | Swap CNH to Fixed (CNH) | Fair value hedges    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Principle amount 1,200,000  
Derivative Assets | Swap SOFR to SOFR (US$) | Fair value hedges    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Principle amount 150,961 150,961
Derivative fair value asset (liability), net 4,949 6,681
Derivative Liabilities | Fair value hedges    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Derivative fair value asset (liability), net (5,437,376) (2,016,256)
Derivative Liabilities | Swap CDI x Fixed (US$) | Fair value hedges    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Principle amount 909,612 1,025,000
Derivative fair value asset (liability), net (2,259,020) (1,305,740)
Derivative Liabilities | Swap Pre-Fixed to US$ | Fair value hedges    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Principle amount 200,000
Derivative fair value asset (liability), net (203,045)
Derivative Liabilities | Swap SOFR to Fixed (US$) | Fair value hedges    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Principle amount 1,973,705 2,555,626
Derivative fair value asset (liability), net (30,695) (363,492)
Derivative Liabilities | Swap IPCA to CDI (notional in Brazilian Reais) | Fair value hedges    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Principle amount 8,128,395 4,274,397
Derivative fair value asset (liability), net (1,753,485) (113,897)
Derivative Liabilities | Swap CDI x SOFR (US$) | Fair value hedges    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Principle amount 610,171 125,000
Derivative fair value asset (liability), net (1,344,937) (6,786)
Derivative Liabilities | Swap CNH to Fixed (CNH) | Fair value hedges    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Principle amount 165,815  
Derivative fair value asset (liability), net (6,440)  
Derivative Liabilities | Swap SOFR to SOFR (US$) | Fair value hedges    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Principle amount 150,961 150,961
Derivative fair value asset (liability), net R$ (42,799) R$ (23,296)
v3.25.1
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT - Fair value hierarchy (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Settled derivatives, received (paid) R$ (550,581) R$ 3,559,286
Operational Hedge    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Settled derivatives, received (paid) 650,845 3,227,743
Commodity Hedge    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Settled derivatives, received (paid) 89,327 80,516
Fair value hedges    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Settled derivatives, received (paid) (1,290,753) 251,027
Zero cost collar (R$ x U.S.$) | Operational Hedge    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Settled derivatives, received (paid) 645,759 2,987,953
NDF (R$ x US$) | Operational Hedge    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Settled derivatives, received (paid) (68,695) 155,458
NDF (Euro x US$) | Operational Hedge    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Settled derivatives, received (paid) 73,781 84,332
Swap VLSFO/other | Commodity Hedge    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Settled derivatives, received (paid) 89,327 80,516
Swap CDI x Fixed (US$) | Fair value hedges    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Settled derivatives, received (paid) (1,635,058) (438,417)
Swap IPCA to CDI (notional in Brazilian Reais) | Fair value hedges    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Settled derivatives, received (paid) (59,243) 256,683
Swap IPCA to Fixed (US$) | Fair value hedges    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Settled derivatives, received (paid) 21,139
Swap Pre-Fixed to US$ | Fair value hedges    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Settled derivatives, received (paid) (221,462) (104,827)
Swap SOFR to SOFR (US$) | Fair value hedges    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Settled derivatives, received (paid) 2,199  
Swap LIBOR to Fixed (US$) | Fair value hedges    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Settled derivatives, received (paid) 19,074 7,729
Swap SOFR to Fixed (US$) | Fair value hedges    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Settled derivatives, received (paid) R$ 603,737 R$ 508,720
v3.25.1
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT - Fair value settled amounts (Details) - At fair value [member] - BRL (R$)
R$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Assets R$ 40,671,678 R$ 35,999,928
Liabilities 10,454,820 2,436,072
Fair value through profit or loss    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities 10,454,820 2,436,072
Fair value through profit or loss | Derivative financial instruments    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities 10,454,820 2,436,072
Level 1    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Assets 1,203,776  
Level 2    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Assets 16,046,835 17,697,740
Liabilities 10,454,820 2,436,072
Level 2 | Fair value through profit or loss    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities 10,454,820 2,436,072
Level 2 | Fair value through profit or loss | Derivative financial instruments    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Liabilities 10,454,820 2,436,072
Level 3    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Assets 23,421,067 18,302,188
Fair value through profit or loss    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Assets 17,250,611 17,697,740
Fair value through profit or loss | Level 1    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Assets 1,203,776  
Fair value through profit or loss | Level 2    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Assets 16,046,835 17,697,740
Fair value through profit or loss | Derivative financial instruments    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Assets 3,887,100 4,430,454
Fair value through profit or loss | Derivative financial instruments | Level 2    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Assets 3,887,100 4,430,454
Fair value through profit or loss | Marketable securities    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Assets 13,363,511 13,267,286
Fair value through profit or loss | Marketable securities | Level 1    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Assets 1,203,776  
Fair value through profit or loss | Marketable securities | Level 2    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Assets 12,159,735 13,267,286
Fair value through other comprehensive income    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Assets 1,138,066 23,606
Fair value through other comprehensive income | Level 3    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Assets 1,138,066 23,606
Fair value through other comprehensive income | Other investments member    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Assets 1,138,066 23,606
Fair value through other comprehensive income | Other investments member | Level 3    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Assets 1,138,066 23,606
Amortized cost    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Assets 22,283,001 18,278,582
Amortized cost | Level 3    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Assets 22,283,001 18,278,582
Amortized cost | Biological assets [domain]    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Assets 22,283,001 18,278,582
Amortized cost | Biological assets [domain] | Level 3    
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT    
Assets R$ 22,283,001 R$ 18,278,582
v3.25.1
CASH AND CASH EQUIVALENTS (Details) - BRL (R$)
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash and cash equivalents        
Cash and banks R$ 6,596,510,000 R$ 6,561,558,000    
Cash equivalents        
Cash and cash equivalents R$ 9,018,818,000 8,345,871,000 R$ 9,505,951,000 R$ 13,590,776,000
Fixed | Cash and banks        
Cash equivalents        
Average yield p.a. % 4.62%      
Domestic (Brazil)        
Cash equivalents        
Fixed-term deposits R$ 2,422,308,000 R$ 1,784,313,000    
Domestic (Brazil) | CDI | Fixed-term deposits        
Cash equivalents        
Percentage of basis used to calculate interest rate 100.96%      
v3.25.1
MARKETABLE SECURITIES (Details) - BRL (R$)
R$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
MARKETABLE SECURITIES    
Marketable securities R$ 13,363,511 R$ 13,267,286
Current 12,971,547 12,823,886
Non-Current 391,964 443,400
Domestic (Brazil)    
MARKETABLE SECURITIES    
Marketable securities 13,293,256 5,889,009
Foreign    
MARKETABLE SECURITIES    
Marketable securities R$ 70,255 7,378,277
Private Funds | CDI    
MARKETABLE SECURITIES    
Percentage of basis used to calculate interest rate 97.76%  
Private Funds | Domestic (Brazil)    
MARKETABLE SECURITIES    
Marketable securities R$ 552,635 1,295,296
Private Securities (CDBs) | CDI    
MARKETABLE SECURITIES    
Percentage of basis used to calculate interest rate 100.91%  
Private Securities (CDBs) | Domestic (Brazil)    
MARKETABLE SECURITIES    
Marketable securities R$ 11,144,881 4,150,313
CDBs - Escrow Account | CDI    
MARKETABLE SECURITIES    
Percentage of basis used to calculate interest rate 101.76%  
CDBs - Escrow Account | Domestic (Brazil)    
MARKETABLE SECURITIES    
Marketable securities R$ 391,964 443,400
Time Deposits | Foreign    
MARKETABLE SECURITIES    
Marketable securities 7,333,308
Average yield p.a. %  
Other | Foreign    
MARKETABLE SECURITIES    
Marketable securities R$ 70,255 44,969
Private Securities | CDI    
MARKETABLE SECURITIES    
Percentage of basis used to calculate interest rate 6.10%  
Private Securities | Domestic (Brazil)    
MARKETABLE SECURITIES    
Marketable securities R$ 1,203,776
v3.25.1
TRADE ACCOUNTS RECEIVABLE - Breakdown of balances (Details) - Trade accounts receivable - BRL (R$)
R$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
TRADE ACCOUNTS RECEIVABLE    
Financial assets R$ 9,132,860 R$ 6,848,454
Factoring of receivables    
TRADE ACCOUNTS RECEIVABLE    
Financial assets 6,821,539 4,273,623
Cost | Domestic (Brazil) | Third party    
TRADE ACCOUNTS RECEIVABLE    
Financial assets 1,989,455 1,785,157
Cost | Domestic (Brazil) | Total for all related parties    
TRADE ACCOUNTS RECEIVABLE    
Financial assets 83,343 45,650
Cost | Foreign | Third party    
TRADE ACCOUNTS RECEIVABLE    
Financial assets 7,090,160 5,049,609
Cost | Foreign | Total for all related parties    
TRADE ACCOUNTS RECEIVABLE    
Financial assets 202
Expected credit losses    
TRADE ACCOUNTS RECEIVABLE    
Financial assets R$ (30,300) R$ (31,962)
v3.25.1
TRADE ACCOUNTS RECEIVABLE - Breakdown of trade accounts receivable by maturity (Details) - Trade accounts receivable - BRL (R$)
R$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
TRADE ACCOUNTS RECEIVABLE    
Financial assets R$ 9,132,860 R$ 6,848,454
Neither past due nor impaired | Current    
TRADE ACCOUNTS RECEIVABLE    
Financial assets 8,216,570 5,904,402
Past due but not impaired | Up to 30 days    
TRADE ACCOUNTS RECEIVABLE    
Financial assets 682,142 644,644
Past due but not impaired | From 31 to 60 days    
TRADE ACCOUNTS RECEIVABLE    
Financial assets 134,674 57,395
Past due but not impaired | From 61 to 90 days    
TRADE ACCOUNTS RECEIVABLE    
Financial assets 38,187 97,639
Past due but not impaired | From 91 to 120 days    
TRADE ACCOUNTS RECEIVABLE    
Financial assets 17,701 40,533
Past due but not impaired | From 121 to 180 days    
TRADE ACCOUNTS RECEIVABLE    
Financial assets 12,402 34,708
Past due but not impaired | From 181 days    
TRADE ACCOUNTS RECEIVABLE    
Financial assets R$ 31,184 R$ 69,133
v3.25.1
TRADE ACCOUNTS RECEIVABLE - Rollforward of the expected credit losses (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Rollforward of the expected credit losses    
Beginning R$ (95,053) R$ (105,989)
Ending (97,934) (95,053)
Trade accounts receivable    
Rollforward of the expected credit losses    
Beginning (31,962) (21,109)
(Provisions)/Reversals, net (2,585) (35,202)
Utilisation Allowance Account For Credit Losses Financial Assetss 5,790 24,230
Increase Decrease In Allowance Account For Credi tLosses Financial Assets (1,543) 119
Ending R$ (30,300) R$ (31,962)
v3.25.1
TRADE ACCOUNTS RECEIVABLE - Main customers (Details)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Net Sales | Pulp    
TRADE ACCOUNTS RECEIVABLE    
Concentration risk percentage 10.00% 10.27%
v3.25.1
INVENTORIES - Balances (Details) - BRL (R$)
R$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Inventory [Line Items]    
Work in process R$ 135,380 R$ 93,325
Spare parts and other 1,302,534 931,052
Expected credit losses (97,934) (95,053)
Inventories 7,962,324 5,946,948
Pulp | Domestic (Brazil)    
Inventory [Line Items]    
Finished goods 801,623 576,774
Pulp | Foreign    
Inventory [Line Items]    
Finished goods 1,510,985 1,271,335
Paper | Domestic (Brazil)    
Inventory [Line Items]    
Finished goods 561,409 569,771
Paper | Foreign    
Inventory [Line Items]    
Finished goods 362,027 137,653
Wood    
Inventory [Line Items]    
Work in process 2,287,406 1,666,817
Operating supplies and packaging    
Inventory [Line Items]    
Work in process R$ 1,098,894 R$ 795,274
v3.25.1
INVENTORIES - Roll-forward of estimated losses (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Roll-forward of estimated losses    
Beginning R$ (95,053) R$ (105,989)
Additional allowance recognised in profit or loss, allowance account for credit losses (83,705) (65,085)
Reversal Allowance Account For Credit Losses Financial Assets 6,352 33,666
Utilisation Allowance Account For Credit Losses Financial Assets 74,472 42,355
Ending R$ (97,934) R$ (95,053)
v3.25.1
RECOVERABLE TAXES - Summary (Details) - BRL (R$)
R$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
RECOVERABLE TAXES      
IRPJ/CSLL - prepayments and withheld taxes R$ 227,464 R$ 464,188  
PIS and COFINS - on acquisitions of property, plant and equipment 187,126 93,866  
PIS and COFINS - operations 789,667 699,717  
PIS/COFINS - exclusion from ICMS 405,407 443,210  
ICMS - on acquisitions of property, plant and equipment 471,825 432,793  
ICMS - operations 1,654,162 1,470,949  
Reintegra program 70,610 64,077  
Other taxes and contributions 64,444 45,821  
Provision for loss of ICMS credits (1,581,961) (1,452,435) R$ (1,103,807)
Tax Assets 2,288,744 2,262,186  
Current assets 1,109,619 888,539  
Non-current assets R$ 1,179,125 R$ 1,373,647  
v3.25.1
RECOVERABLE TAXES - Roll-forward of provision for loss (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
ICMS    
Opening balance R$ (1,452,435) R$ (1,103,807)
Addition 316,741 399,838
Reversal 186,014 51,210
Write-off 1,201
Closing balance R$ (1,581,961) R$ (1,452,435)
v3.25.1
ADVANCES TO SUPPLIERS (Details) - BRL (R$)
R$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Advances to suppliers    
Advances to suppliers R$ 92,133 R$ 113,743
Non current 2,503,537 2,242,229
Forestry development program and partnerships    
Advances to suppliers    
Advances to suppliers 2,503,537 2,242,229
Advance to suppliers - others    
Advances to suppliers    
Advances to suppliers 92,133 113,743
Total Advanced for Suppliers    
Advances to suppliers    
Advances to suppliers R$ 2,595,670 R$ 2,355,972
v3.25.1
RELATED PARTIES - Balances recognized in assets and liabilities and amounts transacted during the period (Details) - BRL (R$)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Related Parties      
Assets R$ 87,493,000 R$ 50,321,000  
Liabilities 1,076,419,000 620,602,000  
Operating result 206,706,000 166,029,000 R$ 213,563,000
Dividends payable 2,200,917,000 1,316,528,000  
Controlling Shareholders      
Related Parties      
Dividends payable 1,074,962,000    
Non-Controlling Shareholders      
Related Parties      
Dividends payable 1,125,955    
Total Interest On Own Capital Payable      
Related Parties      
Dividends payable 2,200,917    
Trade accounts receivable      
Related Parties      
Assets 83,545,000 45,650,000  
Other assets      
Related Parties      
Assets 3,948,000 4,671,000  
Trade accounts payable      
Related Parties      
Liabilities 1,457,000 1,023,000  
Dividends payable      
Related Parties      
Liabilities 1,074,962,000 619,579,000  
Transactions with controlling shareholders      
Related Parties      
Assets 4,000 24,000  
Liabilities 1,074,983,000 619,579,000  
Operating result 66,000 9,000 91,000
Controller      
Related Parties      
Liabilities 336,205,000 193,883,000  
Key management personnel of entity or parent      
Related Parties      
Assets    
Liabilities 55,627,000 31,748,000  
Operating result    
Alden Fundo de Investimento em Acoes      
Related Parties      
Liabilities 52,764,000 30,428,000  
Transactions with companies of the Suzano Group and other related parties      
Related Parties      
Assets 87,489,000 50,297,000  
Liabilities 1,436,000 1,023,000  
Operating result 206,640,000 166,020,000 213,472,000
Management      
Related Parties      
Assets 61,000 61,000  
Operating result 538,000 (906,000) (47,000)
Bexma Participacoes Ltda.      
Related Parties      
Assets  
Operating result 7,000 9,000 38,000
Bizma Investimentos Ltda.      
Related Parties      
Operating result   7,000 10,000
Civelec Participações Ltda      
Related Parties      
Assets 3,860,000 4,575,000  
Operating result   4,825,000  
Fundacao Arymax      
Related Parties      
Assets    
Operating result 5,000 3,000 4,000
Ibema Companhia Brasileira de Papel      
Related Parties      
Assets 83,343,000 45,659,000  
Liabilities 1,413,000 1,023,000  
Operating result 211,482,000 168,621,000 218,226,000
Instituto Ecofuturo - Futuro Para o Desenvolvimento Sustentavel      
Related Parties      
Assets 21,000 2,000  
Liabilities    
Operating result (5,173,000) (5,549,000) (4,603,000)
IPFL Holding S.A      
Related Parties      
Assets 1,000  
Operating result 10,000 5,000 38,000
Mabex Representacoes e Participacoes Ltda.      
Related Parties      
Liabilities 23,000    
Operating result (915,000) (817,000)  
Nemonorte Imoveis e Participacoes Ltda.      
Related Parties      
Operating result (177,000) (178,000) (194,000)
Suzano Holding      
Related Parties      
Assets 4,000 24,000  
Liabilities 630,387,000 363,520,000  
Operating result R$ 66,000 R$ 9,000 R$ 91,000
v3.25.1
RELATED PARTIES - Management compensation (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Short-term benefits      
Salary or compensation R$ 48,469 R$ 49,165 R$ 50,228
Direct and indirect benefits 1,896 2,286 1,099
Bonus 14,881 10,829 7,031
Total short term benefits 65,246 62,280 58,358
Long-term benefits      
Share-based compensation plan 99,051 42,130 36,390
Total long term benefits 99,051 42,130 36,390
Total management compensation R$ 164,297 R$ 104,410 R$ 94,748
v3.25.1
INCOME AND SOCIAL CONTRIBUTION TAXES - Summary (Details)
R$ in Thousands
12 Months Ended
Dec. 31, 2024
BRL (R$)
Major components of tax expense (income) [abstract]  
Base rate for income tax and social contribution taxes 15.00%
Additional income tax rate on taxable income in excess of threshold amount 10.00%
Threshold amount of income for additional tax rate R$ 240
Additional social contribution tax rate on taxable income in excess of threshold amount 9.00%
v3.25.1
INCOME AND SOCIAL CONTRIBUTION TAXES - Deferred income and social contribution taxes (Details) - BRL (R$)
R$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Deferred income and social contribution taxes    
Non-current assets R$ 7,984,015 R$ 545,213
Non-current liabilities 12,596 11,377
Derivative, Passive Temporary Difference 1,321,614 1,506,354
Derivative, Asset Temporary Difference 3,552,449 828,264
Lease, Passive Temporary Difference 1,763,847 1,766,776
Lease, Asset Temporary Difference 2,370,791 2,122,886
Tax loss    
Deferred income and social contribution taxes    
Assets temporary differences 796,831 1,209,968
Negative tax basis of social contribution    
Deferred income and social contribution taxes    
Assets temporary differences 307,143 457,030
Provision for judicial liabilities    
Deferred income and social contribution taxes    
Assets temporary differences 324,873 324,158
Operating provisions and other losses    
Deferred income and social contribution taxes    
Assets temporary differences 1,308,352 1,214,807
Unrealised foreign exchange gains (losses)    
Deferred income and social contribution taxes    
Assets temporary differences 7,385,034 2,384,153
Amortization of fair value adjustments arising from business combinations    
Deferred income and social contribution taxes    
Assets temporary differences 625,745 654,358
Unrealized profit on inventories    
Deferred income and social contribution taxes    
Assets temporary differences 539,157 151,578
Leases    
Deferred income and social contribution taxes    
Assets temporary differences 606,944 356,110
Goodwill - Tax benefit on unamortized goodwill    
Deferred income and social contribution taxes    
Liabilities temporary differences 1,589,887 1,301,654
Property, plant and equipment - deemed cost    
Deferred income and social contribution taxes    
Liabilities temporary differences 1,066,883 1,137,483
Accelerated tax depreciation    
Deferred income and social contribution taxes    
Liabilities temporary differences 733,640 799,857
Borrowing cost    
Deferred income and social contribution taxes    
Liabilities temporary differences 947,482 640,063
Fair value of biological assets    
Deferred income and social contribution taxes    
Liabilities temporary differences 1,317,095 1,115,432
Deferred taxes, net of fair value adjustment    
Deferred income and social contribution taxes    
Liabilities temporary differences 342,141 370,947
Tax credits - gains from tax lawsuit (exclusion of ICMS from the PIS and COFINS basis)    
Deferred income and social contribution taxes    
Liabilities temporary differences 137,928 150,691
Derivatives gains ("MtM")    
Deferred income and social contribution taxes    
Liabilities temporary differences 678,090
Other temporary differences    
Deferred income and social contribution taxes    
Liabilities temporary differences 18,439 24,109
Derivatives losses (“MtM”)    
Deferred income and social contribution taxes    
Assets temporary differences 2,230,835  
Total deferred tax assets    
Deferred income and social contribution taxes    
Assets temporary differences 14,124,914 6,752,162
Total deferred tax liabilities    
Deferred income and social contribution taxes    
Liabilities temporary differences R$ 6,153,495 R$ 6,218,326
v3.25.1
INCOME AND SOCIAL CONTRIBUTION TAXES - Carryforwards (Details) - BRL (R$)
R$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Major components of tax expense (income) [abstract]    
Tax loss carryforward R$ 3,187,324 R$ 4,839,872
Negative tax basis of social contribution carryforward R$ 3,412,700 R$ 5,078,111
v3.25.1
INCOME AND SOCIAL CONTRIBUTION TAXES - Rollforward of deferred tax assets (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Rollforward of net balance of deferred income tax    
Opening balance R$ 533,836 R$ 3,985,297
Tax loss (413,137) 2,872
Negative tax basis of social contribution (149,887) 11,780
(Reversal of) provision for judicial liabilities 715 55,562
Reversal of operating provisions and other losses 93,545 215,779
Exchange rate variation 5,000,881 (1,913,350)
Derivative gains ("MtM") 2,908,925 (668,926)
Amortization of fair value adjustment on business combinations 193 2,219
Unrealized profit on inventories 387,579 (211,474)
Leases 250,834 (8,728)
Goodwill - tax benefit on unamortized goodwill (288,233) (278,551)
Property, plant and equipment - deemed cost 70,600 79,866
Accelerated tax depreciation 66,217 70,140
Borrowing cost (307,419) (429,229)
Fair value of biological assets (201,663) (412,158)
Credits on exclusion of ICMS from the PIS/COFINS tax base 12,763 43,430
Other temporary differences 5,670 (10,693)
Closing balance R$ 7,971,419 R$ 533,836
v3.25.1
INCOME AND SOCIAL CONTRIBUTION TAXES - Reconciliation of effects of income tax and social contribution on profit or loss (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Jun. 13, 2024
Reconciliation of the effects of income tax and social contribution on profit or loss        
Net income (loss) before taxes R$ (13,111,053) R$ 17,997,216 R$ 28,655,581  
Income tax and social contribution benefit (expense) at statutory nominal rate of 34% 4,457,758 (6,119,053) (9,742,898)  
Tax effect on permanent differences        
Taxation (difference) on profits of associates in Brazil and abroad 484,717 1,688,656 4,915,243  
Equity method (4,707) (6,589) 96,685  
Thin capitalization (46,796) (505,553)  
Payment of Interest on own capital 850,000 510,000 0  
Credit related to Reintegra Program 11,896 7,176 7,829  
Director bonuses (9,587) (4,907) (12,208)  
Tax incentives 336,541 128,650 51,839  
Donations / Fines - other (60,271) (47,972) (71,631)  
Income and social contribution benefits (expenses) for the year 6,066,347 (3,890,835) (5,260,694)  
Income tax        
Current (999,421) (352,577) (464,312)  
Deferred 5,482,647 (2,561,991) (3,485,267)  
Total income Tax 4,483,226 (2,914,568) (3,949,579)  
Social Contribution        
Current (366,178) (42,815) (46,584)  
Deferred 1,949,299 (933,452) (1,264,531)  
Total Social Contribution 1,583,121 (976,267) (1,311,115)  
Income and social contribution benefits (expenses) for the year R$ 6,066,347 R$ (3,890,835) R$ (5,260,694)  
Corporate Income Tax Reduction, Percent       75.00%
Corporate Income Tax Reduction, Term       10 years
v3.25.1
BIOLOGICAL ASSETS - Roll-forward of biological assets (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Roll-forward of biological assets      
Opening balance R$ 18,278,582 R$ 14,632,186  
Additions 7,180,450 5,777,952  
Additions of merged companies 366,785  
Depletions (4,831,916) (3,680,997)  
Transfers 102,790 (136,297)  
Gain on fair value adjustment 1,431,530 1,989,831 R$ 1,199,759
Disposals (130,922) (128,370)  
Other write-offs (114,298) (175,723)  
Closing balance R$ 22,283,001 R$ 18,278,582 R$ 14,632,186
Effective area of forest from the year of planting 3 years    
Bottom of range      
Roll-forward of biological assets      
Average cycle of forest formation 6 years    
Top of range      
Roll-forward of biological assets      
Average cycle of forest formation 7 years    
v3.25.1
BIOLOGICAL ASSETS - Measurement of the premises adopted (Details) - ha
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
BIOLOGICAL ASSETS    
Planted useful area (hectare) 1,243,191,000 1,094,611,000
Average Annual Growth Volume Per Hectare Per Year 37,620 37,920
Average gross sale price of eucalyptus 101,380 96,040.00
Label Role Discount rate post-tax 8.80% 8.80%
Mature assets    
BIOLOGICAL ASSETS    
Planted useful area (hectare) 191,737,000 144,942,000
Immature assets    
BIOLOGICAL ASSETS    
Planted useful area (hectare) 1,051,454,000 949,669,000
v3.25.1
BIOLOGICAL ASSETS - Fair value adjustment (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Fair value adjustment of biological assets recognized under other operating income (expense), net      
Physical changes R$ 609,259 R$ 1,575,017  
Price 822,271 414,814  
Fair value adjustment of biological assets R$ 1,431,530 R$ 1,989,831 R$ 1,199,759
v3.25.1
INVESTMENTS - Investments breakdown (Details) - BRL (R$)
R$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Investments in subsidiaries, joint ventures and associates reported in separate financial statements [abstract]    
Investments in associates and joint ventures R$ 453,371 R$ 355,520
Goodwill 225,486 228,887
Other investments evaluated at fair value through other comprehensive income - Celluforce 1,138,066 23,606
Total investments R$ 1,816,923 R$ 608,013
v3.25.1
INVESTMENTS - Investments in associates and joint ventures (Details)
R$ in Thousands
12 Months Ended
Dec. 31, 2024
BRL (R$)
Dec. 31, 2024
BRL (R$)
€ / shares
Dec. 31, 2023
BRL (R$)
Dec. 31, 2023
BRL (R$)
€ / shares
Dec. 31, 2022
BRL (R$)
Dec. 31, 2021
BRL (R$)
INVESTMENTS            
Equity R$ 32,415,575 R$ 32,415,575 R$ 44,810,300 R$ 44,810,300 R$ 33,166,365 R$ 15,175,130
Income (expenses) of the year (7,044,706)   14,106,381   R$ 23,394,887  
Company participation, in the income (expense) of the year R$ (13,845)   R$ (19,379)      
Percentage of ownership interest in subsidiary 100.00%   100.00%      
Non-current financial assets at fair value through other comprehensive income R$ 1,591,437 1,591,437 R$ 379,126 379,126    
Total for all associates | Foreign            
INVESTMENTS            
Company participation, in equity 125,316 125,316 96,123 96,123    
Company participation, in the income (expense) of the year R$ (26,656)   (32,557)      
Ensyn Corporation | Foreign            
INVESTMENTS            
Participation equity (%), Associate 24.80%          
Company participation, in equity R$ 2 2 387 387    
Company participation, in the income (expense) of the year R$ (6,966)   (12,448)      
Spinnova Plc | Foreign            
INVESTMENTS            
Participation equity (%), Associate 18.77%          
Company participation, in equity R$ 95,254 95,254 95,736 95,736    
Company participation, in the income (expense) of the year R$ (19,690)   (20,109)      
Simplifyber, Inc | Foreign            
INVESTMENTS            
Participation equity (%), Associate 13.91%          
Company participation, in equity R$ 30,060 30,060        
Total for all joint ventures            
INVESTMENTS            
Company participation, in equity 328,055 328,055 259,397 259,397    
Company participation, in the income (expense) of the year R$ 12,811   13,178      
Biomas | Domestic (Brazil)            
INVESTMENTS            
Participation equity (%), Joint venture 16.66%          
Company participation, in equity R$ 2,923 2,923 2,797 2,797    
Company participation, in the income (expense) of the year R$ (4,874)   (2,203)      
Ibema Companhia Brasileira de Papel | Domestic (Brazil)            
INVESTMENTS            
Participation equity (%), Joint venture 49.90%          
Company participation, in equity R$ 193,901 193,901 156,703 156,703    
Company participation, in the income (expense) of the year R$ 37,199   35,161      
F&E Technologies LLC | Foreign            
INVESTMENTS            
Participation equity (%), Joint venture 50.00%          
Company participation, in equity R$ 6,378 6,378 4,987 4,987    
Company participation, in the income (expense) of the year        
Woodspin Oy | Foreign            
INVESTMENTS            
Participation equity (%), Joint venture 50.00%          
Company participation, in equity R$ 124,853 124,853 94,910 94,910    
Company participation, in the income (expense) of the year R$ (19,514)   (19,780)      
Bem Agro Integração e Desenvolvimento S.A            
INVESTMENTS            
Percentage of ownership interest in subsidiary 5.82%          
Bem Agro Integração e Desenvolvimento S.A | Domestic (Brazil)            
INVESTMENTS            
Non-current financial assets at fair value through other comprehensive income R$ 4,026 4,026        
Celluforce Inc.            
INVESTMENTS            
Percentage of ownership interest in subsidiary 8.28%          
Celluforce Inc. | Foreign            
INVESTMENTS            
Non-current financial assets at fair value through other comprehensive income R$ 27,823 27,823 23,606 23,606    
Nfinite Nanotechnology Inc. (Indirect)            
INVESTMENTS            
Percentage of ownership interest in subsidiary 5.00%          
Nfinite Nanotechnology Inc. (Indirect) | Foreign            
INVESTMENTS            
Non-current financial assets at fair value through other comprehensive income R$ 6,347 6,347        
Lenzing Aktiengesellschft            
INVESTMENTS            
Percentage of ownership interest in subsidiary 15.00%          
Lenzing Aktiengesellschft | Foreign            
INVESTMENTS            
Non-current financial assets at fair value through other comprehensive income R$ 1,099,870 1,099,870        
Total other investments evaluated at fair value            
INVESTMENTS            
Company participation, in the income (expense) of the year        
Non-current financial assets at fair value through other comprehensive income 1,138,066 1,138,066 R$ 23,606 R$ 23,606    
Ensyn Corporation            
INVESTMENTS            
Equity 6 6        
Income (expenses) of the year (17,776)          
Spinnova Plc            
INVESTMENTS            
Equity 507,482 R$ 507,482        
Income (expenses) of the year (56,117)          
NASDAQ, nordic growth market, average share price | € / shares   R$ 0.95   R$ 2.40    
Biomas | Domestic (Brazil)            
INVESTMENTS            
Equity 17,536 R$ 17,536        
Income (expenses) of the year (30,151)          
Ibema Companhia Brasileira de Papel | Domestic (Brazil)            
INVESTMENTS            
Equity 388,580 388,580        
Income (expenses) of the year 74,547          
F&E Technologies LLC | Foreign            
INVESTMENTS            
Equity 12,756 12,756        
Income (expenses) of the year          
Woodspin Oy | Foreign            
INVESTMENTS            
Equity 249,706 R$ 249,706        
Income (expenses) of the year R$ (38,665)          
v3.25.1
PROPERTY, PLANT AND EQUIPMENT - Summary (Details) - BRL (R$)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Jul. 31, 2024
Property, Plant and Equipment        
Beginning balance R$ 59,289,069,000 R$ 50,656,634,000    
Additions 7,936,068,000 11,281,141,000    
Additions of merged companies 1,702,768,000 589,165,000    
Write-offs (146,002,000) (251,392,000)    
Depreciation, property, plant and equipment (3,803,941,000) (3,029,130,000)    
Transfer and other 8,078,000 42,651,000    
Ending balance R$ 64,986,040,000 59,289,069,000 R$ 50,656,634,000  
Timber XX SPE S.A.        
Property, Plant and Equipment        
Percentage of shares purchase transaction 100.00%     100.00%
Timber VII SPE S.A.        
Property, Plant and Equipment        
Percentage of shares purchase transaction 100.00%     100.00%
Cerrado Project        
Property, Plant and Equipment        
Additions Propert yPlant And Equipment Cerrado Project R$ 1,254,521,000 393,042    
Land        
Property, Plant and Equipment        
Beginning balance 14,859,189,000 14,486,408,000    
Additions 697,000 54,027,000    
Additions of merged companies 1,699,588,000 4,572,000    
Write-offs (10,724,000) (25,090,000)    
Depreciation, property, plant and equipment    
Transfer and other 226,598,000 339,272,000    
Ending balance 16,775,348,000 14,859,189,000 R$ 14,486,408,000  
Buildings        
Property, Plant and Equipment        
Average rate %     3.34%  
Property, Plant and Equipment        
Beginning balance 5,906,494,000 5,764,977,000    
Additions 558,000 15,000    
Additions of merged companies 775,000 111,495,000    
Write-offs (7,455,000) (36,184,000)    
Depreciation, property, plant and equipment (366,398,000) (313,304,000)    
Transfer and other 3,988,619,000 379,495,000    
Ending balance 9,522,593,000 5,906,494,000 R$ 5,764,977,000  
Machinery, equipment and facilities        
Property, Plant and Equipment        
Average rate %     6.78%  
Property, Plant and Equipment        
Beginning balance 20,537,952,000 19,618,653,000    
Additions 415,147,000 467,032,000    
Additions of merged companies 413,000 453,617,000    
Write-offs (118,499,000) (133,249,000)    
Depreciation, property, plant and equipment (3,214,550,000) (2,570,734,000)    
Transfer and other 16,660,035,000 2,702,633,000    
Ending balance 34,280,498,000 20,537,952,000 R$ 19,618,653,000  
Work in progress        
Property, Plant and Equipment        
Beginning balance 17,485,109,000 10,373,151,000    
Additions 7,490,762,000 10,742,118,000    
Additions of merged companies 8,306,000    
Write-offs    
Depreciation, property, plant and equipment    
Transfer and other (21,465,336,000) (3,638,466,000)    
Ending balance 3,510,535,000 17,485,109,000 R$ 10,373,151,000  
Other        
Property, Plant and Equipment        
Average rate %     19.38%  
Property, Plant and Equipment        
Beginning balance 500,325,000 413,445,000    
Additions 28,904,000 17,949,000    
Additions of merged companies 1,992,000 11,175,000    
Write-offs (9,324,000) (56,869,000)    
Depreciation, property, plant and equipment (222,993,000) (145,092,000)    
Transfer and other 598,162,000 259,717,000    
Ending balance 897,066,000 500,325,000 R$ 413,445,000  
Cost        
Property, Plant and Equipment        
Beginning balance 92,324,815,000 80,946,127,000    
Ending balance 98,731,202,000 92,324,815,000 80,946,127,000  
Cost | Land        
Property, Plant and Equipment        
Beginning balance 14,859,189,000 14,486,408,000    
Ending balance 16,775,348,000 14,859,189,000 14,486,408,000  
Cost | Buildings        
Property, Plant and Equipment        
Beginning balance 10,032,317,000 9,644,875,000    
Ending balance 13,816,631,000 10,032,317,000 9,644,875,000  
Cost | Machinery, equipment and facilities        
Property, Plant and Equipment        
Beginning balance 48,456,537,000 45,160,365,000    
Ending balance 62,822,096,000 48,456,537,000 45,160,365,000  
Cost | Work in progress        
Property, Plant and Equipment        
Beginning balance 17,485,109,000 10,373,151,000    
Ending balance 3,510,535,000 17,485,109,000 10,373,151,000  
Cost | Other        
Property, Plant and Equipment        
Beginning balance 1,491,663,000 1,281,328,000    
Ending balance 1,806,592,000 1,491,663,000 1,281,328,000  
Depreciation        
Property, Plant and Equipment        
Beginning balance (33,035,746,000) (30,289,493,000)    
Ending balance (33,745,162,000) (33,035,746,000) (30,289,493,000)  
Depreciation | Land        
Property, Plant and Equipment        
Beginning balance    
Ending balance  
Depreciation | Buildings        
Property, Plant and Equipment        
Beginning balance (4,125,823,000) (3,879,898,000)    
Ending balance (4,294,038,000) (4,125,823,000) (3,879,898,000)  
Depreciation | Machinery, equipment and facilities        
Property, Plant and Equipment        
Beginning balance (27,918,585,000) (25,541,712,000)    
Ending balance (28,541,598,000) (27,918,585,000) (25,541,712,000)  
Depreciation | Work in progress        
Property, Plant and Equipment        
Beginning balance    
Ending balance  
Depreciation | Other        
Property, Plant and Equipment        
Beginning balance (991,338,000) (867,883,000)    
Ending balance R$ (909,526,000) R$ (991,338,000) R$ (867,883,000)  
v3.25.1
PROPERTY, PLANT AND EQUIPMENT - Other disclosures (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Property, Plant and Equipment    
Property, plant and equipment pledged as collateral R$ 22,693,183 R$ 16,332,447
Property, plant and equipment, interest costs capitalized R$ 959,967 R$ 1,160,364
Average monthly rate of interest capitalization 11.17% 10.98%
Asset retirement obligation R$ 65,327,000 R$ 52,566,000
Land    
Property, Plant and Equipment    
Property, plant and equipment pledged as collateral 24,427 3,198,674
Buildings    
Property, Plant and Equipment    
Property, plant and equipment pledged as collateral 1,755,082 1,947,075
Machinery, equipment and facilities    
Property, Plant and Equipment    
Property, plant and equipment pledged as collateral 20,442,189 10,393,344
Work in progress    
Property, Plant and Equipment    
Property, plant and equipment pledged as collateral 427,998 649,081
Other    
Property, Plant and Equipment    
Property, plant and equipment pledged as collateral R$ 43,487 R$ 144,273
v3.25.1
INTANGIBLE - Goodwill and intangible assets with indefinite useful life (Details) - BRL (R$)
R$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
INTANGIBLE    
Goodwill and intangible assets with indefinite useful life R$ 8,192,339 R$ 8,192,076
Facepa    
INTANGIBLE    
Goodwill and intangible assets with indefinite useful life 119,332 119,332
Fibria    
INTANGIBLE    
Goodwill and intangible assets with indefinite useful life 7,897,051 7,897,051
MMC Brasil    
INTANGIBLE    
Goodwill and intangible assets with indefinite useful life 170,859 170,859
Other    
INTANGIBLE    
Goodwill and intangible assets with indefinite useful life R$ 5,097 R$ 4,834
v3.25.1
INTANGIBLE - Valuation assumptions (Details)
12 Months Ended
Dec. 31, 2024
ha
R$ / shares
INTANGIBLE  
Nominal rate (percentage) 3.60%
Discount rate, based on WACC (as a percent) 8.91%
Average exchange rate | ha 5,400
Discount rate (post-tax) 8.91%
Discount rate (pre-tax) 12.50%
After-tax discount rate applied to cash flow projections of both cash-generating units is higher than management's estimates 1.00%
Top of range  
INTANGIBLE  
Discount rate (post-tax) 9.91%
Bottom of range  
INTANGIBLE  
Discount rate (post-tax) 8.91%
Foreign  
INTANGIBLE  
Net average pulp price 684,900
Domestic (Brazil)  
INTANGIBLE  
Net average pulp price 735,500
v3.25.1
INTANGIBLE - Changes in intangible assets with determined useful life (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Intangible assets with determined useful life    
Beginning balance R$ 6,557,009 R$ 7,173,183
Additions 161,779 104,931
Fair value adjustment MMC Brasil 189,655
Write-offs (2)
Amortization (1,008,824) (990,432)
Transfers and others 79,674
Ending balance 5,709,964 6,557,009
Cost    
Intangible assets with determined useful life    
Beginning balance 12,378,761  
Ending balance 12,540,497 12,378,761
Accumulated depreciation, amortisation and impairment    
Intangible assets with determined useful life    
Beginning balance (5,821,752)  
Ending balance (6,830,533) (5,821,752)
Non-compete agreement    
Intangible assets with determined useful life    
Beginning balance 4,818  
Ending balance R$ 4,508 4,818
Amortisation rate, intangible assets other than goodwill 5.00%  
Ports concession    
Intangible assets with determined useful life    
Beginning balance R$ 537,179  
Ending balance R$ 632,253 537,179
Amortisation rate, intangible assets other than goodwill 3.94%  
Lease agreements    
Intangible assets with determined useful life    
Beginning balance R$ 6,875  
Ending balance 6,875
Amortisation rate, intangible assets other than goodwill 16.90%  
Supplier agreements, 12.90%    
Intangible assets with determined useful life    
Beginning balance R$ 40,739  
Ending balance R$ 25,925 40,739
Amortisation rate, intangible assets other than goodwill 12.66%  
Port service contracts    
Intangible assets with determined useful life    
Beginning balance R$ 549,821  
Ending balance R$ 520,459 549,821
Amortisation rate, intangible assets other than goodwill 4.23%  
Cultivars    
Intangible assets with determined useful life    
Beginning balance R$ 40,784  
Ending balance R$ 20,391 40,784
Amortisation rate, intangible assets other than goodwill 14.28%  
Trademarks and patents    
Intangible assets with determined useful life    
Beginning balance R$ 188,723  
Ending balance R$ 170,306 188,723
Amortisation rate, intangible assets other than goodwill 8.35%  
Customer-related intangible assets    
Intangible assets with determined useful life    
Beginning balance R$ 4,925,879  
Ending balance R$ 4,104,900 4,925,879
Amortisation rate, intangible assets other than goodwill 9.09%  
Supplier agreements, 17.64%    
Intangible assets with determined useful life    
Beginning balance R$ 10,861  
Ending balance R$ 295 10,861
Amortisation rate, intangible assets other than goodwill 17.64%  
Computer software    
Intangible assets with determined useful life    
Beginning balance R$ 141,178  
Ending balance R$ 201,476 141,178
Amortisation rate, intangible assets other than goodwill 20.80%  
Others    
Intangible assets with determined useful life    
Beginning balance R$ 110,152  
Ending balance R$ 29,451 R$ 110,152
Amortisation rate, intangible assets other than goodwill 10.00%  
v3.25.1
TRADE ACCOUNTS PAYABLE (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Trade accounts payable    
Trade accounts payable R$ 6,033,285 R$ 5,572,219
Long-term take or pay contracts 26,239,939 14,606,380
Total trade accounts payable    
Trade accounts payable    
Trade accounts payable 6,033,285 5,572,219
Domestic (Brazil) | Third party    
Trade accounts payable    
Trade accounts payable 4,681,065 3,946,185
Trade accounts payables balances subject to factoring at the exclusive option of certain suppliers 555,063 281,350
Domestic (Brazil) | Third party | Cerrado Project    
Trade accounts payable    
Trade accounts payable 241,497 1,080,028
Domestic (Brazil) | Related party    
Trade accounts payable    
Trade accounts payable 1,457 1,023
Foreign | Third party    
Trade accounts payable    
Trade accounts payable 1,350,763 1,625,011
Foreign | Third party | Cerrado Project    
Trade accounts payable    
Trade accounts payable R$ 107,418 R$ 523,408
v3.25.1
LOANS, FINANCING AND DEBENTURES - Breakdown by type (Details) - BRL (R$)
R$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Current      
Current borrowings R$ 10,501,387 R$ 4,758,247  
Interest on financing 1,541,312 1,232,810  
Non-current funding 8,960,075 3,525,437  
Non-current      
Non-current borrowings 90,934,144 72,414,445  
Non-current funding 90,934,144 72,414,445  
Total      
Total borrowings 101,435,531 77,172,692 R$ 74,574,591
Interest on financing 1,541,312 1,232,810  
Non-current funding 99,894,219 75,939,882  
Foreign      
Current      
Current borrowings before other adjustments 9,607,427 3,603,074  
Non-current      
Non-current borrowings before other adjustments 73,397,488 57,701,599  
Total      
Borrowings, before other adjustments 83,004,915 61,304,673  
Foreign | Bonds      
Non-current      
Non-current borrowings R$ 49,166,804    
Foreign | Bonds | Fixed      
LOANS, FINANCING AND DEBENTURES      
Annual average interest rate 5.00%    
Current      
Current borrowings before other adjustments R$ 3,229,641 841,625  
Non-current      
Non-current borrowings before other adjustments 49,166,804 40,122,749  
Total      
Borrowings, before other adjustments 52,396,445 40,964,374  
Foreign | Panda Bonds - CNH      
Non-current      
Non-current borrowings R$ 1,016,331    
Foreign | Panda Bonds - CNH | Fixed      
LOANS, FINANCING AND DEBENTURES      
Annual average interest rate 2.80%    
Current      
Current borrowings before other adjustments R$ 4,224    
Non-current      
Non-current borrowings before other adjustments 1,016,331    
Total      
Borrowings, before other adjustments 1,020,555    
Foreign | Export credits ("export prepayment")      
Non-current      
Non-current borrowings R$ 16,283,736    
Foreign | Export credits ("export prepayment") | SOFR/Fixed      
LOANS, FINANCING AND DEBENTURES      
Annual average interest rate 5.40%    
Current      
Current borrowings before other adjustments R$ 6,236,806 2,690,891  
Non-current      
Non-current borrowings before other adjustments 16,283,736 14,487,252  
Total      
Borrowings, before other adjustments 22,520,542 17,178,143  
Foreign | Assets Financing      
Non-current      
Non-current borrowings R$ 298,252    
Foreign | Assets Financing | SOFR      
LOANS, FINANCING AND DEBENTURES      
Annual average interest rate 3.70%    
Current      
Current borrowings before other adjustments R$ 137,300 61,924  
Non-current      
Non-current borrowings before other adjustments 298,252 220,199  
Total      
Borrowings, before other adjustments 435,552 282,123  
Foreign | ECA - Export Credit Agency      
Non-current      
Non-current borrowings R$ 769,702    
Foreign | ECA - Export Credit Agency | SOFR      
LOANS, FINANCING AND DEBENTURES      
Annual average interest rate 6.30%    
Current      
Current borrowings before other adjustments R$ 7,297  
Non-current      
Non-current borrowings before other adjustments 769,702  
Total      
Borrowings, before other adjustments 776,999  
Foreign | IFC - International Finance Corporation      
Non-current      
Non-current borrowings R$ 5,858,208    
Foreign | IFC - International Finance Corporation | SOFR      
LOANS, FINANCING AND DEBENTURES      
Annual average interest rate 6.00%    
Current      
Current borrowings before other adjustments R$ (12,051) 731  
Non-current      
Non-current borrowings before other adjustments 5,858,208 2,871,399  
Total      
Borrowings, before other adjustments R$ 5,846,157 2,872,130  
Foreign | Other borrowings | Fixed      
LOANS, FINANCING AND DEBENTURES      
Annual average interest rate 1.00%    
Current      
Current borrowings before other adjustments R$ 4,210 7,903  
Non-current      
Non-current borrowings before other adjustments 4,455  
Total      
Borrowings, before other adjustments 8,665 7,903  
Domestic (Brazil)      
Current      
Current borrowings before other adjustments 893,960 1,155,173  
Non-current      
Non-current borrowings before other adjustments 17,536,656 14,712,846  
Total      
Borrowings, before other adjustments 18,430,616 15,868,019  
Total borrowings R$ 101,435,531 77,172,692  
Domestic (Brazil) | Export credits ("export prepayment") | Fixed      
LOANS, FINANCING AND DEBENTURES      
Annual average interest rate    
Current      
Current borrowings before other adjustments 791,306  
Non-current      
Non-current borrowings before other adjustments  
Total      
Borrowings, before other adjustments 791,306  
Domestic (Brazil) | Assets Financing      
Non-current      
Non-current borrowings R$ 56,956    
Domestic (Brazil) | Assets Financing | CDI      
LOANS, FINANCING AND DEBENTURES      
Annual average interest rate 18.10%    
Current      
Current borrowings before other adjustments R$ 18,427 17,037  
Non-current      
Non-current borrowings before other adjustments 56,956 71,235  
Total      
Borrowings, before other adjustments R$ 75,383 88,272  
Domestic (Brazil) | BNDES –UMBNDES | BNDES –UMBNDES      
LOANS, FINANCING AND DEBENTURES      
Annual average interest rate 7.20%    
Current      
Current borrowings before other adjustments R$ 157    
Non-current      
Non-current borrowings before other adjustments 157,555    
Non-current borrowings 157,555    
Total      
Borrowings, before other adjustments R$ 157,712    
Domestic (Brazil) | BNDES – TJLP | TJLP      
LOANS, FINANCING AND DEBENTURES      
Annual average interest rate 8.60%    
Current      
Current borrowings before other adjustments R$ 100,556 49,348  
Non-current      
Non-current borrowings before other adjustments 101,587 199,988  
Non-current borrowings 101,587    
Total      
Borrowings, before other adjustments R$ 202,143 249,336  
Domestic (Brazil) | BNDES – TLP | TLP      
LOANS, FINANCING AND DEBENTURES      
Annual average interest rate 14.80%    
Current      
Current borrowings before other adjustments R$ 94,903 57,060  
Non-current      
Non-current borrowings before other adjustments 4,607,102 3,123,727  
Non-current borrowings 4,607,102    
Total      
Borrowings, before other adjustments R$ 4,702,005 3,180,787  
Domestic (Brazil) | BNDES | Fixed      
LOANS, FINANCING AND DEBENTURES      
Annual average interest rate    
Current      
Current borrowings before other adjustments 4,020  
Non-current      
Non-current borrowings before other adjustments  
Total      
Borrowings, before other adjustments 4,020  
Domestic (Brazil) | BNDES – SELIC | SELIC      
LOANS, FINANCING AND DEBENTURES      
Annual average interest rate 14.50%    
Current      
Current borrowings before other adjustments R$ 243,223 65,013  
Non-current      
Non-current borrowings before other adjustments 704,825 857,419  
Non-current borrowings 704,825    
Total      
Borrowings, before other adjustments R$ 948,048 922,432  
Domestic (Brazil) | BNDES –TR | BNDES –TR      
LOANS, FINANCING AND DEBENTURES      
Annual average interest rate 2.20%    
Current      
Current borrowings before other adjustments R$ 84    
Non-current      
Non-current borrowings before other adjustments 70,015    
Non-current borrowings 70,015    
Total      
Borrowings, before other adjustments 70,099    
Domestic (Brazil) | NCE ("Export Credit Notes")      
Non-current      
Non-current borrowings R$ 100,000    
Domestic (Brazil) | NCE ("Export Credit Notes") | CDI      
LOANS, FINANCING AND DEBENTURES      
Annual average interest rate 18.50%    
Current      
Current borrowings before other adjustments R$ 3,027 3,114  
Non-current      
Non-current borrowings before other adjustments 100,000 100,000  
Total      
Borrowings, before other adjustments 103,027 103,114  
Domestic (Brazil) | NCR ("Rural producer certificate")      
Non-current      
Non-current borrowings R$ 2,000,000    
Domestic (Brazil) | NCR ("Rural producer certificate") | CDI      
LOANS, FINANCING AND DEBENTURES      
Annual average interest rate 14.80%    
Current      
Current borrowings before other adjustments R$ 312,652 101,739  
Non-current      
Non-current borrowings before other adjustments 2,000,000 1,998,270  
Total      
Borrowings, before other adjustments 2,312,652 2,100,009  
Domestic (Brazil) | Debentures      
Non-current      
Non-current borrowings R$ 9,738,616    
Domestic (Brazil) | Debentures | CDI/IPCA      
LOANS, FINANCING AND DEBENTURES      
Annual average interest rate 15.40%    
Current      
Current borrowings before other adjustments R$ 120,931 66,536  
Non-current      
Non-current borrowings before other adjustments 9,738,616 8,362,207  
Total      
Borrowings, before other adjustments R$ 9,859,547 R$ 8,428,743  
v3.25.1
LOANS, FINANCING AND DEBENTURES - Breakdown by maturity - non-current (Details) - BRL (R$)
R$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures R$ 90,934,144 R$ 72,414,445
2026    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 9,308,382  
2027    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 10,884,087  
2028    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 9,561,626  
2029    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 15,477,992  
2030    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 10,466,814  
2031 onwards    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 35,235,243  
Bonds | Foreign    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 49,166,804  
Bonds | Foreign | 2026    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 3,074,751  
Bonds | Foreign | 2027    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 4,318,390  
Bonds | Foreign | 2028    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 3,083,311  
Bonds | Foreign | 2029    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 10,758,081  
Bonds | Foreign | 2030    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 6,150,231  
Bonds | Foreign | 2031 onwards    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 21,782,040  
Panda Bonds - CNH | Foreign    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 1,016,331  
Panda Bonds - CNH | Foreign | 2026    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 1,211  
Panda Bonds - CNH | Foreign | 2027    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 1,017,542  
Panda Bonds - CNH | Foreign | 2028    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures  
Panda Bonds - CNH | Foreign | 2029    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures  
Panda Bonds - CNH | Foreign | 2030    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures  
Panda Bonds - CNH | Foreign | 2031 onwards    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures  
Export credits ("export prepayment") | Foreign    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 16,283,736  
Export credits ("export prepayment") | Foreign | 2026    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 5,668,270  
Export credits ("export prepayment") | Foreign | 2027    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 4,889,574  
Export credits ("export prepayment") | Foreign | 2028    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 3,832,090  
Export credits ("export prepayment") | Foreign | 2029    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 1,893,802  
Export credits ("export prepayment") | Foreign | 2030    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures  
Export credits ("export prepayment") | Foreign | 2031 onwards    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures  
Assets Financing | Foreign    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 298,252  
Assets Financing | Foreign | 2026    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 110,452  
Assets Financing | Foreign | 2027    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 112,204  
Assets Financing | Foreign | 2028    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 69,012  
Assets Financing | Foreign | 2029    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 6,584  
Assets Financing | Foreign | 2030    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures  
Assets Financing | Foreign | 2031 onwards    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures  
Assets Financing | Domestic (Brazil)    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 56,956  
Assets Financing | Domestic (Brazil) | 2026    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 18,741  
Assets Financing | Domestic (Brazil) | 2027    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 19,114  
Assets Financing | Domestic (Brazil) | 2028    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 19,034  
Assets Financing | Domestic (Brazil) | 2029    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 67  
Assets Financing | Domestic (Brazil) | 2030    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures  
Assets Financing | Domestic (Brazil) | 2031 onwards    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures  
ECA - Export Credit Agency | Foreign    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 769,702  
ECA - Export Credit Agency | Foreign | 2026    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 670  
ECA - Export Credit Agency | Foreign | 2027    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 845  
ECA - Export Credit Agency | Foreign | 2028    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 780  
ECA - Export Credit Agency | Foreign | 2029    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 912  
ECA - Export Credit Agency | Foreign | 2030    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 847  
ECA - Export Credit Agency | Foreign | 2031 onwards    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 773,756  
Export Development Canada (“EDC”) | Foreign    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 4,455  
Export Development Canada (“EDC”) | Foreign | 2026    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures  
Export Development Canada (“EDC”) | Foreign | 2027    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures  
Export Development Canada (“EDC”) | Foreign | 2028    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 1,114  
Export Development Canada (“EDC”) | Foreign | 2029    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 1,114  
Export Development Canada (“EDC”) | Foreign | 2030    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 1,114  
Export Development Canada (“EDC”) | Foreign | 2031 onwards    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 1,113  
IFC - International Finance Corporation | Foreign    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 5,858,208  
IFC - International Finance Corporation | Foreign | 2026    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 6,668  
IFC - International Finance Corporation | Foreign | 2027    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 305,291  
IFC - International Finance Corporation | Foreign | 2028    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 1,587,751  
IFC - International Finance Corporation | Foreign | 2029    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 2,613,047  
IFC - International Finance Corporation | Foreign | 2030    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 1,358,787  
IFC - International Finance Corporation | Foreign | 2031 onwards    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures  
Total in foreign currency | Foreign    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 73,397,488  
Total in foreign currency | Foreign | 2026    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 8,844,924  
Total in foreign currency | Foreign | 2027    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 10,642,156  
Total in foreign currency | Foreign | 2028    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 8,572,498  
Total in foreign currency | Foreign | 2029    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 15,271,716  
Total in foreign currency | Foreign | 2030    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 7,509,285  
Total in foreign currency | Foreign | 2031 onwards    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 22,556,909  
BNDES – TJLP | Domestic (Brazil) | TJLP    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 101,587  
BNDES – TJLP | Domestic (Brazil) | 2026 | TJLP    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 90,078  
BNDES – TJLP | Domestic (Brazil) | 2027 | TJLP    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 3,634  
BNDES – TJLP | Domestic (Brazil) | 2028 | TJLP    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 3,634  
BNDES – TJLP | Domestic (Brazil) | 2029 | TJLP    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 3,634  
BNDES – TJLP | Domestic (Brazil) | 2030 | TJLP    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 607  
BNDES – TJLP | Domestic (Brazil) | 2031 onwards | TJLP    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures  
BNDES – TLP | Domestic (Brazil) | TLP    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 4,607,102  
BNDES – TLP | Domestic (Brazil) | 2026 | TLP    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 98,668  
BNDES – TLP | Domestic (Brazil) | 2027 | TLP    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 158,812  
BNDES – TLP | Domestic (Brazil) | 2028 | TLP    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 155,980  
BNDES – TLP | Domestic (Brazil) | 2029 | TLP    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 141,823  
BNDES – TLP | Domestic (Brazil) | 2030 | TLP    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 366,249  
BNDES – TLP | Domestic (Brazil) | 2031 onwards | TLP    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 3,685,570  
BNDES – SELIC | Domestic (Brazil) | SELIC    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 704,825  
BNDES – SELIC | Domestic (Brazil) | 2026 | SELIC    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 254,966  
BNDES – SELIC | Domestic (Brazil) | 2027 | SELIC    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 33,888  
BNDES – SELIC | Domestic (Brazil) | 2028 | SELIC    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 33,933  
BNDES – SELIC | Domestic (Brazil) | 2029 | SELIC    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 33,979  
BNDES – SELIC | Domestic (Brazil) | 2030 | SELIC    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 34,024  
BNDES – SELIC | Domestic (Brazil) | 2031 onwards | SELIC    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 314,035  
BNDES –TR | Domestic (Brazil) | BNDES –TR    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 70,015  
BNDES –TR | Domestic (Brazil) | 2026 | BNDES –TR    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 4,178  
BNDES –TR | Domestic (Brazil) | 2027 | BNDES –TR    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 4,734  
BNDES –TR | Domestic (Brazil) | 2028 | BNDES –TR    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 4,734  
BNDES –TR | Domestic (Brazil) | 2029 | BNDES –TR    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 4,734  
BNDES –TR | Domestic (Brazil) | 2030 | BNDES –TR    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 4,734  
BNDES –TR | Domestic (Brazil) | 2031 onwards | BNDES –TR    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 46,901  
BNDES –UMBNDES | Domestic (Brazil) | BNDES –UMBNDES    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 157,555  
BNDES –UMBNDES | Domestic (Brazil) | 2026 | BNDES –UMBNDES    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 4,258  
BNDES –UMBNDES | Domestic (Brazil) | 2027 | BNDES –UMBNDES    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 8,516  
BNDES –UMBNDES | Domestic (Brazil) | 2028 | BNDES –UMBNDES    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 8,516  
BNDES –UMBNDES | Domestic (Brazil) | 2029 | BNDES –UMBNDES    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 8,516  
BNDES –UMBNDES | Domestic (Brazil) | 2030 | BNDES –UMBNDES    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 8,516  
BNDES –UMBNDES | Domestic (Brazil) | 2031 onwards | BNDES –UMBNDES    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 119,233  
NCE ("Export Credit Notes") | Domestic (Brazil)    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 100,000  
NCE ("Export Credit Notes") | Domestic (Brazil) | 2026    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures  
NCE ("Export Credit Notes") | Domestic (Brazil) | 2027    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 25,000  
NCE ("Export Credit Notes") | Domestic (Brazil) | 2028    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 25,000  
NCE ("Export Credit Notes") | Domestic (Brazil) | 2029    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 25,000  
NCE ("Export Credit Notes") | Domestic (Brazil) | 2030    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 25,000  
NCE ("Export Credit Notes") | Domestic (Brazil) | 2031 onwards    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures  
NCR ("Rural producer certificate") | Domestic (Brazil)    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 2,000,000  
NCR ("Rural producer certificate") | Domestic (Brazil) | 2026    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures  
NCR ("Rural producer certificate") | Domestic (Brazil) | 2027    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures  
NCR ("Rural producer certificate") | Domestic (Brazil) | 2028    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures  
NCR ("Rural producer certificate") | Domestic (Brazil) | 2029    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures  
NCR ("Rural producer certificate") | Domestic (Brazil) | 2030    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 2,000,000  
NCR ("Rural producer certificate") | Domestic (Brazil) | 2031 onwards    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures  
Debentures | Domestic (Brazil)    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 9,738,616  
Debentures | Domestic (Brazil) | 2026    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 7,431  
Debentures | Domestic (Brazil) | 2027    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 11,767  
Debentures | Domestic (Brazil) | 2028    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 738,297  
Debentures | Domestic (Brazil) | 2029    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 11,477  
Debentures | Domestic (Brazil) | 2030    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 518,399  
Debentures | Domestic (Brazil) | 2031 onwards    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 8,512,595  
Total in local currency | Domestic (Brazil)    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 17,536,656  
Total in local currency | Domestic (Brazil) | 2026    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 463,458  
Total in local currency | Domestic (Brazil) | 2027    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 241,931  
Total in local currency | Domestic (Brazil) | 2028    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 989,128  
Total in local currency | Domestic (Brazil) | 2029    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 206,276  
Total in local currency | Domestic (Brazil) | 2030    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures 2,957,529  
Total in local currency | Domestic (Brazil) | 2031 onwards    
LOANS, FINANCING AND DEBENTURES    
Loans, financing and debentures R$ 12,678,334  
v3.25.1
LOANS, FINANCING AND DEBENTURES - Rollforward in loans, financing and debentures (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Disclosure of detailed information about borrowings [abstract]    
Opening balance R$ 77,172,692 R$ 74,574,591
Fundraising, net issuances 15,692,905 10,944,794
Interest accrued 5,413,707 4,797,094
Monetary and exchange rate variations, net 17,728,324 (4,185,675)
Settlement of principal 9,410,807 4,296,447
Settlement of interest 5,241,389 4,728,998
Amortization of fundraising costs 80,099 67,333
Closing balance R$ 101,435,531 R$ 77,172,692
v3.25.1
LOANS, FINANCING AND DEBENTURES - Fundraising costs (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Bonds    
LOANS, FINANCING AND DEBENTURES    
Cost R$ 434,970  
Amortization 266,520  
Balance to be amortized 168,450 R$ 164,825
CRA and NCE    
LOANS, FINANCING AND DEBENTURES    
Cost 125,222  
Amortization 125,222  
Balance to be amortized 2,696
Export credits ("export prepayment")    
LOANS, FINANCING AND DEBENTURES    
Cost 219,946  
Amortization 156,866  
Balance to be amortized 63,080 52,162
Debentures    
LOANS, FINANCING AND DEBENTURES    
Cost 159,675  
Amortization 34,012  
Balance to be amortized 125,663 102,235
BNDES    
LOANS, FINANCING AND DEBENTURES    
Cost 81,730  
Amortization 55,953  
Balance to be amortized 25,777 9,854
IFC - International Finance Corporation    
LOANS, FINANCING AND DEBENTURES    
Cost 81,726  
Amortization 3,007  
Balance to be amortized 78,719 38,911
Other borrowings    
LOANS, FINANCING AND DEBENTURES    
Cost 20,912  
Amortization 14,113  
Balance to be amortized 6,799 598
Total    
LOANS, FINANCING AND DEBENTURES    
Cost 1,124,181  
Amortization 655,693  
Balance to be amortized R$ 468,488 R$ 371,281
v3.25.1
LOANS, FINANCING AND DEBENTURES - Relevant transactions entered into the year (Details)
¥ in Thousands, $ in Thousands
Apr. 30, 2024
USD ($)
Apr. 30, 2024
BRL (R$)
Feb. 15, 2024
USD ($)
Feb. 15, 2024
BRL (R$)
May 21, 2025
Dec. 26, 2024
BRL (R$)
Dec. 20, 2024
BRL (R$)
Dec. 10, 2024
USD ($)
Dec. 10, 2024
BRL (R$)
Nov. 15, 2024
USD ($)
Nov. 15, 2024
BRL (R$)
Nov. 15, 2024
CNY (¥)
Nov. 08, 2024
BRL (R$)
Oct. 16, 2024
BRL (R$)
Aug. 26, 2024
BRL (R$)
Jun. 27, 2024
BRL (R$)
Jun. 21, 2024
USD ($)
Jun. 21, 2024
BRL (R$)
Jun. 05, 2024
USD ($)
Jun. 05, 2024
BRL (R$)
May 29, 2024
BRL (R$)
May 17, 2024
USD ($)
May 17, 2024
BRL (R$)
Mar. 28, 2024
BRL (R$)
Aug. 25, 2023
SOFR | February 2029                                                  
LOANS, FINANCING AND DEBENTURES                                                  
Floating rate increasing annually until maturity     0.05% 0.05%                                          
BNDES | December 2043                                                  
LOANS, FINANCING AND DEBENTURES                                                  
Principle amount                               R$ 65,000,000                  
BNDES | May 2044                                                  
LOANS, FINANCING AND DEBENTURES                                                  
Principle amount                             R$ 1,110,000                    
BNDES | October 2042                                                  
LOANS, FINANCING AND DEBENTURES                                                  
Principle amount                           R$ 32,000                      
BNDES | December 2037                                                  
LOANS, FINANCING AND DEBENTURES                                                  
Principle amount                         R$ 154,000                        
BNDES | December 2040                                                  
LOANS, FINANCING AND DEBENTURES                                                  
Principle amount             R$ 61,000                                    
BNDES | December 2044                                                  
LOANS, FINANCING AND DEBENTURES                                                  
Principle amount           R$ 208,981                                      
Rural Credit Note | CDI | March 2025                                                  
LOANS, FINANCING AND DEBENTURES                                                  
Borrowings, adjustment to interest rate basis                                               100.00%  
Rural Credit Note | Banco Safra [Member] | March 2025                                                  
LOANS, FINANCING AND DEBENTURES                                                  
Maximum borrowing capacity                                               R$ 200,000,000  
Debentures                                                  
LOANS, FINANCING AND DEBENTURES                                                  
Principle amount                                         R$ 5,900,000        
Debentures | May 2035 and May 2036                                                  
LOANS, FINANCING AND DEBENTURES                                                  
Principle amount                                         900,000        
Debentures | CDI | May 2031 and May 2032                                                  
LOANS, FINANCING AND DEBENTURES                                                  
Principle amount                                         R$ 1,000,000        
Borrowings, adjustment to interest rate basis                                         0.80%        
Borrowing, Term                                         8 years        
Debentures | CDI | May 2033 and May 2034                                                  
LOANS, FINANCING AND DEBENTURES                                                  
Principle amount                                         R$ 4,000,000        
Borrowings, adjustment to interest rate basis                                         1.00%        
Borrowing, Term                                         10 years        
Debentures | IPCA [Member] | May 2035 and May 2036                                                  
LOANS, FINANCING AND DEBENTURES                                                  
Borrowings, adjustment to interest rate basis                                         6.11%        
Borrowing, Term                                         12 years        
Advance of exchange contract (ACC) | May 2024                                                  
LOANS, FINANCING AND DEBENTURES                                                  
Interest rate                                           6.00% 6.00%    
Maximum borrowing capacity                                           $ 100,000 R$ 555,890,000    
Advance of exchange contract (ACC) | June 2024                                                  
LOANS, FINANCING AND DEBENTURES                                                  
Interest rate                                 6.52% 6.52%              
Maximum borrowing capacity                                 $ 35,000 R$ 194,561,000              
Advance of exchange contract (ACC) | May 2025                                                  
LOANS, FINANCING AND DEBENTURES                                                  
Borrowings, adjustment to interest rate basis         6.54%                                 6.46% 6.46%    
Advance of exchange contract (ACC) | BNP Bank | June 2024                                                  
LOANS, FINANCING AND DEBENTURES                                                  
Maximum borrowing capacity                                     $ 15,000 R$ 83,383,000          
Advance of exchange contract (ACC) | BNP Bank | June 2025                                                  
LOANS, FINANCING AND DEBENTURES                                                  
Interest rate                                     6.43% 6.43%          
Funds raised from BNDES | BNDES | BNDES – TLP                                                  
LOANS, FINANCING AND DEBENTURES                                                  
Interest rate                         5.23% 5.27% 5.48% 5.56%                  
Funds raised from BNDES | BNDES | Fixed                                                  
LOANS, FINANCING AND DEBENTURES                                                  
Borrowings, adjustment to interest rate basis           1.65% 2.24%           1.65% 1.75% 1.75% 1.75%                  
Panda Bonds - CNH | Jun 2027                                                  
LOANS, FINANCING AND DEBENTURES                                                  
Interest rate                   2.80% 2.80% 2.80%                          
Maximum borrowing capacity                   $ 166 R$ 960,891 ¥ 1,200,000                          
IFC - International Finance Corporation                                                  
LOANS, FINANCING AND DEBENTURES                                                  
Maximum borrowing capacity               $ 350 R$ 2,118,515                                
IFC - International Finance Corporation | December 2029                                                  
LOANS, FINANCING AND DEBENTURES                                                  
Interest rate               1.60% 1.60%                                
Maximum borrowing capacity               $ 105 R$ 635,554                                
IFC - International Finance Corporation | December 2030                                                  
LOANS, FINANCING AND DEBENTURES                                                  
Interest rate               1.80% 1.80%                                
Maximum borrowing capacity               $ 245 R$ 1,482,961                                
Export Prepayment Agreements ("EPP") | February 2029                                                  
LOANS, FINANCING AND DEBENTURES                                                  
Repayments of borrowings, classified as financing activities     $ 780,000 R$ 3,877,380                                          
Export Prepayment Agreements ("EPP") | SOFR | February 2029                                                  
LOANS, FINANCING AND DEBENTURES                                                  
Borrowings, adjustment to interest rate basis     1.65% 1.65%                                          
Export Development Canada (“EDC”) | April 2031                                                  
LOANS, FINANCING AND DEBENTURES                                                  
Repayments of borrowings, classified as financing activities $ 125,000 R$ 646,475                                              
Export Development Canada (“EDC”) | SOFR | April 2031                                                  
LOANS, FINANCING AND DEBENTURES                                                  
Borrowings, adjustment to interest rate basis                                                 1.74%
v3.25.1
LOANS, FINANCING AND DEBENTURES - Relevant transactions settled in the year (Details) - Several banks (a syndicated operation)
R$ in Thousands, $ in Thousands
Jun. 07, 2024
BRL (R$)
Feb. 15, 2024
USD ($)
Feb. 15, 2024
BRL (R$)
SOFR      
LOANS, FINANCING AND DEBENTURES      
Borrowings, adjustment to interest rate basis   1.41% 1.41%
CDI      
LOANS, FINANCING AND DEBENTURES      
Borrowings, adjustment to interest rate basis   112.50% 112.50%
February 2026 | SOFR      
LOANS, FINANCING AND DEBENTURES      
Principle amount   $ 620,000 R$ 3,209,057
June 2026 | CDI      
LOANS, FINANCING AND DEBENTURES      
Principle amount R$ 4,926,631    
v3.25.1
LEASES - Right of use assets (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Right of use assets    
Beginning balance R$ 5,196,631 R$ 5,109,226
Additions and Updates to Right of Use Assets 744,226 813,909
Depreciation (757,064) (707,707)
Write-offs (3,102) (18,797)
Ending balance 5,180,691 5,196,631
Lands and farms    
Right of use assets    
Beginning balance 3,380,298 3,283,156
Additions and Updates to Right of Use Assets 506,373 496,236
Depreciation (408,000) (386,436)
Write-offs (3,102) (12,658)
Ending balance 3,475,569 3,380,298
Machines and equipment    
Right of use assets    
Beginning balance 184,813 112,553
Additions and Updates to Right of Use Assets 157,542 206,847
Depreciation (167,312) (134,587)
Write-offs  
Ending balance 175,043 184,813
Buildings    
Right of use assets    
Beginning balance 127,432 85,756
Additions and Updates to Right of Use Assets 41,235 101,124
Depreciation (54,275) (59,448)
Write-offs  
Ending balance 114,392 127,432
Ships and boats    
Right of use assets    
Beginning balance 1,498,228 1,623,118
Additions and Updates to Right of Use Assets
Depreciation (124,890) (124,890)
Write-offs  
Ending balance 1,373,338 1,498,228
Vehicles    
Right of use assets    
Beginning balance 5,860 4,643
Additions and Updates to Right of Use Assets 39,076 9,702
Depreciation (2,587) (2,346)
Write-offs (6,139)
Ending balance R$ 42,349 R$ 5,860
v3.25.1
LEASES - Lease liabilities (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Lease Liabilities      
Present value of liabilities R$ 6,972,915 R$ 6,243,782 R$ 6,182,530
Additions 744,226 813,909  
Lease Liabilities, Write-Offs (3,102) (18,797)  
Lease liabilities, Payments (1,325,398) (1,218,399)  
Accrual of financial charges 700,283 664,651  
Exchange rate variation 613,124 (180,112)  
Lease liabilities 872,228 753,399  
Lease liabilities R$ 6,100,687 5,490,383  
Lands and farms      
Lease Liabilities      
Average rate - % p.a. 12.27%    
Maturity period of lease liabilities October/2052    
Present value of liabilities R$ 3,951,880    
Machines and equipment      
Lease Liabilities      
Average rate - % p.a. 11.19%    
Maturity period of lease liabilities April/2035    
Present value of liabilities R$ 273,019    
Buildings      
Lease Liabilities      
Average rate - % p.a. 10.75%    
Maturity period of lease liabilities May/2031    
Present value of liabilities R$ 117,387    
Ships and boats      
Lease Liabilities      
Average rate - % p.a. 11.25%    
Maturity period of lease liabilities February/2039    
Present value of liabilities R$ 2,626,083    
Vehicles      
Lease Liabilities      
Average rate - % p.a. 11.10%    
Maturity period of lease liabilities November/2028    
Present value of liabilities R$ 4,546    
Leased Land | Non-current biological assets      
Lease Liabilities      
Capitalized interest R$ 249,135 R$ 223,055  
v3.25.1
LEASES - Changes in lease liabilities (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Leased Land | Non-current biological assets    
Lease Liabilities    
Capitalized interest R$ 249,135 R$ 223,055
v3.25.1
LEASES - Amounts recognized in the statement of income for the year (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Presentation of leases for lessee [abstract]    
Expenses relating to short-term assets R$ 6,477 R$ 8,005
Expenses relating to low-value assets 4,083 2,611
Total amount recognized R$ 10,560 R$ 10,616
v3.25.1
PROVISION FOR JUDICIAL LIABILITIES - Roll-forward and changes in the provision for probable losses, net of judicial deposits (Details)
12 Months Ended
Dec. 31, 2024
BRL (R$)
item
Dec. 31, 2023
BRL (R$)
item
Probable losses    
PROVISION FOR JUDICIAL LIABILITIES    
Balance provision at the beginning for the period R$ 3,112,877,000 R$ 3,440,154,000
Payments (156,097,000) (41,903,000)
Write-off (129,252,000) (620,907,000)
Additions 239,750,000 270,681,000
Monetary adjustment 37,890,000 64,852,000
Provision balance 3,105,168,000 3,112,877,000
Judicial deposits 178,418,000 252,468,000
Balance provision at the end for the period 2,926,750,000 2,860,409,000
Probable losses | Fibria    
PROVISION FOR JUDICIAL LIABILITIES    
Reversal due to a change in probability, cancellation and/or due to settlement   372,541,000
Civil, environment and real estate    
PROVISION FOR JUDICIAL LIABILITIES    
Possible losses for which no provision was recorded 5,065,714  
Civil, environment and real estate | Probable losses    
PROVISION FOR JUDICIAL LIABILITIES    
Balance provision at the beginning for the period 139,435,000 118,729,000
Payments (6,795,000) (3,014,000)
Write-off (1,951,000) (11,337,000)
Additions 72,605,000 21,335,000
Monetary adjustment 12,259,000 13,722,000
Provision balance 215,553,000 139,435,000
Judicial deposits 20,076,000 15,694,000
Balance provision at the end for the period R$ 195,477,000 R$ 123,741,000
Civil, environment and real estate | Possible losses and remote losses    
PROVISION FOR JUDICIAL LIABILITIES    
Number of lawsuits | item 97 76
Civil, environment and real estate | Possible losses and remote losses | Fibria    
PROVISION FOR JUDICIAL LIABILITIES    
Estimate of possible loss R$ 133,281,000 R$ 140,470
Civil, environment and real estate | Possible losses    
PROVISION FOR JUDICIAL LIABILITIES    
Number of lawsuits | item 201 219
Possible losses for which no provision was recorded   R$ 4,462,964
Contingent liabilities assumed | Probable losses    
PROVISION FOR JUDICIAL LIABILITIES    
Balance provision at the beginning for the period R$ 2,155,545,000 2,645,705,000
Payments
Write-off (27,820,000) (490,160,000)
Additions
Monetary adjustment
Provision balance 2,127,725,000 2,155,545,000
Balance provision at the end for the period 2,127,725,000 2,155,545,000
Tax contingent liability | Possible losses and remote losses | Fibria    
PROVISION FOR JUDICIAL LIABILITIES    
Estimate of possible loss R$ 1,994,444,000 R$ 2,015,075
Tax contingent liability | Possible losses    
PROVISION FOR JUDICIAL LIABILITIES    
Number of lawsuits | item 673 733
Possible losses for which no provision was recorded R$ 9,837,082 R$ 9,775,068
Taxes and social security    
PROVISION FOR JUDICIAL LIABILITIES    
Possible losses for which no provision was recorded 9,837,082,000 9,775,068,000
Taxes and social security | Probable losses    
PROVISION FOR JUDICIAL LIABILITIES    
Balance provision at the beginning for the period 468,839,000 419,915,000
Payments (60,081,000) (1,717,000)
Write-off (9,540,000) (18,035,000)
Additions 4,689,000 37,656,000
Monetary adjustment 4,057,000 31,020,000
Provision balance 407,964,000 468,839,000
Judicial deposits 66,746,000 154,469,000
Balance provision at the end for the period R$ 341,218,000 R$ 314,370,000
Taxes and social security | Possible losses and remote losses    
PROVISION FOR JUDICIAL LIABILITIES    
Number of administrative proceedings and lawsuits | item 58 32
Labor    
PROVISION FOR JUDICIAL LIABILITIES    
Possible losses for which no provision was recorded R$ 171,480,000 R$ 194,883,000
Labor | Probable losses    
PROVISION FOR JUDICIAL LIABILITIES    
Balance provision at the beginning for the period 349,058,000 255,805,000
Payments (89,221,000) (37,172,000)
Write-off (89,941,000) (101,375,000)
Additions 162,456,000 211,690,000
Monetary adjustment 21,574,000 20,110,000
Provision balance 353,926,000 349,058,000
Judicial deposits 91,596,000 82,305,000
Balance provision at the end for the period R$ 262,330,000 R$ 266,753,000
Labor | Possible losses and remote losses    
PROVISION FOR JUDICIAL LIABILITIES    
Number of lawsuits | item 1,178 1,241
Labor | Possible losses    
PROVISION FOR JUDICIAL LIABILITIES    
Number of lawsuits | item 1,135 1,034
Possible losses for which no provision was recorded R$ 171,480 R$ 194,883
v3.25.1
PROVISION FOR JUDICIAL LIABILITIES - Contingencies with possible losses (Details)
1 Months Ended
Mar. 31, 2009
BRL (R$)
Dec. 31, 2024
BRL (R$)
item
Dec. 31, 2023
BRL (R$)
item
Taxes and social security      
PROVISION FOR JUDICIAL LIABILITIES      
Possible losses for which no provision was recorded   R$ 9,837,082,000 R$ 9,775,068,000
Labor      
PROVISION FOR JUDICIAL LIABILITIES      
Possible losses for which no provision was recorded   171,480,000 194,883,000
Labor | Possible losses      
PROVISION FOR JUDICIAL LIABILITIES      
Possible losses for which no provision was recorded   R$ 171,480 R$ 194,883
Number of lawsuits | item   1,135 1,034
Civil and environment      
PROVISION FOR JUDICIAL LIABILITIES      
Possible losses for which no provision was recorded   R$ 5,065,714,000 R$ 4,462,964,000
Total      
PROVISION FOR JUDICIAL LIABILITIES      
Possible losses for which no provision was recorded   15,074,276,000 14,432,915,000
Tax contingent liability | Possible losses      
PROVISION FOR JUDICIAL LIABILITIES      
Possible losses for which no provision was recorded   R$ 9,837,082 R$ 9,775,068
Number of lawsuits | item   673 733
Tax contingent liability | Possible losses | PIS/COFINS - Goods and services - 2009 to 2011      
PROVISION FOR JUDICIAL LIABILITIES      
Possible losses for which no provision was recorded   R$ 201,199 R$ 190,875
Tax contingent liability | Possible losses | Tax assessment - taxation on a universal basis, Year 2015      
PROVISION FOR JUDICIAL LIABILITIES      
Possible losses for which no provision was recorded   4,712 176,917
Tax contingent liability | Possible losses | Tax incentive - Agency for the Development of Northeastern Brazil ("ADENE")      
PROVISION FOR JUDICIAL LIABILITIES      
Possible losses for which no provision was recorded   150,869 143,912
Tax contingent liability | Possible losses | Offsetting - IRRF - period 2000      
PROVISION FOR JUDICIAL LIABILITIES      
Possible losses for which no provision was recorded   125,489 120,871
Tax contingent liability | Possible losses | IRPJ/CSLL partial approval of offset of 1997 tax loss      
PROVISION FOR JUDICIAL LIABILITIES      
Possible losses for which no provision was recorded   122,319 117,130
Tax loss offset approved by tax authorities R$ 83,000    
Difference of tax loss and owned to tax authorities R$ 51,000    
Tax contingent liability | Possible losses | Income tax assessment - IRPJ/CSLL Administrative process requiring the collection of IRPJ and CSLL for the 2015 calendar year [Member]      
PROVISION FOR JUDICIAL LIABILITIES      
Possible losses for which no provision was recorded   112,168 106,477
Tax contingent liability | Possible losses | Income tax assessment - IRPJ/CSLL - Income tax assessment - IRPJ/CSLL - Decision Order that partially approved the compensation carried out by the Company [Member]      
PROVISION FOR JUDICIAL LIABILITIES      
Possible losses for which no provision was recorded     102,496
Tax contingent liability | Possible losses | IRPJ/CSLL partial approval of offset of 2000 tax loss      
PROVISION FOR JUDICIAL LIABILITIES      
Possible losses for which no provision was recorded   101,654  
Tax contingent liability | Possible losses | Income tax assessment - IRPJ/CSLL - Swap of industrial and forestry assets      
PROVISION FOR JUDICIAL LIABILITIES      
Possible losses for which no provision was recorded   1,688,690 1,630,537
Tax contingent liability | Possible losses | Income tax assessment - IRPJ/CSLL: This is an administrative proceeding initiated in October 2023 [Member]      
PROVISION FOR JUDICIAL LIABILITIES      
Possible losses for which no provision was recorded   920,628 845,164
Tax contingent liability | Possible losses | Income tax assessment - IRPJ/CSLL disallowance of depreciation, amortization and depletion expenses - 2010      
PROVISION FOR JUDICIAL LIABILITIES      
Possible losses for which no provision was recorded   875,466 827,186
Tax contingent liability | Possible losses | Tax assessment - Corporate Income Tax and Social Contribution      
PROVISION FOR JUDICIAL LIABILITIES      
Possible losses for which no provision was recorded   R$ 609,548 R$ 563,723
v3.25.1
PROVISION FOR JUDICIAL LIABILITIES - Possible losses, labor (Details)
Dec. 31, 2024
BRL (R$)
item
Dec. 31, 2023
BRL (R$)
item
Labor    
PROVISION FOR JUDICIAL LIABILITIES    
Possible losses for which no provision was recorded | R$ R$ 171,480,000 R$ 194,883,000
Labor | Possible losses    
PROVISION FOR JUDICIAL LIABILITIES    
Number of lawsuits | item 1,135 1,034
Possible losses for which no provision was recorded | R$ R$ 171,480 R$ 194,883
Labor | Possible losses and remote losses    
PROVISION FOR JUDICIAL LIABILITIES    
Number of lawsuits | item 1,178 1,241
Civil, environment and real estate    
PROVISION FOR JUDICIAL LIABILITIES    
Possible losses for which no provision was recorded | R$ R$ 5,065,714  
Civil, environment and real estate | Possible losses    
PROVISION FOR JUDICIAL LIABILITIES    
Number of lawsuits | item 201 219
Possible losses for which no provision was recorded | R$   R$ 4,462,964
Civil, environment and real estate | Possible losses and remote losses    
PROVISION FOR JUDICIAL LIABILITIES    
Number of lawsuits | item 97 76
v3.25.1
PROVISION FOR JUDICIAL LIABILITIES - Possible losses, civil and environmental (Details)
Dec. 31, 2024
BRL (R$)
item
Dec. 31, 2023
BRL (R$)
item
Fibria    
PROVISION FOR JUDICIAL LIABILITIES    
Fair value adjustment of probable contingencies R$ 2,108,635,000 R$ 2,135,869,000
Civil, environment and real estate    
PROVISION FOR JUDICIAL LIABILITIES    
Possible losses for which no provision was recorded R$ 5,065,714  
Possible losses | Civil, environment and real estate    
PROVISION FOR JUDICIAL LIABILITIES    
Number of lawsuits | item 201 219
Possible losses for which no provision was recorded   R$ 4,462,964
v3.25.1
EMPLOYEE BENEFIT PLANS - Summary of Plans (Details) - Suzano Prev - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
EMPLOYEE BENEFIT PLANS    
Maximum aggregate percentage of contribution by employee 12.00%  
Employer contributions R$ 21,719 R$ 18,342
Nominal salary greater than 10 URS    
EMPLOYEE BENEFIT PLANS    
Percentage of contribution by the employee 0.50%  
Nominal salary greater than 10 URS | Bottom of range    
EMPLOYEE BENEFIT PLANS    
Percentage of contribution by the employee 1.00%  
Nominal salary greater than 10 URS | Top of range    
EMPLOYEE BENEFIT PLANS    
Percentage of contribution by the employee 6.00%  
Nominal salary less than 10 URS | Bottom of range    
EMPLOYEE BENEFIT PLANS    
Percentage of contribution by the employee 0.50%  
Percentage of contribution by the Company 0.50%  
Nominal salary less than 10 URS | Top of range    
EMPLOYEE BENEFIT PLANS    
Percentage of contribution by the employee 1.00%  
v3.25.1
EMPLOYEE BENEFIT PLANS - Roll-forward of actuarial liability (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Roll-forward of actuarial liability    
Opening balance R$ 833,683 R$ 691,424
Interest on actuarial liabilities 73,853 67,272
Current service cost, defined benefit plans 1,997 1,959
Actuarial loss – experience (125) 57,765
Decrease (increase) in net defined benefit liability (asset) resulting from gain (loss) on remeasurement in other comprehensive income 137,649 70,762
Benefits paid (50,199) (55,499)
Closing balance R$ 721,560 R$ 833,683
v3.25.1
EMPLOYEE BENEFIT PLANS - Economic actuarial assumptions and biometric data (Details) - Pension defined benefit plans
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
EMPLOYEE BENEFIT PLANS    
Retirement Age 65 years 65 years
Family composition 4 4
Percentage of retirees who are married 90.00% 90.00%
Percentage of Permanency in the Plan 100.00% 100.00%
Discount rate    
EMPLOYEE BENEFIT PLANS    
Nominal discount rate – medical assistance and life insurance 11.16% 9.14%
Medical cost growth rate    
EMPLOYEE BENEFIT PLANS    
Medical cost growth rate 6.86% 6.86%
Nominal inflation    
EMPLOYEE BENEFIT PLANS    
Nominal inflation 3.50% 3.50%
Ages: 0 to 24 years    
EMPLOYEE BENEFIT PLANS    
Percentage of Aging Factor 1.50% 1.50%
Ages: 25 to 54 years    
EMPLOYEE BENEFIT PLANS    
Percentage of Aging Factor 2.50% 2.50%
Ages: 55 to 79 years    
EMPLOYEE BENEFIT PLANS    
Percentage of Aging Factor 4.50% 4.50%
Ages: Above 80 years    
EMPLOYEE BENEFIT PLANS    
Percentage of Aging Factor 2.50% 2.50%
Actuarial assumption of mortality rates [member]    
EMPLOYEE BENEFIT PLANS    
Biometric table of general mortality AT-2000 AT-2000
Biometric table of mortality for disabled persons IAPB 57 IAPB 57
Percentage of Turnover 1.00% 1.00%
v3.25.1
EMPLOYEE BENEFIT PLANS - Sensitivity Analysis (Details)
R$ in Thousands
Dec. 31, 2024
BRL (R$)
Discount rate | Sensitivity Analysis, +0.50%  
Sensitivity analysis regarding the relevant assumptions of the plans  
Increase in present value, net R$ 691,494
Medical cost growth rate | Sensitivity Analysis, +1.00%  
Sensitivity analysis regarding the relevant assumptions of the plans  
Increase in present value, net R$ 788,124
v3.25.1
EMPLOYEE BENEFIT PLANS - Forecast amounts and average duration of payments of obligations (Details)
R$ in Thousands
Dec. 31, 2024
BRL (R$)
2025  
EMPLOYEE BENEFIT PLANS  
Estimated future benefit payments R$ 53,601
2026  
EMPLOYEE BENEFIT PLANS  
Estimated future benefit payments 57,267
2027  
EMPLOYEE BENEFIT PLANS  
Estimated future benefit payments 60,995
2028  
EMPLOYEE BENEFIT PLANS  
Estimated future benefit payments 64,862
2029  
EMPLOYEE BENEFIT PLANS  
Estimated future benefit payments 68,645
2029 to 2034  
EMPLOYEE BENEFIT PLANS  
Estimated future benefit payments R$ 397,704
v3.25.1
SHARE-BASED COMPENSATION PLAN - Long term compensation plans ("PS and SAR") (Details)
12 Months Ended
Dec. 31, 2024
BRL (R$)
shares
R$ / shares
shares
Dec. 31, 2023
BRL (R$)
shares
R$ / shares
Dec. 31, 2022
BRL (R$)
SHARE-BASED COMPENSATION PLAN      
Time to calculate the average price of shares based on recent trading sessions 90 days    
Number of shares      
Share-based compensation plans | R$ R$ 361,974,000 R$ 268,489,000  
Phantom Share Units Psus      
Number of shares      
Average exercise price | R$ / shares R$ 42.36 R$ 58.07  
PSO      
Number of shares      
Opening balance 9,728,425    
Granted during of the year 2,981,547    
Cancelled (923,167)    
Exercised (1,690,308)    
Closing balance 10,096,497 9,728,425  
Available For Completion Share Units 458,664    
Restricted Stock, Year One 3,591,140    
Restricted Stock, Year Two 3,049,039    
Restricted Stock, Year Three 2,793,223    
Restricted Stock, Year Four 204,431    
Share-based compensation plans | R$ R$ 361,974,000 R$ 268,489,000 R$ 162,117,000
Increase Provision Share Based Payment | R$ 173,486,000 154,318,000  
Decrease Provision Share Based Payment | R$ (80,001,000) R$ (47,946,000)  
PSO | Grant Year 2019      
Number of shares      
Fair value on the grant date | R$ R$ 42.81    
Opening balance 39,461    
Granted during of the year 903    
Cancelled    
Exercised (40,364)    
Closing balance 39,461  
Available For Completion Share Units    
Restricted Stock, Year One    
Restricted Stock, Year Two    
Restricted Stock, Year Three    
Restricted Stock, Year Four    
PSO | Grant Year 2020      
Number of shares      
Fair value on the grant date | R$ R$ 38.36    
Opening balance 984,160    
Granted during of the year 22,525    
Cancelled (204,963)    
Exercised (768,338)    
Closing balance 33,384 984,160  
Available For Completion Share Units 33,384    
Restricted Stock, Year One    
Restricted Stock, Year Two    
Restricted Stock, Year Three    
Restricted Stock, Year Four    
PSO | Grant Year 2021      
Number of shares      
Fair value on the grant date | R$ R$ 62.15    
Opening balance 1,724,020    
Granted during of the year 39,387    
Cancelled (66,231)    
Exercised (822,696)    
Closing balance 874,480 1,724,020  
Available For Completion Share Units 425,280    
Restricted Stock, Year One 449,200    
Restricted Stock, Year Two    
Restricted Stock, Year Three    
Restricted Stock, Year Four    
PSO | Grant Year 2022      
Number of shares      
Fair value on the grant date | R$ R$ 57.54    
Opening balance 3,686,722    
Granted during of the year 84,207    
Cancelled (286,478)    
Exercised (23,014)    
Closing balance 3,461,437 3,686,722  
Available For Completion Share Units    
Restricted Stock, Year One 3,113,607    
Restricted Stock, Year Two 324,611    
Restricted Stock, Year Three 23,219    
Restricted Stock, Year Four    
PSO | Grant Year 2023      
Number of shares      
Fair value on the grant date | R$ R$ 48.79    
Opening balance 3,294,062    
Granted during of the year 74,647    
Cancelled (283,548)    
Exercised (32,982)    
Closing balance 3,052,179 3,294,062  
Available For Completion Share Units    
Restricted Stock, Year One 28,333    
Restricted Stock, Year Two 2,721,535    
Restricted Stock, Year Three 302,311    
Restricted Stock, Year Four    
PSO | Grant Year 2024      
Number of shares      
Fair value on the grant date | R$ R$ 56.52    
Opening balance    
Granted during of the year 2,759,878    
Cancelled (81,947)    
Exercised (2,914)    
Closing balance 2,675,017  
Available For Completion Share Units    
Restricted Stock, Year One    
Restricted Stock, Year Two 2,893    
Restricted Stock, Year Three 2,467,693    
Restricted Stock, Year Four 204,431    
SAR and PLUS | PSO | Top of range      
SHARE-BASED COMPENSATION PLAN      
Vesting period 5 years    
v3.25.1
SHARE-BASED COMPENSATION PLAN - Restricted shares plan (Details)
12 Months Ended
Dec. 31, 2024
Restricted share units | SAR and PLUS | Top of range  
SHARE-BASED COMPENSATION PLAN  
Vesting period 5 years
v3.25.1
SHARE-BASED COMPENSATION PLAN - Amounts recognized in the financial Statements (Details)
12 Months Ended
Dec. 31, 2024
BRL (R$)
shares
shares
Dec. 31, 2023
BRL (R$)
shares
Dec. 31, 2022
BRL (R$)
SHARE-BASED COMPENSATION PLAN      
Share-based compensation plans | R$ R$ 361,974,000 R$ 268,489,000  
Restricted share units      
SHARE-BASED COMPENSATION PLAN      
Quantity of outstanding options granted 2,980,111 592,749  
Granted during of the year 3,392,475    
Number of other equity instruments exercised or vested in share-based payment arrangement (1,005,113)    
Restricted Stock, Year One 453,265    
Restricted Stock, Year Two 489,074    
Restricted Stock, Year Three 417,772    
Restricted Stock, Year Four 1,620,000    
Share-based compensation plans | R$ R$ 60,226,000 R$ 26,744,000 R$ 18,425,000
Increase Provision Share Based Payment | R$ 81,276,000 8,319,000  
Decrease Provision Share Based Payment | R$ R$ (47,794,000)  
Restricted share units | Grant Year 2021      
SHARE-BASED COMPENSATION PLAN      
Fair value on the grant date | R$   R$ 51.70  
Quantity of outstanding options granted 111,685  
Granted during of the year 2,559    
Number of other equity instruments exercised or vested in share-based payment arrangement (114,244)    
Restricted Stock, Year One    
Restricted Stock, Year Two    
Restricted Stock, Year Three    
Restricted Stock, Year Four    
Restricted share units | Grant Year 2022      
SHARE-BASED COMPENSATION PLAN      
Fair value on the grant date | R$   R$ 53.81  
Quantity of outstanding options granted 115,800 113,161  
Granted during of the year 2,639    
Number of other equity instruments exercised or vested in share-based payment arrangement    
Restricted Stock, Year One 115,800    
Restricted Stock, Year Two    
Restricted Stock, Year Three    
Restricted Stock, Year Four    
Restricted share units | Grant Year 2023      
SHARE-BASED COMPENSATION PLAN      
Fair value on the grant date | R$   R$ 51.45  
Quantity of outstanding options granted 383,568 367,903  
Granted during of the year 15,665    
Number of other equity instruments exercised or vested in share-based payment arrangement    
Restricted Stock, Year One    
Restricted Stock, Year Two 268,534    
Restricted Stock, Year Three 115,034    
Restricted Stock, Year Four    
Restricted share units | Grant Year 2024      
SHARE-BASED COMPENSATION PLAN      
Fair value on the grant date | R$   R$ 55.27  
Quantity of outstanding options granted 2,480,743  
Granted during of the year 3,371,612    
Number of other equity instruments exercised or vested in share-based payment arrangement (890,869)    
Restricted Stock, Year One 337,465    
Restricted Stock, Year Two 220,540    
Restricted Stock, Year Three 302,738    
Restricted Stock, Year Four 1,620,000    
v3.25.1
LIABILITIES FOR ASSETS ACQUISITIONS AND ASSOCIATES (Details) - BRL (R$)
R$ in Thousands
1 Months Ended
Mar. 31, 2018
Dec. 31, 2024
Dec. 31, 2023
LIABILITIES FOR ASSETS ACQUISITIONS AND SUBSIDIARIES      
Liabilities for assets acquisitions and associates   R$ 21,166 R$ 93,405
Liabilities for assets acquisitions and associates   99,324 93,782
Facepa      
LIABILITIES FOR ASSETS ACQUISITIONS AND SUBSIDIARIES      
Business combination   27,182 25,924
Total consideration for assets acquisition R$ 307,876    
Payment amount for asset acquisition R$ 267,876    
VFFIP      
LIABILITIES FOR ASSETS ACQUISITIONS AND SUBSIDIARIES      
Business combination   93,308 161,263
Total Business Combination      
LIABILITIES FOR ASSETS ACQUISITIONS AND SUBSIDIARIES      
Business combination   R$ 120,490 R$ 187,187
v3.25.1
SHAREHOLDERS' EQUITY - Share capital (Details) - BRL (R$)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Aug. 30, 2024
SHAREHOLDERS' EQUITY      
Share capital R$ 19,235,546,000 R$ 9,235,546,000  
Percentage of ownership interest in subsidiary 100.00% 100.00%  
SUZB3 common shares quoted (per share) R$ 61.78 R$ 55.63  
Issued capital, ordinary shares R$ 10,000,000,000    
Suzano Holding      
SHAREHOLDERS' EQUITY      
Percentage of ownership interest in subsidiary 29.08% 27.76%  
Controller      
SHAREHOLDERS' EQUITY      
Percentage of ownership interest in subsidiary 15.51% 14.81%  
Key management personnel of entity or parent      
SHAREHOLDERS' EQUITY      
Percentage of ownership interest in subsidiary 2.59% 2.42%  
Alden Fundo de Investimento em Acoes      
SHAREHOLDERS' EQUITY      
Percentage of ownership interest in subsidiary 2.07% 1.98%  
Controlling Shareholders      
SHAREHOLDERS' EQUITY      
Percentage of ownership interest in subsidiary 49.25% 46.97%  
Other shareholders      
SHAREHOLDERS' EQUITY      
Percentage of ownership interest in subsidiary 48.78% 50.40%  
Ordinary shares | Suzano Holding      
SHAREHOLDERS' EQUITY      
Number of shares outstanding 367,612,329 367,612,329  
Ordinary shares | Controller      
SHAREHOLDERS' EQUITY      
Number of shares outstanding 196,065,636 196,065,636  
Ordinary shares | Key management personnel of entity or parent      
SHAREHOLDERS' EQUITY      
Number of shares outstanding 32,784,440 32,105,783  
Ordinary shares | Alden Fundo de Investimento em Acoes      
SHAREHOLDERS' EQUITY      
Number of shares outstanding 26,154,744 26,154,744  
Ordinary shares | Controlling Shareholders      
SHAREHOLDERS' EQUITY      
Number of shares outstanding 622,617,149 621,938,492  
Ordinary shares | Other shareholders      
SHAREHOLDERS' EQUITY      
Number of shares outstanding 616,624,679 667,413,523  
Share Capital      
SHAREHOLDERS' EQUITY      
Share capital R$ 19,269,281,000   R$ 19,269,281
Share issue related cost R$ 33,735,000    
Share Capital | Ordinary shares      
SHAREHOLDERS' EQUITY      
Number of shares outstanding 1,264,117,615 1,324,117,615  
Treasury shares      
SHAREHOLDERS' EQUITY      
Number of shares outstanding     1,264,117,615
Percentage of ownership interest in subsidiary 1.97% 2.63%  
Treasury shares | Ordinary shares      
SHAREHOLDERS' EQUITY      
Number of shares outstanding 24,875,787 34,765,600  
v3.25.1
SHAREHOLDERS' EQUITY - Dividends and reserve calculations (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 04, 2024
Disclosure of classes of share capital [abstract]      
Minimum annual dividend as a percent of adjusted net income 25.00%    
Minimum annual dividend as a percentage of consolidated operating cash generation 10.00%    
Interest on own capital distributed     R$ 2,500
EBITDA   R$ 19,537,398  
Non-recurring and non-cash items   (1,264,428)  
Adjusted EBITDA   18,272,970  
Reserves for capital expenditures   (6,706,367)  
GCO = adjusted EBTIDA - capex maintenance   11,566,603  
Minimum mandatory dividends of the bylaws   1,156,660  
Amount of interim dividends declared   1,500,000  
Withholding income tax   (190,119)  
Interest on own capital distributed in excess   R$ (153,221)  
v3.25.1
SHAREHOLDERS' EQUITY - Income reserves (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
SHAREHOLDERS' EQUITY    
Operating profit, reserve balance R$ 299,515  
Reserve balance increase (decrease) R$ 14,574 R$ 7,582
Legal Reserve    
SHAREHOLDERS' EQUITY    
Percentage of limited balance of share capital 20.00%  
Reserve balance R$ 1,847,109 1,847,109
Legal Reserve | Top of range    
SHAREHOLDERS' EQUITY    
Percentage of remaining balance of net income 5.00%  
Percentage of limited balance of share capital 20.00%  
Percentage of limited legal reserve plus capital reserve of share capital 30.00%  
Reserve for capital increase    
SHAREHOLDERS' EQUITY    
Percentage of limited balance of share capital 80.00%  
Reserve balance R$ 2,807,632 15,670,952
Reserve for capital increase | Top of range    
SHAREHOLDERS' EQUITY    
Percentage of remaining balance of net income 90.00%  
Percentage of limited balance of share capital 80.00%  
Special statutory reserve    
SHAREHOLDERS' EQUITY    
Percentage of limited balance of share capital 20.00%  
Reserve balance R$ 1,847,109 1,887,576
Special statutory reserve | Top of range    
SHAREHOLDERS' EQUITY    
Percentage of remaining balance of net income 10.00%  
Percentage of limited balance of share capital 20.00%  
Retained earnings, Tax incentives    
SHAREHOLDERS' EQUITY    
Reserve balance R$ 1,319,908 998,237
Investment reserve    
SHAREHOLDERS' EQUITY    
Reserve balance 5,157,140 R$ 14,972,324
Loss absorption R$ (7,315,184)  
v3.25.1
SHAREHOLDERS' EQUITY - Other reserves (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
SHAREHOLDERS' EQUITY      
Beginning balances R$ 44,810,300 R$ 33,166,365 R$ 15,175,130
Gain (loss) on conversion of financial statements and on foreign investments 163,185 4,707 (16,035)
Ending balances 32,415,575 44,810,300 33,166,365
Other reserves      
SHAREHOLDERS' EQUITY      
Beginning balances 1,538,296 1,719,516 2,114,907
Actuarial gain (loss) 90,931 (84,828)  
Gains (losses) on conversion of financial statements and on foreign investments (364,231) (865)  
Gain (loss) on conversion of financial statements and on foreign investments 163,185 5,178  
Partial realization of deemed cost, net of taxes (79,385) (100,705)  
Ending balances 1,348,796 1,538,296 1,719,516
Debenture conversion 5th issue      
SHAREHOLDERS' EQUITY      
Beginning balances (45,746) (45,746)  
Ending balances (45,746) (45,746) (45,746)
Actuarial loss      
SHAREHOLDERS' EQUITY      
Beginning balances (229,627) (144,799)  
Actuarial gain (loss) 90,931 (84,828)  
Ending balances (138,696) (229,627) (144,799)
Reserve of gains and losses on remeasuring available-for-sale financial assets [member]      
SHAREHOLDERS' EQUITY      
Beginning balances 1,298 2,163  
Gains (losses) on conversion of financial statements and on foreign investments (364,231) (865)  
Ending balances (362,933) 1,298 2,163
Reserve of exchange differences on translation      
SHAREHOLDERS' EQUITY      
Beginning balances 8,396 3,218  
Gain (loss) on conversion of financial statements and on foreign investments 163,185 5,178  
Ending balances 171,580 8,396 3,218
Deemed Cost      
SHAREHOLDERS' EQUITY      
Beginning balances 1,803,975 1,904,680  
Partial realization of deemed cost, net of taxes (79,385) (100,705)  
Ending balances R$ 1,724,590 R$ 1,803,975 R$ 1,904,680
v3.25.1
SHAREHOLDERS' EQUITY - Treasury shares - Summary (Details) - BRL (R$)
12 Months Ended
Aug. 09, 2024
Jan. 26, 2024
Dec. 31, 2024
Dec. 31, 2023
Aug. 30, 2024
Dec. 31, 2022
SHAREHOLDERS' EQUITY            
Treasury stock (in shares)     24,875,787,000 34,765,600,000   51,911,569,000
Weighted average price per share     R$ 53.84 R$ 42.69   R$ 40.84
Treasury shares     R$ 1,339,197,000 R$ 1,484,014,000   R$ 2,120,324,000
Market value     R$ 1,536,826,000 R$ 1,934,010,000   R$ 2,504,214,000
Stock canceled during period, shares     (60,000,000,000) (37,145,969,000)    
Number of shares authorized for repurchase     11,115,300,000      
Treasury shares cancelled            
SHAREHOLDERS' EQUITY            
Stock canceled during period, shares 40,000,000 20,000,000        
Share repurchase program authorized         40,000,000  
Period for shares to be held as treasury shares   18 months        
v3.25.1
SHAREHOLDERS' EQUITY - Treasury shares - Changes (Details) - BRL (R$)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Quantity      
Balance, beginning of the year 34,765,600,000 51,911,569,000  
Repurchase 51,115,300,000 20,000,000,000  
Stock Repurchase Program, Number of Shares Authorized to be Exercised (1,005,113,000)    
Stock canceled during period, shares (60,000,000,000) (37,145,969,000)  
Balance, end of the year 24,875,787,000 34,765,600,000 51,911,569,000
Average cost per share      
Balance, beginning of the year R$ 42.69 R$ 40.84  
Repurchase 54.91 44.05  
Share Exercised, Price Paid Per Share 47.55    
Weighted Average Price Per Share of Treasury Shares Canceled During the Period 48.40 40.84  
Balance, end of the year R$ 53.84 R$ 42.69 R$ 40.84
Historical value      
Balance, beginning of the year R$ 1,484,014,000 R$ 2,120,324,000  
Shares repurchased 2,806,764,000 880,914,000 R$ (1,904,424,000)
Total amount of exercised shares (47,794,000)    
Stock Canceled During The Period Value (2,903,787,000) (1,517,224,000)  
Balance, end of the year 1,339,197,000 1,484,014,000 2,120,324,000
Market value      
Balance, beginning of the year 1,934,010,000 2,504,214,000  
Repurchase 2,806,764,000 880,914,000  
Stock Exercised During Period, Market Value (54,213,000)    
Stock Canceled During Period, Market Value (3,238,200,000) (1,570,532,000)  
Balance, end of the year R$ 1,536,826,000 R$ 1,934,010,000 R$ 2,504,214,000
v3.25.1
SHAREHOLDERS' EQUITY - Distribution of results (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
SHAREHOLDERS' EQUITY    
Distribution of results R$ (7,074,198) R$ 14,084,848
Reserve balances 13,039,124 35,402,942
Realization of deemed cost, net of taxes    
SHAREHOLDERS' EQUITY    
Distribution of results (79,385) (100,705)
Retained earnings, Tax incentives    
SHAREHOLDERS' EQUITY    
Distribution of results 321,671 118,959
Reserve balances R$ 1,319,908 998,237
Legal Reserve    
SHAREHOLDERS' EQUITY    
Limit on share capital % 20.00%  
Distribution of results   443,010
Reserve balances R$ 1,847,109 1,847,109
Reserve for capital increase    
SHAREHOLDERS' EQUITY    
Limit on share capital % 80.00%  
Distribution of results   10,911,226
Reserve balances R$ 2,807,632 15,670,952
Special statutory reserve    
SHAREHOLDERS' EQUITY    
Limit on share capital % 20.00%  
Distribution of results   1,212,358
Reserve balances R$ 1,847,109 1,887,576
Investment reserve    
SHAREHOLDERS' EQUITY    
Distribution of results (7,315,184)  
Reserve balances 5,157,140 14,972,324
Other    
SHAREHOLDERS' EQUITY    
Reserve balances 60,226 26,744
Unclaimed dividend forfeited    
SHAREHOLDERS' EQUITY    
Distribution of results (1,300)  
Interest on own capital    
SHAREHOLDERS' EQUITY    
Distribution of results R$ 1,500,000
v3.25.1
EARNINGS (LOSS) PER SHARE - Basic (Details) - BRL (R$)
R$ / shares in Units, shares in Thousands, R$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Basic earnings per share      
Resulted of the year attributable to controlling shareholders' R$ (7,074,198) R$ 14,084,848 R$ 23,381,617
Weighted average number of shares in the year - in thousands 1,289,637 1,330,020 1,361,264
Weighted average treasury shares - in thousands (24,836) (32,827) (31,043)
Weighted average number of outstanding shares - in thousands 1,264,801 1,297,193 1,330,221
Basic earnings (loss) per common share - R$ R$ (5.59313) R$ 10.85794 R$ 17.57724
v3.25.1
EARNINGS (LOSS) PER SHARE - Diluted (Details) - BRL (R$)
R$ / shares in Units, R$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Diluted earnings per share      
Resulted of the year attributable to controlling shareholders' R$ (7,074,198) R$ 14,084,848 R$ 23,381,617
Weighted average number of shares duing the year (except treasury shares) - in thousands 1,264,801,000 1,297,193,000 1,330,221,000
Average number of potential shares (stock options) - in thousands 2,980,000 487,000 317,000
Weighted average number of shares (diluted) - in thousands 1,264,801,000 1,297,680,000 1,330,538,000
Diluted earnings (loss) per common share - R$ R$ (5.59313) R$ 10.85387 R$ 17.57305
v3.25.1
NET FINANCIAL RESULT (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Financial expenses      
Interest expense on borrowings R$ (4,453,739) R$ (3,636,730) R$ (3,648,330)
Amortization Of Debt Issuance Cost (80,099) (67,353) (69,881)
Financial Expenses, Interest Expense on Lease Liabilities (451,148) (441,596) (433,613)
Amortization of fair value adjustment (18,887)
Other finance cost (556,917) (513,483) (419,659)
Finance Cost, Before Exchange Differences on Translation (5,541,903) (4,659,162) (4,590,370)
Financial income      
Cash and cash equivalents and marketable securities 1,598,111 1,668,408 818,780
Other 139,323 157,241 148,230
Financial income 1,737,434 1,825,649 967,010
Results from derivative financial instruments      
Income 2,669,394 10,149,730 11,969,288
Losses on change in fair value of derivatives (11,782,077) (4,623,016) (5,207,721)
Results from derivative financial instruments (9,112,683) 5,526,714 6,761,567
Monetary and exchange rate variations, net      
Exchange rate variation on loans, financing and debentures (17,728,324) 4,185,675 3,949,020
Leases (613,124) 180,112 186,241
Other assets and liabilities 2,456,455 (1,278,060) (840,668)
Monetary and exchange rate variations, net (15,884,993) 3,087,727 3,294,593
Finance income (cost) (28,802,145) 5,780,928 R$ 6,432,800
Capitalized loan costs 959,968 1,160,364  
Transaction costs for loans and financing 19    
Reclassification to biological assets R$ 249,135 R$ 223,055  
v3.25.1
NET SALES (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Disclosure of disaggregation of revenue from contracts with customers [abstract]      
Gross sales R$ 57,017,142 R$ 47,601,020 R$ 59,550,424
Sales deductions      
Returns and cancelations (234,643) (155,950) (91,291)
Discounts and rebates (6,936,630) (5,526,032) (7,459,520)
Total 49,845,869 41,919,038 51,999,613
Taxes on sales (2,442,587) (2,163,463) (2,168,667)
Net sales R$ 47,403,282 R$ 39,755,575 R$ 49,830,946
v3.25.1
SEGMENT INFORMATION - Operating segment results (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
SEGMENT INFORMATION      
Net sales R$ 47,403,282 R$ 39,755,575 R$ 49,830,946
Cost of sales (27,401,527) (25,076,675) (24,821,288)
Adjusted EBITDA 23,849,200 18,272,970 28,194,902
Adjustments to EBITDA 1,065,887 1,264,428 1,435,769
Depreciation and amortisation expense (9,223,995) (7,321,110) (7,407,890)
Financial Result (28,802,145) 5,780,928 6,432,800
Profit (loss) before tax (13,111,053) 17,997,216 28,655,581
Increase (decrease) in fair value measurement, assets 1,431,532 1,989,831 1,199,759
Gains (losses) on disposals of property, plant and equipment (169,284) (232,143) 19,436
Accrual for ICMS credit losses (130,726) (348,628) (58,003)
Adjustment to EBITDA, other (65,635) (144,632) 274,577
Total Net Sales      
SEGMENT INFORMATION      
Net sales 47,403,282 39,755,575 49,830,946
Domestic (Brazil)      
SEGMENT INFORMATION      
Net sales 9,573,844 8,863,292 8,524,638
Foreign      
SEGMENT INFORMATION      
Net sales 37,829,438 30,892,283 41,306,308
Asia      
SEGMENT INFORMATION      
Net sales 15,785,567 13,660,165 18,298,105
Europe      
SEGMENT INFORMATION      
Net sales 12,251,178 9,003,272 13,093,824
North America      
SEGMENT INFORMATION      
Net sales 7,879,965 6,158,439 7,664,359
Central and South America      
SEGMENT INFORMATION      
Net sales 1,849,997 1,995,782 2,233,637
Africa      
SEGMENT INFORMATION      
Net sales 62,730 74,625 16,383
Pulp      
SEGMENT INFORMATION      
Cost of sales (21,261,705) (19,694,674) (19,958,000)
Adjusted EBITDA 20,866,160 15,194,660 25,098,535
Pulp | Total Net Sales      
SEGMENT INFORMATION      
Net sales 37,593,462 30,677,265 41,384,322
Pulp | Domestic (Brazil)      
SEGMENT INFORMATION      
Net sales 2,295,258 2,144,199 2,665,746
Pulp | Foreign      
SEGMENT INFORMATION      
Net sales 35,298,204 28,533,066 38,718,576
Pulp | Asia      
SEGMENT INFORMATION      
Net sales 15,760,800 13,588,032 18,294,046
Pulp | Europe      
SEGMENT INFORMATION      
Net sales 11,895,394 8,701,141 12,768,321
Pulp | North America      
SEGMENT INFORMATION      
Net sales 6,965,731 5,682,010 7,055,625
Pulp | Central and South America      
SEGMENT INFORMATION      
Net sales 670,157 558,601 592,360
Pulp | Africa      
SEGMENT INFORMATION      
Net sales 6,122 3,282 8,224
Paper      
SEGMENT INFORMATION      
Cost of sales (6,139,822) (5,382,001) (4,863,288)
Adjusted EBITDA 2,983,040 3,078,310 3,096,367
Paper | Total Net Sales      
SEGMENT INFORMATION      
Net sales 9,809,820 9,078,310 8,446,624
Paper | Domestic (Brazil)      
SEGMENT INFORMATION      
Net sales 7,278,586 6,719,093 5,858,892
Paper | Foreign      
SEGMENT INFORMATION      
Net sales 2,531,234 2,359,217 2,587,732
Paper | Asia      
SEGMENT INFORMATION      
Net sales 24,767 72,133 4,059
Paper | Europe      
SEGMENT INFORMATION      
Net sales 355,784 302,131 325,503
Paper | North America      
SEGMENT INFORMATION      
Net sales 914,234 476,429 608,734
Paper | Central and South America      
SEGMENT INFORMATION      
Net sales 1,179,840 1,437,181 1,641,277
Paper | Africa      
SEGMENT INFORMATION      
Net sales R$ 56,608 R$ 71,343 R$ 8,159
v3.25.1
SEGMENT INFORMATION - Net sales by product (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
SEGMENT INFORMATION      
Net sales R$ 47,403,282 R$ 39,755,575 R$ 49,830,946
Market pulp      
SEGMENT INFORMATION      
Net sales R$ 37,593,462 R$ 30,677,265 41,384,322
Market pulp | CHINA      
SEGMENT INFORMATION      
Percentage of total net sales 36.92% 41.36%  
Market pulp | UNITED STATES      
SEGMENT INFORMATION      
Percentage of total net sales 16.08% 15.32%  
Fluff pulp      
SEGMENT INFORMATION      
Percentage of total net sales 0.70% 0.80%  
Printing and writing paper      
SEGMENT INFORMATION      
Net sales R$ 8,478,489 R$ 7,567,320 6,912,984
Printing and writing paper | UNITED STATES      
SEGMENT INFORMATION      
Percentage of total net sales 22.50% 19.49%  
Printing and writing paper | ARGENTINA      
SEGMENT INFORMATION      
Percentage of total net sales 10.96% 23.68%  
Tissue      
SEGMENT INFORMATION      
Percentage of total net sales 5.80% 5.10%  
Paperboard      
SEGMENT INFORMATION      
Net sales R$ 1,270,872 R$ 1,417,075 1,421,338
Other      
SEGMENT INFORMATION      
Net sales 60,459 93,915 112,302
Total of products      
SEGMENT INFORMATION      
Net sales R$ 47,403,282 R$ 39,755,575 R$ 49,830,946
v3.25.1
SEGMENT INFORMATION - Goodwill based on expected future profitability (Details) - BRL (R$)
R$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Pulp      
SEGMENT INFORMATION      
Goodwill based on expected future profitability   R$ 7,897,051 R$ 7,897,051
Paper      
SEGMENT INFORMATION      
Goodwill based on expected future profitability R$ 290,191 290,191  
Total      
SEGMENT INFORMATION      
Goodwill based on expected future profitability R$ 8,187,242 R$ 8,187,242  
v3.25.1
RESULTS BY NATURE (Details) - BRL (R$)
R$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cost of sales      
Personnel expenses R$ (1,741,347) R$ (1,450,428) R$ (1,467,896)
Costs of raw materials, materials and services (11,468,545) (10,981,883) (11,463,862)
Logistics cost (5,186,872) (4,341,369) (4,795,161)
Depreciation, depletion and amortization (8,135,016) (6,718,474) (6,406,610)
Other (869,747) (1,584,521) (687,759)
Total cost of sales (27,401,527) (25,076,675) (24,821,288)
Cost of idle capacity and maintenance downtime 587,345 650,592  
Selling expenses      
Personnel expenses (330,178) (281,673) (244,681)
Services (247,585) (173,494) (146,184)
Logistics cost (1,288,670) (1,067,031) (1,065,416)
Depreciation and amortization (955,201) (952,033) (951,626)
Other (116,913) (122,146) (75,287)
Total selling expenses (2,938,547) (2,596,377) (2,483,194)
General and Administrative expenses      
Personnel expenses (1,661,843) (1,172,538) (1,039,733)
Services (503,086) (406,001) (378,986)
Depreciation and amortization (143,600) (118,771) (101,764)
Other (311,315) (225,918) (189,284)
Total General and Administrative expenses (2,619,844) (1,923,228) (1,709,767)
Other operating (expenses) income net      
Rents and leases 2,188 3,971 2,164
Result from sale of other products, net 77,817 79,046 58,880
Result from sale and disposal of property, plant and equipment, intangible and biological assets, net (163,033) (331,285) (509)
Result on fair value adjustment of biological assets 1,431,530 1,989,831 1,199,759
Depletion and amortization 9,822 468,168 52,110
Tax credits - gains in tax lawsuits (exclusion of ICMS from the PIS/COFINS calculation basis)     (1,324)
Provision for judicial liabilities (148,952) (167,563) (156,243)
Tax Credit 52,201 34,204 (33,121)
Provision for legal fees 1,261,573 2,076,372 R$ 1,121,716
Cost of idle capacity and maintenance downtime R$ 587,345 R$ 650,592  
v3.25.1
INSURANCE COVERAGE (Details) - 12 months ended Dec. 31, 2024
R$ in Thousands, $ in Thousands
USD ($)
BRL (R$)
INSURANCE COVERAGE    
Maximum insurance coverage for operational risks $ 1,000,000 R$ 6,192,300
Maximum insurance coverage for civil general liabilities 20,000 123,846
Maximum coverage for domestic transportation insurance policy   60,000
Maximum coverage for international transportation insurance policy $ 75,000 R$ 464,423
v3.25.1
SUBSEQUENT EVENTS (Details) - BRL (R$)
Dec. 31, 2024
Aug. 30, 2024
Dec. 31, 2023
Events subsequent to the reporting date      
Share capital R$ 19,235,546,000   R$ 9,235,546,000
Share Capital      
Events subsequent to the reporting date      
Share capital R$ 19,269,281,000 R$ 19,269,281  
Share Capital | Ordinary shares      
Events subsequent to the reporting date      
Quantity of ordinary shares 1,264,117,615   1,324,117,615